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ABSTRACT
A COMBINED EXPERIMENTAL AND COMPUTATIONAL APPROACH TO STUDY THE
BIOLOGIC EFFECT OF HEMODYNAMICS IN END-TO-SIDE VASCULAR BYPASS GRAFTS
Stephanie Michelle Kute, Ph.D.
University of Pittsburgh, 2002
A diseased artery often becomes blocked, compromising blood flow to downstream tissues and
organs. One common surgical intervention is to bypass this blocked region with a vascular graft.  However,
these grafts can fail due to an overhealing response, known as intimal hyperplasia (IH), which occurs at the
graft/artery junction (i.e., anastomosis).  The goal of this research was to determine if a quantitative
correlation exists between the hemodynamic phenomena at the distal anastomosis of a vascular bypass graft
and carefully selected, acute biological precursors of intimal hyperplasia.
To accomplish this task, we perfused porcine, artery-artery, end-to-side and end-to-end anastomoses
ex vivo and developed computational fluid dynamics (CFD) models incorporating the reconstructed geometry
and perfusion conditions present in each experimental anastomosis.  The perfusion experiments allowed us
to assess the levels of immediate early gene (IEG) proteins and vascular cell apoptosis at various regions
along the anastomoses.  Since the pressure and flow rate in the ex vivo perfusion model were precisely
vknown, the CFD models utilized this information along with the 3D reconstructed anastomotic geometries
to accurately estimate wall shear stress (WSS) and WSS gradient (WSSG) in the same regions of interest.
This process allowed for a distinct and unique coupling between the perfusion experiments and the
computational simulations that has not been achieved previously.  Through linear and nonlinear regression
analyses on this directly-coupled data, we found that low levels of WSS and WSSG cause upregulation of
IEG proteins.  Because increased levels of IEG expression lead to IH formation, our results suggest that low
levels of WSS and WSSG correlate with increased IH formation. 
 Our coupled experimental and computational approach has allowed us to evaluate IEG protein
expression by vascular cells in response to the hemodynamics present in vascular anastomoses.   Based on
the correlations we found between low levels of WSS and WSSG and the subsequent increase in IEG protein
expression, treatments such as graft geometry optimization or targeted gene therapy may improve the clinical
success rate of  vascular bypass grafts.  However, some issues need to be addressed before the results of this
study can be applied clinically.
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1Figure 1.1 Coronary artery bypass grafts (CABG).
On the left, the vessel blockage is bypassed using a
saphenous vein and another blockage on the right is




A diseased artery often becomes blocked, compromising blood flow to downstream tissues and organs.
One common surgical intervention is to bypass this blocked region with a vascular graft.  These blockages
are usually caused by the build-up of atherosclerotic plaque, which can occur anywhere in the arterial tree.
The most frequently bypassed regions occur in the coronary and peripheral arterial networks.  Coronary heart
disease is the leading cause of death in the United States, accounting for more than 40% of all deaths [1].
Over 570,000 coronary artery bypass grafting (CABG) procedures (see Figure 1.1) were performed in 1999
and the total direct and indirect costs of coronary heart disease was estimated to be over $111 billion [1].
Peripheral arterial disease, usually involving the lower extremity, is less prevalent than coronary heart disease
but still affects a large number of patients [2].  Approximately 12% of the adult population in the U.S., 8 to
10 million people, are affected by peripheral arterial disease and need bypass grafts to restore blood flow to
2their extremities in order to avoid amputation [4].  Therefore, vascular bypass grafting is a frequent and
important surgical procedure.
For small arteries such as the coronary or peripheral arteries, autologous vascular segments are normally
the grafts of choice, if a suitable artery or vein can be extracted from the patient.  Arteries, such as the
internal mammary, are the most successful bypass conduits but there is a severely limited supply of available
autologous arteries for grafting procedures [5].  The autologous vessel most frequently used, for both
coronary and peripheral bypass grafts, is the saphenous vein obtained from the leg.  Although this is the gold-
standard, there are a number of problems with using the saphenous vein including a limited length, the
possibility of disease and the detrimental biological changes that occur when a vein is placed into the high
pressure, pulsatile environment of the arterial system [5-8].  Also, the caliber of the patient’s saphenous vein
may not be suitable for the vessel that needs to by bypassed [9].  When the autologous vessels can not be
utilized, prosthetic tubes made from Dacron or Polytetrafluoroethylene (PTFE) may be used as bypass
conduits.  However, these non-biologic grafts are more likely to thrombose (i.e., clot) and do not have the
biomechanical characteristics of the native artery, including arterial compliance and vasoreactivity (i.e., the
ability of the vessel to change diameter in response to a mechanical and chemical stimulus) [2].  Therefore,
there are a number of challenges to be overcome in the field of vascular grafts.
1.2 Anastomosis Construction
1.2.1 Suturing and Vascular Clips
The junction between the graft and the host artery is called the anastomosis. The upstream junction is
known as the proximal anastomosis and the downstream junction is the distal anastomosis.  The anastomosis
can be secured using either surgical suture or vascular clips. The use of surgical suture to connect the
anastomosis involves sewing the vessels together to form an intact conduit.  First, the vessels are brought
close to one another and a needle with suture is passed through the vessel walls [10]. Two to four individual
sutures are placed around the circumference of the anastomosis to initially attach the vessels.  Then the
3anastomosis is completed by one of a number of conventional sewing techniques including interrupted
(separate, individual sutures) or continuous suturing.  These techniques are designed to provide a blood-tight
connection as well as to provide adequate tensile strength without constricting or tearing the vessels [10].
Another technique for creating vascular anastomoses is the VCS™ vascular clip system [11].  It was
originally designed for use in microvascular reconstructions and has shown promising results for creating
all size vascular reconstructions.  These arcuate-legged, titanium clips do not puncture the vessel walls and
therefore have the potential of causing less trauma to the vessels.  Also, anastomoses can be created in
significantly less time than using conventional suturing techniques [12].   A drawing of an end-to-end
anastomosis being created with the VCS™ system is shown in Figure 1.2 [13].  For the VCS™ clip
procedure, the graft and native vessel are approximated and the ends of the vessels are everted so that the
intimal, or inner, surface of the vessels touch.  Special everting forceps, shown in the top of Figure 1.2, are
used to facilitate this process.  One mattress suture is placed at the 12 and 6 o’clock positions in order to
stabilize the vessels and the nonpenetrating clips are squeezed into place using the clip applier seen in the
bottom of the Figure 1.2. There are four sizes of  VCS™ clips (0.9, 1.4, 2.0 and 3.0 mm) and the chosen size
depends on the caliber of the vessels being anastomosed.  An example of a completed anastomosis created
with VCS™ clips is shown in Figure 1.3 [13].
1.2.2 End-to-End and End-to-Side Anastomoses
Two anastomosis configurations  used for vascular reconstruction are end-to-end (ETE) and end-to-side
(ETS).  For the ETE anastomosis, the end of the graft is connected to the end of the native vessel, as seen
in Figures 1.2 and 1.3.  In this case, the blocked region of the native vessel is physically removed and the
graft is sewn in its place.  For the ETS anastomosis, the blockage in the native vessel is bypassed instead of
removed.  The end of the graft is connected to the side of the native vessel, making this is a more technically-
involved procedure. A schematic of a distal ETS anastomosis is shown in Figure 1.4, and depicts the regions
known as the heel, toe and floor. For the ETS anastomosis, a slit is cut in the side of the native vessel in a
region of healthy tissue downstream from the blockage.  The distal section of the graft is then cut at a
4Figure 1.2 Pictorial representation of and end-to-end
anastomosis being created with the  VCS™ system.
Image from [13].
Figure 1.3 Actual end-to-end anastomosis created
with  VCS™ system.  Image from [13].
Figure 1.4 Distal end-to-side anastomosis
depicting the characteristic heel, toe and floor
regions.  Image from [14].
specified angle, depending on the size of the graft, size of the native vessel and the desired angle of graft
insertion (see Figure 1.5 A-E).  For the conventional suturing technique, the first needle puncture typically
occurs near the heel (12 o’clock position) of the anastomosis and the suturing continues around the
circumference of the anastomosis to the toe (6 o’clock position) and meets at the 9 o’clock position as shown
in Figure 1.5 F-H.  For the VCS™ vascular clip technique, the graft and native vessel tissue is everted and
single mattress sutures are placed at the heel and toe of the anastomosis to stabilize the vessels. The clips are
placed from the heel to the toe on one side and then this process is repeated on the other side to complete the
anastomosis.
5Figure 1.5 Construction of the end-to-side anastomosis A-
E) Illustrations of the different techniques of preparing the
graft for insertion F-H) Illustrations of the conventional
suturing procedure.  Image from [15].
1.3 Graft Failure Mechanisms and Costs
Although most bypass grafting procedures are at least initially successful, a large number of bypass
grafts fail.  Angina, or chest pain, occurs in up to 20% of patients undergoing CABG within the first year
after surgery  [16].  Repeat grafting procedures are required for 4% of patients within 5 years of their initial
surgery, 19% of patients within 10 years and 31% of patients within 12 years [16].  According to the
American Heart Association, 216,000 repeat CABG procedures were performed in 1999 at an estimated cost
of $42 billion [1]. Lower extremity peripheral bypass grafts have similar failure rates, up to 20-30% at 5
years post-operation [17].  Because of the high percentage of graft failures and the high cost of subsequent
repeat grafting procedures, it is important to find a way to increase the success rate of vascular bypass grafts.
Advances in the field will require an understanding of  the mechanisms that cause graft failure.  Within
one month of bypass graft surgery, the principal cause of graft failure is thrombosis, which is the formation
of a blood clot that compromises flow in the graft.  For autologous grafts, early thrombosis is associated with
the disruption of the antithrombotic inner lining of the blood vessel, the endothelium.  The endothelium can
be destroyed or damaged during the extraction of the vessel, handling of the tissue and surgical insertion of
6Figure 1.6 Schematic diagram of a blood vessel showing
the intima, media and adventitia.
the graft.  In addition, for veins used in the arterial system, the graft is suddenly exposed to a high pressure
and pulsatile environment that can damage the venous endothelium [7].  For prosthetic grafts, thrombotic
occlusion occurs in response to blood contacting the artificial surface.  Additionally, thrombosis for any graft
can occur for technical reasons including low blood flow through the graft, anastomotic constriction and/or
poor graft placement.  Therefore, a number of factors promote thrombosis and can lead to graft failure [15].
Intimal hyperplasia (IH), or overgrowth of the innermost layer of the graft, is usually responsible for
graft failures occurring one month to one year after surgery.  A blood vessel is composed of three layers;
intima, media and adventitia as seen in Figure 1.6.  The intima is the blood-contacting layer of the vessel and
is lined by a single layer of endothelial cells (EC).  The media is the middle region of the vessel and is
comprised mostly of smooth muscle cells (SMC), which give the vessel its tone.  The adventitia is the
outermost layer and is composed mostly of loose, connective tissue.  In intimal hyperplasia, the SMC
proliferate and migrate from the media to the intima and increase extracellular matrix production [6, 18]. This
causes an increase in intimal thickness that decreases the cross-sectional (luminal) area available for blood
flow.  This blockage of blood flow leads to graft failure [15].
Late graft failure, occurring anytime after the first year post-surgery, is caused by accelerated
atherosclerosis.  This atherosclerotic formation is similar to the disease process that was initially present in
7the native vessel requiring bypass, but this atherosclerotic formation occurs on a much faster timescale.  The
initial disease process may have taken many decades before presenting clinically whereas vascular graft
atherosclerosis can occur within a few years.  Vascular graft atherosclerosis is an extension of the formation
of intimal hyperplasia whereby mononuclear leukocytes accumulate in the hyperplastic intimal layer.  These
leukocytes accumulate lipids and become foam cells that form the fatty streak which is the  first grossly
recognizable stage of atherosclerosis [17].  This fatty streak formation further decreases the cross-sectional
area available for blood flow so that grafts that previously did not have a critical blockage due to intimal
hyperplasia become symptomatic.  The final stage of atherosclerosis is the formation of a plaque.  Unstable
plaques can rupture, initiating the coagulation cascade and causing acute thrombosis of the graft. This may
completely block blood flow and therefore cause graft failure [15].
1.4 Etiology of Intimal Hyperplasia
The failure mechanism that this dissertation has addressed is intimal hyperplasia.   It is generally
accepted that IH is initiated as a “response to injury” of the endothelial cells [19-21].   Because endothelial
cells (EC) are in direct contact with the blood, they are affected by changes in hemodynamics (e.g., shear
stress) and can respond by modulating their expression of a number of vasoreactive substances including
growth factors, vasorelaxation and vasoconstriction molecules, coagulation products and chemotactic agents.
These vasoreactive substances not only affect neighboring EC but also the SMC in the media of the vessel
as well as circulating cells such as leukocytes [19-22].  In this manner, EC are able to initiate a global
reaction to a changing hemodynamic environment.
As stated, IH is characterized by the proliferation and migration of SMC and by the accumulation of
extracellular matrix within the intima. This  intimal thickening is not solely dependent on the proliferation
of SMC; it is a net result of the balance between proliferation and regulated cell death (apoptosis).  That is,
IH occurs when the normal balance between cell proliferation and apoptosis is altered [23].  An increase in
SMC proliferation and migration, by definition, favors IH formation.  The role of apoptosis, however, is less
8clear.  Increased apoptosis results in voids in the tissue structure that can promote SMC proliferation and
migration as well as ECM production.  Conversely, decreased apoptosis inherently results in a larger quantity
of cells in the tissue since they are not being removed via this regulated process of cell death.  Therefore, it
may simply be an alteration in the normal apoptosis process, as well as the proliferation rate, that leads to
IH formation.
The proliferation and apoptosis cycles are not independent processes; a single stimulus can regulate
both processes [24-26].  In particular, certain immediate early genes (IEG) are involved in the signaling
pathways for both regulatory mechanisms [25, 27-29].  When IEG are expressed due to extracellular
stimulation, their protein products translocate to the nucleus.  These proteins form transcription factors that
are responsible for regulating the expression of a number of different genes.  Which genes they upregulate
and downregulate, to what degree and during what timespan, eventually cause the cell to either become
proliferative or apoptotic.  Because IEG are involved in both proliferation and apoptosis and the overall
balance of these processes leads to IH, IEG are pivotal in the failure of vascular bypass grafts.
The individual processes of cell proliferation and apoptosis as well as the specific roles of certain IEG
in these processes are further described in the subsections below.
1.4.1 Cell Proliferation
Cell proliferation is the process of reproduction in which offspring cells with similar phenotypes are
produced via mitosis.  This is a highly regulated process and only occurs when cells need to be replaced to
maintain homeostasis.  However, this regulatory mechanism can become dysfunctional causing an excessive
amount of proliferation and subsequent disease formation such as intimal hyperplasia [30]. 
There are a number of external stimuli that can cause a cell to proliferate including biochemical agents
(i.e. growth factors), microbiological factors (i.e. viruses) and biomechanical forces (i.e. shear stress).  These
external stimuli must be transduced to the nucleus of the cell in order to initiate proliferation.  This is
accomplished through a complex cell signaling process.  An external stimulus is sensed by receptors on the
cell surface that have intracellular kinase domains and this initiates a cascade of kinase phosphorylations.
9The activated end products of these cascades in turn activate genes whose protein products translocate to the
nucleus.  Once in the nucleus, these proteins either act independently or dimerize to form transcription
factors.  These transcription factors then regulate the expression of late-response genes such as growth
factors and adhesion molecules that modulate proliferation.  This signaling cascade allows the cell to respond
quickly to external stimuli and is an evolutionary mechanism that allows the cell to adapt to its environment
in order to survive [30].
Vascular cell  proliferation is an integral part of the formation of IH in vascular bypass grafts.  Galea
et al. measured SMC proliferation in human saphenous veins used for coronary artery bypass [31].  Pressure
distended veins and non-distended control vessels were kept in organ culture for 24 hours to determine cell
proliferation via tritiated thymidine.  There was a significant decrease in thymidine incorporation in the
distended vein versus the non-distended control.  However, there was no difference in proliferation rates
when assessed with immunohistochemical staining for proliferating cell nuclear antigen (PCNA) [31].
Hayakawa et al. determined the SMC proliferation in radial arteries of patients undergoing repeat AV shunt
surgery for hemodialysis [32].  They determined SMC proliferation using immunohistochemical staining for
PCNA and found a positive correlation between SMC proliferation and the percent stenosis of the vessel
[32].  Kockx et al. obtained significantly (70% or greater) occluded human aortocoronary grafts from patients
undergoing repeat coronary bypass operation [33].  They found that a significant fraction of the cells in the
neointima were positive for PCNA and Ki-67, another immunohistochemical marker of proliferation.
Similarly, Wang et al. studied occluded human aortocoronary grafts and found an increase in PCNA positive
cells in the thickened but non-atherosclerotic regions of the intima and media [34].  
These studies demonstrate that the proliferation of vascular cells is altered when human vessels are used
as vascular bypass grafts.
1.4.2 Apoptosis
Apoptosis is the natural counterpart to cell proliferation.  It is regulated cell death, distinct from
necrosis, and occurs naturally to maintain tissue homeostasis while necrosis (i.e. accidental cell death) results
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when the cell is unable to maintain homeostasis.  Apoptosis affects a single cell at a time and is initiated from
inside the cell as opposed to necrosis, which usually involves entire areas of tissue at a time and is caused
by external disruption of the cellular membranes.  Apoptosis is characterized morphologically by cell
membrane shrinkage, condensation of nuclear chromatin, DNA segmentation, cellular fragmentation into
apoptotic bodies and phagocytosis by neighboring cells [35].  In general, this process of cell death does not
elicit an inflammatory response [24].
Analogous to cell proliferation, the process of apoptosis involves complex signaling pathways to
translate an extracellular stimulus to intracellular death mechanisms.  In fact, many of the same signaling
pathways that lead to proliferation can alternatively result in apoptosis [36].  Therefore, it is likely that an
interaction between a large number of pathway substrates and the timing of the production of these molecular
products determines if a cell will ultimately respond in a proliferative or apoptotic manner [37, 38].
Apoptosis has been implicated in the formation of IH in vascular bypass grafts.  Galea et al. measured
SMC apoptosis in pressure distended human saphenous veins and non-distended control vessels kept in organ
culture for 24 hours [31].    There was a significant increase in the number of apoptotic cells in the distended
vein versus the non-distended control.  Hayakawa et al. determined the SMC apoptosis in radial arteries of
patients undergoing repeat AV shunt surgery for hemodialysis [32].  They found a positive correlation
between SMC apoptosis (in the intima and media) and the percent stenosis of the vessel.  In the same study
of occluded human, aortocoronary grafts by Kockx et al. mentioned in the previous section, a large fraction
of apoptotic SMC were found in the thickened intima along with the proliferating cells [33].  Similarly, in
the study of occluded bypass grafts by Wang et al. mentioned in the previous section, the numbers of
apoptotic cells in the non-atherosclerotic but thickened regions of the intima and media correlated with the
number of proliferating cells.  
These studies demonstrate that increased SMC apoptosis occurs in human vessels used for vascular
bypass grafts.  This apoptosis leads to an imbalance in the usual SMC proliferation/apoptosis relationship
and potentially causes long-term IH formation.
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Figure 1.7 The cell signaling pathways involved in the mechanotransduction of shear stress on an
endothelial cell that ultimately leads to changes in gene expression.  Diagram adapted from [27,28].
1.4.3 Role of Immediate Early Genes
Immediate early genes such as c-fos, c-jun and early growth response factor-1 (egr-1) are linked to both
increased proliferation and apoptosis of surrounding cells, although they affect these processes to varying
degrees [39].  These IEG are also expressed in endothelial cells (EC) in response to biochemical or
biomechanical stimuli [40-45].  Certain IEG have been shown to be differentially expressed in human
arteriovenous fistulas [32] and human saphenous veins that have been manipulated for use as bypass grafts
[31, 46, 47].  Therefore, expression of certain IEG may upset the normal balance between cell proliferation
and apoptosis and could play a vital role in IH formation in vascular bypass grafts.
IEG play key roles in the mechanotransduction processes responsible for proliferation and apoptosis
as illustrated in Figure 1.7 and explained in detail in other publications [27, 28, 48-50].  For example, when
EC are exposed to shear stress, the tyrosine kinases in the focal adhesion sites relay the signal to downstream
Ras proteins.  These proteins further activate multiple kinase phosphorylations pathways including extra-
cellular signal-regulated kinase (ERK) and Jun N-terminal kinase (JNK) pathways.  Activated ERKs
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phosphorylate factors that activate the c-fos gene, leading to synthesis of the c-fos protein.  Similarly,
activated JNKs phosphorylate factors that activate the c-jun gene, leading to synthesis of the c-jun protein.
Other products of the ERK and JNK pathways induce expression of the egr-1 gene and lead to the synthesis
of the egr-1 protein.  The c-fos and c-jun proteins then translocate from the cytoplasm to the nucleus and
form the transcription factor, activator protein-1 (AP-1) which can either be a c-jun/c-jun or a c-fos/c-jun
dimer complex.  AP-1 then binds with the tissue 12-O-tetradecanoylphorbol 13-acetate (TPA)- responsive
element (TRE) of the promoter for genes including tissue  factor (TF) and monocyte chemotactic protein
(MCP-1) and mediate their  expression [27, 49, 50].  Similarly, egr-1 protein translocates to the nucleus and
alters the transcription of several genes implicated in proliferation and apoptosis including TF, platelet
derived growth  factor (PDGF), fibroblast growth factor (FGF), apolipoprotein A1, intracellular adhesion
molecule-1 (ICAM-1), tumor necrosis factor-alpha (TNF-α) and p53 [28].  Therefore, IEG expression,
protein production and translocation are key elements of the signal transduction system and result in the
regulation of genes implicated in cardiovascular disease.
A number of IEG (e.g., c-fos, c-myc, egr-1) have been shown to increase SMC proliferation [51].
Sylvester et al. demonstrated that rat vascular SMC proliferation is associated with the expression of c-fos
[52].  In both in vitro and in vivo models, the expression of c-fos occurred before the onset of proliferation
and remained elevated during the proliferative response.  Cirillo et al. exposed rabbit SMC in culture to
activated platelets and leukocytes [40].  These cells released products that resulted in increased c-fos
expression and subsequently enhanced SMC proliferation.  They found a correlation between the intensity
of c-fos expression and the degree of SMC proliferation.  Further evidence using antisense oligonucleotides
(ASO) to IEG demonstrate that these genes are involved in the process of SMC proliferation and migration
[53]. ASO are single-stranded DNA molecules synthesized with a base pair sequence complementary to the
mRNA sequence of the target gene.  They bind to the native RNA and thereby inhibit translation of the target
gene (i.e. IEG) [45].  Ebbecke et al. [54] and Shi et al. [55] exposed cultured human SMC (from the
ascending aorta and saphenous vein) to ASO targeted to c-myc (an IEG) and found that the SMC
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proliferation rate was strongly inhibited in a concentration–dependent manner.  Similarly, Biro et al. [56],
Bennett et al. [57] and Edelman et al. [58] exposed cultured rat SMC to c-myc ASO and found a decrease
in both SMC proliferation and migration that was dependent on the concentration of the ASO.  Sachinidis
et al. performed a similar experiment except they used an ASO directed to egr-1 and found that the
oligonucleotide inhibited proliferation of aortic SMC [59].  These studies demonstrate that IEG expression
is linked to increased SMC proliferation and migration and these cellular processes are suppressed when the
genes are blocked.
Similarly, a number of IEG (e.g., c-fos, c-jun, c-myc) have been implicated in vascular cell apoptosis
[31, 60-64].  Li et al. exposed rat vascular SMC to hydrogen peroxide and found that this chemical increased
c-fos gene expression and subsequently resulted in SMC apoptosis [60].   Preston et al. have demonstrated
that c-fos protein induces apoptosis in hamster embryo cells [61] and Smeyne et al., using a transgenic mouse
model, provided evidence that the continuous expression of c-fos was associated with subsequent apoptosis
[62].  Bossy-Wetzel et al. demonstrated that c-jun induces apoptosis in fibroblasts and they determined that
this process is separate from c-jun induction of proliferation [63].  Evan et al. determined that deregulated
c-myc expression leads to fibroblast apoptosis [64]. Galea et al. subjected human saphenous veins to a
pressure distention of 350-400 mmHg for 2 minutes in order to simulate the surgical trauma that occurs when
preparing these veins as coronary artery bypass grafts [31].  They found a peak in c-fos expression 1 hour
after removal from the venous circulation in non-distended veins, which was elevated in distended veins.
They determined that the expression of c-fos correlated with the level of vascular cell apoptosis, not the level
of proliferation.  These studies demonstrate that IEG expression is linked to vascular cell apoptosis.
From these and other studies, it is apparent that IEG upregulation can lead to an increase in both
vascular cell proliferation and apoptosis [31].  Table 1.1 summarizes the research relating IEG expression
with proliferation and apoptosis discussed in this section.  Although it is still unclear how the interaction
between these two processes leads to IH formation, both are intricately involved in the disease process and
the expression of IEG are an important unifying component [24]. 
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IEG Proliferation Apoptosis
c-fos [[40,52] [[31, 60-62]
c-jun [[63] [[63]
c-myc [[54-58] [[64]
egr-1 [ [59] N/A
Table 1.1 Summary table of research determining the
effect of increased IEG expression on cell
proliferation and apoptosis.
1.5 Previous Research on the Role of Hemodynamics in Intimal Hyperplasia
The hemodynamic environment present in the vascular system appears to be a crucial element in the
formation of IH.  In native arteries, IH tends to form at curves, branches and bifurcations (i.e. coronary artery
branch and the carotid bifurcation) where uniform flow is diverted or split [65, 66].  In canine vascular
reconstructions, IH occurs preferentially in the ETS anastomotic configuration as opposed to the ETE
configuration where the flow is essentially unchanged from the original situation [67].  Clinically, IH is more
prevalent at the distal anastomosis of an ETS graft, where the flow is more disturbed, than at the proximal
anastomosis, where the flow is more uniform [68, 69].  Since IH is one of the primary causes of bypass graft
failure, accounting for 20-50% of bypass graft occlusion [18, 70, 71], it is important to determine which
features of the hemodynamic environment cause this pathological condition and how the process is triggered.
To accomplish this goal, previous researchers have characterized the hemodynamic environment present
at the distal anastomosis of ETS vascular bypass grafts as well as the cellular response associated with IH.
The studies focusing on the distal anastomosis hemodynamics have included in vivo human or animal
models, physical flow models or computational simulations.  The studies focusing on the cellular response
to hemodynamics (i.e. vascular cell proliferation, apoptosis and IEG expression) have included cell culture
studies, animal or human in vivo models.  These studies are summarized in the subsections below.
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Figure 1.8 Figure from [73] showing the decrease in mean WSS (MWSSp) and
corresponding increase in intima-media thickness (IMT) of the common femoral
artery relative to the superficial artery.  No correlation was found between IMT and
peak systolic WSS (PWSSp) or the maximum cyclic change in WSS (DWSSp).
1.5.1 Human Studies
A number of human tissue or clinical studies have demonstrated that hemodynamics affect IH
formation.  Porter et al. filleted open human saphenous veins and exposed the luminal surface to venous and
arterial wall shear stress (WSS) for 14 days using an ex vivo perfusion system [72]. They found that the veins
exposed to venous levels of WSS (~1 dynes/cm2) developed significantly thicker neointimas than veins
exposed to arterial levels of WSS (~9 dynes/cm2) and the veins cultured in static conditions developed
significantly thicker neointimas than those exposed to venous or arterial conditions.  Kornet et al. measured
the mean WSS in the common femoral and superficial femoral arteries in 54 presumed healthy patients using
noninvasive ultrasound [73].  They found a significantly lower WSS in the common femoral artery compared
to the superficial artery (see Figure 1.8).  This significantly decreased WSS correlated with significantly
increased intima-media thicknesses present on the common femoral artery (see Figure 1.8).  Hofstra et al.
studied the relationship between flow velocity and IH formation at the distal ETS anastomosis in
arteriovenous fistulas of 24 patients receiving hemodialysis [74]. They found that grafts with extensive IH
at the distal anastomosis had high initial flow rates suggesting that high WSS (~3 times higher than
physiological levels) leads to IH formation.  Taylor et al. have developed an improved prosthetic bypass graft
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configuration that incorporates a vein patch at the distal ETS anastomosis [75, 76].  The Taylor patch design
has significantly increased prosthetic bypass graft patency rates one and five years after placement and they
attribute this improvement to the modified hemodynamic environment at the anastomosis. 
 These studies demonstrate that the hemodynamic environment, particularly non-physiologic (low or
high) levels of WSS, influences the formation of IH in human tissue.
1.5.2 Animal Studies  
A number of animal studies have demonstrated a correlation between the hemodynamics and IH
formation in ETS bypass grafts.  Dobrin et al. compared the mechanical and histologic changes in ETE
verses ETS femoral vein bypass grafts of the femoral artery in dogs [67].  They found that IH occurs
preferentially in the ETS grafts, where the flow is dramatically altered from normal physiologic conditions,
as opposed to ETE configurations.  LoGerfo et al. placed Dacron femoro-femoral grafts in dogs and
compared the amount of IH occurring at the proximal and distal anastomoses [68].  They found a significant
increase in IH at the distal anastomosis of an ETS graft where the flow is more disturbed than at the proximal
anastomosis where the flow is more uniform. Sottiurai et al. and Bassiouny et al.have also used dog models
of ilio-femoral ETS bypass grafts [77, 78].  They found that IH forms exclusively at the heel and toe (recall
Figure 1.4) of the distal ETS anastomosis and on the floor of the native artery.  These areas include flow
separation and stagnation zones characterized by low WSS. [77, 78].  Similarly, Keynton et al. found
increased incidence of IH in the toe and floor regions of PTFE grafts implanted in dogs [79].  They also
observed that over 75% of the IH occurred at or below a mean wall shear rate of 100 s-1 while approximately
92% occurred at or below a mean WSS equal to one half that of the native artery.   Rittgers et al. placed
iliofemoral vein grafts with various proximal anastomotic angles to provide a wide range of flow conditions
in the dog grafts [80]. They used hot-film velocity measurements to determine the velocity profiles and WSS
in the grafts.  They found an inverse correlation between the WSS and the degree of intimal proliferation.
Similarly, Mattsson et al. found that baboon prosthetic ETS grafts exposed to elevated WSS (by creating a
downstream AV fistula) exhibited significantly less IH proliferation than grafts exposed to normal WSS [81].
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These animal studies provide additional evidence that the formation of IH is affected by the flow and
WSS present at the distal anastomosis of ETS bypass grafts.  In particular, IH formation in animal models
occurs in regions of flow separation, flow stagnation and low WSS.
1.5.3 Physical Flow Models  
Several researchers have focused on visualizing the hemodynamic phenomena at the distal anastomosis
of a vascular bypass graft.  Typically, transparent, rigid models made either from idealized representations
of the anastomosis (intersecting tubes) or based on casts made from animal models have been studied using
flow visualization to determine the flow patterns.  Bassiouny et al. accompanied their in vivo study with a
scaled-up, transparent, Sylgard model of the ETS anastomosis [78]. They determined from flow visualization
that a stagnation zone existed along the floor of the artery and separation regions and secondary flows existed
at the heel and toe of the graft. They concluded that low WSS corresponds to regions of intimal thickening
in the animal model.  Similarly, Loth et al. created a scaled-up, Sylgard model from a canine ilio-femoral
graft cast [82]. They used laser Doppler anemometry to determine the flow field and resulting WSS at the
anastomosis during steady flow.  They found a region of low WSS on the floor of the native artery that
extended up the sidewalls to the hood and conclude that this large region of low WSS would induce IH
formation.  Ojha et al. used the photochromic tracer technique to visualize flow in an idealized Plexiglas
model of an ETS anastomosis [83].  They found regions of low WSS at the heel and toe along with sharp
temporal and spatial variations of WSS gradient (WSSG) along the floor of the artery, including a stagnation
zone.  They determined that these regions correlated with areas of IH formation demonstrated by others.
Zarins et al. [66] and Ku et al. [84] studied the flow in a carotid artery bifurcation that has disturbed flow
similar to an ETS graft.  They used laser Doppler velocimetry and found a quantitative correlation between
the areas of intimal thickening in human cadavers and areas of low or oscillating WSS found in the Plexiglas
model.  
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These physical models give detailed information about the hemodynamics present in ETS bypass grafts
and demonstrate that regions of flow separation, secondary flow, low and oscillating WSS and WSSG
correlate with areas of IH formation.
1.5.4 Computational Simulations 
A number of research groups have utilized computational fluid dynamics (CFD) to understand the
precise local hemodynamics at the distal anastomosis of an ETS vascular graft.  Steinman et al. developed
a two dimensional CFD model, which demonstrated elevated WSS at the toe and heel (recall Figure 1.4) of
the anastomosis and along the floor of the host artery [85].  Additionally, they noted highly variable WSS
over the cardiac cycle and elevated WSSG.  Hofer et al. developed a CFD model of an ETS anastomosis with
distensible vessel walls [86].  Their results demonstrate large secondary motion, flow separation and
recirculation along the artery floor and along the inner wall downstream from the toe.  They concluded that
regions of low WSS correlated with areas of IH formation.  Similarly, Henry et al. developed a three
dimensional CFD model and demonstrated that regions of the ETS anastomosis corresponding to IH
formation had low WSS but were also sites of increased spatial WSSG [87].  Fei et al. used a three
dimensional CFD model to study the effect of graft angle on the flow in an ETS anastomosis [88].  They
concluded that grafts should be placed with a minimal angle (<20 degrees) so as to decrease the amount of
flow separation and WSS extremes experienced by the artery walls.  Ethier et al. developed a three
dimensional CFD model to study the effect of various flow waveforms on the hemodynamics at the distal
ETS anastomosis [89].  The spatial distribution of normalized, average WSS was different depending on the
imposed flow waveform as shown in Figure 1.9.  They found larger regions of temporal and spatial WSSG
for the femoral waveform than for the coronary waveform and suggest that this may lead to more IH
formation.  Lei and Kleinstreuer et al. used a three dimensional CFD model to optimize the anastomosis
geometry in order to eliminate severe WSSG [90, 91]. They hypothesize that the increased success of Taylor
patch anastomoses, which have a more gradual transition from the straight graft segment to the native artery,
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Figure 1.9 Figure from [89] showing the different
patterns of WSS depending on the imposed flow
waveform.
versus standard anastomoses is due to the decrease in temporal and spatial WSSG in the Taylor patch
geometry.
Other researchers have reconstructed three dimensional geometries from in vivo data of different
regions of the vascular system and incorporated this information into a CFD model. Chandran et al. used
intravascular ultrasound to obtain the cross-sectional images needed to reconstruct a segment of the
abdominal aorta in a dog [92].  They determined the WSS distribution at peak systole in normal caliber
vessels and in artificially stenosed vessels (25 and 40% lumen area reduction).  Krams et al. used a
combination of intravascular ultrasound and angiography to reconstruct human coronary arteries [93].  They
applied steady flow through the reconstructions and found an inverse correlation between wall thickness and
WSS using this minimally invasive technique.  Perktold et al. obtained a human heart at autopsy and created
a cast of the bifurcation of the left anterior descending coronary artery [94].  This cast was both digitized and
reconstructed into a CFD model (shown in Figure 1.10) and a transparent model was made for flow
visualization and verification of the CFD results.  They determined the flow field and WSS distribution for
pulsatile flow through the bifurcation and concluded that low and oscillating WSS occurs in the same regions
as atherosclerotic lesions.  Xu et al. used a non-invasive, magnetic resonance angiographic and velocity
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Figure 1.10 Figure from [94] showing the CFD model of
the reconstructed left anterior descending coronary artery
bifurcation.
imaging technique to reconstruct a human aortic bifurcation and developed a CFD model [95].  They found
that the geometry, velocity profiles and resulting WSS patterns were highly non-planar.  Another research
group has used magnetic resonance to reconstruct complex vascular geometries and develop CFD models
of the carotid artery bifurcation and ETS anastomosis [96-101].  They have demonstrated that it is feasible
to reconstruct these complex geometries in a patient-specific manner using non-invasive magnetic resonance
techniques and emphasized the importance of applying the appropriate amount of surface smoothing to the
reconstructed geometry in order to accurately determine the hemodynamics.  Specifically, in the ETS
anastomosis studies, they found that simplified models, with a lot of smoothing, captured the qualitative
aspects of the hemodynamic environment that can be correlated to general disease states.  However, more
complex models with less smoothing are necessary for correlating quantitative hemodynamic and
pathophysiologic data, as long as the geometry itself is not so rough that it induces error [99].  Therefore
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Hemodynamic Parameter Intimal Hyperplasia
flow separation, stagnation [[77, 78, 83, 102]
low WSS [[ 72, 73, 77-83, 86, 87, 93, 94, 102]
high WSS [[74]
oscillatory WSS [[66, 84, 89, 94]
spatial WSSG [[66, 93, 85, 87, 89-91, 102]
temporal WSSG [[84, 94]
Table 1.2 Summary table of research determining the effect of hemodynamics on
IH formation.
there is an optimal degree of smoothing which must be applied to three dimensional reconstructions of
complex vascular geometries in order to accurately recreate the quantitative hemodynamic environment.
These CFD studies demonstrate that the hemodynamic environment at the distal ETS anastomosis is
complex and the hemodynamic variables (i.e. WSS, WSSG) can be calculated quantitatively and correlated
with regional data of IH formation. Additionally, three dimensional in vivo geometries can be reconstructed
using minimally or non-invasive techniques (i.e. intravascular ultrasound and magnetic resonance) and
developed into a CFD model to elucidate patient-specific patterns of WSS and WSSG that may lead to IH
formation.
From these and other studies, it is apparent that hemodynamic parameters affect the formation of IH.
Table 1.2 summarizes the research relating hemodynamics and IH discussed in this section.
1.6 Previous Research on the Hemodynamic Response of Vascular Cells Leading to IH
The previous research presented above demonstrates that the altered hemodynamic environment
influences the formation of IH.  However, this research does not explain how and why the vessel wall
responds in this fashion.  A separate line of research has focused on determining the mechanism by which
vascular cells sense the hemodynamic environment and then initiate a hyperplastic response.  Studies on
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vascular cell proliferation, apoptosis and IEG expression in response to hemodynamic stimuli have been
conducted, and are summarized in this section.
1.6.1 Vascular Cell Proliferation in Response to Hemodynamic Stimuli
SMC proliferation is one of the key processes in IH formation.  It leads to the increase of intimal mass
and eventual occlusion of the affected vessel.  Since there is evidence of a correlation between
hemodynamics and IH formation, researchers have studied the specific effect of hemodynamic parameters
on SMC proliferation using cell culture models, animal models and human tissue.  These are discussed
separately below.  
1.6.1.1 Cell Culture Studies
Cell culture studies have demonstrated that SMC proliferation is affected by the application of WSS
and WSSG.  Nackman et al. used an in vitro co-culture model to determine SMC proliferation in response
to EC stimulation by WSS [103].  They cultured bovine aortic EC (BAEC) and SMC (BASMC) on opposite
sides of a semi-permeable membrane that allowed for cell-to-cell contact and then exposed the EC side of
the membrane to laminar WSS of 0, 1 or 10 dynes/cm2 for 24 hours.  They found a dramatic decrease in SMC
proliferation for membranes exposed to 1 and 10 dynes/cm2 compared to the static controls.  Sterpetti et al.
performed a number of studies using cultured BASMC on fibronectin-coated polystyrene cylinders and
exposed them to WSS values of 0, 3, 6, and 9 dynes/cm2 for 24 hours [104-106].  In all studies, they found
a significant reduction in SMC proliferation that was proportional to the level of WSS applied. Ueba et al.
exposed cultured human vascular SMC to WSS of 14 or 28 dynes/cm2 for 24 hours using a cone-and-plate
viscometer [107].  They also found a significant decrease in SMC proliferation that was dependent on the
magnitude of applied WSS (see Figure 1.11).  DePaola et al. exposed BAEC to a disturbed flow environment
for 48 hours using a modified cone-and-plate flow chamber [108].  EC proliferation decreased in the region
with high WSSG while high cell densities were observed downstream of the disturbance indicating EC
migration away from the region of high WSSG.  
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Figure 1.11 Figure from [107] showing the decrease in the number of SMC for
cultures exposed to no flow (C), WSS of 14 dynes/cm2 (SS(1.4)) and WSS of 18
dynes/cm2 (SS(2.8)) for 24 hours.  B denotes the cell count before the initiation of
the experiment.
These studies demonstrate that SMC in culture have increased proliferation when they are exposed to
decreased WSS and have increased proliferation when exposed to increased WSSG.  This data is consistent
with the IH data presented in section 1.5 and Table 1.2 that demonstrated an increase in IH formation in
regions exposed to low WSS and high WSSG.
1.6.1.2 Animal Studies
Animal models of vascular bypass grafts have demonstrated that the amount of blood flow and hence
WSS applied to the graft affects SMC proliferation.  Zwolak et al. used a rabbit model to determine the time
course of SMC proliferation in jugular vein grafts placed in the carotid artery circulation [109].  They found
a dramatic increase in SMC proliferation in vein grafts compared to vein and artery controls that peaked 1
week after surgery.  SMC proliferation decreased from this maximal value by 4 weeks and returned to
baseline 12 weeks post-op [109].  Kraiss, Geary and colleagues determined the effect of WSS on SMC
proliferation in prosthetic grafts implanted in baboons [110, 111].  In one study, they created 3 ETS bypass
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grafts: one superceliac to the infarenal aorta and two aorto-iliac grafts [110]. The aorta was ligated so that
flow from the proximal aorto-aortic graft would go directly to the two aorto-iliac grafts allowing twice as
much blood flow in the proximal graft (~40 cm/sec) compared to each of the distal aorto-iliac grafts (~17
cm/sec).  They found a significant decrease in SMC proliferation in the high-flow grafts that were exposed
to a WSS of approximately 24 dynes/cm2 compared to the low-flow grafts that were exposed to a WSS of
approximately 11 dynes/cm2.  In another study, they placed bilateral aortoiliac PTFE grafts into baboons with
bilateral femoral AV fistulas [111].  Eight weeks later, they ligated one fistula, which caused high blood flow
in the graft with the corresponding open AV fistula and normal flow in the graft with the ligated fistula.
They found a significant decrease in SMC proliferation in the high flow grafts on days 4 and 7 after the
ligation of one AV fistula.  Additionally, they found a progressive increase in SMC in the neointima of the
normal flow grafts throughout the 28 day study.  Yamamura et al. used a canine “poor run-off” model to
determine the effect of WSS on SMC proliferation [112].  They ligated all tributary arteries distal to the
saphenous artery in one limb and allowed the animal to recover for 4 weeks.  Then they placed the femoral
vein from the “poor run-off” limb in the femoral artery circulation of the same limb and performed the same
grafting procedure on the normal limb.  This provided a WSS of approximately 31 dynes/cm2 in the “poor
run-off” graft and 77 dynes/cm2 in the control graft.  They found a significant increase in SMC proliferation
in the intima of the “poor run-off” graft compared to the control graft indicating that the decrease in WSS
initiated SMC proliferation.  Liu determined the effect of disturbed blood flow on the proliferation of SMC,
assessed immunohistochemically with 5-bromo-2'-deoxyuridine labeling, using a canine ETE vein graft
model [113].  The diameter of the vein graft (jugular vein) was larger than the host artery (aorta) and
therefore caused the formation of eddy blood flow at the anastomosis. In some experiments, he eliminated
this diameter mismatch (and eddy flow) by wrapping the vein with a piece of fixative-treated intestine.  Liu
found a significant increase in SMC proliferation in leading and trailing regions of the grafts with eddy flow
(nonengineered) compared to the same regions in grafts without eddy flow (engineered) (see Figure 1.12 A
and C).  These results suggested that disturbed flow (e.g. increased WSSG) caused the upregulation of SMC
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Figure 1.12 Figure from [113] showing the increase in SMC proliferation (BrdU labeling) in the leading and
trailing regions of nonengineered grafts with disturbed flow as compared to the same regions in engineered
grafts without disturbed flow.  An angiotensin II type I receptor agonist, Losartan, partially blocked the
proliferative response.
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proliferation.  He also examined the effect of the angiotensin II type 1  receptor on SMC proliferation by
using Losartan, an angiotensin II type 1  receptor antagonist and found that this agonist partially blocked the
increase in SMC proliferation in the nonengineered grafts (see Figure 1.12 B).
Taken together, these animal models demonstrate that SMC proliferation is increased in bypass grafts
exposed to low WSS and high WSSG conditions.  This is consistent with the data in section 1.5 and Table
1.2 that demonstrated an inverse correlation between WSS and IH formation and a positive correlation
between WSSG and IH formation.
 1.6.1.3 Human Studies
Alterations of SMC proliferation due to the hemodynamic environment have also been seen in studies
of human vascular tissue.  Because flow conditions can not be altered and regulated safely in vivo for
humans, studies on the hemodynamic effect of vascular grafts have been performed in ex vivo perfusion
systems.  For example, Mavromatis et al. perfused matched pairs of freshly isolated human saphenous vein
under arterial and venous flow conditions for three days [114].  They found an increase in cell proliferation
in the veins exposed to pulsatile, increased pressure and flow conditions.  Porter et al. found similar results
when perfusing human saphenous veins for 14 days [115].  Other researchers have studied cellular
proliferation in human atheromas present at branch points in the vasculature and in coronary arteries.
Yoshida et al. studied the difference between SMC proliferation in regions of branching arteries exposed to
different WSS environments and found an increase in SMC proliferation in the areas of low, turbulent WSS
relative to those exposed to high, laminar WSS [116].  Wentzel et al. used intravascular ultrasound and CFD
techniques to determine the effect of shear stress on neointimal growth in human coronary arteries six months
after stent placement [117].  As shown in Figure 1.13, regions of decreased shear stress resulted in increased
neointimal thickness and they concluded that the degree of neointimal proliferation was inversely
proportional to the shear stress.  
These studies demonstrate that when human vascular tissue is exposed to altered hemodynamic forces,
vascular cell proliferation occurs and is a precursor of IH.
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Figure 1.13 Figure from [117] suggesting a relationship between decreased shear stress
and increased neointimal thickness in human coronary arteries.
1.6.2 Vascular Cell Apoptosis in Response to Hemodynamic Stimuli
Vascular cell apoptosis is involved in the formation of IH. Since there is evidence of a correlation
between hemodynamics and IH formation, researchers have studied the specific effect of hemodynamic
parameters on vascular cell apoptosis using cell culture models, animal models and human tissue.  These are
discussed separately below.
1.6.2.1 Cell Culture Studies
There have not been any studies on the effect of hemodynamics on the apoptosis of SMC in culture.
However, there have been a number of studies on cultured EC apoptosis in response to hemodynamics [37,
118-121].  EC apoptosis has been implicated in vascular disease including atherosclerosis and restenosis and
may be associated with IH formation [36, 38, 122, 123].  Kaiser et al. cultured human umbilical vein EC
under static or dynamic (0.05-0.1 dynes/cm2) conditions for up to 10 days [118].  On days 1-4, 6 and 10, they
found a significant increase in the number of apoptotic cells in the plates cultured under static conditions and
concluded that the lack of hemodynamic forces is directly responsible for the increased apoptosis.  Hu et al.
exposed BAEC to a laminar WSS of 12 dynes/cm2 in a rectangular flow chamber [37].  They found that the
application of WSS for 12 hours did not cause apoptosis.  Dimmeler et al. performed a number of
experiments in which they subjected apoptotic human umbilical vein EC cultures to laminar WSS of 15
dynes/cm2 using a cone-and-plate flow apparatus [119-121].  Apoptosis was induced in the EC cultures by
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stimulating them with either TNF-", H2O2 or xanthine/xanthine oxidase in order to determine if a
biomechanical stimulus (WSS) could reverse this biochemical induction of apoptosis.  In all cases, they
found a significant decrease in the number of apoptotic cells in the cultures exposed to shear stress for 18
hours compared to the static controls.
These studies demonstrate that cells in static culture are more prone to apoptotic cell death than those
exposed to WSS for hours or days.  Since increased apoptosis occurs in cells exposed to little or no WSS and
low WSS typically increases IH formation, these studies suggest a positive correlation between apoptosis
and IH.
1.6.2.2 Animal Studies
Although animal studies relating particular hemodynamic parameters to the degree of apoptosis have
not been completed, vascular injury models have demonstrated that mechanical forces cause apoptosis in
SMC [26, 124-126]. Malik et al. used a porcine model of coronary angioplasty and determined the degree
of SMC apoptosis and proliferation [26].  In the media, they found a significant increase in apoptotic cells
as early as 1 hour after injury, a peak at 6 and 18 hours and return to baseline by 14 days as shown in Figure
1.14 C.  Interestingly, they did not find an increase SMC proliferation until 3 days post-surgery.  There was
a quantitative difference between the amount apoptosis and proliferation that favored apoptosis at early time-
points (1, 6 and 18 hours) and proliferation at later time-points (3, 7, 14, and 28 days) leading to long-term
IH formation.  Perlman et al. determined SMC apoptosis in both a rat carotid and rabbit external iliac arterial
injury model [124].  In both models, there was a peak in the number of apoptotic cells 30 minutes after injury
that declined sharply by 4 hours and led to a 65% reduction in medial cell density.  Pollman et al. performed
balloon angioplasty on rabbit carotid arteries [125].  They observed apoptotic nuclei in the media as early
as 30 minutes after injury that persisted for 24 hours.  In addition, they performed a second balloon injury
4 weeks after the initial trauma to determine the degree of apoptosis experienced by vessels that have already
been injured and remodeled.  Surprisingly, they found that the intimal cells were more resistant to apoptosis
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Figure 1.14 Figure from [26] showing the temporal variation of proliferation (PCNA) and apoptosis
(TUNEL) in the A) adherent thrombus, B) neointima, C) media, D) adventitia and E) loose connective tissue
of injured porcine arteries.
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after the second injury.  Kamenz et al. determined the degree of apoptosis after balloon angioplasty of
atherosclerotic rabbit carotid arteries [126].  Although there was a peak in the number of apoptotic cells 7
days after injury, the number of proliferating cells was much greater at this and all other time-points leading
to the IH formation. 
 These animal models demonstrate that SMC undergo apoptosis within hours of mechanical stimulation
of whole tissue.  This alters the normal balance between SMC proliferation and apoptosis and correlates with
long-term IH formation.
1.6.2.3 Human Studies
Alterations of SMC apoptosis, related to hemodynamics, have also been seen in human studies of
vascular pathogenesis [118, 127-129].  Wang et al. obtained sections of saphenous vein grafts at repeat
CABG surgeries and found evidence of apoptosis in the hyperplastic intima and adjacent media [127].  Tricot
et al. determined the effect of blood flow on EC apoptosis in human carotid plaques [128].  They found a
7-fold increase in EC apoptosis in the downstream sections of the plaques exposed to low shear stress in
comparison with the upstream regions exposed to high shear stress.  Isner et al. performed histological
studies on hyperplastic lesions in human peripheral and coronary arteries [129].  They found evidence of
apoptosis in over 85% of specimen obtained from regions from repeat procedures compared to less than 45%
of specimen obtained from initial procedures indicating that the hemodynamic alterations caused by the
initial procedures increases vascular cell apoptosis.  Kaiser et al. exposed human umbilical veins to steady
shear stress and found a decrease in apoptosis in the perfused segment versus nonperfused controls [118].
They concluded that physiologic levels of shear stress reduce cell death. 
Taken together, these human studies demonstrate that apoptosis is evident in regions of vascular disease
where the concurrent hemodynamics are altered from the normal, physiologic environment.
1.6.3 Immediate Early Gene Expression in Response to Hemodynamic Stimuli
IEG, such as c-fos, c-jun and egr-1, provide an immediate response to an external signal that results in
a long-term alteration in the expression of other genes [130].  As discussed in section 1.4.3, IEG expression
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occurs in response to a number of different chemical and mechanical stimuli, including shear stress [43-45].
This latter stimulus appears to be regulated by the shear stress responsive element (SSRE), a cis-acting
element originally discovered in the 5’promoter region of platelet-derived growth factor B (PDGF-B) and
found to be responsible for the upregulation of PDGF-B in response to physiological levels of WSS [131].
This same SSRE, consisting of the core sequence of nucleic acids GAGACC, has been found in other genes
regulated by shear stress including PDGF-A, tissue plasminogen activator (tPA), ICAM-1, TGF-β and MCP-
1 [132-137].  The SSRE is also present in IEG including c-fos and c-jun and regulates their expression in the
presence of shear stress [138]. Because IEG expression is a key component of the signal transduction systems
which may initiate IH, a number of cell culture, animal and human studies have been conducted to determine
how these genes/proteins are regulated by hemodynamic stimuli.  These studies are summarized separately
below.
1.6.3.1 Cell Culture Studies
Cell culture studies have demonstrated an upregulation of IEG expression in response to WSS and
WSSG [43-45, 139].  Hsieh et al. placed cultured human umbilical vein EC in a parallel plate apparatus and
applied a steady or pulsatile WSS for 4 hours [43].  A steady WSS of 16 dynes/cm2 resulted in a 24-fold
increase in c-fos expression 30 minutes after the onset of flow.  An average pulsatile WSS of 16 dynes/cm2
caused a 62-fold increase in c-fos expression 30 minutes after the onset of flow. The expression of c-fos
returned to the initial zero value of expression at all subsequent time-points.  In addition, a direct relationship
existed between the magnitude of WSS and the expression of c-fos.  Stationary cultures of human umbilical
vein EC had a detectable level of c-jun expression that doubled or tripled when exposed to either steady or
pulsatile flow for 0.5-4 hours.  Stationary cultures also had a basal expression of c-myc, which increased
slightly to a peak at 2 hours and decreased during the following 2 hours of exposure to either steady or
pulsatile flow.  Ranjan and Diamond exposed human umbilical vein EC cultures to low (4 dynes/cm2) and
arterial levels (25 dynes/cm2) of steady laminar WSS for 1 hour and determined the amount of c-fos protein
present in the nuclei of sheared cells [44].  They found a 5.4-fold increase in intracellular c-fos protein in the
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nuclei of cells exposed to arterial levels of WSS compared to stationary controls.  In contrast, cells exposed
to low levels of WSS demonstrated only a slight increase in intracellular c-fos protein that was not localized
in the nucleus.  Nagel et al. exposed cultured human umbilical vein EC for 30 minutes to well-defined flow
consisting of both uniform and disturbed flow regions [45].  They used a modified cone-and-plate flow
apparatus and quantified the amount of nuclear localized IEG protein using image analysis.  They found a
significant increase in c-fos, c-jun and egr-1 protein in the nuclei of cells exposed to uniform flow (increased
WSS) versus static cultures as shown in Figure 1.15.  They also found a significant further increase in c-fos,
c-jun and egr-1 expression in cells exposed to disturbed flow (WSSG).
Taken together, these studies demonstrate that WSS and WSSG regulate the expression of IEG such
as c-fos, c-jun and egr-1 at time points less than 6 hours after stimulation.  Specifically, there is an increase
in IEG expression in cells exposed to arterial levels of WSS and in cells exposed to WSSG.
1.6.3.2 Animal Studies
In vivo animal studies have also illustrated IEG expression caused by the insertion of bypass grafts and
the implication of these genes in IH formation [46, 140, 141].  Ramirez et al. determined the amount of c-myc
protein present in rat epigastric vein grafts inserted into the femoral artery circulation [46].  They found a
steady increase in c-myc protein that peaked 1 week after surgery.  The high levels of c-myc protein
coincided with increased SMC proliferation.  Suggs et al. used the same rat vein graft model to determine
the time course of c-fos and c-jun expression and the effect of antisense oligonucleotides to these IEG [140].
They found an increase in the amount of c-fos and c-jun protein 15 minutes after graft insertion, which
increased dramatically and peaked at 2 hours. The amount of c-fos protein remained at its peak level until
24 hours after surgery and then decreased until 48 hours.  The amount of c-jun protein decreased from its
peak level but remained elevated up to 48 hours after surgery.  Some grafts were treated with a gel containing
antisense oligonucleotides to c-fos or c-jun and were explanted 2 weeks after surgery.  The antisense
oligonucleotides treated grafts had a 30% decrease in intimal and wall thicknesses that was significant
compared to the untreated control grafts.  Mannion et al. placed saphenous vein incubated ex vivo with c-myc
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Figure 1.15 Figure from [45] showing the expression of IEG proteins in cultured EC exposed to no flow,
uniform flow (arterial WSS) and disturbed flow (WSSG). 
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antisense oligonucleotides as carotid artery interposition grafts in pigs [141].  Three months after surgery,
they found a significant decrease in neointimal and wall thickness in grafts treated with c-myc antisense
oligonucleotides than in untreated controls indicating that the early inhibition of c-myc expression caused
a long-term, beneficial effect on IH formation.  
These animal models demonstrate that IEG expression is increased in vessels inserted as bypass grafts
within minutes after insertion and this increase in IEG expression correlates with SMC proliferation.  There
is a further correlation between the expression of IEG and IH formation since treating vessels with antisense
oligonucleotides inhibited both the IEG expression and IH formation at time points weeks and months after
surgery.
1.6.3.3 Human Studies
Vascular grafting procedures in humans have also been demonstrated to alter the expression of IEG [31,
47, 142].  Moggio et al. studied the expression of c-fos and c-myc in human saphenous veins harvested for
coronary bypass operations [47].  They found a dramatic increase in c-fos expression from 30 minutes to 2
hours after harvest, which decreased by 4 to 6 hours and reinitiated 8 to 10 hours after manipulation.  The
expression of c-myc was elevated 30 minutes after harvest and remained high up to 10 hours later.  Galea
et al. subjected human saphenous veins to a pressure distention of 350-400 mmHg for 2 minutes in order to
simulate the surgical trauma that occurs when preparing these veins as coronary artery bypass grafts [31].
They found a peak in c-fos expression 1 hour after removal from the venous circulation in non-distended
veins, which was even greater for distended veins.   Gan et al. exposed human umbilical veins to different
levels of WSS for 1.5 to 6 hours and determined the gene and protein levels of c-jun and c-fos [142].  The
expression of c-jun was higher in the vessels exposed to high (25 dynes/cm2) WSS compared to those
exposed to low (<4 dynes/cm2) WSS at all time points studied (as shown in Figure 1.16a) and the level of
protein also increased over time.  They also found an increase in c-fos gene expression in the vessels exposed
to high WSS for 6 hours as shown in Figure 1.16c but the protein level remained unchanged.
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Figure 1.16 Figure from [142] showing the increase in c-jun (a) and c-fos (c) gene expression in human veins














static (no flow) N/A [[104-107, 112,
116, 117]
[[128] \[44, 142] \[142]
low WSS N/A \[110, 111] N/A [[43, 139,
142]
[[142]
high WSS [[108] [[113] N/A [[45] N/A
spatial WSSG N/A [[103] [[118-121] \[43-45, 139] N/A
Table 1.3 Summary table of research determining the effect of hemodynamics on vascular cell response
leading to IH.  There is no information available in the literature on the relationship between WSS and
apoptosis.
These studies of human veins demonstrate an increase in IEG expression minutes and hours after
mechanical stimulation, which may explain why these vessels frequently fail due to long-term IH formation.
From the studies reviewed in this section and others, it is apparent that hemodynamic parameters affect
the formation of IH.  Table 1.3 summarizes the research relating hemodynamics and the biologic response
of vascular cells discussed in this section.
1.7 Summary and Limitations of Previous Research
Although there is a significant amount of research on the hemodynamic implications in IH, the results
of these studies are not conclusive.  Most studies have demonstrated a correlation between low WSS and IH
(recall Table 1.2) [72, 73, 77-83, 86, 87, 94, 102], however, others have suggested that high WSS or WSS
outside a prescribed “safe range” initiates IH formation [74, 85].  Still others have demonstrated a correlation
between spatial and/or temporal wall shear stress gradient (WSSG) and IH formation (recall Table 1.2) [66,
84, 85, 87, 89-91, 94].  In addition to these global studies of hemodynamics and IH, a number of in vitro and
in vivo experimental models have demonstrated that both high and low WSS cause a pathophysiologic
response in vascular cells including changes in SMC proliferation, apoptosis and IEG expression (recall
Table 1.3).  For example, a number of cell culture and animal models demonstrate that increased WSS leads
to decreased SMC proliferation [103-107, 110-112, 143].   However, studies of human saphenous vein tissue
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demonstrate that exposing the vein to increased WSS causes an increase in SMC proliferation and IH
formation [114, 115].  Other studies have demonstrated that disturbed flow and increased WSSG causes
increased SMC proliferation [108, 113] while exposing cells and vascular tissue to physiologic WSS
conditions decreases apoptosis [37, 118-121].  Finally, cell culture and human tissue studies have
demonstrated that IEG expression is upregulated in response to WSS [43-45, 139, 142] and disturbed flow
[45] and that genetically blocking the expression of IEG decreased IH formation [140, 141].  
Although a significant amount of research has attempted to isolate the influence of hemodynamics on
IH formation, no study has determined a quantitative correlation between a specific hemodynamic parameter
and a particular cellular response that leads to IH.  In previous studies there has been at least one of three key
limitations that prevented this correlation:
1) no direct coupling between quantitative biologic and hemodynamic measurements
2) the values of these parameters were not continuously known or regulated 
3) the biologic model was not complete 
For example, physical flow and CFD models, such as those discussed in sections 1.5.3 and 1.5.4, only
give information about the hemodynamic environment and do not include any biologic measurements.
Findings from these studies about the influence of hemodynamics on IH formation are based on qualitative
or general quantitative biologic data from separate studies and are not conclusive. For in vivo human and
animal investigations, such as those discussed in sections 1.5.1 and 1.5.2, the biologic endpoints (i.e. intimal
thickness) and hemodynamic parameters (i.e. WSS) are measured either at the start of the experiment or after
the chosen time period (i.e. days, weeks, months) during which the hemodynamic parameters can not be
tightly regulated. Therefore, the findings from these studies do not include any knowledge of how the
hemodynamic parameters vary over time and the results from these could be misleading. Most of the previous
studies on the vascular cell response to hemodynamic stimuli have been limited to cell culture studies, such
as those discussed in sections 1.6.1.1, 1.6.2.1 and 1.6.3.1, which do not include the effects of surrounding
vascular cells and the structure of the vessel wall. In vivo animal and human models, such as those discussed
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in sections 1.6.1.2, 1.6.1.3, 1.6.2.2, 1.6.2.3, 1.6.3.2 and 1.6.3.3, give more applicable results to the clinical
environment but the effect of hemodynamics can not be isolated. For example, the use of prosthetic grafts
or saphenous veins impose a compliance mismatch at the anastomosis. 
Given these limitations of previous studies, there is a need for research that exposes an intact vessel
to a well-controlled hemodynamic environment and quantifies the resulting biologic and hemodynamic
parameters in a directly coupled manner.
1.8 Specific Aims
The proposed work is designed to test the following hypothesis:
A quantitative correlation exists between the hemodynamic phenomena at the distal anastomosis of a
vascular bypass graft and carefully selected, acute biological markers of intimal hyperplasia.
 The specific aims that were executed to address this hypothesis are as follows:
Specific Aim #1: Utilize experimental methods to determine the spatial variation of acute biological
markers related to IH formation (c-fos, c-jun, egr-1 protein expression and apoptosis) in
artery-artery, end-to-side anastomoses exposed to well-controlled ex vivo perfusion.
Specific Aim #2: Utilize computational methods to determine the spatial variation of wall shear stress
(WSS) and wall shear stress gradient (WSSG) in three-dimensional, reconstructed models
of each experimental distal anastomosis perfusion.
Specific Aim #3: Determine whether a quantitative correlation exists between the spatial variation of IH-
related molecular endpoints and the spatial variation of WSS and/or WSSG in order to
understand the precise hemodynamic factors that lead to IH formation.
This research project involved two main components: the perfusion of intact vessels ex vivo (Specific
Aim #1) and the estimation of precise hemodynamic parameters using a CFD model incorporating the
perfusion conditions and a realistic geometry (Specific Aim #2).  The perfusion experiments allowed us to
assess the regional variation of IEG protein expression and vascular cell apoptosis associated with the acute
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intimal hyperplastic response of an artery-artery, ETS anastomosis.  Since the pressure and flow rate in the
ex vivo perfusion model were precisely known, the CFD model utilized this information along with the
anastomotic geometry to accurately estimate WSS and WSSG.  This process allowed for a distinct and
unique coupling between the perfusion experiment and the computational simulation that has not been
achieved previously.  The final step was to assess the possible quantitative correlation between the IEG
protein expression and/or apoptosis in the perfused vessels and the local WSS and WSSG acting on the
vessel walls (Specific Aim #3).
The overall goal of this research was to  provide specific evidence of the influence of hemodynamics
on the acute, pathological mechanisms that result in IH.  In the long-term, this research may help improve
the clinical success rate of vascular bypass grafts.  That is, once the important hemodynamic variables that
cause a pathologic response at the distal anastomosis are determined, surgeons may be able to tailor the
anastomosis to achieve optimal hemodynamics.  Specifically, surgeons have some control over the geometry
of the anastomosis, and therefore have the ability to alter the hemodynamics in order to minimize the
pathologic variables leading to IH formation.  Additionally, once the important hemodynamically induced
molecular players are identified, clinicians could treat the surrounding tissue pharmaceutically or genetically
to reduce the production of these molecules at the time of bypass grafting.
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2 .0 EX VIVO PERFUSION EXPERIMENTS
2.1 Introduction
2.1.1 Advantages of an Ex Vivo Perfusion System
The experimental aspect of this research utilizes a whole-vessel,  ex vivo perfusion system because of
the advantages of this system over other models.  As demonstrated in sections 1.5 and 1.6, most of the
previous research on the biologic response of vascular cells to hemodynamic stimuli has been conducted in
cell culture models or in vivo animal models. Although cell monolayer and co-culture models allow for the
precise control over imposed the biomechanical environment, they do not incorporate the true vessel
structure.  Therefore the results can not be extrapolated to the clinical setting.  In vivo animal models do
incorporate the complete vascular structure but do not allow for the precise control over individual
hemodynamic parameters (i.e. pressure and flow) over the duration of the experiment,  which can last days,
weeks or months for IH studies.  Therefore, this research utilizes a whole-vessel ex vivo perfusion system
that allows for the precise and individual regulation of pressure and flow within the vessels and maintains
these values throughout the experiment.
2.1.2 Previous Research Utilizing an Ex Vivo Perfusion System 
A number of research groups have studied the effect of biomechanical stimulation on intact vascular
tissue using ex vivo perfusion systems [72, 144-150].  Specifically, our group and its predecessors at the
University of Pittsburgh have developed a system and utilized it extensively for a variety of applications
[144, 146, 147, 150-153].  Berceli et al. developed paired perfusion systems to expose human saphenous vein
segments to arterial or venous flow and pressure conditions for 20 hours [144].  They found alterations in
endothelial cell morphology and low-density lipoprotein metabolism in the veins exposed to arterial
conditions.  Labadie et al. improved this system by incorporating a computer-controlled in-line gate valve
that allowed for the generation of physiologic, arterial pressure waveforms as seen in Figure 2.1 [146].  They
validated the system by evaluating vascular homeostasis ex vivo using vasomotor bioassays after one, 24 and
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Figure 2.1 Schematic of the arterial perfusion system used by Labadie et al. where tissue culture
medium is pumped by a centrifugal pump (A) through a heat exchanger (B) and past a pressure
regulator (C). A gate valve (D) creates pulsatility and the pressure is measured with pressure
transducers (E). The vessel is secured in the vessel housing chamber (F).  The flow rate is
maintained with a needle valve flow resistor (G) and measured with an in-line flow probe (H).  The
perfusate is then collected in the reservoir for recirculation through the system. Figure from [146].
48 hours of perfusion.  Additionally, human saphenous vein segments were perfused for 24 hours and the
resulting confocal and transmission electron  micrographs demonstrated typical vascular morphology.  Vorp
et al. further modified the system so that cyclic strains, consistent with those found in native blood vessels,
could be applied to intact vessels using a combination of twisting and axial stretching as shown in Figure 2.2
[147].  This apparatus, called the dynamic vascular testing (DVT) device, was successfully utilized by
Severyn et al. [151] and Muluk et al.[150] to study the effect of coronary and lower extremity arterial
biomechanics on the thrombogenicity of porcine and human vascular segments.  Muluk et al. found a
significant enhancement of TF expression in veins exposed to coronary arterial vein graft conditions
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Figure 2.2 Schematic of the DVT system showing the
twisting and stretching motors.  Figure from [147].
compared to those exposed to venous conditions.  In a similar study, Vorp et al. exposed porcine arteries to
cyclic bending consistent with that found in coronary arteries in vivo [152].  Their results demonstrated a
consistent and significant downregulation of E-selectin and matrix metalloproteinase-1 (MMP-1) in the
specimens subjected to cyclic bending as compared to the non-bending control.  Kute et al. also used this
ex vivo perfusion system to determine the effect of disturbed flow on TF and IEG expression in porcine
femoral arteries [153].  Before the initiation of flow, umbilical tape was used to constrict each vessel at its
center for approximately 1/3 the length of the vessel, resulting in a 30% reduction in the local diameter.  The
constricted arteries were then perfused under steady flow and pressure conditions (100 mmHg and 100
cc/min).  These flow conditions resulted in a normal wall shear rate (WSR) distribution (~480 sec-1) in the
constricted region and low WSR in the proximal and distal segments (~80 sec-1).  They found a significant
increase in c-fos, c-jun and TF gene expression in the constricted regions compared to the proximal, non-
constricted segments of the same vessels.  Additionally, TF surface activity in the constricted segments was
significantly higher than in the distal, non-constricted segments. 
These studies demonstrate that the ex vivo perfusion system developed and modified by our research
group at the University of Pittsburgh can apply a wide range of well-controlled physiologic and pathologic
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Figure 2.3 Schematic diagram of the Zero Flow Perfusion System.  Note the occluded tubing
proximal to the anastomosis in the arterial (host) segment.
biomechanical forces on intact vascular tissue, while preserving the basic structural and phenotypic
characteristics of the vessels.
2.2 Methods
2.2.1 Modification of the Ex Vivo Perfusion System
The basic ex vivo perfusion system, shown in Figure 2.1 and used for numerous research projects in the
past [146, 147, 150-153], was modified slightly in order to accommodate the distal ETS bypass graft
geometry (see Figures 2.3 and 2.4).  Because these perfusions did not require pulsatility, the gate valve was
removed from the system.  The removable spool  in the vascular housing chamber was modified to
accommodate the graft segment; i.e., another tee entered the chamber at a 30 degree angle.  Also, the flow
path was altered to allow for two different flow condition in the proximal artery.  For perfusions with no flow
entering through the proximal artery, the tubing connected to this tee was simply clamped as shown in Figure
2.3.  For perfusions with retrograde flow in the proximal artery, tubing was attached to the proximal artery
tee, and a flow probe, pressure transducer and flow resistor were inserted in this branch of tubing as shown
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Figure 2.4 Schematic diagram of the Retrograde Flow Perfusion System.
in Figure 2.4.  This allowed for independent control of pressure and flow in all three inlets/outlets of the
distal, ETS anastomosis (graft, proximal and distal artery). 
2.2.2 Tissue Source and Harvest
The right and left femoral arteries were harvested under semi-sterile conditions from ~230 kg pigs at
Green Valley Packing Company, an abattoir in Claysville, PA.  Care was taken to ligate any visible
tributaries before removal of the vessel to limit handling of the tissue in the laboratory.  The vessels were
maintained at in situ length using two custom vascular clamps [144, 146] and the vessels were transported
to our laboratory in a cold, Ringer’s solution supplemented with antibiotics (Mefoxin, 0.5 g/liter) in order
to prevent infection, papaverine (60 mg/liter) in order to prevent spasm and Heparin (500 units/liter) to
prevent blood clot formation.
2.2.3 Experimental Design
For each experiment, an ETE and an ETS anastomosis was constructed and each was perfused in a
separate perfusion system.  The ETE anastomosis was used a control since it received the same surgical
45
trauma and mechanical forces induced by the vascular clips as the ETS anastomosis but did not experience
disturbed flow.  This allowed us to attribute any significant regional variations in biologic parameter in the
ETS anastomosis to hemodynamic parameters as long as a regional variation in the same biologic parameters
was not present in the ETE anastomosis.  For a second control, a small segment of the vessel used for the
ETE anastomosis was removed before creating the anastomosis.  This nonperfused control was used to
determine the baseline biologic values for each animal and to as sure that the perfusion was responsible for
an alteration in biologic parameters.
2.2.4 Construction of ETE and ETS Distal Anastomoses
After transporting the vessels to the laboratory, one artery was arbitrarily chosen for the ETE
anastomosis and the other was used for the ETS anastomosis.  For the ETE anastomosis, the procedure
described in section 1.2.2 was utilized.  Specifically, the chosen artery was secured with 2-0 suture
proximally and distally to two in-line perfusion tees supported within the removable spool.  Media-199 was
perfused through the vessel to check for previously undetected leaks, which were ligated with 4-0 suture.
The vessel was then cut at the midsection and the intima-to-intima contact method was used to create the
ETE anastomosis with VCS™ vascular clips under loupe magnification. This protocol causes the least
amount of damage to the native vessels during the creation of the anastomosis and allows for a leak-free
anastomosis [12].  A completed ETE anastomosis is shown in Figure 2.5.  
For the ETS anastomosis, the procedure described in section 1.2.2 was utilized.  Specifically, the
proximal 1/3 of the other femoral artery was cut and designated as the “graft” segment and sutured at its
proximal end to a tee entering the spool proximally at a 30 degree angle to the two in-line tees (see Figure
2.3).  The remaining 2/3 of the same femoral artery was attached proximally and distally to two in-line
perfusion tees using purse string sutures and a leak check was performed.  A slit was cut in the midsection
of the in-line vessel segment and the edges were everted and approximated to the everted edges of the distal
end of the graft segment.  Under loupe magnification, a few VCS™ vascular clips were placed at the toe and
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Figure 2.5 Completed ETE anastomosis. Figure 2.6 Completed ETS anastomosis. 
heel of the ETS anastomosis to stabilize the vessels and then VCS™ vascular clips were placed continually
from heel to toe on both sides of the anastomosis. A completed ETS anastomosis is shown in Figure 2.6.  
The vessels were irrigated during anastomosis construction to assure vessel viability and the completed
anastomosis were placed in the perfusion system within 3 hours of harvest and within 30 minutes of the
anastomosis construction initiation. After the completion of each anastomosis, the tees were locked in place
so that the vessels were maintained at in vivo length and the removable spool was placed into the vessel
housing chamber.  Flow of perfusion media was slowly initiated to reintroduce fluid into the anastomoses,
and pressure and flow rate were gradually increased to the experimental levels described in sections 2.2.6
and 2.2.7.
2.2.5 General Perfusion Conditions
Vessels mounted into the ex vivo perfusion systems were exposed to precisely controlled
hemodynamics.  The closed-loop perfusion systems (recall Figure 2.3) allowed the circulation of perfusate
(tissue culture Media-199 supplemented with 0.5 g/liter antibiotic/antimycotic) through the  anastomosis
contructions.  All components of both perfusion systems that came in contact with the sterile perfusate (i.e.
centrifugal pump head, Tygon™ tubing, connectors, flow resistors, tees, heat exchanger, vessel housing
47
chamber, reservoir, etc) were sterilized with ethylene-oxide before the experiment in order to minimize vessel
contamination. 
A Bio-Medicus™ centrifugal flow pump provided steady flow and variable needle-valve flow resistors
in the flow circuit allowed for the independent adjustment of pressure and flow rates in the graft, proximal
and distal artery segments.  The pressures at each vessel segment were measured with standard pressure
transducers attached to ports on the tees and the flow rate was measured with an ultrasonic flow transducer.
In a separate loop, a roller pump circulated a sterile adventitial bath solution (Media-199 supplemented
with 0.5 g/liter antibiotic/antimycotic) around the specimen mounted in the sealed vessel housing chamber.
Both the perfusate and adventitial bath media were maintained at 37°C, oxygenated and the pO2 levels were
measured every hour and the oxygen level was adjusted, if necessary, in order to maintain physiologic
conditions.  A pH indicator (phenol red) was present in the perfusate media to allow for the identification
of any leaks in the vessels into the clear adventitial bath.  Phenol red also allowed for continual visual
inspection of the pH level which was measured in the perfusate and adventitial bath with a hand-held probe
every hour and adjusted, if necessary. 
The anastomoses were exposed for six hours to the well-controlled flow and pressure levels explained
in the following sections. This time point was chosen based on previous research of the shear-induced
alteration of IEG protein levels in both cell culture and in vivo models [44, 140, 142], and because apoptosis
can occur over this time period [38].
2.2.6 Perfusion Conditions for the ETS Anastomoses
Three flow conditions in the proximal artery of the distal ETS anastomosis can occur clinically when
bypassing a blocked region of the native artery.  A partial stenosis of a bypassed arterial segment may allow
residual prograde flow through the proximal artery entering the distal anastomosis of the graft.  A complete
stenosis may allow for zero flow in the proximal artery segment or retrograde flow due to the presence of
small collateral vessels upstream.  In a computational model of a three-dimensional, idealized ETS
anastomosis, we examined the effect of the proximal artery flow condition (i.e. prograde, zero and retrograde
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Figure 2.7 Contour plots of WSS and WSSG magnitude for each flow case (prograde, zero and
retrograde).  Figure from [154].
flow) on the hemodynamics at the distal ETS anastomosis [154].  We found a marked difference in both the
magnitude and spatial distribution of WSS and WSSG between the three conditions (see Figure 2.7).  For
example, as shown in Figure 2.8, the maximum WSS magnitude on the floor of the artery proximal to the
anastomosis for the prograde and zero flow cases is 1.8 and 3.9 dynes/cm2, respectively, while it is increased
to 10.3 dynes/cm2 in the retrograde flow case.  Similarly, the maximum value of WSSG magnitude on the
floor of the artery proximal to the anastomosis for the prograde flow case is 4.9 dynes/cm3 while it is
increased to 13.6 and 24.2 dynes/cm3, respectively, in the zero and retrograde flow cases.  We also calculated
the severity parameter (SP), a quantification of hemodynamic variation [90, 155], at the anastomosis and the
value of SP is highest for the retrograde flow case (13.7 dynes/cm3) and 8.1% and 12.1% lower than this for
the prograde (12.6 dynes/cm3) and zero (12.0 dynes/cm3) flow cases, respectively.  Therefore, our model
results indicated that a wide range of hemodynamic parameters could be imposed by varying the flow
condition in the proximal artery.  Because the largest difference in the maximum WSS and WSSG magnitude
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Figure 2.8 Comparison of WSS and WSSG magnitude along the
artery floor and the value of SP at the anastomosis for the three
flow cases (prograde, zero, retrograde).  Figure from [154].  
1 Arteries in vivo maintain a WSS of approximately 15-20 dynes/cm2 [156].  Based on the
viscosity of blood (i.e., 3.5 cP), a physiologic arterial WSR is 430-570 sec-1.
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Figure 2.9 Perfusion conditions for the ETS anastomosis.  Each anastomosis was exposed to one
of two flow protocols; zero (n=5) or retrograde (n=5) flow in the proximal artery.  
on the floor of the artery proximal to the anastomosis, and in the value of SP at the anastomosis, occurred
between the zero and retrograde flow conditions, we simulated these conditions for  the ETS anastomoses
perfused ex vivo.  Accordingly, each ETS anastomosis was exposed to one of two flow protocols described
below and shown schematically in Figure 2.9.  
2.2.6.1 Zero Flow in the Proximal Artery
For the zero flow protocol, the tubing attached to the proximal artery branch tee of the ETS anastomosis
was clamped so that all flow entered the graft and exited through the distal artery segment.  The graft inlet
and distal artery outlet flow rates were maintained at 325 cc/min and the graft inlet pressure was maintained
at 100 mmHg.  This flow rate was chosen so that, based on the inner diameter of the vessels and tees
(approximately 5mm), a WSR of approximately 440 sec-1 was imposed on the graft segment1.  
A total of five ETS anastomoses were perfused under these conditions.  Based on previous studies of
IEG  expression in constricted porcine femoral arteries in our laboratory, we initially estimated the sample
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size based on the formula for comparing two means of two groups with equal sample size using a two-sided
test with significance level " and power 1 - $ [157]:
[2.1]
where F is the standard deviation for the desired measurement in the control group and ) is the expected
change in means.  The average ratio for the previous IEG studies was 0.26/0.55 = 0.47.  Assuming that " =
0.05 and  $ = 0.025 so that Z1-"/2 = Z1-$ =1.96, this gave a sample size of seven.  However, after analyzing the
biologic data from the first set of zero flow ETS experiments, statistical significance (see section 2.2.13) was
reached after only three experiments.  Therefore, a total of five experiments was determined sufficient.
2.2.6.2 Retrograde Flow in the Proximal Artery
For the retrograde flow protocol, the tubing attached the proximal artery tee was not clamped so that
flow could exit through this branch of tubing as well as the distal artery outlet.  For this protocol, the graft
inlet flow rate (325 cc/min) and pressure (100 mmHg) were maintained the same as in the zero flow protocol,
but the outlet flow rates were adjusted to allow for the retrograde flow through the proximal artery.
Specifically, the flow resistors downstream of the proximal and distal artery segments were adjusted so that
20% of the graft inlet flow rate (65 cc/min) exited through the proximal artery segment with the remaining
flow (260 cc/min) exiting through the distal artery. This division of outflow rates was chosen based on the
results of the computational study of the idealized ETS anastomosis that demonstrated elevated WSS, WSSG
and SP in the retrograde flow model with a 5:1 division of flow  (recall Figures 2.7 and 2.8) [154].  Based
on similar arguments as presented in section 2.2.6.1, a total of five ETS anastomoses were perfused under
these conditions.
2.2.7 Perfusion Conditions for the ETE Anastomosis
All distal ETE anastomoses were exposed to the same perfusion conditions as shown in Figure 2.10.
The graft inlet flow rate (325 cc/min) and pressure (100 mmHg) were the same as both ETS flow protocols
and since an ETE construction consists essentially of a straight tube, all flow exited through the distal artery.
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Figure 2.10 Perfusion condition for all ETE anastomoses (n=10).
A total of ten ETE anastomoses (5 paired with the zero flow ETS experiments and 5 paired with the
retrograde flow ETS experiments) were perfused under these conditions.
2.2.8 Post-Perfusion Processing of the Tissue
2.2.8.1 Pressure Fixation
At the completion of the six hour perfusion, the ETE and ETS anastomoses were pressure fixed as
follows.  The adventitial bath media was first drained from the vessel housing chambers for each anastomosis
and replaced with 2% paraformaldehyde.  This fixative was also flushed through the anastomoses, the distal
artery (for ETE and ETS) and proximal artery (for ETS only) outlets were clamped off and a pressure
infusion bag attached to the graft inlet tubing maintained the pressure of the fixative at 100mmHg for one
hour.  The nonperfused control tissue was simply immersed in fixative for one hour at the beginning of the
experiment.  After fixation, the anastomoses were removed from the housing chambers and all tissue was
placed in 30 % sucrose overnight at 4°C.  
2.2.8.2 Cryopreservation
For further processing of the anastomosis tissue, the VCS™ vascular clips had to be removed but the
original anastomosis geometry needed to be maintained.  Therefore, a few VCS™ vascular clips were
removed at a time using a VCS™ universal clip remover under loupe magnification and the clips were
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Figure 2.11 Photographs of ETE and ETS anastomoses from Retrograde Flow Experiment #4 before
complete clip removal (left column) and after replacing clips with suture (right column).  
replaced by continuous suturing with 6-0 prolene suture as shown in Figure 2.11.  This was repeated until
all clips were removed and replaced with suture.  The anastomoses were then placed on filter paper and
submerged in liquid-nitrogen-cooled isopentane for 20 seconds as shown in Figure 2.12. The vessels were
immediately transferred to liquid nitrogen for 5 seconds to complete the freezing process and then set on a
rack above liquid nitrogen so they would remain frozen.  Next, they were embedded in TBS/TFM tissue
freezing medium (Fisher Scientific) using a custom mold (Figure 2.12 C).  The Teflon® mold was lined with
aluminum foil and placed on a rack over liquid nitrogen. Tissue freezing medium was placed in the frozen
mold and the vessels were submerged, careful to eliminate any air bubbles. Once the vessels were frozen,
they were stored at -80°C until further processing.
2.2.8.3 Slicing
A custom vessel cutter was machined from a block of aluminum and had the same geometry as the
freezing mold with the addition of thin grooves that allowed the penetration of a cryostat blade (see Figure
2.13).  One by one, parallel slices were made every 2mm along the length of the vessel in the cold
environment of a cryostat chamber. The orientation of the vessel slices were noted and the slices were stored
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Figure 2.12 Photographs showing the freezing process A) ETS anastomosis submerged in liquid-cooled
isopentane. B) All vessels from one experiment (nonperfused segment, ETE and ETS) after the freezing
process.  C) Custom mold.  D) ETS anastomosis submerged in freezing medium in the mold lined with
aluminum foil. 
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Figure 2.13 Diagram of the custom vessel cutter showing the three orthogonal views.
Figure 2.14 Schematic diagram of the ten regions of interest for each experiment including ETS
graft, proximal artery, distal artery, heel, toe, hood and floor, ETE proximal and anastomosis, and
the nonperfused segment.
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in separate cassettes at -80°C.  A total of ten regions of interest were studied in detail including seven regions
from the ETS anastomosis (graft, proximal artery, distal artery, heel, toe, hood and floor), two regions from
the ETE anastomosis (proximal and anastomosis) and the nonperfused segment as shown in Figure 2.14.
Cross-sections from these regions of interest were cut with four micron thickness using a cryostat and
mounted on gelatin coated microscope slides.  The slides were stored at -80°C until staining.
2.2.9 Immunohistochemistry Technique for IEG Protein Staining
Immunofluorescence on serial slides was used to identify c-fos, c-jun and egr-1 protein expression.  The
slides were removed from the -80°C freezer and 2% paraformaldehyde was immediately placed on the
sections for one hour at room temperature in order to fix the tissue to the slide.   The slides were blocked with
5% goat serum for 45 minutes and incubated with the primary antibody (mouse anti-human c-fos monoclonal
(sc-7481), rabbit anti-human c-jun polyclonal (sc-1694) or  rabbit anti-human egr-1 polyclonal (sc-189), all
from Santa Cruz Biotechnology) at a 1:100 dilution in bovine serum albumin for one hour.  Next, the sections
were incubated in the dark with the corresponding fluorescent secondary antibody (goat anti-mouse CY3
(115-165-003) for c-fos and goat anti-rabbit CY3 (111-165-003) for c-jun and egr-1, all from Jackson
Immunoresearch Labs) at a 1:3000 dilution for one hour.  Nuclei were counterstained with Hoechst
(Molecular Probes H-1398) for 30 seconds and the slides were coverslipped using gel mount-Biomeda
mounting medium (Fisher Scientific).  Negative control slides received all incubation steps except the
primary antibody.  All slides were stored in the dark at 4°C until microscopy.
2.2.10 TUNEL Technique for Apoptosis Staining
To identify apoptosis, the terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick-end
labeling (TUNEL) technique was used which fluorescently labels genomic DNA that is cleaved by an
endonuclease selectively activated during apoptosis [36, 158].  Immediately after the slides were removed
from the -80°C freezer, they were submerged in cold methanol for 30 minutes at -20°C to fix the tissue to
the slide. The TUNEL mixture consisting of deionized water, TdT buffer, TdT, CoCl2 (all from Roche
Molecular Biochemicals #220582) and biotin-16-2'-deoxyuridine-5'-triphosphate (Roche Molecular
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Biochemicals #1093070) was placed on the slides, which were then coverslipped.  The slides were incubated
with the TUNEL mixture for 1 hour in a humidified chamber at 37°C.  The coverslips were removed and the
streptavidin CY3 secondary antibody (Jackson ImmunoResearch #016-160-064) placed on the sections for
one hour at room temperature.  Nuclei were counterstained with Hoechst (Molecular Probes H-1398) for 30
seconds and the slides were coverslipped using gel mount-Biomeda mounting medium (Fisher Scientific).
Positive control slides were incubated with DNAse1 to induce DNA fragmentation before the TUNEL
mixture was applied.  Negative control slides were incubated in deionized water and biotin only.  All slides
were stored in the dark at 4°C until microscopy.
2.2.11 Fluorescent Microscopy
Fluorescent images were digitally captured from an Olympus Provis microscope in the Center for
Biologic Imaging at the University of Pittsburgh.  The images were taken at 40X magnification with high
numerical aperture, color corrected, oil immersion objectives and a high sensitivity, integrating three chip
Sony color camera, (700X600 pixels) and Corecco frame grabber board.  Multicolor cubes were used as
filters to visualize the CY3 and Hoechst staining and separate images were taken so that one image showed
the IEG protein or TUNEL (apoptosis) staining, and one showed all nuclei.  For each region of interest,
twelve images were taken around the circumference of the cross-section.  Because the ETS hood and floor
regions are not complete circles, as many images as possible (typically 6-8) were taken at regular, non-
overlapping intervals.  Images were saved in the 24-bit TIFF format.
2.2.12 Quantification of IEG Protein and Apoptosis Staining
The amount of IEG protein expression and apoptosis was quantified on a dedicated PC using the image
analysis software Bioquant Nova (Version 5.00.8, R&M Biometrics, Nashville, TN).  Because IEG proteins
must translocate to the nucleus to affect transcription, CY3 staining was considered positive only if it
overlapped nuclear (Hoechst) staining. Similarly, TUNEL fluorescently labels DNA fragments in the nucleus
so CY3 staining for these slides was also only considered positive if it overlapped nuclear (Hoechst) staining.
IEG protein staining was almost exclusively limited to the endothelium so only the amount of EC staining
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was quantified for the IEG proteins.  Apoptosis was present in both the endothelial and medial layers so the
amount of apoptotic EC and SMC staining was quantified.
The step-by-step process for quantifying EC staining is demonstrated in Figure 2.15.  For each paired
set of images, the number of nuclei was first quantified as follows.  The area of interest was drawn freehand
along the internal elastic lamina to isolate the endothelium. The image was then thresholded by the user to
highlight the bright nuclear staining.  The software automatically determined the outline of nuclear staining
based on this threshold level (Figure 2.15A).  Some user intervention was required to split cells that were
close to each other and to delete erroneous tracings in order to get an accurate cell count.  Once the nuclear
tracings and cell count were complete, the degree of staining was quantified as follows.  The corresponding
CY3 image was opened and the same area of interest as used in the cell count was utilized.  The threshold
for the bright CY3 staining was set by the user who utilized the tracings from the nuclei image as a guide.
The outlines of CY3 staining was automatically determined by the software and adjusted by the user as
necessary (Figure 2.15B). These tracings were overlapped with the nuclei tracings (Figure 2.15C) so that the
user could determine which CY3 stainings were positive (Figure 2.15D).  The false CY3 positive counts and
tracings were then discarded.  As a final check, the positive tracings were compared to an color overlay
image (Figure 2.15E) of the CY3 (red) and nuclei staining (blue) in which only the pink/purple regions are
positive for nuclear IEG protein or apoptosis.   This process yielded the total number of EC nuclei and the
total number of IEG protein positive or apoptotic EC for each set of paired images.  This was repeated for
all images taken for each cross-section.  Care was used to ensure that at least 100 EC were counted for each
region of interest in order to have a representative count.
An analogous process was used to quantify the degree of SMC apoptosis.  The only difference was that
the region of interest for each image included the media defined as the area between the internal elastic
lamina and clearly distinguishable fibrous tissue of the adventitia.  The number of SMC per image was much
greater than the number of EC so the total number of SMC counted per region of interest was at least 1000.
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Figure 2.15 Process of EC staining quantification, using a c-fos example.  EC region of interest is
highlighted and the tracings of A) nuclei staining and B) CY3 staining  are created.  These tracings
are overlapped (C) and only the ones that match are considered positive (D).  These are compared
to a color overlay image (E) that shows positive nuclear staining as pink or purple.  
For each region of interest, the staining index (i.e. percentage of positive staining) was calculated by
taking the total number of positive stained cells divided by the total number of nuclei for the entire cross-
section.
[2.2]
Therefore, five quantitative, biological parameters were calculated for each region of interest; i.e., staining
indices for c-fos (EC), c-jun (EC), egr-1 (EC) and apoptosis (both EC and SMC).  A mean staining index for
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[2.3]
Finally, the Mean Staining Index was calculated, which represented the percent of staining in all tissue
exposed to one flow condition. This single, quantitative value was calculated by averaging the Mean Staining
Index ROI over all regions of interest (m).
[2.4]
These data are presented as the mean ± standard error of the mean (SEM). 
2.2.13 Statistical Analysis
To compare Mean Staining Indices between flow conditions (e.g., c-fos for the zero flow experiments
versus c-fos for the retrograde flow experiments), unpaired Student’s t-tests were performed using the mean
staining indices for each region of interest calculated for the five experiments.  A difference was considered
significant if this test rendered a p-value less than 0.05.  To compare the mean staining indices between types
of staining (e.g., c-fos versus c-jun for the zero flow experiments), one-way ANOVA was performed [157].
If a significant (p < 0.05) F value was obtained, a post-hoc paired comparisons test was completed to
determine which staining indices were significantly (p < 0.05) different from each other. 
When assessing the regional variation of IEG protein expression and apoptosis, a normalized staining
index was used to eliminate experiment to experiment variability.  The normalized staining index for each
region of interest in one experiment (Normalized Staining Index ROI) was calculated by dividing the Staining
Index ROI by the Mean Staining Index ROI averaged over all regions of interest for the same experiment (Mean
Staining Index Experiment). 
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[2.5]
Similar to the non-normalized data, a mean normalized staining index for each region of interest (Mean
Normalized Staining Index ROI) was calculated for all experiments with the same flow condition as:
[2.6]
The data are presented as mean ± SEM.
One-way ANOVA was used to determine if the Mean Normalized Staining Index ROI for each stain (i.e.,
c-fos (EC), c-jun (EC), egr-1 (EC) and apoptosis (both EC and SMC)) varied between regions of interest for
each flow condition.  If a significant (p < 0.05) F value was obtained, a post-hoc paired comparisons test was
completed to determine which regions of interest were significantly (p < 0.05) different from each other.
To compare the Mean Normalized Staining Indices  ROI between flow conditions (e.g., c-fos in the toe
region for the zero flow experiments versus c-fos in the toe region for the retrograde flow experiments),
unpaired Student’s t-tests were performed using the Mean Normalized Staining Indices for each region of
interest calculated for the five experiments.  A difference was considered significant if this test rendered a
p-value less than 0.05.
2.2.14 Reliability
In order to minimize error, a single user performed the quantification protocol for one stain for all
regions of interest of a particular experiment.  To determine if there was a significant difference in the
staining quantification completed by different users, the normalized staining indices for all regions of interest
were quantified by two users for one experiment.  Using a paired Student’s t-test, there was no significant
difference between the normalized staining index for c-fos (p = 0.98), c-jun (p = 0.99), egr-1 (p = 0.63), EC
apoptosis (p = 0.62) or SMC apoptosis (p = 0.42).  Therefore, the results shown below are independent of
which user performed the quantification.
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Figure 2.16 Mean Staining Indices (see Equation 2.4) for 1) c-fos, 2) c-jun, 3) egr-1, 4) EC
apoptosis and 5) SMC apoptosis for the zero flow (black) and retrograde flow (grey)
experiments.  The numbers above each data point indicate which indices are significantly
different from that index.  An asterisk (*) indicates a significant difference between flow
conditions for that index.
2.3 Results
2.3.1 Mean Staining Index
The Mean Staining Indices (mean ± SEM), calculated as per Equation 2.4, for c-fos, c-jun, egr-1, EC
and SMC apoptosis for both flow conditions are presented in Figure 2.16.  Note that negative control slides
for all markers were devoid of nuclear staining.  For the zero flow experiments, the c-jun (44.76% ± 5.98)
and egr-1 (39.38% ± 5.12) Mean Staining Indices were significantly higher than the c-fos (21.91% ± 6.36),
EC apoptosis (15.59% ± 4.93) and  SMC apoptosis (5.7%  ± 2.29) Mean Staining Indices.  The SMC
apoptosis Mean Staining Index (5.7%  ± 2.29) was significantly lower than the c-fos (21.91% ± 6.36), c-jun
(44.76% ± 5.98), egr-1 (39.38% ± 5.12) and EC apoptosis (15.59% ± 4.93) Mean Staining Indices.  For the
retrograde flow experiments, both c-jun  (45.36% ± 5.47) and egr-1 (39.16% ± 7.5%) were significantly
higher than the EC and SMC apoptosis Mean Staining Indices (32.21% ± 7.36 and 5.99%  ± 1.89,
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respectively) while only the c-jun Mean Staining Index (45.36% ± 5.47) was significantly higher than the
c-fos Mean Staining Index (36.27% ± 5.77). Similar to the zero flow experiments, the SMC apoptosis Mean
Staining Index (5.99%  ± 1.89) was significantly lower than the c-fos (36.27% ± 5.77), c-jun  (45.36% ±
5.47), egr-1 (39.16% ± 7.5%) and EC apoptosis (32.21% ± 7.36) Mean Staining Indices.  The c-fos and EC
apoptosis Mean Staining Indices for the zero flow condition (21.91% ± 6.36 and 15.59% ± 4.93, respectively)
were significantly lower than the same indices for the retrograde flow experiments (36.27% ± 5.77 and
32.21% ± 7.36, respectively).
2.3.2 Mean Normalized Staining Index ROI
The Mean Normalized Staining Indices ROI (mean ± SEM), calculated as per Equation 2.6, for c-fos, c-
jun, egr-1, EC and SMC apoptosis are presented for each region of interest and both flow conditions in
Figures  2.17, 2.18, 2.19 and 2.20, respectively.  Additionally, similar graphs incorporating all the data (zero
and retrograde flow experiments) are shown in Figures 2.21 (c-fos and c-jun) and 2.22(egr-1 and apoptosis).
2.3.2.1 Regional Variation of C-fos Protein
The regional variation of c-fos protein expression followed the same trend for both flow conditions
(Figure 2.17).  In the zero flow experiments, the regions that were significantly different from the highest
number of other regions were ETS proximal and ETS toe.  The ETS proximal region (1.62 ± 0.203) had the
highest c-fos Mean Normalized Staining Index ROI and this value was significantly higher than the c-fos Mean
Normalized Staining Index ROI for the ETS heel (0.873 ± 0.058), toe (0.713 ± 0.175), floor (0.824 ± 0.147)
and hood (0.772  ± 0.195) regions.  The ETS toe region (0.713 ± 0.175) had the lowest c-fos Mean
Normalized Staining Index ROI of the perfused regions and this value was significantly lower than the c-fos
Mean Normalized Staining Index ROI for the ETS proximal (1.62 ± 0.203), distal (1.261 ± 0.339) and ETE
proximal (1.290 ± 0.176) and anastomosis (1.334 ± 0.170) regions.  
In the retrograde flow experiments, the regions that were significantly different from the highest number
of other regions were ETS distal and ETS hood.  The ETS distal region (1.345 ± 0.157) had the highest c-fos
Mean Normalized Staining Index ROI and this value was significantly higher than the c-fos Mean Normalized
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Figure 2.17 Mean Normalized Staining Index ROI (see Equation 2.6) for c-fos for the zero flow (top) and
retrograde flow (bottom) experiments.  The numbers above or below each data point indicate which regions
(1-ETS proximal artery, 2-ETS heel, 3-ETS toe, 4-ETS distal artery, 5-ETS graft, 6-ETS floor, 7-ETS hood,
8-ETE proximal, 9-ETE anastomosis and 10-nonperfused segment) are significantly different from that
region.
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Figure 2.18 Mean Normalized Staining Index ROI (see Equation 2.6) for c-jun for the zero flow (top) and
retrograde flow (bottom) experiments.  The numbers above or below each data point indicate which regions
(1-ETS proximal artery, 2-ETS heel, 3-ETS toe, 4-ETS distal artery, 5-ETS graft, 6-ETS floor, 7-ETS hood,
8-ETE proximal, 9-ETE anastomosis and 10-nonperfused segment) are significantly different from that
region.
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Figure 2.19 Mean Normalized Staining Index ROI (see Equation 2.6) for egr-1 for the zero flow (top) and
retrograde flow (bottom) experiments.  The numbers above or below each data point indicate which regions
(1-ETS proximal artery, 2-ETS heel, 3-ETS toe, 4-ETS distal artery, 5-ETS graft, 6-ETS floor, 7-ETS hood,
8-ETE proximal, 9-ETE anastomosis and 10-nonperfused segment) are significantly different from that
region.
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Figure 2.20 Mean Normalized Staining Index ROI (see Equation 2.6) for apoptosis (EC-black, SMC-grey) for
the zero flow (top) and retrograde flow (bottom) experiments.  The numbers above or below each data point
indicate which regions (1-ETS proximal artery, 2-ETS heel, 3-ETS toe, 4-ETS distal artery, 5-ETS graft, 6-
ETS floor, 7-ETS hood, 8-ETE proximal, 9-ETE anastomosis and 10-nonperfused segment) are significantly
different from that region.
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Figure 2.21 Mean Normalized Staining Indices ROI (see Equation 2.6) for c-fos and c-jun for all experiments.
The numbers above or below each data point indicate which regions (1-ETS proximal artery, 2-ETS heel,
3-ETS toe, 4-ETS distal artery, 5-ETS graft, 6-ETS floor, 7-ETS hood, 8-ETE proximal, 9-ETE anastomosis
and 10-nonperfused segment) are significantly different from that region.  
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Figure 2.22 Mean Normalized Staining Indices ROI (see Equation 2.6) for egr-1 and apoptosis (EC-black,
SMC- grey) for all experiments.  The numbers above or below each data point indicate which regions (1-ETS
proximal artery, 2-ETS heel, 3-ETS toe, 4-ETS distal artery, 5-ETS graft, 6-ETS floor, 7-ETS hood, 8-ETE
proximal, 9-ETE anastomosis and 10-nonperfused segment) are significantly different from that region.  
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Staining Index ROI for the ETS heel (0.981 ± 0.171), toe (0.988 ± 0.088), graft (0.95 ± 0.088), floor (0.855
±0.132) and hood (0.795 ± 0.115) regions.  The ETS hood region (0.795 ± 0.115) had the lowest c-fos Mean
Normalized Staining Index ROI of the perfused regions and this value was significantly lower than the c-fos
Mean Normalized Staining Index ROI for the ETS proximal (1.285 ± 0.109), distal (1.345 ± 0.157), ETE
proximal (1.162 ± 0.081) and anastomosis (1.134 ± 0.077) regions.
Although the regional variation of c-fos Mean Normalized Staining Index ROI depended on the flow
condition in the proximal artery, there were no statistically significant differences for any of the regions of
interest due to the imposed flow condition.  For example, even though the c-fos Mean Normalized Staining
Index ROI in the ETS proximal artery region was higher in the zero flow experiments (1.62 ± 0.203) as
opposed to the retrograde flow experiments (1.285 ± 0.109), this difference was not statistically significant
(p = 0.183). 
When the data from both flow conditions were pooled together (Figure 2.21), a global understanding
of the regional variation of c-fos protein levels in vascular bypass grafts can be determined. The ETS
proximal region (1.452± 0.122) had the highest c-fos Mean Normalized Staining Index ROI followed by the
ETS distal region (1.303 ± 0.177).  These protein levels were significantly higher than those of the ETS heel
(0.927 ± 0.087),  toe (0.850 ± 0.103), floor (0.840 ± 0.093) and hood (0.783 ± 0.107).  The ETS proximal
c-fos Mean Normalized Staining Index ROI (1.452 ± 0.122) was also significantly higher than the ETS graft
(1.039 ± 0.072) region. The ETE proximal (1.226 ± 0.094) and anastomosis (1.234 ± 0.094) regions had the
next highest c-fos Mean Normalized Staining Indices ROI and these were significantly higher than the ETS
toe (0.850 ± 0.103), floor (0.840 ± 0.093) and hood (0.783 ± 0.107) regions.
For all experiments, the ETE proximal and anastomosis regions were not significantly different from
each other indicating that surgical trauma and use of the VCS™ clips does not induce appreciable nuclear
c-fos protein expression. Further evidence that the regional variation of c-fos protein levels was caused by
hemodynamics is the fact that all regions of interest from perfused vessels (except ETS hood for the
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retrograde flow experiments) showed significantly higher c-fos protein levels compared to the nonperfused
segment.
2.3.2.2 Regional Variation of C-jun Protein
The c-jun Mean Normalized Staining Indices ROI followed the same trend for both flow conditions,
however, more significant regional variation occurred in the zero flow experiments (Figure 2.18).  In the zero
flow experiments, the regions that were significantly different from the highest number of other regions were
ETS proximal, toe, distal and ETE proximal.  The ETS proximal region (1.198 ± 0.203) had the highest c-jun
Mean Normalized Staining Index ROI followed by the ETE proximal (1.181 ± 0.109) and ETS distal (1.219
± 0.046) regions.  These c-jun indices were significantly higher than those for the ETS heel (0.896 ± 0.065),
toe (0.804 ± 0.119) and hood (0.888 ± 0.052) regions.  The ETS toe region (0.804 ± 0.119) had the lowest
c-jun Mean Normalized Staining Index ROI of the perfused regions and this value was significantly lower than
the c-jun Mean Normalized Staining Index ROI for the ETS proximal (1.198 ± 0.203), distal (1.219 ± 0.046),
floor (1.124 ± 0.100) and ETE proximal (1.181 ± 0.109) and anastomosis (1.066 ± 0.124) regions.
In the retrograde flow experiments, the regions that were significantly different from the highest number
of other regions were ETS distal, toe, ETE proximal and anastomosis.  The ETS distal (1.191 ± 0.100) and
ETE anastomosis (1.211 ± 0.062) regions had the highest c-jun Mean Normalized Staining Indices ROI.  These
values were significantly higher than the c-jun Mean Normalized Staining Index ROI for the ETS toe (0.916
± 0.100) and  ETE proximal (0.946 ± 0.076) regions, which had the lowest c-jun indices of the perfused
regions.
Although the regional variation of c-jun Mean Normalized Staining Index ROI depended on the flow
condition in the proximal artery, there were no statistically significant differences for any of the regions of
interest due to the imposed flow condition.  For example, even though the c-jun Mean Normalized Staining
Index ROI in the ETS hood region was lower in the zero flow experiments (0.888 ± 0.052) as opposed to the
retrograde flow experiments (1.021 ± 0.061), this difference was not statistically significant (p = 0.136).
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When the data from both sets of experiments were pooled (Figure 2.21), the region that had the most
significantly different c-jun Mean Normalized Staining Index ROI was the ETS toe region.  The c-jun Mean
Normalized Staining Index ROI for ETS toe (0.860 ± 0.075) was significantly less than the c-jun Mean
Normalized Staining Index ROI for the ETS proximal (1.126 ± 0.081), distal (1.205 ± 0.052), graft (1.047 ±
0.050), floor (1.095 ± 0.055), ETE proximal (1.064 ± 0.074) and anastomosis  (1.138 ± 0.070) regions.  The
highest c-jun Mean Normalized Staining Indices ROI occurred for the ETS distal (1.205 ± 0.052) and ETE
proximal (1.064 ± 0.074) regions.  These values were significantly higher than those for the ETS heel (0.957
± 0.060), toe (0.860 ± 0.075) and hood (0.955 ± 0.044) regions.
Similar to the c-fos data, there was evidence that the regional variation of c-jun protein levels was due
to hemodynamic forces.  The ETE proximal and anastomosis regions were not significantly different from
each other indicating that surgical trauma and use of the VCS™ clips did not induce nuclear c-jun protein
expression. Additionally, all regions of interest from perfused vessels (except ETS toe for the zero flow
experiments) showed significantly higher c-jun protein levels compared to the nonperfused segment
indicating that the perfusion was responsible for the nuclear c-jun protein expression.
2.3.2.3 Regional Variation of Egr-1 Protein
The egr-1 Mean Normalized Staining Indices ROI followed the same trend for both flow conditions
(Figure 2.19).  In the zero flow experiments, the ETE proximal region was the only region that was
significantly different from others.  The ETE proximal region (0.865 ±0.082) had the lowest egr-1 Mean
Normalized Staining Index ROI of the perfused regions and this value was significantly lower than the egr-1
Mean Normalized Staining Index ROI for the ETS toe (1.086 ± 0.078), distal (1.175 ± 0.073), graft (1.102 ±
0.042) and floor (1.121 ± 0.095) regions.
In the retrograde flow experiments, the ETE proximal region (0.839 ± 0.116) again had the lowest egr-1
Mean Normalized Staining Index ROI.  This value was statistically significant with respect to the ETS hood
(1.248 ± 0.077) and ETE anastomosis (1.245 ± 0.180) regions, which had the highest egr-1 expression.
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Although the regional variation of egr-1 Mean Normalized Staining Index ROI depended on the flow
condition in the proximal artery, there were no statistically significant differences for any of the regions of
interest due to the imposed flow condition.  For example, even though the egr-1 Mean Normalized Staining
Index ROI in the ETS hood region was lower in the zero flow experiments (1.067 ± 0.059) as opposed to the
retrograde flow experiments (1.248 ± 0.077), this difference was not statistically significant (p = 0.097).
When the data from both sets of experiments are pooled (Figure 2.22), the significant reduction in egr-1
expression in the ETE proximal region becomes even more pronounced.  The egr-1 Mean Normalized
Staining Index ROI for ETE proximal (0.852 ± 0.067) is significantly lower than that of the ETS heel (1.082
± 0.052), distal (1.129 ± 0.065), graft (1.070 ± 0.075), floor (1.080 ± 0.065), hood (1.158 ± 0.055) and ETE
anastomosis (1.117 ± 0.101).
Contrary to the c-fos and c-jun data, there is not clear evidence that the regional variation of egr-1
protein expression is caused  by hemodynamic forces.  Although all regions of interest from perfused vessels
showed significantly higher egr-1 protein levels compared to the nonperfused segment, the expression of egr-
1 in the ETE proximal and anastomosis regions was significantly different from each other.  Therefore it is
possible that the surgical manipulation necessary to construct the anastomoses or other factors induced a
larger amount of nuclear egr-1 protein expression than the regional variation of hemodynamics.
2.3.2.4 Regional Variation of EC and SMC Apoptosis
Contrary to the IEG protein data, the EC and SMC apoptosis Mean Normalized Staining Indices ROI did
not vary significantly between regions (Figure 2.20).  In the zero flow experiments, the ETS toe region (1.349
± 0.363) had the highest EC apoptosis Mean Normalized Staining Index ROI and the ETS floor region (0.498
± 0.135) had the lowest although neither of these were significantly different from any other region,
including the nonperfused segment.  The ETS toe region (1.675 ± 0.578) also had the highest SMC apoptosis
Mean Normalized Staining Index ROI, while the ETS hood region (0.604 ± 0.277) had the lowest level of
SMC apoptosis.  However, these were not significantly different from any other region, including the
nonperfused segment.  
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In the retrograde flow experiments, the EC apoptosis Mean Normalized Staining Indices ROI qualitatively
followed the same trend as the c-fos Mean Normalized Staining Indices ROI for the same flow condition.
However, the highest levels of EC apoptosis, occurring in the ETS proximal (1.263 ± 0.138) and distal artery
(1.235 ± 0.230) regions, were not  significantly higher than that of the region with the lowest EC apoptosis
Mean Normalized Staining Index ROI, the ETS floor (0.672 ± 0.174).  The SMC apoptosis Mean Normalized
Staining Index ROI was again highest in the ETS toe region (1.439 ± 0.375) and the lowest level of SMC
apoptosis occurred in the ETS graft region (0.593 ± 0.284) yet neither of these were significantly different
from the other regions. 
Although the regional variation of EC and SMC apoptosis Mean Normalized Staining Indices ROI
depended on the flow condition in the proximal artery, there were no statistically significant differences for
any of the regions of interest due to the imposed flow condition.  For example, even though the EC apoptosis
Mean Normalized Staining Index ROI in the ETS hood region was lower in the zero flow experiments (0.597
± 0.215) as opposed to the retrograde flow experiments (1.011 ± 0.139), this difference was not statistically
significant (p = 0.145).  Similarly, even though the SMC apoptosis Mean Normalized Staining Index ROI in
the ETS floor region was higher in the zero flow experiments (1.082 ± 0.567) as opposed to the retrograde
flow experiments (0.627 ± 0.190), this difference was not statistically significant (p = 0.469).  
When the data from both sets of experiments were pooled (Figure 2.22), the reduction in EC apoptosis
Mean Normalized Staining Index ROI in the ETS floor region becomes more pronounced.  However, the EC
apoptosis Mean Normalized Staining Index ROI for ETS floor (0.585 ± 0.108) was still not significantly lower
than that of any region including those with the highest EC apoptosis Mean Normalized Staining Indices ROI,
the ETS proximal (1.198 ± 0.137), toe (1.148 ± 0.200), and distal (1.168 ± 0.296).  The pooled SMC
apoptosis data showed an enhanced increase in the SMC apoptosis Mean Normalized Staining Index ROI in
the ETS toe region (1.557 ± 0.327) and the ETS graft region had the lowest SMC apoptosis Mean
Normalized Staining Index ROI (0.647 ± 0.498) but neither of these were significantly different from the other
regions.
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For all experiments, the EC and SMC apoptosis Mean Normalized Staining Index ROI in the perfused
regions were not significantly different from the EC and SMC apoptosis Mean Normalized Staining Index
ROI found in the nonperfused segment.  Therefore, the surgical manipulation of the vessels during anastomosis
construction does not induce regulated EC death.  In addition, the use of the VCS™ clips to secure the
anastomosis did not induce EC or SMC apoptosis since there was no significant difference between the EC
and SMC apoptosis Mean Normalized Staining Indices ROI for the proximal and anastomosis regions of the
ETE construct.
2.4 Discussion
2.4.1 Regional Variation of IEG Protein
A significant, regional variation of IEG protein existed in ETS anastomoses perfused ex vivo but the
degree of EC and SMC apoptosis did not vary regionally.  In our experiments, nuclear protein staining for
c-fos, c-jun and egr-1 was localized primarily to the endothelial layer while both EC and SMC exhibited
apoptosis.  For the zero flow experiments, the c-fos and EC apoptosis Mean Staining Indices were
significantly lower than the c-jun and egr-1 Mean Staining Indices.  For the retrograde flow experiments, the
c-fos and EC apoptosis Mean Staining Indices increased significantly compared to their levels for the zero
flow condition but these levels were still lower than the c-jun Mean Staining Index.  The c-jun Mean Staining
Index was also significantly higher than the egr-1 Mean Staining Index.  For all experiments, the SMC
apoptosis Mean Staining Index was significantly lower than all other Mean Staining Indices.
The ETS regions of interest that had significantly different Mean Normalized Staining Indices ROI as
compared to the ETE proximal artery segment (i.e., control) for all of the experiments are presented in Table
2.1.  The arrows indicate a significantly increased or decreased Mean Normalized Staining Index ROI in that
region compared to the ETE proximal artery segment. 
The regions with the most number of significant differences relative to the ETE proximal artery segment
were the ETS toe and hood regions.  For the ETS toe region, the c-fos and c-jun Mean Normalized Staining
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Indices ROI were significantly decreased in the zero flow experiments while the egr-1 Mean Normalized
Staining Index ROI was significantly increased.  It is expected that c-fos and c-jun protein expression may
follow the same trend since they  bind together to form the AP-1 transcription factor that regulates
downstream gene expression [27, 49, 51].  For the ETS hood region, the c-jun Mean Normalized Staining
Index ROI was significantly decreased in the zero flow experiments.  The c-fos Mean Normalized Staining
Index ROI in the ETS hood was significantly decreased for the retrograde flow experiments while the egr-1
Mean Normalized Staining Index ROI was significantly increased.
The Mean Normalized Staining Indices ROI with the most number of regions with significant differences
were the c-jun and egr-1 Mean Normalized Staining Indices ROI.  For the zero flow experiments, the c-jun
Mean Normalized Staining Index ROI was significantly decreased in the ETS heel, toe and hood regions.  The
egr-1 Mean Normalized Staining Index ROI was significantly increased in the ETS toe, distal, graft and floor
regions.  For the retrograde flow experiments, the c-jun Mean Normalized Staining Index ROI was
significantly increased in the ETS distal region while no significant differences existed for the egr-1 Mean
Normalized Staining Index ROI.
C-fos C-jun Egr-1 EC/SMC Apoptosis
Zero Retro Zero Retro Zero Retro Zero Retro
ETS proximal - - - - - - - -
ETS heel - -      - - - - -
ETS toe      -      -     - - -
ETS distal - - -         - - -
ETS graft - - - -     - - -
ETS floor - - - -     - - -
ETS hood -           - -     - -
Table 2.1 Summary of the Mean Normalized Staining Indices ROI in the ETS regions of interest for the
two flow conditions (zero and retrograde) in the proximal artery.  The arrows indicate a significantly (p
< 0.05) increased or decreased value of the Mean Normalized Hemodynamic Index ROI in that region
compared to the ETE proximal artery segment (i.e., control) for the same flow condition.
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In all cases where the Mean Normalized Staining Indices ROI for a particular region of interest was
significantly different for one flow condition, it was not significant for the other flow condition.  For
example, the c-fos and c-jun Mean Normalized Staining Indices ROI for the ETS toe region were significantly
decreased in the zero flow experiments but there were no significant differences in these indices for the
retrograde flow experiments.  Similarly, the egr-1 Mean Normalized Staining Index RO I was significantly
increased in the ETS toe, distal, graft and floor regions for the zero flow experiments while there were no
significant differences for these regions in the retrograde flow experiments.  In fact, 8 of the 11 significant
differences occurred for the zero flow experiments while only 3 occurred for the retrograde flow
experiments.
In most cases, the Mean Normalized Staining Index RO I for the ETE proximal artery segment and the
ETE anastomosis region were not significantly different (see Figures 2.17 - 2.20).  These data indicate that
the significant differences for the ETS regions of interest are due to the altered hemodynamics in the ETS
anastomosis as opposed to the surgical manipulation of the vessels and use of the VCS™ clips to secure the
anastomosis.  However, there were significant differences in the c-jun and egr-1 Mean Normalized Staining
Indices ROI in the ETE anastomosis region compared to the ETE proximal artery region for the retrograde
flow experiments.  Therefore the significant increases in the c-jun Mean Normalized Staining Index ROI for
the ETS distal region and the egr-1 Mean Normalized Staining Index ROI in the ETS hood region for the
retrograde flow experiments may not solely be due to the altered hemodynamic environment in the ETS
anastomosis. 
While there were significant differences in the Mean Normalized Staining Index ROI for c-fos, c-jun and
egr-1 in the ETS regions of interest, the EC apoptosis and SMC apoptosis Mean Normalized Staining Indices
ROI were not significantly different from the control segment.  In addition, the levels of EC and SMC
apoptosis Mean Normalized Staining Indices ROI in the perfused regions were not significantly different from
that found in the nonperfused segments (see Figure 2.20).  Because there was no significant difference
between the EC apoptosis indices for the proximal and anastomosis regions of the ETE construct, the surgical
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manipulation of the vessels and use of the VCS™ clips to secure the anastomosis does not induce regulated
EC death.
2.4.2 Limitations
We chose an ex vivo perfusion model so that we could control the pressure and flow conditions in ETS
and ETE anastomoses in a precise manner.  Although an in vivo model would be more physiologically
relevant, we would not be able to regulate or even continuously measure the pressure and flow over time.
Therefore, the ex vivo perfusion model allows us to isolate the hemodynamic influence on IEG protein
expression and EC apoptosis while providing a simulated physiologic environment (i.e. pH, oxygen,
temperature, nutrients, etc.) for the vessels.  However, we have neglected one main physiological component,
pulsatility.  We chose to complete these experiments under steady flow conditions because of the technical
difficulties in creating and perfusing anastomoses ex vivo.  Future studies in our laboratory could easily
incorporate pulsatility since the perfusion system already has these capabilities and we have now had
extensive experience in creating the anastomoses.
2.5 Conclusion
We have shown that a significant regional variation of IEG proteins (c-fos, c-jun and egr-1) exists in
ETS and ETE anastomoses perfused ex vivo under two flow conditions imposed in the proximal artery (zero
and retrograde flow).  The levels of c-fos and c-jun protein are highest in the ETS proximal and distal artery
segments while the lowest levels of c-fos and c-jun protein occur in the regions in and near the anastomosis
including the ETS heel, toe, floor and hood.  There was no significant difference between the ETE proximal
and anastomosis regions indicating that the surgical manipulation and use of vascular clips to create an
anastomosis do not contribute to differences in c-fos and c-jun protein expression.  In contrast, the only
region showing consistently different egr-1 protein expression was the ETE anastomosis segment, which was
lower than almost all other regions.  This indicates that the surgical trauma associated with the creation of
the anastomosis may be the primary cause of egr-1 protein expression.  EC/SMC apoptosis did not vary
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significantly between any regions and therefore does not appear to be important regionally at this acute time
point. 
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3 .0 COMPUTATIONAL FLUID DYNAMIC MODELS
3.1 Introduction
Computational fluid dynamics is a method for solving the flow field in a complex geometry.  Although
analytical equations can be solved for a small set of idealized geometries, most realistic geometries require
the use of CFD.  For CFD models, the geometry is discretized into many smaller domains (a grid) over which
the basic governing equations can be solved and, through an iterative technique, a solution for the entire
domain can be determined.  There are a number of discretization techniques including the finite volume
method, the finite element method, the finite difference method and the boundary element method.  The
models for this project were developed using the finite volume method.
3.1.1 Finite Volume Method
The finite volume method is a discretization technique that is useful for fluid flow solutions because
it conserves flow quantities. The large, complex geometry is first sectioned into smaller domains known as
finite volumes which comprise the computational grid.  Once this grid, or mesh, is constructed, the governing
equations can be solved for each finite volume, or cell.   The governing equations for incompressible flow
(neglecting gravity) are the conservation of linear momentum (Equation 3.1) and continuity (Equation 3.2):
[3.1]
[3.2]
where t is time, D is the density of the fluid, V is the velocity vector (V = ui + vj + wk), L is the gradient
operator given by
[3.3]
p is the pressure and J is the viscous stress tensor.  For a Newtonian fluid, the viscous stress tensor is given
by:
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Figure 3.1 Two dimensional, uniform grid used for
finite volume discretization. 
[3.4]
where : is the dynamic viscosity of the fluid .  
These partial differential equations are discretized on the computational grid, forming a corresponding
set of algebraic equations.  For illustration purposes, the finite volume discretization of the governing
equations for steady flow for a two-dimensional cell on a uniform grid (shown in Figure 3.1) is derived.  For
more detailed information, the interested reader is referred to [159].  The cell of interest, P, is surrounded
by its neighbors, east (E), west (W), north (N) and south (S).  Discrete values of velocity are stored at the
cell centroids along with the fluid viscosity.  The cell faces e, w, n, s are associated with area vectors Ae, Aw,
An and As that are positive pointing outwards from cell P.  The volume of the cell (per unit thickness) is given
by ) =  )x )y.  Each of the  x and y components of the linear momentum equation (Equation 3.1) for
steady flow of a Newtonian fluid can be written in the form of a general transport equation as: 
[3.5]
where, for the x-component,  S is given by
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[3.6]
and J is given by 
[3.7]
and M = u, ' = µ.  Note that for the y-component, S = -Mp/dy and M = v.  Since similar methods are used for
the discretization of the equations for the x and y components, we will focus only on the x-component for
this demonstration.  Equation 3.5 is integrated over ) to obtain
[3.8]
Applying the divergence theorem to the first integral results in
[3.9]
where A is the perimeter of the cell P.  In the finite volume discretization technique, J is assumed to vary
linearly over each face of the cell P.  Therefore, the value of J on each face may be represented by its value
at the face centroid.  Assuming that the mean value of the source term over the control volume is S*,
integrating Equation 3.9 over cell P yields
[3.10]
where S* is given by
[3.11]
and pe and pw are the pressures at the east and west faces of cell P.  Then, Equation 3.10 can be written as
[3.12]
where for unit thickness of the cell, the area vectors are given by
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[3.13]
Using Equations 3.7 and 3.13, the flux term for the east face has the following form:
[3.14]
and the terms for the other faces are analogous.  Assuming that M varies linearly between cell centroids, the
flux term for the east face becomes
[3.15]
and the terms for the other faces are analogous.  We also assume that p varies linearly between cell centroids,
so that the pressure term becomes
[3.16]
Rearranging Equation 3.12 and using the flux terms analogous to Equation 3.15 for all faces along with





As mentioned previously, the y-component of linear momentum is discretized for each cell in the same
manner and the resulting equation has the same form as Equations 3.17 and 3.18 except that M = v and b =
(pS - pN))y.  In addition, the continuity equation is also discretized for each cell and has the following form:
[3.19]
The following set of algebraic equations, consisting of the discretized forms of the x and y components of
the linear momentum equations (Equation 3.20) and the continuity equation (Equation 3.21), are developed
for each cell in the grid and are then solved numerically:
[3.20]
[3.21]
A velocity-pressure coupling technique is used to determine the components of velocity and the pressure
term as shown schematically in Figure 3.2.  An initial guess for the pressure term is determined and then the
set of algebraic equations corresponding to the linear momentum equation is solved numerically, yielding
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Figure 3.2 Flowchart of the iterative algorithm used to solve for the pressure and
velocity fields.
the components of velocity.  This velocity field is placed into the set of equations corresponding to the
continuity equation to determine if continuity is satisfied.  If not, another iteration is performed with a
modified guess for the pressure term.  An iterative solution scheme is utilized so that the solution for each
grid point is improved for each iteration until the error for the entire domain is acceptably small.   
There are a number of commercially-available CFD software programs that utilize the finite volume
method, including CFD-ACE™ (CFD Research Corporation, Huntsville, AL).  These programs allow the
user to create a desired complex geometry, create a computational grid, apply desired boundary conditions
and solve for the velocity and pressure field within the domain.  Hemodynamic parameters such as WSS and
WSSG can be calculated from the resulting velocity field, providing a continuous representation of these
parameters.
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3.1.2 Advantages of CFD
There are a number of advantages to using CFD as opposed to relying on analytical or experimental
determinations of hemodynamic parameters.  Most striking is the ability to identify the velocity field in a
complex, physiologically realistic geometry.  Analytical equations can only be used for simple, idealized
geometries that have closed form solutions [159] such as cylindrical tubes.  However, such geometries do
not capture the reality of bending and branching vasculature.  CFD also provides a complete definition of
the flow field.  Experimental flow visualization models can be used to understand the general flow dynamics
in a complex geometry but the velocity measurements are made at discrete points and do not allow for the
determination of the entire velocity field.   Additionally, there are severe limitations in the resolution and
accuracy of the velocity measurements and these errors are magnified for quantities such as WSS and WSSG
that are derived from the flow field.  These same problems occur for in vivo studies using velocity
transducers.
Because CFD allows for the continuous representation of the flow field and derived hemodynamic
parameters in complex geometries, it is ideal for characterizing blood flow.  The progressive increase in
computational power, speed and the development of commercially-available CFD packages, have allowed
this technology to be used extensively for studies of the cardiovascular system as detailed in section 1.5 [66,
78, 83-87, 89-102, 154].
3.2 Methods
To obtain an accurate and precise measurement of the hemodynamic environment present in each of
the experimental anastomoses described in Chapter 2, three dimensional reconstructions of each ETS and
ETE anastomosis were created.  Since the pressure and flow rate in the ex vivo perfusions were set and
maintained throughout the experiment, CFD models utilized this information along with the anastomotic
geometry to accurately estimate WSS and WSSG.  This process allows for a distinct and unique coupling
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between the perfusion experiment (i.e., the spatial distribution of biologic end points) and the computational
simulation (i.e., the spatial distribution of WSS and WSSG) that has not been previously achieved.
3.2.1 Three Dimensional Reconstruction
3.2.1.1 Ellipse Fitting
As explained in section 2.2.8.3., the anastomoses were sliced into 2mm segments. High resolution,
digital photographs of the frozen slices were taken with a Nikon Coolpix 950 digital camera as seen in
Figures 3.3, 3.4 and 3.5.  These JPEG images were converted to TIFF images using Adobe Photoshop.  Using
Scion Image, the best-fit ellipse for each cross-section was determined.  Each TIFF image was scaled based
on the ruler included in the photograph.  For each cross-section, the binary threshold level was optimized to
reveal the inner wall and the automatic boundary detection algorithm was implemented as shown in Figure
3.5.  This highlighted the outline of the inner wall and, by using the analyze-measure command, the best-fit
ellipse parameters (major  axis, minor axis, angle of orientation) were recorded.  This was repeated for all
cross-sections for the ETS graft, proximal and distal artery regions as well as for all cross-sections of the
ETE anastomosis.  For the ETS anastomosis cross-sections, two separate ellipses were fit to the hood and
floor.
3.2.1.2 Surface Creation
A three dimensional surface was created by stacking the two dimensional ellipses fit to each cross-
section as follows. Note that the detailed protocol can be found in Appendix A.  The models were assumed
to be symmetric since the experimental apparatus held the vessels in a plane of symmetry.  To impose
symmetry, the ellipse angle of orientation was forced to be either 0, 90, 180 or 270 degrees with respect to
the plane of symmetry. Ellipses with measured angles of orientation between 0 and 45 degrees were set to
0 degrees. Ellipses with measured angles of orientation between 45 and 90 degrees were set to 90 degrees
and so on.  These modified ellipses were input into CFD-GEOM, the preprocessor for CFD-ACE™.  
For the ETE models, a lofted surface was created whereby the surface was extruded from one cross-
section to the next, using splines to smooth the portion of the surface between the cross-sections.  The lofted
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Figure 3.3 Frozen cross-sections of the graft and
proximal artery regions from an ETS anastomosis. 
Figure 3.5 Procedure for determining the best-fit ellipse for each cross-section The original image
(left) is scaled and the threshold level is optimized for the cross-sections of interest (left center).  The
boundary is automatically detected (right center) and the best-fit ellipse parameters are determined
by Scion Image (right).
Figure 3.4 Frozen cross-sections of the distal artery
regions from an ETS anastomosis. 
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surface was created by connecting the most proximal ellipse to the next ellipse in line until the surface was
complete (see Figure 3.6).  Note that the X = 0 plane was defined as the cross-section where the VCS™ clips
were placed and the centroids of all ellipses determined the Y = 0 and Z = 0 planes.  For the ETS models,
the first or second set (depending on the individual geometry) of overlapping ellipses was chosen as the
intersection point for the graft, proximal and distal artery surfaces.  A lofted proximal artery surface was
created by connecting the most proximal ellipse to the next ellipse in line until the intersection point was
reached (see Figure 3.7).  A similar method was used to create the graft surface.  To construct the distal
artery surface, the remaining overlapping ellipses were intersected and trimmed to create a figure-eight shape.
These figure-eight shapes were lofted in succession and the surface continued by lofting the single distal
artery ellipses.  This allowed for a smooth surface along the toe of the ETS anastomosis.  Note that the X =
0 plane was defined as the most distal cross-section with double ellipses and the centroids of all proximal
artery, floor and distal artery ellipses determined the Y = 0 and Z = 0 planes.
To allow for fully developed flow at the inlets and outlets of the models, additional straight tube
surfaces were created upstream of the proximal artery segments and downstream of the distal artery segment
for all models as shown in Figures 3.8A and 3.9A.  The ETS models had an additional straight tube extension
upstream from the graft (see Figure 3.9A).  For the ETE proximal artery extension, a circular cross-section
with a diameter equal to the average of the minor and major axis dimensions of the most proximal elliptical
cross-section was placed ~20 diameters upstream from the most proximal elliptical cross-section.  A lofted
surface was created by connecting the upstream circular cross-section to the most proximal elliptical cross-
section.  The ETE distal artery and ETS extensions were created in a similar manner.  The lengths of all
extensions were based on the dimensions used in our previous studies of idealized ETS anastomosis models
and those of other research groups [89, 96, 154].  Each extension had a different length depending on the
magnitude of disturbed flow expected in that region.  For example, the extensions for the ETE proximal
artery and ETS graft were ~20 diameters because these were inlet regions where uniform plug flow was
prescribed upstream and the flow needed a length of approximately 10 diameters to fully develop, depending
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Figure 3.6 Three dimensional  ETE surface reconstruction technique.  The ETE surface is created by lofting
single ellipses along the length of the anastomosis.  
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Figure 3.7 Three dimensional ETS surface reconstruction technique.  Each surface is created by lofting
either single ellipses (black=proximal artery, light grey=graft) and intersecting and single ellipses (dark grey
= distal artery).
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on the velocity magnitude [219].  The extension for the ETE distal region was also ~20 diameters because
the flow exiting the ETE model was expected to be fairly uniform.  However, the flow exiting the ETS
models was not expected to be uniform so the distal artery extension was much longer, ~75 diameters.  For
the zero flow ETS models, no flow exited the proximal artery so the extension was short, ~5 diameters. For
the retrograde flow ETS models, some flow exited the proximal artery region so the extension was slightly
longer, ~10 diameters, but still much shorter than the ETS distal artery extension since only 20% of the flow
exited this segment.  For each model, it was confirmed that the resulting flow field was fully developed (i.e.,
parabolic velocity profile) before entering the reconstructed region and before exiting the distal artery.
Additionally, for the ETS models, it was confirmed that the proximal artery boundary did not interfere with
the recirculation region in the proximal artery.
3.2.2 Mesh Creation
In order to numerically solve the governing equations using CFD, it was necessary to discretize the three
dimensional geometry.  This physical discretization is known as grid, or mesh, development.  For these
models, a body-fitted, structured grid was created using CFD-GEOM™.  Body-fitted meshes conform to the
boundaries of the surface geometry and are required for irregularly-shaped geometries.  Structured grids have
a specific layout such that the control volumes, or cells, are arranged in rows, columns and layers.  A
structured grid was chosen because of the ability to tightly regulate the spacing of the grid which is
particularly important when calculating derived, near-wall quantities such as WSS.  All cells in these models
were hexahedrals, or six-sided blocks. 
The ETE models consisted of 6 interconnecting blocks: an outer and inner block for the reconstructed
region and the two straight tube extensions (see Figure 3.8 B, C). Similarly, the mesh for the ETS models
consisted of 12 interconnecting blocks: an outer and inner block for the graft, proximal and distal artery
segments as well as the three straight tube extensions (see Figure 3.9 B, C).  The inner block mesh allowed
for well-aligned cells along the wall, crucial for accurate WSS calculation.  The cells were ordered such that
the I direction generally followed along the long axis of the vessel, the J direction generally followed the 
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Figure 3.8 Body-fitted, structured mesh for the complete ETE anastomosis model.  The top figure (A) shows
the complete model including the reconstructed region and the straight extensions.  Perspective views of the
mesh illustrating the B) outer and C) inner blocks are shown in the center figures where I, J and K refer to
the mesh direction.  The bottom figure (D) shows a perspective view of the reconstructed region.
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Figure 3.9 Body-fitted, structured mesh for the complete ETS anastomosis model.  The top figure (A) shows
the complete model including the reconstructed region and the straight extensions.  Perspective views of the
mesh illustrating the B) outer and C) inner blocks are shown in the center figures where I, J and K refer to
the mesh direction.  The bottom figure (D) shows a perspective view of the reconstructed region.
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Mesh 1 Mesh 2 Mesh 3 Mesh4
ETS zero 33920 78624 138852 285714
ETS retrograde 36320 84096 148596 305694
ETE 27360 61056 106372 221112
Table 3.1 Number of cells in the ETS zero flow, ETS retrograde flow
and ETE models used to determine mesh independence.
circumferential direction around the vessel and the K direction was radial in orientation; i.e., from the
innermost layer of the vessel to the outer wall (see Figures 3.8 B, C and 3.9 B, C).  Figures 3.8D and 3.9D
show a close-up view of the high density mesh in the reconstructed region.  The mesh for the straight tube
extensions was not as dense because the flow field was not complex in these regions. 
3.2.3 Mesh Independence
To determine the mesh density needed for all simulations, four different grids were created for one
model each for the ETS zero flow case, ETS retrograde flow case and the ETE case.  The initial mesh
distribution and density was based on the mesh used in our previous studies of idealized ETS anastomosis
models [154].  For each ETS and ETE case, a mesh with approximately twice as many cells as the initial
mesh was developed, as well as meshes with half and a quarter number of the cells, where the change in
density was uniform in all three dimensions. This is a well-established method for determining mesh
independence [94, 160].  Table 3.1 shows the number of cells for each mesh. The ETS zero flow meshes
ranged from 33920 to 285714 cells.  The number of cells in the ETS retrograde flow meshes ranged from
36320 to 305694 cells.  The number of cells in the ETE meshes ranged from 27360 to 221112 cells.  The
most dense mesh (mesh 4) was used as the standard for comparison for the other grid densities, since a mesh
with the highest density should result in the most accurate solution [159]. The spatial averages of WSS and
WSSG magnitude were calculated at the seven regions of interest for the ETS models and the two regions
of interest in the ETE models.  The percent differences between the WSS and WSSG values obtained in




The pressure and flow rate boundary conditions for the models were determined by the conditions
prescribed in each experimental perfusion that was modeled (see Chapter 2).  The graft inlet boundary
condition for the ETS models and the proximal artery inlet condition for the ETE models were assigned as
a plug flow (flat velocity profile) equal to the experimentally applied value in each case.  Table 3.2 shows
that experimental flow rate values for the inlets/outlets for each anastomosis and the corresponding velocity
imposed in the CFD models.  The ETS graft and ETE proximal artery domains were long enough (>10 vessel
diameters), both in the experiments and the CFD models, to ensure fully-developed flow before reaching the
anastomosis.  For the retrograde flow ETS models, the proximal artery extension outlet had a plug flow rate
equal to the experimentally applied value in each case.  The proximal and distal artery segments were long
enough to avoid any interference between the flow at the anastomosis and the prescribed outlet conditions.
Finite volume methods require that a reference pressure be prescribed for at least one grid point.  Therefore,
for all models, a fixed pressure (arbitrarily chosen as zero) was prescribed at the distal artery outlet.  All
boundaries other than the symmetry plane had the no-slip boundary condition.
3.2.5 Solution Parameters 
CFD-ACE™ was used to solve the full Navier-Stokes equations for steady flow of a Newtonian fluid
(perfusion media) with a dynamic viscosity of 1 cP and density of 1000 kg/m3.  The Reynold’s number for
each simulation was between 600 and 1400, based on the density and viscosity of the fluid, mean velocity
in the graft and the graft diameter for the ETS models and on the mean velocity and diameter of the proximal
artery for the ETE models (see Table 3.2). The advection scheme was second-order upwind, the linear
equation solver was conjugate gradient and the pressure correction term was calculated using the SIMPLEC
algorithm.  The velocity and pressure under-relaxation values were 0.02 and 0.2, respectively.  The iterations
continued until the residuals were reduced by five orders of magnitude, which required typically ~1000
iterations.  An example of the output file from CFD-ACE™ is shown in the Appendix B. 
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Table 3.2 Experimental flow rate values for the inlets/outlets for each anastomosis and the corresponding
velocity imposed in the CFD models.  The Reynold’s number for each ETS anastomosis is based on the
density (1000 kg/m3) and viscosity (1 cP) of the perfusate, mean velocity prescribed at the graft inlet and the
graft diameter.  For the ETE anastomoses, the Reynold’s number is based on the mean velocity prescribed
at the proximal artery inlet and the proximal artery diameter.
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3.2.6 Calculation of Hemodynamic Parameters
Post-processing of the results included plotting the velocity vectors output from CFD-ACE™ as well
as calculating secondary flow, WSS and spatial WSSG, three parameters shown to be associated with IH
formation [78, 85, 90, 91, 138, 161-163].  The velocity at each cell was output directly from CFD-ACE™
and we plotted the velocity vectors on the symmetry plane in order to get a general understanding of the flow
field throughout the anastomosis.  In each cell, we then calculated the magnitude of secondary flow, R:
[3.22]
and plotted it on various cross-sections along the length of the anastomosis to visualize the degree of
nonuniform flow throughout the model.
The axial (i.e., along the I direction of the structured grid; see Figures 3.8 B, C and 3.9 B, C) and
circumferential (i.e., perpendicular to the I direction) components of WSS, along with the WSS magnitude
were calculated using custom FORTRAN code and Tecplot (Version 9.0, Amtec Engineering, Bellevue, WA)
as follows.  Note that the detailed protocol can be found in Appendix C. The normal vector (ni) on the outer
face of each cell was calculated with the CFD Analyzer add-in for Tecplot and was used to calculate the
vectors in the axial and circumferential directions using the custom FORTRAN program.  The first step in
determining the vector in the axial direction was to calculate the length and direction between the normal
vector of the current cell (ni) and the normal vector of the next cell (ni+1) in the axial direction (see Figure
3.10).  This calculated vector (dashed line arrow) was projected onto the cell surface and normalized,
resulting in the tangent vector in the axial direction, tax.  The vector in the circumferential direction, tcirc was
calculated orthogonal to both the normal (ni) and axial vectors (tax).  In order to calculate the axial and
circumferential components of WSS, the stress vector (J) was first calculated by multiplying the viscous
stress tensor, J (Equation 3.4), by the normal vector (ni).  Then the axial WSS was calculated as the dot
product between the stress vector (J) and the axial tangent vector (tax).  Similarly, the circumferential WSS
was calculated as the dot product between the stress vector (J) and the circumferential tangent vector (tcirc).
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Figure 3.10 Vector used to calculate the axial and
circumferential components of WSS.
The WSS magnitude was computed as the square root of the sum of the axial and circumferential components
squared.  The equations for the axial and circumferential components of WSS (Jax and Jcirc) and WSS
magnitude, |J|, are:
[3.23]
For the calculation of the axial and circumferential components and magnitude of WSSG, the gradients
of Jax and Jcirc, LJax and LJcirc, were computed in Tecplot:
[3.24]
Another FORTRAN program calculated the axial component of WSSG as the dot product between the
normalized axial gradient of Jax , LJax, and axial tangent vector, tax.  Similarly, the circumferential component
100
of WSSG was calculated as the dot product between the normalized circumferential gradient of Jcirc, LJcirc,
and the circumferential tangent vector, tcirc. The WSSG magnitude was computed as the square root of the
sum of the axial and circumferential components squared.  The equations for the axial and circumferential
components of WSSG (WSSGax and WSSGcirc) and WSSG magnitude, |WSSG|, are:
[3.25]
To determine a single, quantitative value for each hemodynamic parameter at the same regions of
interest chosen for the biologic endpoints (see section 2.2.8.3), each hemodynamic parameter was spatially
averaged over the region of interest.  Using the Tecplot CFD Analyzer add-in, a hemodynamic index was
calculated for each region of interest (Hemodynamic Index ROI) using the following formula:
[3.26]
Because the integration required a continuous mesh, each region of interest was defined as the mesh on the
outer wall (see Figure 3.11) that most closely corresponded to the 2mm slice used for the biologic endpoints.
For example, if the second axial slice was used for the biologic quantification for the proximal artery
segment, the mesh that overlapped the region between the second and third elliptical cross-sections was used
to define the computational proximal artery region of interest.  This process was used to determine six Mean
Hemodynamic Indices (i.e., axial, circumferential and magnitude of both WSS and WSSG) at the nine
regions of interest (i.e., ETS graft, proximal artery, distal artery, heel, toe, hood, floor, ETE proximal and
anastomosis regions).  A mean hemodynamic index for each region of interest (Mean Hemodynamic Index
ROI) was calculated by averaging the Hemodynamic Index ROI over all experiments (n) with the same flow
condition.
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Figure 3.11 The CFD regions of interest for a representative ETS model. 
[3.27]
Finally, the Mean Hemodynamic Index was calculated, which represented the mean value of the
hemodynamic parameter in all tissue exposed to one flow condition. This single, quantitative value was
calculated by averaging the Hemodynamic Index ROI over all regions of interest (m).
[3.28]
These data are presented as mean ± standard error of the mean (SEM).
3.2.7 Statistical Analysis
To compare Mean Hemodynamic Indices between flow conditions (i.e., axial WSS for the zero flow
experiments versus axial WSS for the retrograde flow experiments), unpaired Student’s t-tests were
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performed using the mean hemodynamic indices for each region of interest calculated for the five
experiments.  A difference was considered significant if this test rendered a p-value less than 0.05.
To be consistent with the Normalized Staining Index ROI used for the statistical analysis of the biologic
data, a Normalized Hemodynamic Index ROI was computed.  The normalized hemodynamic index for each
region of interest in one experiment (Normalized Hemodynamic Indices ROI) was calculated by dividing by
the corresponding mean hemodynamic index averaged over all regions of interest for the same experiment
(Mean Hemodynamic Index Experiment). 
[3.29]
Similar to the non-normalized data, a mean normalized hemodynamic index for each region of interest (Mean
Normalized Hemodynamic Index ROI) was calculated for all experiments (n) with the same flow condition
as:
[3.30]
The data are presented as mean ± SEM.
One-way ANOVA was used to determine if the Mean Normalized Hemodynamic Index ROI for each
hemodynamic parameter (i.e., axial, circumferential and magnitude of both WSS and WSSG) varied between
regions of interest for each flow condition [157].  If a significant (p < 0.05) F value was obtained, a post-hoc
paired comparisons test was completed to determine which regions of interest were significantly (p < 0.05)
different from each other.
To compare the Mean Normalized Hemodynamic Indices  ROI between flow conditions (e.g. axial WSS
in the toe region for the zero flow experiments versus axial WSS in the toe region for the retrograde flow
experiments), unpaired Student’s t-tests were performed using the Mean Normalized Hemodynamic Indices
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for each region of interest calculated for the five experiments.  A difference was considered significant if this
test rendered a p-value less than 0.05.
3.3 Results
3.3.1  Mesh Independence
The results of the mesh independence studies are shown in Figure 3.12 where the meshes were as
defined in Table 3.1.  For all models, the percent difference for WSSG was higher than for WSS since the
calculation of WSSG requires taking another derivative of the velocity field, thus magnifying errors.  The
highest percent differences occurred for the ETS zero flow models. 
For the ETS zero flow models, there was a dramatic decrease in the average percent difference when
increasing the grid density from mesh 1 (33920 cells) to mesh 2 (78624 cells).  The average percent
difference for WSS decreased from 50% to 23%.   The average percent difference for WSSG decreased from
74% to 35%.  When using mesh 3 (138852 cells), the decrease in the average percent difference was less
pronounced, decreasing to 14% for WSS and 18% for WSSG.  Because the slope of the average percent
difference for both WSS and WSSG decreased markedly when using mesh 3, we determined that the
substantial increase in CPU resources needed to calculate the results for all the simulations using mesh 4
(approximately 1 week versus 1 day) was not warranted. 
For the ETS retrograde flow models, there was a decrease in the average percent difference when
increasing the grid density from mesh 1 (36320 cells) to mesh 2 (84096 cells).  The average percent
difference for WSS decreased from 14% to 8%.   The average percent difference for WSSG decreased from
26% to 15%.  When using mesh 3 (148596 cells), the decrease in the average percent difference was less
pronounced, decreasing to 5% for WSS and 10% for WSSG.  Because the average percent difference for both
WSS and WSSG was less than 11% when using mesh 3, this mesh density was chosen, again in light of the
computational savings.
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Figure 3.12 WSS and WSSG magnitude percent differences (with respect to the most dense mesh, mesh 4)
averaged over the anastomosis regions of interest for the three types of simulations: A) ETS zero flow, B)
ETS retrograde flow and C) ETE models. 
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The mesh independence studies for the ETE models had similar results as those from the retrograde
flow models.  The average percent difference in WSS decreased from 13% to 7% when increasing the mesh
density from mesh 1 (27360 cells) to mesh 2 (61056 cells)and the average percent difference in WSSG
decreased from 22% to 15%.  A similar decrease in differences occurred when using mesh 3 (106372 cells)
where the average percent difference in WSS and WSSG decreased to 3% and 7%, respectively.  Because
the average percent difference for both WSS and WSSG was less than or equal to 7% when using mesh 3,
this mesh density was again chosen.
Therefore, all subsequent results are from the models with mesh 3.  Each ETS zero flow model
consisted of 138852 cells.  Each ETS retrograde flow model consisted of 148956 cells and each ETE model
consisted of 106372 cells.
3.3.2 Geometry
For clarity, the five ETS zero flow models will be referred to here as ETS-Z1, ETS-Z2, ..., ETS-Z5, and
the ETE control models as ETE-Z1, ETE-Z2, ..., ETE-Z5.  Similarly, the five ETS retrograde flow models
will be referred to as ETS-R1, ETS-R2, ..., ETS-R5, and the ETE control models as ETE-R1, ETE-R2, ...,
ETE-R5.  The geometry of each anastomosis is shown in the top panel (A) of Figures 3.13 - 3.17 (ETS-Z1
to ETS-Z5), 3.18 - 3.22 (ETS-R1 to ETS-R5), 3.23 - 3.27 (ETE-Z1 to ETE-Z5) and 3.28 - 3.32 (ETE-R1 to
ETE-R5), where all models  are shown on the same scale for comparison. Note that vessel caliber and degree
of tapering along the vessels varies between anastomoses.  For example, ETS-Z3 had a much smaller caliber
vessel segment used for the graft compared to the other experiments (see Figure 3.15). The corresponding
ETE anastomosis, ETE-Z3, also had a smaller caliber vessel (see Figure 3.25).  Along the length of all
anastomoses, there was a  variation in size and orientation of the elliptical cross-sections used to create the
reconstructions.  These changes in shape and size occurred because of the ligation of branching vessels
present along the native vessels as well as due to the tension caused by connecting the vessels together with
the vascular clips.  These variations in native vessels and anastomosis construction, underscore the necessity
of individual three dimensional reconstructions for each experiment.
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3.3.3 Velocity Vectors
The velocity vectors on the symmetry plane for each reconstructed anastomosis are shown in the center
panel (B) of Figures 3.13 - 3.17 (ETS-Z1 to ETS-Z5), 3.18 - 3.22 (ETS-R1 to ETS-R5), 3.23 - 3.27 (ETE-Z1
to ETE-Z5) and 3.28 - 3.32 (ETE-R1 to ETE-R5).  Note that the dimension and velocity scales are different
in this panel of each figure in order to optimize visualization.  There are a number of features of the flow
field which occur in all of the ETS models (see Figures 3.13 - 3.22).  Most notably, there is significant
skewing of the velocity towards the floor of the artery due to the entrance of the flow from the graft.  There
is also a recirculation region in the proximal artery near the heel that is intensified in the retrograde flow
simulations.  Additionally, regions of local geometric constriction leads to increased velocity while regions
of expansion develop recirculation zones.  Although these phenomena also occur in the ETE models (see
Figures  3.23 - 3.32), in general, the flow is more uniform for these than in the ETS models. 
3.3.4 Secondary Flow
The contours of secondary flow magnitude and streamlines on cross-sections at axial positions along
the anastomoses (i.e., proximal artery, graft, heel, hood, floor, toe and distal artery) are shown in the bottom
panels of Figures 3.13 - 3.17 (ETS-Z1 to ETS-Z5), 3.18 - 3.22 (ETS-R1 to ETS-R5), 3.23 - 3.27 (ETE-Z1
to ETE-Z5) and 3.28 - 3.32 (ETE-R1 to ETE-R5).  Note that the dimension scales are different in these
panels for each figure in order to optimize visualization.  The ETS models have regions of significant
secondary flow magnitude (see Figures 3.13 - 3.22).  The magnitude of the secondary flow is much lower
in the ETE models, as expected, although some recirculation regions do exist (see Figures 3.23 - 3.32).  Note
that for all models, the streamlines are projected onto the cross-section and are numerically drawn even if
the variations in secondary flow magnitude are close to zero.  This causes streamlines to appear to originate
or terminate at a wall.  Therefore, the most important information to be taken from the streamlines in the
areas of recirculation.
Similarities exist in the secondary flow present in the ETS zero and retrograde flow models (Figures
3.13 - 3.22).  All models have at least one region of secondary flow magnitude reaching 0.05 m/s.  All models
107
Figure 3.13 Geometry and velocity fields for ETS-Z1.  A) Profile of the outer walls of the
reconstructed geometry.  The solid outlines indicate the proximal artery, graft and distal artery
surfaces.  Note that the scale is the same for all ETS and ETE models.  B) Zoomed view of the model
showing the velocity vectors on the symmetry plane at different axial positions.  The bottom panels
show the contour plots of the secondary flow magnitude and streamlines at the axial positions
denoted in panel B: A1) graft, A2) proximal artery, B1) heel (in graft segment), B2) heel (in artery
segment), C) hood and floor, D) toe and E) distal artery.  Note that each panel illustrates a half cross-
section and the view is as if standing at the end of the proximal artery and looking downstream.  A
small recirculation region is present upstream of the heel and the velocity vectors distal to the
anastomosis are skewed toward the floor of the artery. 
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Figure 3.14 Geometry and velocity fields for ETS-Z2.  A) Profile of the outer walls of the
reconstructed geometry.  The solid outlines indicate the proximal artery, graft and distal artery
surfaces.  Note that the scale is the same for all ETS and ETE models.  B) Zoomed view of the model
showing the velocity vectors on the symmetry plane at different axial positions.  The bottom panels
show the contour plots of the secondary flow magnitude and streamlines at the axial positions
denoted in panel B: A1) graft, A2) proximal artery, B1) heel (in graft segment), B2) heel (in artery
segment), C) hood and floor, D) toe and E) distal artery.  Note that each panel illustrates a half cross-
section and the view is as if standing at the end of the proximal artery and looking downstream.  A
small recirculation region is present upstream of the heel and the velocity vectors distal to the
anastomosis are skewed toward the floor of the artery. 
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Figure 3.15 Geometry and velocity fields for ETS-Z3.  A) Profile of the outer walls of the
reconstructed geometry.  The solid outlines indicate the proximal artery, graft and distal artery
surfaces.  Note that the scale is the same for all ETS and ETE models.  B) Zoomed view of the model
showing the velocity vectors on the symmetry plane at different axial positions.  The bottom panels
show the contour plots of the secondary flow magnitude and streamlines at the axial positions
denoted in panel B: A1) graft, A2) proximal artery, B1) heel (in graft segment), B2) heel (in artery
segment), C) hood and floor, D) toe and E) distal artery.  Note that each panel illustrates a half cross-
section and the view is as if standing at the end of the proximal artery and looking downstream.  A
small recirculation region is present upstream of the heel and the velocity vectors distal to the
anastomosis are skewed toward the floor of the artery.  
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Figure 3.16 Geometry and velocity fields for ETS-Z4.  A) Profile of the outer walls of the
reconstructed geometry.  The solid outlines indicate the proximal artery, graft and distal artery
surfaces.  Note that the scale is the same for all ETS and ETE models.  B) Zoomed view of the model
showing the velocity vectors on the symmetry plane at different axial positions.  The bottom panels
show the contour plots of the secondary flow magnitude and streamlines at the axial positions
denoted in panel B: A1) graft, A2) proximal artery, B1) heel (in graft segment), B2) heel (in artery
segment), C) hood and floor, D) toe and E) distal artery.  Note that each panel illustrates a half cross-
section and the view is as if standing at the end of the proximal artery and looking downstream.  A
small recirculation region is present upstream of the heel and the velocity vectors distal to the
anastomosis are skewed toward the floor of the artery.  
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Figure 3.17 Geometry and velocity fields for ETS-Z5.  A) Profile of the outer walls of the
reconstructed geometry.  The solid outlines indicate the proximal artery, graft and distal artery
surfaces.  Note that the scale is the same for all ETS and ETE models.  B) Zoomed view of the model
showing the velocity vectors on the symmetry plane at different axial positions.  The bottom panels
show the contour plots of the secondary flow magnitude and streamlines at the axial positions
denoted in panel B: A1) graft, A2) proximal artery, B1) heel (in graft segment), B2) heel (in artery
segment), C) hood and floor, D) toe and E) distal artery.  Note that each panel illustrates a half cross-
section and the view is as if standing at the end of the proximal artery and looking downstream.  A
small recirculation region is present upstream of the heel and the velocity vectors distal to the
anastomosis are skewed toward the floor of the artery. 
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Figure 3.18 Geometry and velocity fields for ETS-R1.  A) Profile of the outer walls of the
reconstructed geometry.  The solid outlines indicate the proximal artery, graft and distal artery
surfaces.  Note that the scale is the same for all ETS and ETE models.  B) Zoomed view of the model
showing the velocity vectors on the symmetry plane at different axial positions.  The bottom panels
show the contour plots of the secondary flow magnitude and streamlines at the axial positions
denoted in panel B: A1) graft, A2) proximal artery, B1) heel (in graft segment), B2) heel (in artery
segment), C) hood and floor, D) toe and E) distal artery.  Note that each panel illustrates a half cross-
section and the view is as if standing at the end of the proximal artery and looking downstream.  As
with the zero flow cases, the velocity vectors distal to the anastomosis are skewed toward the floor
of the artery, though a larger  recirculation region is present upstream of the heel than in those cases.
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Figure 3.19 Geometry and velocity fields for ETS-R2.  A) Profile of the outer walls of the
reconstructed geometry.  The solid outlines indicate the proximal artery, graft and distal artery
surfaces.  Note that the scale is the same for all ETS and ETE models.  B) Zoomed view of the model
showing the velocity vectors on the symmetry plane at different axial positions.  The bottom panels
show the contour plots of the secondary flow magnitude and streamlines at the axial positions
denoted in panel B: A1) graft, A2) proximal artery, B1) heel (in graft segment), B2) heel (in artery
segment), C) hood and floor, D) toe and E) distal artery.  Note that each panel illustrates a half cross-
section and the view is as if standing at the end of the proximal artery and looking downstream.  As
with the zero flow cases, the velocity vectors distal to the anastomosis are skewed toward the floor
of the artery, though a larger  recirculation region is present upstream of the heel than in those cases.
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Figure 3.20 Geometry and velocity fields for ETS-R3.  A) Profile of the outer walls of the
reconstructed geometry.  The solid outlines indicate the proximal artery, graft and distal artery
surfaces.  Note that the scale is the same for all ETS and ETE models.  B) Zoomed view of the model
showing the velocity vectors on the symmetry plane at different axial positions.  The bottom panels
show the contour plots of the secondary flow magnitude and streamlines at the axial positions
denoted in panel B: A1) graft, A2) proximal artery, B1) heel (in graft segment), B2) heel (in artery
segment), C) hood and floor, D) toe and E) distal artery.  Note that each panel illustrates a half cross-
section and the view is as if standing at the end of the proximal artery and looking downstream.  As
with the zero flow cases, the velocity vectors distal to the anastomosis are skewed toward the floor
of the artery, though a larger  recirculation region is present upstream of the heel than in those cases.
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Figure 3.21 Geometry and velocity fields for ETS-R4.  A) Profile of the outer walls of the
reconstructed geometry.  The solid outlines indicate the proximal artery, graft and distal artery
surfaces.  Note that the scale is the same for all ETS and ETE models.  B) Zoomed view of the model
showing the velocity vectors on the symmetry plane at different axial positions.  The bottom panels
show the contour plots of the secondary flow magnitude and streamlines at the axial positions
denoted in panel B: A1) graft, A2) proximal artery, B1) heel (in graft segment), B2) heel (in artery
segment), C) hood and floor, D) toe and E) distal artery.  Note that each panel illustrates a half cross-
section and the view is as if standing at the end of the proximal artery and looking downstream.  As
with the zero flow cases, the velocity vectors distal to the anastomosis are skewed toward the floor
of the artery, though a larger  recirculation region is present upstream of the heel than in those cases.
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Figure 3.22 Geometry and velocity fields for ETS-R5.  A) Profile of the outer walls of the
reconstructed geometry.  The solid outlines indicate the proximal artery, graft and distal artery
surfaces.  Note that the scale is the same for all ETS and ETE models.  B) Zoomed view of the model
showing the velocity vectors on the symmetry plane at different axial positions.  The bottom panels
show the contour plots of the secondary flow magnitude and streamlines at the axial positions
denoted in panel B: A1) graft, A2) proximal artery, B1) heel (in graft segment), B2) heel (in artery
segment), C) hood and floor, D) toe and E) distal artery.  Note that each panel illustrates a half cross-
section and the view is as if standing at the end of the proximal artery and looking downstream.  As
with the zero flow cases, the velocity vectors distal to the anastomosis are skewed toward the floor
of the artery, though a larger  recirculation region is present upstream of the heel than in those cases.
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Figure 3.23 Geometry and velocity fields for ETE-Z1.  A) Profile of the outer wall of the
reconstructed geometry.  Note that the scale is the same for all ETS and ETE models.  B) Zoomed
view of the model showing the velocity vectors on the symmetry plane at different axial positions.
The bottom panels show the contour plots of the secondary flow magnitude and streamlines at the
axial positions denoted in panel B: C) proximal artery, D) anastomosis and E) distal artery.  Note
that each panel illustrates a half cross-section and the view is as if standing at the end of the proximal
artery and looking downstream.  Velocity increases in regions of constriction and recirculation
occurs in expansions.
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Figure 3.24 Geometry and velocity fields for ETE-Z2.  A) Profile of the outer wall of the
reconstructed geometry.  Note that the scale is the same for all ETS and ETE models.  B) Zoomed
view of the model showing the velocity vectors on the symmetry plane at different axial positions.
The bottom panels show the contour plots of the secondary flow magnitude and streamlines at the
axial positions denoted in panel B: C) proximal artery, D) anastomosis and E) distal artery.  Note
that each panel illustrates a half cross-section and the view is as if standing at the end of the proximal
artery and looking downstream.  Velocity increases in regions of constriction and recirculation
occurs in expansions. 
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Figure 3.25 Geometry and velocity fields for ETE-Z3.  A) Profile of the outer wall of the
reconstructed geometry.  Note that the scale is the same for all ETS and ETE models.  B) Zoomed
view of the model showing the velocity vectors on the symmetry plane at different axial positions.
The bottom panels show the contour plots of the secondary flow magnitude and streamlines at the
axial positions denoted in panel B: C) proximal artery, D) anastomosis and E) distal artery.  Note
that each panel illustrates a half cross-section and the view is as if standing at the end of the proximal
artery and looking downstream.  Velocity increases in regions of constriction and recirculation
occurs in expansions.
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Figure 3.26 Geometry and velocity fields for ETE-Z4.  A) Profile of the outer wall of the
reconstructed geometry.  Note that the scale is the same for all ETS and ETE models.  B) Zoomed
view of the model showing the velocity vectors on the symmetry plane at different axial positions.
The bottom panels show the contour plots of the secondary flow magnitude and streamlines at the
axial positions denoted in panel B: C) proximal artery, D) anastomosis and E) distal artery.  Note
that each panel illustrates a half cross-section and the view is as if standing at the end of the proximal
artery and looking downstream.  Velocity increases in regions of constriction and recirculation
occurs in expansions.
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Figure 3.27 Geometry and velocity fields for ETE-Z5.  A) Profile of the outer wall of the
reconstructed geometry.  Note that the scale is the same for all ETS and ETE models.  B) Zoomed
view of the model showing the velocity vectors on the symmetry plane at different axial positions.
The bottom panels show the contour plots of the secondary flow magnitude and streamlines at the
axial positions denoted in panel B: C) proximal artery, D) anastomosis and E) distal artery.  Note
that each panel illustrates a half cross-section and the view is as if standing at the end of the proximal
artery and looking downstream.  Velocity increases in regions of constriction and recirculation
occurs in expansions.
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Figure 3.28 Geometry and velocity fields for ETE-R1.  A) Profile of the outer wall of the
reconstructed geometry.  Note that the scale is the same for all ETS and ETE models.  B) Zoomed
view of the model showing the velocity vectors on the symmetry plane at different axial positions.
The bottom panels show the contour plots of the secondary flow magnitude and streamlines at the
axial positions denoted in panel B: C) proximal artery, D) anastomosis and E) distal artery.  Note
that each panel illustrates a half cross-section and the view is as if standing at the end of the proximal
artery and looking downstream.  Velocity increases in regions of constriction and recirculation
occurs in expansions.
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Figure 3.29 Geometry and velocity fields for ETE-R2.  A) Profile of the outer wall of the
reconstructed geometry.  Note that the scale is the same for all ETS and ETE models.  B) Zoomed
view of the model showing the velocity vectors on the symmetry plane at different axial positions.
The bottom panels show the contour plots of the secondary flow magnitude and streamlines at the
axial positions denoted in panel B: C) proximal artery, D) anastomosis and E) distal artery.  Note
that each panel illustrates a half cross-section and the view is as if standing at the end of the proximal
artery and looking downstream.  Velocity increases in regions of constriction and recirculation
occurs in expansions.
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Figure 3.30 Geometry and velocity fields for ETE-R3.  A) Profile of the outer wall of the
reconstructed geometry.  Note that the scale is the same for all ETS and ETE models.  B) Zoomed
view of the model showing the velocity vectors on the symmetry plane at different axial positions.
The bottom panels show the contour plots of the secondary flow magnitude and streamlines at the
axial positions denoted in panel B: C) proximal artery, D) anastomosis and E) distal artery.  Note
that each panel illustrates a half cross-section and the view is as if standing at the end of the proximal
artery and looking downstream.  Velocity increases in regions of constriction and recirculation
occurs in expansions.
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Figure 3.31 Geometry and velocity fields for ETE-R4.  A) Profile of the outer wall of the
reconstructed geometry.  Note that the scale is the same for all ETS and ETE models.  B) Zoomed
view of the model showing the velocity vectors on the symmetry plane at different axial positions.
The bottom panels show the contour plots of the secondary flow magnitude and streamlines at the
axial positions denoted in panel B: C) proximal artery, D) anastomosis and E) distal artery.  Note
that each panel illustrates a half cross-section and the view is as if standing at the end of the proximal
artery and looking downstream.  Velocity increases in regions of constriction and recirculation
occurs in expansions.
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Figure 3.32 Geometry and velocity fields for ETE-R5.  A) Profile of the outer wall of the
reconstructed geometry.  Note that the scale is the same for all ETS and ETE models.  B) Zoomed
view of the model showing the velocity vectors on the symmetry plane at different axial positions.
The bottom panels show the contour plots of the secondary flow magnitude and streamlines at the
axial positions denoted in panel B: C) proximal artery, D) anastomosis and E) distal artery.  Note
that each panel illustrates a half cross-section and the view is as if standing at the end of the proximal
artery and looking downstream.  Velocity increases in regions of constriction and recirculation
occurs in expansions.
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have recirculation regions half-way down the distal artery along the lateral wall.  In most cases, this
recirculation region flows counter-clockwise according to the view shown in the figures.  
There are also differences in the secondary flow between the ETS zero flow, ETS retrograde flow and
ETE models.  In all of the ETS zero flow models (see Figures  3.13 - 3.17), recirculation regions exist in the
floor cross-section while recirculation in this region is only present in ETS retrograde flow models ETS-R1
(Figure 3.18) and ETS-R2 (Figure 3.19).  In all of the ETS retrograde flow models (Figures 3.18 - 3.22),
recirculation regions exist in the heel cross-sections while this recirculation region is only present in ETS-Z3
(Figures 3.15) and ETS-Z4 (Figure 3.16).  Additionally, in four of the five retrograde flow models (ETS-R1
(Figure 3.18), ETS-R2 (Figure 3.19), ETS-R3 (Figure 3.20) and ETS-R5 (Figure 3.22)), recirculation regions
exist in the proximal artery while recirculation does not occur in this region for any of the ETS zero flow
models (see Figures 3.13 - 3.17).  For the ETE models, the magnitude of the secondary flow is quite small
(see Figures 3.23 - 3.32).  Recirculation regions only occur in regions of expansions and contractions since
the flow is not coming in at an angle as it is in the ETS models.
In addition to the differences between the ETS zero flow, ETS retrograde flow and ETE models, there
are differences within the groups.  For example, the ETS-Z3 has very high magnitudes of secondary flow due
to its small graft diameter (see Figure 3.15).  This causes large recirculation regions in the floor, toe and
distal regions as well as recirculation at the heel.  In three of the ETS zero flow models, dual recirculation
regions occur in the same cross-section.  This happens in the hood/floor cross-section in ETS-Z1 (see Figure
3.13), the heel, hood/floor and toe cross-sections in ETS-Z3 (see Figure 3.15) as well as the hood/floor cross-
section in ETS-Z4 (see Figure 3.16).  For the ETS retrograde flow models, recirculation regions in the toe
cross-section occur in ETS-R1 (see Figure 3.18) and ETS-R4 (Figure 3.21), but not in the other three models
(see Figures 3.19, 3.20 and 3.22).  Dual recirculation regions are present in four of the ETS retrograde flow
although they occur in different cross-sections.  Dual recirculation regions exist in the heel segment in ETS-
R2 (Figure 3.19), ETS-R4 (Figure 3.21) and ETS-R5 (Figure 3.22) and exist in the distal cross-section in
ETS-R3 (Figure 3.20) and ETS-R5 (Figure 3.22).  For the ETE models, there is not as much variation, since
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there is not much secondary flow (see Figures 3.23 - 3.32).  However, recirculation regions do exist in three
of the ETE models.  In ETE-Z1 (Figure 3.23), dual recirculation regions occur in the anastomosis and distal
cross-sections which are regions of expansion.  Similarly, in ETE-R1 (Figure 3.28), dual recirculation regions
occur in the distal artery cross-sections although the direction of these recirculation regions is opposite to
those in ETE-Z1 (Figure 3.23).  Weak dual recirculation also exists in proximal segment of the ETE-Z5
(Figure 3.27) as well as the proximal segment of ETE-R1 (Figure 3.28).  Therefore, differences in secondary
flow exist for all models due to the imposed flow conditions and the global and local variations in geometry.
3.3.5 Wall Shear Stress
The axial component of WSS for all models are shown in Figures 3.33 - 3.36, the circumferential
component of WSS for all models are shown in Figures 3.37 - 3.40 and the magnitude of WSS for all models
are shown in Figures 3.41 - 3.44.  Note that the dimension scales are different for each anastomosis in order
to optimize visualization.  All models exhibit regional variation of WSS due to the alteration in diameter
along the length of the vessels.  In addition, the ETS models have WSS variations due to the disturbed flow
caused by the angled insertion of the graft.  In particular, there are regions (e.g. toe) where the
circumferential WSS (see Figures 3.37 and 3.38) is the same order of magnitude as the axial component of
WSS (see Figures 3.33 and 3.34) due to the secondary flow in these regions.  This does not occur in the ETE
models (see Figures 3.39 and 3.40) because the secondary flow is almost zero.  Note that the upper range of
the contour levels for WSS magnitude in these simulations is 7 dynes/cm2  (see Figures  3.41 - 3.44).
Although the WSS magnitude did reach as high as 30 dynes/cm2 in some regions (i.e., toe region of ETS-Z3),
in general, the levels of WSS in these simulations were lower than the normal physiologic value of 15
dynes/cm2.  This is because the experiments were designed to match normal physiologic wall shear rate (440
sec-1) based on an assumed vessel inner diameter of 5 mm, yielding a WSS of 4.3 dynes/cm2.  Therefore, all
subsequent comments on WSS levels as “high” or “low” is relative to the WSS range present in these models.
Similarities exist in the values of axial and circumferential WSS as well as the magnitude of WSS
present in the ETS zero and retrograde flow models.  In all ETS models, except ETS-Z3 and ETS-Z4, the 
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Figure 3.33 Contour plot of the axial component of WSS for
each of the ETS zero flow models.
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Figure 3.34 Contour plot of the axial component of WSS for
each of the ETS retrograde flow models.
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Figure 3.35 Contour plot of the axial component of WSS for
each of the ETE models corresponding to the ETS zero flow
experiments.
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Figure 3.36 Contour plot of the axial component of WSS for
each of the ETE models corresponding to the ETS retrograde
flow experiments.
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Figure 3.37 Contour plot of the circumferential component of
WSS for each of the ETS zero flow models.
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Figure 3.38 Contour plot of the circumferential component of
WSS for each of the ETS retrograde flow models.
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Figure 3.39 Contour plot of the circumferential component
of WSS for each of the ETE models corresponding to the
ETS zero flow experiments.  The patchy appearance is an
artifact due to the change in contour level at 0 dynes/cm2,
which is the value for most of the vessel.
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Figure 3.40 Contour plot of the circumferential component
of WSS for each of the ETE models corresponding to the
ETS retrograde flow experiments.  The patchy appearance
is an artifact due to the change in contour level at 0
dynes/cm2, which is the value for most of the vessel.
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Figure 3.41 Contour plot of WSS magnitude for each of the
ETS zero flow models.
138
Figure 3.42 Contour plot of WSS magnitude for each of the
ETS retrograde flow models.
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Figure 3.43 Contour plot of WSS magnitude for each of the
ETE models corresponding to the ETS zero flow experiments.
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Figure 3.44 Contour plot of WSS magnitude for each of the
ETE models corresponding to the ETS retrograde flow
experiments.
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axial (Figures 3.33 and 3.34) and circumferential (Figures 3.37 and 3.38) components and magnitude of WSS
(Figures 3.41 and 3.42) were small in the graft and proximal artery segments.  Also, the circumferential WSS
in the distal artery of all models was predominantly negative, due to the secondary flow in the counter-
clockwise direction discussed in the previous section (see Figures 3.37 and 3.38). 
There are also differences in the components and magnitude of WSS between the ETS zero flow, ETS
retrograde flow and ETE models.  In the ETS zero flow models, the axial component of WSS (Figure 3.33)
as well as the magnitude of WSS (Figure 3.41) appears to be increased in the distal artery segment compared
to the ETS retrograde flow models, most likely because all of the fluid is exiting through the distal artery in
the zero flow models.  In the ETS retrograde models, there is a region of negative axial WSS along the floor
near the heel of the anastomosis due to the increased recirculation region caused by the exit of flow from the
proximal artery (see Figure 3.34).  This also leads to an increased WSS magnitude in the same region for the
ETS retrograde flow models (see Figure 3.42). All ETS retrograde flow models (Figure 3.38), except ETS-
R1, appear to have lower circumferential WSS than the ETS zero flow models (Figure 3.37).  Similarly, ETS-
R3, ETS-R4 and ETS-R5 appear to have lower magnitudes of WSS (Figure 3.42) throughout the models
compared to the ETS zero flow models (Figure 3.41), although the region on the floor across from the heel
appears to be relatively increased.  The ETE models have very little circumferential WSS since there is little
secondary flow in these straight-tube models (see Figures 3.39 and 3.40).  The WSS values vary spatially
due to the expansion and constriction of the artery along its length.
In addition to the noted differences between the ETS zero flow, ETS retrograde flow and ETE models,
there are marked differences within the groups.  For the ETS zero flow models, ETS-Z3 and ETS-Z4 appear
to have increased values of axial (Figure 3.33) and circumferential components (Figure 3.37), and magnitude
of WSS (Figure 3.41) in the graft and distal artery regions.  This is likely due to the relatively small vessel
diameters and resulting increased velocity magnitude. ETS-Z3 also has a more extensive region of negative
circumferential WSS in the distal artery due to the stronger secondary flow caused by the increased graft
flow impinging on the flow of the artery (see Figure 3.37).  ETS-Z4 has a larger region of increase
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circumferential WSS along the anastomosis due to the secondary flow caused by the expansion of the hood.
For the ETS retrograde flow cases, ETS-R1 and ETS-R2 appear to have increased axial WSS (Figure 3.34)
as well as WSS magnitude (Figure 3.42), likely due to their decreased vessel diameters.  The increased
secondary flow in these models appears to also cause more extensive regions of circumferential WSS.  For
the ETE models, ETE-Z2 appears to have decreased axial component (Figure 3.35) and therefore WSS
magnitude (Figure 3.43), most likely due to its increased vessel diameter.  Analogous to this, ETE-Z3 and
the ETE-R2 appear to have increased axial component (Figures 3.35 and 3.36, respectively) and WSS
magnitude (Figures 3.43 and 3.44, respectively), likely due to their decreased vessel diameters.  Therefore,
differences in axial, circumferential WSS as well as WSS magnitude appear to exist for all models due to
the imposed flow conditions and the global and local variations in geometry.
3.3.6 Wall Shear Stress Gradient
The axial component of WSSG for all models are shown in Figures 3.45 - 3.48, the circumferential
component of WSSG for all models are shown in Figures 3.49 - 3.52 and the magnitude of WSSG for all
models are shown in Figures 3.53 - 3.56.  Note that the dimension scales are different for each anastomosis
in order to optimize visualization.  All models exhibit regional variation of WSSG due to the alteration in
diameter along the length of the vessels.  In addition, the  ETS models have WSSG variations due to the
disturbed flow caused by the angled insertion of the graft.  Note that in a purely uniform flow region, the
magnitude of WSSG would be zero so any non-zero value of WSSG denotes a nonuniform hemodynamic
environment.
Similarities exist in the values of axial and circumferential WSSG as well as the magnitude of WSSG
present in the ETS zero and retrograde flow models.  In all ETS models, there appears to be an increased
level of axial (see Figures 3.45 and 3.46) and circumferential (see Figures 3.49 and 3.50) components, and
magnitude of WSSG (see Figures 3.53 and 3.54) at the toe of the anastomosis.  Additionally, there are
alternating regions of positive and negative axial components of WSS along the distal artery segment (see
Figures 3.33 and 3.34).  This causes large regions of increased WSSG magnitude in the distal artery for all
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Figure 3.45 Contour plot of the axial component of WSSG for
each of the ETS zero flow models.
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Figure 3.46 Contour plot of the axial component of WSSG for
each of the ETS retrograde flow models.
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Figure 3.47 Contour plot of the axial component of WSSG for
each of the ETE models corresponding to the ETS zero flow
experiments.
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Figure 3.48 Contour plot of the axial component of WSSG for
each of the ETE models corresponding to the ETS retrograde
flow experiments.
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Figure 3.49 Contour plot of the circumferential component of
WSSG for each of the ETS zero flow models.
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Figure 3.50 Contour plot of the circumferential component of
WSSG for each of the ETS retrograde flow models.
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Figure 3.51 Contour plot of the circumferential component of
WSSG for each of the ETE models corresponding to the ETS
zero flow experiments.
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Figure 3.52 Contour plot of the circumferential component of
WSSG for each of the ETE models corresponding to the ETS
retrograde flow experiments.
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Figure 3.53 Contour plot of WSSG magnitude for each of the
ETS zero flow models.
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Figure 3.54 Contour plot of WSSG magnitude for each of the
ETS retrograde flow models.
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Figure 3.55 Contour plot of WSSG magnitude for each of the
ETE models corresponding to the ETS zero flow experiments.
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Figure 3.56 Contour plot of WSSG magnitude for each of the
ETE models corresponding to the ETS retrograde flow
experiments.
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models (see Figures 3.53 and 3.54). The ETE models have alternating regions of high and low axial WSSG
(see Figures 3.47 and 3.48) and high WSSG (see Figures 3.55 and 3.56) magnitude that appears to be
comparable to those present in the ETS models.
There are also differences in the components and magnitude of WSSG between the ETS zero flow, ETS
retrograde flow and ETE models.  In the ETS zero flow models, there are more regions of positive and
negative axial WSSG in the distal artery (see Figure 3.45) compared to last three ETS retrograde flow
models, ETS-R3, ETS-R4 and ETS-R5 (see Figure 3.46).  This appears to be due to the increased range of
axial WSS present in the ETS zero flow models (see Figure 3.33) allowing for the possibility of increased
axial WSSG.  All of the ETS zero flow models, except ETS-Z5, also appear to have more regions of
circumferential WSSG (Figure 3.49) than the last three ETS retrograde flow models, ETS-R3, ETS-R4 and
ETS-R5 (see Figure 3.50) and this again appears to be due to the increased range of circumferential WSS
present in the ETS zero flow models (see Figure 3.37).  The increase in axial and circumferential WSSG in
the ETS zero flow models appears to lead to an increase in the magnitude of WSSG in these models (see
Figure 3.53) compared to the last three ETS retrograde flow models, ETS-R3, ETS-R4 and ETS-R5 (see
Figure 3.54).  In contrast to the ETS models, the ETE models did not have regions of high or low
circumferential WSSG (see Figure 3.51 and 3.52), most likely because the value of the circumferential
component of WSS (see Figures 3.39 and 3.40) appeared to be very low in these models.
In addition to the differences between the ETS zero flow, ETS retrograde flow and ETE models, there
are differences within the groups.  For the ETS zero flow models, ETS-Z3 appears to have more extensive
regions of positive and negative circumferential WSSG (see Figure 3.49), which appear to lead to increased
WSSG magnitude that extends across the entire model except for the proximal artery segment (see Figure
3.53).  ETS-Z4  also appears to have more extensive increased circumferential WSSG (see Figure 3.49) that
appears to lead to increased WSSG magnitude (see Figure 3.53) that covers most of the anastomosis but does
not extend up into the graft.  For the ETS retrograde flow models, ETS-R1 and ETS-R2 appear to have more
extensive regions of alternating positive and negative axial (see Figure 3.46) and circumferential components
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Figure 3.57 Mean Hemodynamic Indices (see Equation 3.28) for axial and circumferential
components and magnitude of WSS (left) and WSSG (right) for the zero and retrograde flow
experiments.  An asterisk (*) indicates a significant difference between flow conditions for that
index.
of WSSG (see Figure 3.50) that appear to lead to higher levels of WSSG magnitude along the floor of the
anastomosis and the distal artery (see Figure 3.54).  For the ETE models, ETE-Z2 appears to have very small
regions of positive or negative axial WSSG (see Figure 3.47), likely due to the smaller values of axial WSS
in this model (see Figure 3.35) and therefore appears to lead to low WSSG magnitude along the entire model
(see Figure 3.55). ETE-Z3 and ETE-R2 appear to have the most number of regions of high WSSG magnitude
(see Figures 3.55 and 3.56), likely due to the increased levels of WSS along the models (see Figures 3.43 and
3.44).  Therefore, differences in axial, circumferential WSSG as well as WSSG magnitude appear to exist
for all models due to the imposed flow conditions and the global and local variations in geometry.
3.3.7 Regional Variation of Hemodynamic Parameters
The Mean Hemodynamic Indices (mean ± SEM), calculated as per Equation 3.28, including the axial
and circumferential components and magnitude of WSS and WSSG for both flow conditions are presented
in Figure 3.57.  The Mean Axial WSS Index for the zero flow experiments (3.11 ± 2.27) was significantly
higher (p < 0.05) than the same index for the retrograde flow experiments (0.87 ± 0.91).  The Mean WSS
Magnitude Index was also significantly higher (p < 0.05) for the zero flow experiments (4.31 ± 2.77) as
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compared to the retrograde flow experiments (1.75 ± 0.75).  Similarly, the Mean WSSG Magnitude Index
was significantly higher (p < 0.05) for the zero flow experiments (23.88 ± 17.36) than for the retrograde flow
experiments (8.45 ± 4.51).  
The Mean Normalized Hemodynamic Indices ROI (mean ± SEM), calculated as per Equation 3.30, for
both flow conditions are presented in Figures 3.58 (axial WSS), 3.59 (circumferential WSS), 3.60 (WSS
magnitude), 3.61 (axial WSSG), 3.62 (circumferential WSSG) and 3.63 (WSSG magnitude).  Additionally,
similar graphs incorporating all the data (zero and retrograde flow experiments) are shown in Figures 3.64
(axial WSS and WSSG), 3.65 (circumferential WSS and WSSG) and 3.66 (WSS and WSSG magnitude).
3.3.7.1 Regional Variation of Mean Normalized Axial WSS ROI
The regional variation of Mean Normalized Axial WSS Index ROI followed the same trend for both flow
conditions although it was more pronounced in the retrograde flow experiments (see Figure 3.58).  In the zero
flow experiments, the ETS toe, distal artery, graft and ETE proximal artery regions had the highest values
of Mean Normalized Axial WSS Index ROI.  These regions had significantly higher Mean Normalized Axial
WSS Index ROI  than the regions with the lowest values of Mean Normalized Axial WSS Index ROI , which
included the ETS proximal artery, heel and floor regions.  Specifically, the ETS toe region (2.6 ± 0.4) was
significantly higher than the ETS proximal artery (0.0 ± 0.01, p = 0.0001), heel (0.0 ± 0.05, p = 0.0001) and
floor (-0.1 ± 0.2, p = 0.0001) regions.   The ETS distal artery region (2.0 ± 0.8) was also significantly higher
than the ETS proximal artery (0.0 ± 0.01, p = 0.002), heel (0.0 ± 0.05, p = 0.002) and floor (-0.1 ± 0.2, p =
0.002) regions.  The ETS graft region (1.3 ± 0.2) was significantly higher than the ETS proximal artery (0.0
± 0.01, p = 0.032), heel (0.0 ± 0.05, p = 0.026) and floor (-0.1 ± 0.2, p = 0.025) regions.  The ETE proximal
artery region (1.5 ± 0.7) was also significantly higher than the ETS proximal artery (0.0 ± 0.01, p = 0.021),
heel (0.0 ± 0.05, p = 0.017) and floor (-0.1 ± 0.2, p = 0.016) regions.  In addition, the ETS toe (2.6 ± 0.4)
region was significantly higher than the ETS graft (1.3 ± 0.2, p = 0.049) , hood (1.0 ± 0.2, p = 0.012) and
ETE anastomosis (0.8 ± 0.4, p = 0.005) regions. 
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Figure 3.58 Mean Normalized Axial WSS Index ROI (see Equation 3.30) for the zero (top)
and retrograde (bottom) flow experiments.  The data for each region of interest of one
experiment are normalized by the mean hemodynamic index for the same experiment.  The
numbers above and/or below each data point indicate which regions (1-ETS proximal
artery, 2-ETS heel, 3-ETS toe, 4-ETS distal artery, 5-ETS graft, 6-ETS floor, 7-ETS hood,
8-ETE proximal, 9-ETE anastomosis) are significantly different from that region.
159
Figure 3.59 Mean Normalized Circumferential WSS Index ROI (see Equation 3.30) for the
zero (top) and retrograde (bottom) flow experiments.  The data for each region of interest
of one experiment are normalized by the mean hemodynamic index for the same
experiment.  The numbers above and/or below each data point indicate which regions (1-
ETS proximal artery, 2-ETS heel, 3-ETS toe, 4-ETS distal artery, 5-ETS graft, 6-ETS
floor, 7-ETS hood, 8-ETE proximal, 9-ETE anastomosis) are significantly different from
that region.
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Figure 3.60 Mean Normalized WSS Magnitude Index ROI (see Equation 3.30) for the zero
(top) and retrograde (bottom) flow experiments.  The data for each region of interest of one
experiment are normalized by the mean hemodynamic index for the same experiment.  The
numbers above and/or below each data point indicate which regions (1-ETS proximal
artery, 2-ETS heel, 3-ETS toe, 4-ETS distal artery, 5-ETS graft, 6-ETS floor, 7-ETS hood,
8-ETE proximal, 9-ETE anastomosis) are significantly different from that region.
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Figure 3.61 Mean Normalized Axial WSSG Index ROI (see Equation 3.30) for the zero (top)
and retrograde (bottom) flow experiments.  The data for each region of interest of one
experiment are normalized by the mean hemodynamic index for the same experiment.  The
numbers above and/or below each data point indicate which regions (1-ETS proximal
artery, 2-ETS heel, 3-ETS toe, 4-ETS distal artery, 5-ETS graft, 6-ETS floor, 7-ETS hood,
8-ETE proximal, 9-ETE anastomosis) are significantly different from that region.
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Figure 3.62 Mean Normalized Circumferential WSSG Index ROI (see Equation 3.30) for the
zero (top) and retrograde (bottom) flow experiments.  The data for each region of interest
of one experiment are normalized by the mean hemodynamic index for the same
experiment.  The numbers above and/or below each data point indicate which regions (1-
ETS proximal artery, 2-ETS heel, 3-ETS toe, 4-ETS distal artery, 5-ETS graft, 6-ETS
floor, 7-ETS hood, 8-ETE proximal, 9-ETE anastomosis) are significantly different from
that region.
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Figure 3.63 Mean Normalized WSSG Magnitude Index ROI (see Equation 3.30) for the zero
(top) and retrograde (bottom) flow experiments.  The data for each region of interest of one
experiment are normalized by the mean hemodynamic index for the same experiment.  The
numbers above and/or below each data point indicate which regions (1-ETS proximal
artery, 2-ETS heel, 3-ETS toe, 4-ETS distal artery, 5-ETS graft, 6-ETS floor, 7-ETS hood,
8-ETE proximal, 9-ETE anastomosis) are significantly different from that region.
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Figure 3.64 Mean Normalized Axial WSS and WSSG Index ROI (see Equation 3.30) for the
pooled data from all experiments.  The data for each region of interest of one experiment
are normalized by the mean hemodynamic index for the same experiment.  The numbers
above and/or below each data point indicate which regions (1-ETS proximal artery, 2-ETS
heel, 3-ETS toe, 4-ETS distal artery, 5-ETS graft, 6-ETS floor, 7-ETS hood, 8-ETE
proximal, 9-ETE anastomosis) are significantly different from that region.
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Figure 3.65 Mean Normalized Circumferential WSS and WSSG Index ROI (see Equation
3.30) for the pooled data from all experiments.  The data for each region of interest of one
experiment are normalized by the mean hemodynamic index for the same experiment.  The
numbers above and/or below each data point indicate which regions (1-ETS proximal
artery, 2-ETS heel, 3-ETS toe, 4-ETS distal artery, 5-ETS graft, 6-ETS floor, 7-ETS hood,
8-ETE proximal, 9-ETE anastomosis) are significantly different from that region.
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Figure 3.66 Mean Normalized WSS and WSSG Magnitude Index ROI (see Equation 3.30)
for the pooled data from all experiments.  The data for each region of interest of one
experiment are normalized by the mean hemodynamic index for the same experiment.  The
numbers above and/or below each data point indicate which regions (1-ETS proximal
artery, 2-ETS heel, 3-ETS toe, 4-ETS distal artery, 5-ETS graft, 6-ETS floor, 7-ETS hood,
8-ETE proximal, 9-ETE anastomosis) are significantly different from that region.
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In the retrograde flow experiments (Figure 3.58), the ETS toe and distal artery regions also had the
highest values of Mean Normalized Axial WSS Index ROI and these values were higher than in the zero flow
experiments.  Similar to the zero flow experiments, these values were significantly higher than the Mean
Normalized Axial WSS Index ROI for the regions with the lowest values of Mean Normalized Axial WSS
Index ROI which included the ETS proximal artery, heel and floor regions.  Specifically, the ETS toe region
(4.6 ± 1.1) was significantly higher than the ETS proximal artery (-0.7 ± 0.1, p < 0.0001), heel (-1.1 ± 0.1,
p < 0.0001) and floor (-1.5 ± 0.4, p < 0.0001) regions.  Similarly, the ETS distal artery region  (2.8 ± 0.8) was
significantly higher than the ETS proximal artery (-0.7 ± 0.1, p = 0.0004), heel (-1.1 ± 0.1, p = 0.0001) and
floor (-1.5 ± 0.4, p < 0.0001) regions.  In addition, the ETS toe (4.6 ± 1.1) region was significantly higher
than the ETS graft (1.3 ± 0.3, p = 0.001), hood (0.0 ± 0.2, p < 0.0001), ETE proximal artery (2.4 ± 0.9, p =
0.023) and anastomosis (1.2 ± 0.6, p = 0.001) regions.
When the Mean Normalized Axial WSS Index ROI for each region of interest exposed to the zero flow
condition was compared to the same region of interest exposed to retrograde flow,  statistically significant
differences were found.  For example, the Mean Normalized Axial WSS Index ROI in the ETS proximal, heel,
floor and hood regions were higher in the zero flow experiments (0.0 ± 0.01, 0.0 ± 0.05, -0.1 ± 0.2, 1.0 ± 0.2,
respectively) as opposed to the retrograde flow experiments (-0.7 ± 0.1, -1.1 ± 0.1, -1.5 ± 0.4, 0.0 ± 0.2,
respectively).  These differences were statistically significant (p = 0.0002, p = 0.0001, p = 0.018, p = 0.024,
respectively) while the other regions of interest did not vary significantly due to the imposed flow condition
in the proximal artery.
When the data from both flow conditions were pooled together (Figure 3.64), an understanding of the
regional variation of axial WSS  in vascular bypass grafts can be determined. The ETS toe (3.6 ± 0.7) region
had significantly higher Mean Normalized Axial WSS Index ROI than all the other regions of interest
including the ETS proximal (-0.4 ± 0.1, p < 0.0001), heel (-0.6 ± 0.2, p < 0.0001 ), distal (2.4 ± 0.5, p =
0.046), graft (1.3 ± 0.2, p = 0.0002), floor (-0.8 ± 0.3, p < 0.0001), hood (0.5 ± 0.2, p < 0.0001), ETE
proximal (1.9 ± 0.6, p = 0.005) and anastomosis (1.0 ± 0.3, p < 0.0001) regions. The ETS proximal, heel and
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floor regions had the lowest level of Mean Normalized Axial WSS Index ROI.  The ETS proximal region (-0.4
± 0.1) was significantly lower than the ETS toe (3.6 ± 0.7, p < 0.0001), distal (2.4 ± 0.5, p < 0.0001), graft
(1.3 ± 0.2, p = 0.004),  ETE proximal artery (1.9 ± 0.6, p = 0.0002) and anastomosis (1.0 ± 0.3, p = 0.018)
regions.  Similarly, the ETS heel region (-0.6 ± 0.2) was significantly lower than the ETS toe (3.6 ± 0.7, p
< 0.0001), distal (2.4 ± 0.5, p < 0.0001), graft (1.3 ± 0.2, p = 0.0001), ETE proximal artery (1.9 ± 0.6, p <
0.0001) and anastomosis (1.0 ± 0.3, p = 0.007) regions.  The ETS floor region (-0.8 ± 0.3) was also
significantly lower than the ETS toe (3.6 ± 0.7, p < 0.0001), distal (2.4 ± 0.5, p < 0.0001), graft (1.3 ± 0.2,
p = 0.0004), ETE proximal artery (1.9 ± 0.6, p < 0.0001) and anastomosis (1.0 ± 0.3, p = 0.0.003) regions.
3.3.7.2 Regional Variation of Mean Normalized Circumferential WSS ROI
In the zero flow experiments (Figure 3.59), only three regions exhibited significant levels of Mean
Normalized Circumferential WSS Index ROI.  The ETS toe and distal artery regions had the highest level of
Mean Normalized Circumferential WSS Index ROI.  These values were significantly higher than those of all
of the other regions of interest.  Specifically, the ETS toe region (5.6 ± 2.4) was significantly higher than the
ETS proximal (0.0 ± 0.01, p = 0.004), heel (0.2 ± 0.1, p = 0.005), graft (0.6 ± 0.3, p = 0.009), floor (1.5 ±
0.8, p = 0.033), hood (-4.4 ± 1.5, p < 0.0001), ETE proximal (0.0 ± 0.003, p = 0.004) and anastomosis (0.0
± 0.004, p = 0.004) regions.  Similarly, the ETS distal artery region (5.6 ± 2.4) had significantly higher Mean
Normalized Circumferential WSS Index ROI than the ETS proximal (0.0 ± 0.01, p = 0.004), heel (0.2 ± 0.1,
p = 0.005), graft (0.6 ± 0.3, p = 0.009), floor (1.5 ± 0.8, p = 0.031), hood (-4.4 ± 1.5, p < 0.0001), ETE
proximal (0.0 ± 0.003, p = 0.004) and anastomosis (0.0 ± 0.004, p = 0.004) regions.  The region with the
lowest Mean Normalized Circumferential WSS Index ROI was the ETS hood (-4.4 ± 1.5) and this value was
significantly lower than all other regions of interest including the ETS proximal (0.0 ± 0.01, p = 0.020), heel
(0.2 ± 0.1, p = 0.015), toe (5.6 ± 2.4, p < 0.0001), graft (0.6 ± 0.3, p = 0.009), floor (1.5 ± 0.8, p = 0.002),
ETE proximal (0.0 ± 0.003, p = 0.020) and anastomosis (0.0 ± 0.004, p = 0.020) regions.  Because the value
for the hood region was negative, the direction of the normalized circumferential WSS was in the opposite
direction of the other regions but the hood region still exhibited a relatively large magnitude of Mean
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Normalized Circumferential WSS Index ROI.  Therefore the regions with low magnitudes of Mean Normalized
Circumferential WSS Index ROI were the ETS proximal (0.0 ± 0.01), heel (0.2 ± 0.1), graft (0.6 ± 0.3), floor
(1.5 ± 0.8), ETE proximal (0.0 ± 0.003) and anastomosis (0.0 ± 0.004) regions, which were shown above to
have significantly lower Mean Normalized Circumferential WSS Index ROI compared to the ETS toe and
distal artery regions. 
In the retrograde flow experiments (see Figure 3.59), the ETS toe (5.4 ± 1.9) again had the highest level
of Mean Normalized Circumferential WSS Index ROI.  This value was significantly higher than the Mean
Normalized Circumferential WSS Index ROI present in all other regions of interest including the ETS
proximal (0.3 ± 0.2, p < 0.0001), heel (1.3 ± 0.1, p = 0.001), distal artery (2.5 ± 0.5, p = 0.017), graft (-0.1
± 0.04, p < 0.0001), floor (2.1 ± 1.3, p = 0.006), hood (-2.5 ± 0.5, p > 0.0001), ETE proximal (0.0 ± 0.03,
p < 0.0001) and anastomosis (0.0 ± 0.01, p < 0.0001) regions.  Similar to the zero flow experiments, the ETS
hood (-2.5 ± 0.5) region had the lowest value of Mean Normalized Circumferential WSS Index ROI and this
was significantly lower than the same value for all other regions including the ETS proximal (0.3 ± 0.2, p
= 0.017), heel (1.3 ± 0.1, p = 0.002), toe (5.4 ± 1.9, p < 0.0001), distal artery (2.5 ± 0.5, p = 0.0001), graft
(-0.1 ± 0.04, p = 0.040), floor (2.1 ± 1.3, p = 0.0003), ETE proximal (0.0 ± 0.03, p = 0.033) and anastomosis
(0.0 ± 0.01, p = 0.035) regions.  Again, although this value was negative, it indicates that the hood region
had a large magnitude of Mean Normalized Circumferential WSS Index ROI that was in the opposite direction
of the other regions.  Therefore, similar to the zero flow experiments, the regions with significantly low
magnitudes of Mean Normalized Circumferential WSS Index ROI were the ETS proximal (0.3 ± 0.2), heel (1.3
± 0.1), graft (-0.1 ± 0.04), floor (2.1 ± 1.3), ETE proximal (0.0 ± 0.03) and anastomosis (0.0 ± 0.01) regions,
which were shown above to be significantly lower than the ETS toe region (5.4 ± 1.9). 
When the Mean Normalized Circumferential WSS Index ROI for each region of interest exposed to the
zero flow condition was compared to the same region of interest exposed to retrograde flow,  statistically
significant differences were found.  For example, the Mean Normalized Circumferential WSS Index ROI in
the ETS heel region was lower in the zero flow experiments (0.19 ± 0.14) as opposed to the retrograde flow
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experiments (1.33 ± 0.3).  This difference was statistically significant (p = 0.0003) while the other regions
of interest did not vary significantly due to the imposed flow condition in the proximal artery.
When the data from all experiments were pooled together (Figure 3.65), the ETS toe and distal artery
regions have significantly higher Mean Normalized Circumferential WSS Index ROI than all other regions of
interest.  Specifically, the ETS toe region (5.5 ± 1.4) was significantly higher than the ETS proximal (0.2 ±
0.1, p < 0.0001), heel (0.8 ± 0.2, p < 0.0001),  graft (0.2 ± 0.2, p < 0.0001), floor (1.8 ± 0.7, p = 0.0008),
hood (-3.5 ± 0.8, p < 0.0001), ETE proximal (0.0 ± 0.01, p < 0.0001) and anastomosis (0.0 ± 0.004, p <
0.0001) regions.  Similarly, the ETS distal artery region (4.1 ± 1.3) was significantly higher than the ETS
proximal (0.2 ± 0.1, p = 0.0004), heel (0.8 ± 0.2, p = 0.003),  graft (0.2 ± 0.2, p = 0.0005), floor (1.8 ± 0.7,
p = 0.035), hood (-3.5 ± 0.8, p < 0.0001), ETE proximal (0.0 ± 0.01, p = 0.0003) and anastomosis (0.0 ±
0.004, p = 0.0002) regions.  The ETS hood (-3.5 ± 0.8) region had significantly lower Mean Normalized
Circumferential WSS Index ROI than all other regions of interest including the ETS proximal (0.2 ± 0.1, p =
0.001), heel (0.8 ± 0.2, p = 0.0001),  toe (5.5 ± 1.4, p < 0.0001), distal (4.1 ± 1.3, p < 0.0001), graft (0.2 ±
0.2, p < 0.0007), floor (1.8 ± 0.7, p < 0.0001), ETE proximal (0.0 ± 0.01, p = 0.001) and anastomosis (0.0
± 0.004, p = 0.002) regions.  Once again, the negative value means that the ETS hood region had a large
magnitude of Mean Normalized Circumferential WSS Index ROI but the direction was opposite to the other
regions.  Therefore, the regions with significantly low magnitudes of Mean Normalized Circumferential WSS
Index ROI were the ETS proximal (0.2 ± 0.1), heel (0.8 ± 0.2), graft (0.2 ± 0.2), floor (1.8 ± 0.7), ETE
proximal (0.0 ± 0.01) and anastomosis (0.0 ± 0.004) regions, which were shown above to have significantly
lower Mean Normalized Circumferential WSS Index ROI compared to the ETS toe and distal artery regions.
3.3.7.3 Regional Variation of Mean Normalized WSS Magnitude ROI
In the zero flow experiments (Figure 3.60), the ETS toe and distal artery regions had the largest Mean
Normalized WSS Magnitude Index ROI and these values were significantly higher than all other regions of
interest.  Specifically, the Mean Normalized WSS Magnitude Index ROI for the ETS toe region (2.7 ± 0.3) was
significantly higher than the ETS proximal artery (0.0 ± 0.01, p < 0.0001), heel (0.1 ± 0.1, p < 0.0001),  graft
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(1.0 ± 0.2, p = 0.0005), floor (0.5 ± 0.2, p < 0.0001), hood (1.0  ± 0.2, p = 0.0004) and ETE proximal (1.1
± 0.5, p = 0.001) and anastomosis (0.7 ± 0.3, p < 0.0001) segments.  Similarly, the ETS distal artery (1.9 ±
0.6) region had a significantly higher Mean Normalized WSS Magnitude Index ROI than the ETS proximal
artery (0.0 ± 0.01, p = 0.0001), heel (0.1 ± 0.1, p = 0.0001),  graft (1.0 ± 0.2, p = 0.041), floor (0.5 ± 0.2, p
= 0.001), hood (1.0  ± 0.2, p = 0.0030) and ETE proximal (1.1 ± 0.5, p = 0.049) and anastomosis (0.7 ± 0.3,
p = 0.008) segments.  The ETS proximal artery  and heel regions had the smallest Mean Normalized WSS
Magnitude Index ROI.  Specifically, the Mean Normalized WSS Magnitude Index ROI for the ETS proximal
artery region (0.0 ± 0.01) was significantly lower than the ETS toe (2.7 ± 0.3, p < 0.0001), distal (1.9 ± 0.6,
p = 0.0001), graft (1.0 ± 0.2, p = 0.022), hood (1.0  ± 0.2, p = 0.030) and ETE proximal (1.1 ± 0.5, p = 0.018)
segments.  Similarly, the ETS heel region (0.1 ± 0.1) was significantly lower than the ETS toe (2.7 ± 0.3, p
< 0.0001), distal (1.9 ± 0.6, p = 0.0001), graft (1.0 ± 0.2, p = 0.034), hood (1.0  ± 0.2, p = 0.046) and ETE
proximal (1.1 ± 0.5, p = 0.028) segments.
In the retrograde flow experiments (Figure 3.60), the ETS toe and distal artery segments had the highest
values of Mean Normalized WSS Magnitude Index ROI, similar to the zero flow experiments.  The value of
the Mean Normalized WSS Magnitude Index ROI for the ETS toe (2.5 ± 0.6) region was significantly higher
than all other regions of interest, including the ETS proximal (0.4 ± 0.1, p < 0.0001), heel (0.6 ± 0.04, p <
0.0001), distal (1.5 ± 0.4, p = 0.019), graft (0.6 ± 0.1, p < 0.0001), floor (1.0 ± 0.2, p = 0.0005), hood (1.0
± 0.2, p < 0.0001), ETE proximal (1.1 ± 0.3, p = 0.001) and anastomosis (0.8 ± 0.2, , p = 0.0001) regions.
The value for the ETS distal artery (1.5 ± 0.4) segment was significantly higher than the ETS proximal (0.4
± 0.1, p = 0.005), heel (0.6 ± 0.04, p = 0.029), graft (0.6 ± 0.1, p = 0.019) and hood (1.0 ± 0.2, p = 0.013)
regions.
When the Mean Normalized WSS Magnitude Index ROI for each region of interest exposed to the zero
flow condition was compared to the same region of interest exposed to retrograde flow, statistically
significant differences were found.  For example, the Mean Normalized WSS Magnitude Index ROI in the ETS
proximal, heel, floor and hood regions were higher in the zero flow experiments (0.0 ± 0.01, 0.1 ± 0.1, 0.5
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± 0.2, 1.0 ± 0.2, respectively) as opposed to the retrograde flow experiments (0.4 ± 0.1, 0.6 ± 0.04, 1.0 ± 0.2,
1.0 ± 0.2, respectively).  These differences were statistically significant (p < 0.0001, p = 0.0001, p = 0.043,
p = 0.041, respectively) while the other regions of interest did not vary significantly due to the imposed flow
condition in the proximal artery.
When the data from all experiments were pooled together (Figure 3.66), the ETS toe and distal artery
(1.7 ± 0.3) regions again had the highest Mean Normalized WSS Magnitude Index ROI and these values were
significantly higher than all other regions.  Specifically, the ETS toe region (2.6 ± 0.3) was significantly
higher than the ETS proximal artery (0.2 ± 0.06, p < 0.0001), heel (0.4 ±  0.1, p < 0.0001),  distal (1.7 ± 0.3,
p = 0.005), graft (0.8 ± 0.1, p < 0.0001), floor (0.7 ± 0.1, p < 0.0001), hood (0.7 ± 0.1, p < 0.0001), ETE
proximal (1.1 ± 0.3, p < 0.0001) and anastomosis (0.8 ± 0.2, p < 0.0001) regions.  Similarly, the ETS distal
artery region (1.7 ± 0.3) was significantly higher than the ETS proximal artery (0.2 ± 0.06, p < 0.0001), heel
(0.4 ±  0.1, p < 0.0001), toe (2.6 ± 0.3, p = 0.005), graft (0.8 ± 0.1, p = 0.002), floor (0.7 ± 0.1, p = 0.001),
hood (0.7 ± 0.1, p = 0.001), ETE proximal (1.1 ± 0.3, p = 0.027) and anastomosis (0.8 ± 0.2, p = 0.001)
regions.  The ETS proximal artery (0.2 ± 0.06) region had the lowest Mean Normalized WSS Magnitude
Index ROI and this was significantly lower than that of the ETS toe (2.6 ± 0.3, p < 0.0001), distal (1.7 ± 0.3,
p < 0.0001), graft (0.8 ± 0.1, p = 0.030), ETE proximal (1.1 ± 0.3, p = 0.002) and anastomosis (0.8 ± 0.2, p
= 0.048) regions.
3.3.7.4 Regional Variation of Mean Normalized Axial WSSG ROI
In the zero flow experiments (Figure 3.61), there was no significant regional variation of Mean
Normalized Axial WSSG Index ROI.  The highest levels of Mean Normalized Axial WSSG Index ROI occurred
in the ETS toe (4.8 ± 1.7) and floor (2.5 ± 3.6) segments but these values were not significantly higher than
any other region.  The ETS hood (-1.3 ± 1.1) region had the lowest level of Mean Normalized Axial WSSG
Index ROI but this was not significantly different from the other regions of interest.
Similarly, in the retrograde flow experiments (Figure 3.61), no significant regional variation of
normalized axial WSSG existed.  The ETS distal (3.2 ± 4.6) and ETE proximal (11.6 ± 6.9) regions had the
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highest levels of Mean Normalized Axial WSSG Index ROI.  The ETS floor (-3.3 ± 3.3) region had the lowest
value of Mean Normalized Axial WSSG Index ROI.  However, none of these values were significantly
different from the other regions of interest.
When the Mean Normalized Axial WSSG Index ROI for each region of interest exposed to the zero flow
condition was compared to the same region of interest exposed to retrograde flow, statistically significant
differences were found.  For example, the Mean Normalized Axial WSSG Index ROI in the ETS proximal
artery region was lower in the zero flow experiments (0.01 ± 0.02) as opposed to the retrograde flow
experiments (0.78 ± 0.3).  This difference was statistically significant (p = 0.049) while the other regions of
interest did not vary significantly due to the imposed flow condition in the proximal artery.
When the data from all experiments were pooled together (Figure 3.64), there was still no significant
regional variation of normalized axial WSSG.  The ETE proximal (6.6 ± 3.7) segment had the highest level
of Mean Normalized Axial WSSG Index ROI but this value was not significantly different from the other
regions of interest.
3.3.7.5 Regional Variation of Mean Normalized Circumferential WSSG ROI
In the zero flow experiments (Figure 3.62), the ETS toe region was the only region that had a
significantly different Mean Normalized Circumferential WSSG Index ROI.  The ETS toe (4.6 ± 1.1) region
had significantly higher Mean Normalized Circumferential WSSG Index ROI than all other regions of interest
including the ETS proximal (0.1 ± 0.1, p = 0.001), heel (1.2 ± 1.2, p = 0.009),  distal (0.1 ± 0.9, p = 0.001),
graft (0.4 ± 0.2, p = 0.002), floor (0.6 ± 0.9, p = 0.003), hood (1.9 ± 1.6, p = 0.033), ETE proximal (0.0 ± 0.4,
p = 0.001) and anastomosis (0.2 ± 0.5, p = 0.001) regions.
In the retrograde flow experiments (Figure 3.62), there was no regional variation of Mean Normalized
Circumferential WSSG Index ROI.  The ETS toe (6.5 ± 2.8) and ETE proximal (5.1 ± 5.7) segments had the
highest levels of Mean Normalized Circumferential WSSG Index ROI.  The ETS floor (-2.1 ± 5.4) segment
had the lowest level of Mean Normalized Circumferential WSSG Index ROI.  However,  none of these values
were significantly different from the other regions of interest.
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When the Mean Normalized Circumferential WSSG Index ROI for each region of interest exposed to the
zero flow condition was compared to the same region of interest exposed to retrograde flow, statistically
significant differences were found.  For example, the Mean Normalized Circumferential WSSG Index ROI in
the ETS proximal artery region was lower in the zero flow experiments (0.08 ± 0.08) as opposed to the
retrograde flow experiments (0.59 ± 0.3).  This difference was statistically significant (p = 0.025) while the
other regions of interest did not vary significantly due to the imposed flow condition in the proximal artery.
When the data from all experiments were pooled together (Figure 3.65), no region of interest had a
significantly different value of Mean Normalized Circumferential WSSG Index ROI.  The ETS toe (5.6 ± 1.4)
and ETS floor (-0.7 ± 2.6) regions had the highest and lowest levels of Mean Normalized Circumferential
WSSG Index ROI, respectively, but these values were not significantly different from the other regions of
interest. 
3.3.7.6 Regional Variation of Normalized WSSG Magnitude ROI
The regional variation of Mean Normalized WSSG Magnitude Index ROI (see Figure 3.63) followed the
same trend as the regional variation in Mean Normalized WSS Magnitude Index ROI (see Figure 3.60).  In the
zero flow experiments, the ETS toe and distal artery segments had the highest Mean Normalized WSSG
Magnitude Index ROI.  Specifically, the value for the ETS toe (3.5 ± 0.4) region was significantly higher than
all other regions of interest including the ETS proximal (0.0 ± 0.01, p < 0.0001), heel (0.1 ± 0.1, p < 0.0001),
distal (1.5 ± 0.4 , p < 0.0001), graft (0.7 ± 0.2, p < 0.0001), floor (0.7 ± 0.3, p < 0.0001), hood (1.1 ± 0.2, p
< 0.0001), ETE proximal (0.6 ± 0.3 , p < 0.0001) and anastomosis (0.7 ± 0.4, p < 0.0001) regions.  The value
for the ETS distal region (1.5 ± 0.4) was significantly higher than the ETS proximal (0.0 ± 0.01, p = 0.0004),
heel (0.1 ± 0.1, p = 0.001), toe (3.5 ± 0.4, p < 0.0001), graft (0.7 ± 0.2, p = 0.037), floor (0.7 ± 0.3, p =
0.045), ETE proximal (0.6 ± 0.3 , p = 0.024) and anastomosis (0.7 ± 0.4, p = 0.036) regions.  
In the retrograde flow experiments (Figure 3.63), the ETS toe region (2.4 ± 0.5) had the highest Mean
Normalized WSSG Magnitude Index ROI and this value was significantly higher than the ETS proximal (0.2
± 0.1, p < 0.0001), heel  (0.4 ± 0.1, p = 0.0001), distal (1.2 ± 0.3, p = 0.013), graft (0.2 ± 0.1, p < 0.0001),
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floor (1.4 ± 0.3, p = 0.029), hood (0.5 ± 0.1, p = 0.0001) and ETE anastomosis (1.2 ± 0.4, p = 0.010) regions.
The ETS proximal and graft regions had the lowest levels of normalized WSSG magnitude.  The Mean
Normalized WSSG Magnitude Index ROI for the ETS proximal region (0.2 ± 0.1) was significantly lower than
that of the ETS toe (2.4 ± 0.5, p < 0.0001), distal (1.2 ± 0.3, p = 0.040), floor (1.4 ± 0.3, p = 0.018), ETE
proximal (1.6 ± 0.6, p = 0.005) and anastomosis (1.2 ± 0.4, p = 0.047) regions.  The ETS graft region  (0.2
± 0.1) had lower Mean Normalized WSSG Magnitude Index ROI than the ETS toe (2.4 ± 0.5, p < 0.0001),
distal (1.2 ± 0.3, p = 0.033), floor (1.4 ± 0.3, p = 0.014), ETE proximal (1.6 ± 0.6, p = 0.004) and
anastomosis (1.2 ± 0.4, p = 0.039) regions. 
When the Mean Normalized WSSG Magnitude Index ROI for each region of interest exposed to the zero
flow condition was compared to the same region of interest exposed to retrograde flow,  statistically
significant differences were found.  For example, the Mean Normalized WSSG Magnitude Index ROI in the
ETS proximal artery region was lower in the zero flow experiments (0.01 ± 0.01) as opposed to the
retrograde flow experiments (0.22 ± 0.06).  This difference was statistically significant (p = 0.007) while the
other regions of interest did not vary significantly due to the imposed flow condition in the proximal artery.
When the data from all experiments were pooled together (Figure 3.66), the ETS toe (3.0 ± 0.3) region
had significantly higher Mean Normalized WSSG Magnitude Index ROI than all other regions of interest
including the ETS proximal (0.1 ± 0.04, p < 0.0001), heel (0.3 ± 0.1, p < 0.0001), distal (1.4 ± 0.2, p <
0.0001), graft (0.4 ± 0.1, p < 0.0001), floor (1.0 ± 0.2, p < 0.0001), hood (0.8 ± 0.2, p < 0.0001), ETE
proximal (1.1 ± 0.4, p < 0.0001) and anastomosis (0.9 ± 0.3, p < 0.0001) regions.   The ETS proximal (0.1
± 0.04) region had the lowest level of Mean Normalized WSSG Magnitude Index ROI and this value was
significantly lower than the ETS toe (3.0 ± 0.3, p < 0.0001), distal (1.4 ± 0.2, p = 0.0002), floor (1.0 ± 0.2,




3.4.1 CFD Models of ETS and ETE Bypass Graft Anastomoses
Because the geometries (i.e., vessel caliber, number and placement of ligated branching vessels, size
and shape of the anastomosis) varied greatly from experiment to experiment, a general, idealized model could
not be used to determine the flow field and calculate the resulting hemodynamic parameters.  Therefore, we
developed three-dimensional reconstructions of each ETS and ETE anastomosis perfused ex vivo for the
purposes of CFD analysis. The computational results illustrate that although some similarities could be
determined, the mapping of hemodynamic parameters varied greatly between the type of anastomosis (ETS
versus ETE) as well as between the individual anastomoses.  In all ETS models, the velocity vectors in the
distal artery were skewed toward the floor due to the impingement of flow from the angled graft which also
caused secondary flow (Figures 3.13 - 3.22).  The degree of the skewing and magnitude of the secondary
flow depended on the geometry of the anastomosis and the imposed flow rate into the graft.  For example,
the skewing of the velocity vectors and the magnitude and extent of secondary flow was especially high in
ETS-Z3 (Figure 3.15) because the graft had a small diameter, which increased the velocity of the fluid in the
graft.  In all ETS models, a recirculation zone occurred near the heel (Figures 3.13 - 3.22).  The size and
magnitude of this recirculation depended on which flow condition was prescribed in the proximal artery (zero
or retrograde) as well as the geometry of the anastomosis.  For example, the strength of the recirculation zone
at the heel ranged from relatively weak in ETS-Z1 (Figure 3.13) to strong in ETS-R4 (Figure 3.21).  Flow
in the ETE models (Figures 3.23 - 3.32) was generally more uniform than in the ETS models, although
disturbances did occur due to local changes in vessel diameter along the length of the anastomosis.  This was
most prominent in ETE-Z3 (Figure 3.25) and ETE-R1 (Figure 3.28).  All of these differences in the flow field
resulted in local variations of WSS and WSSG.  Therefore, computational reconstructions were necessary
to quantify the hemodynamic parameters at regions of interest along each anastomosis.  
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3.4.2 Regional Variation of Hemodynamic Parameters
Our results showed that there exists a significant, regional variation of all normalized hemodynamic
parameters examined in the three-dimensional reconstructions of vascular bypass graft anastomoses.  The
ETS regions of interest that had significantly different Mean Normalized Hemodynamic Indices ROI as
compared to the ETE proximal artery segment (i.e., control) for all of the experiments are presented in Table
3.3.  The arrows indicate a significantly increased or decreased Mean Normalized Hemodynamic Index ROI
in that region compared to the ETE proximal artery segment. 
The region with the most number of significant differences relative to the ETE proximal artery segment
was the ETS toe region.  The Mean Normalized Circumferential WSS and WSS Magnitude Indices ROI for
the ETS toe region were significantly increased in this region for both flow conditions.  The same region had
increased Mean Normalized Hemodynamic Indices ROI for circumferential WSSG and WSSG magnitude only
for the zero flow condition, while the Mean Normalized Axial WSS Magnitude Index ROI for the ETS toe













Zero Retro Zero Retro Zero Retro Zero Retro Zero Retro Zero Retro
ETS proximal           - -      - - - - - -     
ETS heel           - -      - - - - - -     
ETS toe -                - -    -    -
ETS distal - -          - - - - -    -
ETS graft - - - - - - - - - - -     
ETS floor           - - - - - - - - - -
ETS hood -                - - - - - - -     
Table 3.3 Summary of the Mean Normalized Hemodynamic Indices ROI in the ETS regions of interest for
the two flow conditions (zero and retrograde) in the proximal artery.  The arrows indicate a significantly
(p < 0.05) increased or decreased value of the Mean Normalized Hemodynamic Index ROI in that region
compared to the ETE proximal artery segment (i.e., control) for the same flow condition.
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in the ETS toe region was not statistically different from the ETE proximal artery segment for either flow
condition.  
The Mean Normalized Hemodynamic Indices ROI with the most number of regions with significant
differences were those for axial WSS and WSSG magnitude. For the zero flow models, the Mean Axial WSS
Index ROI for the ETS proximal artery, heel and floor regions were significantly decreased.  The Mean WSSG
Magnitude Index ROI for the ETS toe and distal artery regions were significantly increased compared to the
ETE proximal artery segment.  For the retrograde flow models, the Mean Axial WSS Index ROI for the ETS
proximal artery, heel, floor and hood regions were significantly decreased and the index for the ETS toe
region was significantly increased.  The Mean WSSG Magnitude Index ROI for the ETS proximal artery, heel,
graft and hood regions were significantly decreased compared to the ETE proximal artery segment.  
The Mean Normalized Hemodynamic Indices ROI for circumferential WSS and WSS magnitude also had
a number of regions with significant differences relative to the ETE proximal artery.  The Mean Normalized
Circumferential WSS ROI was significantly increased in the ETS toe and distal regions and significantly
decreased in the hood region for both flow conditions.  For the zero flow models, the Mean Normalized WSS
Magnitude ROI was significantly decreased in the ETS proximal artery and heel regions, and significantly
increased in the ETS toe and distal regions.  For the retrograde flow models, the only significant difference
for the Mean Normalized WSS Magnitude ROI was an increase for the ETS toe segment.
The Mean Normalized Axial and Circumferential WSSG Indices RO I did not have many regions with
significant differences relative to the ETE proximal segment.  The Mean Normalized Axial WSSG Index ROI
was not significantly different for any region of interest for either flow condition.  The Mean Normalized
Circumferential WSSG was significantly increased only in the ETS toe region for the zero flow models.
The statistical differences between the Mean Normalized Hemodynamic Indices ROI for the ETS regions
of interest and the ETE proximal artery segment depended on the imposed flow condition for 12 of the 19
hemodynamic parameter and region combinations that exhibited significant differences.  For example, for
the retrograde flow models, the Mean Normalized Axial WSS Index ROI was significantly increased for the
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ETS toe region and significantly decreased for the ETS hood region, but there were no significant differences
for these regions in the zero flow models.  The Mean Normalized WSS  Magnitude Index ROI for the ETS
proximal artery and heel regions was significantly decreased while the ETS distal region had a significant
increase in this index for the zero flow models.  However, none of these regions had significant differences
in the Mean Normalized WSS Magnitude Index ROI for the retrograde flow models.  The Mean Normalized
Circumferential WSSG Index ROI for the ETS toe region was significantly increased as was the Mean
Normalized WSSG Magnitude Index ROI for the ETS toe and distal regions in the zero flow models but there
was no significant difference for the retrograde flow models.  The Mean Normalized WSSG  Magnitude
IndexROI was significantly decreased in the ETS proximal artery, heel, graft and hood regions only for the
retrograde flow experiments.
In general, the regions with the most number of significant variations in Mean Normalized
Hemodynamic IndicesROI occurred in the ETS proximal artery, heel, toe, distal artery and hood regions.  In
general, the ETS proximal artery, heel and hood segments had low axial WSS and WSS magnitude
(compared to at least four other regions of interest).  The ETS toe and distal segments had high axial WSS,
circumferential WSS and magnitudes of WSS and WSSG.  Because these regions, particularly the toe and
heel, have previously been shown to be prone to intimal hyperplasia formation [77, 78], these data suggest
that low and/or high values of axial WSS and magnitudes of WSS and WSSG may play key roles in the
formation of intimal hyperplasia.
3.4.3 Comparison to Other Research
Other researchers have developed three dimensional reconstructions of cardiovascular structures
including single vessels, the carotid bifurcation and ETS anastomoses [92, 93, 95-101, 164].  Although our
reconstruction methodology differs from the many types used in these studies, mostly due to their need for
non-invasive in vivo imaging techniques, some similarities exist.  Krams et al. reconstructed human coronary
arteries using a combination of angiography and intravascular ultrasound imaging techniques [93].  The
reconstructed surface shown in their publication exhibits a non-uniform diameter along the length of the
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Figure 3.67 Reconstruction of a human coronary artery by
Krams et al. [93].
vessel as shown in Figure 3.67.  This is similar to the non-uniform diameter present in the vessels of our ETS
and ETE models although our models have more variations due to the ligation of branching vessels (see
Figures 3.13 - 3.32).  Leuprecht et al. developed computational models from castings of sheep end-to-side
bypass grafts [164].  In a pulsatile, deformable wall simulation of a conventional ETS anastomosis with no
flow in the proximal artery, they found counter-rotating recirculation zones on a cross-section of the hood
and floor regions as shown in Figure 3.68 (panel a, cross-section B).  This is similar to the dual recirculation
zones present in the hood/floor cross-section in ETS-Z1 (see Figure 3.13).  They also found a recirculation
zone in the distal cross-section (Figure 3.68, panel a, cross-section D) similar to those present in all of our
ETS zero flow models Figures (3.13 - 3.17).  These previous studies show that the general geometric and
flow features of our models are realistic and  comparable to other reconstructed models.
To our knowledge, these are the first data showing a regional variation of hemodynamic parameters in
three dimensional reconstructions of ETS and ETE bypass grafts perfused ex vivo.  However, a number of
other computational and flow visualization studies of idealized ETE and ETS anastomoses have been
completed  [66, 78, 83-87, 89-91, 102, 165-167].  Although the details of their anastomosis geometries and
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Figure 3.68 Results from Leuprecht, et al. [164].  In-plane
velocity vectors in cross-sections B (hood/floor) and D (distal
artery) during systolic deceleration for (a)  conventional type
anastomosis and (b) Miller-cuff type; dashed lines denote
cross-section of rigid wall model corresponding to diastolic
pressure.
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Figure 3.69 Results from Hyun, et al.[165]  showing the
velocity vector fields for axisymmetric expansion
geometries at representative time steps. Note the regions
of flow reversal and recirculation immediately following
the smooth expansions in panels b and d.
imposed flow conditions are different than the models we presented, general characteristics of the flow field
and resulting hemodynamic parameters of the most closely related models can be compared to our results.
The computational work of Hyun et al. on arterial expansions can be compared to our ETE models
[165].  They found that smooth, symmetric enlargements in the diameter of the artery produce regions of flow
reversal and recirculation as shown in Figure 3.69.  This is similar to the flow reversal and recirculation
regions present in our ETE models due to the variation in diameter along the length of the vessels (see
Figures 3.23 - 3.32). 
The computational work presented by Henry et al. [87] offers a comparison to our ETS zero flow
simulations.  They modeled a 30 degree anastomosis formed from vessels of the same diameter and a fully
occluded proximal artery so that no flow entered from this region.  As we did, they imposed a steady flow
in this three dimensional model.  Similar to our findings in the ETS zero flow models (see Figures 3.13 -
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Figure 3.70 Flow visualization results from Hughes et al. showing a small recirculation region at the heel
for the zero flow model (A) and a captive vortex at the heel for the retrograde flow model (B) [166].
3.17), they showed that the proximal artery flow was essentially quiescent with a small region of
recirculation at the heel.  
The flow visualization work presented by Hughes and How [166] offers a comparison to our ETS zero
and retrograde flow models.  They used transparent polyurethane models to study various distal anastomoses
idealized as 8mm tubes intersecting at various angles under steady and pulsatile flow conditions.  A particle
tracking technique was utilized to qualitatively determine the flow field at the anastomosis for different flow
rate ratios for the graft versus the proximal artery.  A 30 degree model with zero flow in the proximal artery
showed a small recirculation region at the heel as shown in Figure 3.70A, similar to the results of Henry et
al. and our ETS zero flow models (Figures 3.13 - 3.17).  Retrograde flow with a magnitude of 1/4 of graft
flow (comparative to our 1/5 value) caused a captive vortex at the heel of the anastomosis and a region of
flow reversal formed at the toe as shown in Figure 3.70B.  These results are consistent with our ETS
retrograde flow models, as recirculation zones and secondary flow were present at the heel for all ETS
retrograde flow models (see Figures 3.18 - 3.22) and flow reversal occurred near the toe for ETS-R4 (Figure
3.21) and ETS-R5 (Figure 3.22).
Li and Rittgers used a pulsatile flow model to study the effect of zero and retrograde flow in the
proximal artery [167]. They used flow visualization to determine the general flow patterns in a compliant
anastomosis.  They also used laser Doppler anemometry (LDA) to measure velocity at discrete intervals
along the artery floor and graft hood regions.   From these measurements, they derived the WSS magnitude
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and spatial WSSG magnitude.  They showed a statistical difference between the mean WSS magnitude along
the hood of the graft for both flow cases.  Specifically, the mean WSS magnitude in the hood of the graft was
higher in the zero flow case as compared to the retrograde flow case but there was no statistically significant
difference in spatial WSSG.  We also determined that the normalized WSS magnitude in the hood region for
the ETS zero flow models (1.0 ± 0.2) was higher than in the retrograde flow models (0.5 ± 0.1, see Figure
3.60).  In order to compare our results to theirs, we performed an unpaired Student’s t-test on the data.  We
also determined that this difference in WSS magnitude for the hood region was statistically significant (p =
0.041). However, contrary to Li and Rittgers, we determined that the difference in the normalized WSSG
magnitude in the hood region between the zero (1.1 ± 0.2) and retrograde (0.5 ± 0.1) flow models was also
significant (p = 0.039).  
Taken together, comparison of our results to those of the previous studies indicate that the general flow
features found in our CFD models are realistic.
3.4.4 Limitations
We have developed relatively simplistic CFD models in that they do not incorporate physiologically
relevant features such as pulsatility (i.e., unsteady flow), compliant walls and non-Newtonian fluid
mechanics.  In addition, our models considered only planar ETS geometries; i.e., the graft and artery lied
within the same plane.  Although other research groups have developed CFD models incorporating some or
all of these complexities [86, 89, 96, 99, 164, 168, 169], the ultimate goal of this research was to recreate the
experimental conditions.  The experimental anastomoses were perfused with steady flow of a Newtonian
fluid (i.e., cell culture media).  The anastomoses were held fixed in space in a planar configuration.  Because
the flow was steady, a compliant wall model would not have made a difference; the rigid wall model would
provide the same results.  Therefore, our CFD models did not incorporate all the complexities
computationally possible because the goal of these CFD models was to reconstruct the hemodynamic
environment present in the accompanying experimental studies.
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The reconstruction techniques used in this study were novel and, to our knowledge, have not been used
previously.  Because of the tissue processing required for the biologic endpoints in the experimental studies,
certain possible limitations existed in the reconstruction technique.  Arterial tissue is naturally under
longitudinal tension in vivo.  Therefore, care was taken during the extraction of the vessels, construction and
perfusion of the anastomoses to maintain the vessels at the in vivo length.  To maintain the vessel geometry
after removing the anastomoses from the housing chamber, vessels were first pressure fixed by filling the
vessels with 2% paraformaldehyde and maintaining the internal pressure at the same value used during the
perfusion experiment.  Additionally, the bath around the vessels was filled with paraformaldehyde to enhance
the cross-linking process.  This fixation process lasted for one hour, which is the maximum length of time
recommended for optimal immunohistochemical staining.  Even though these techniques were used to
maintain the anastomosis geometry when removing it from the housing chamber, the vessels may have
shortened slightly causing the lumen to expand due to the incompressibility of the tissue.  This longitudinal
contraction and circumferential expansion would occur uniformly along the anastomosis with the clips acting
as a stabilization point.  In the reconstruction process, this would result in artificially large cross-sectional
diameters and consequently, artificially decreased WSS values.  These decreased WSS values would be
uniform along the anastomosis and would results in a decrease in the average hemodynamic values for the
entire anastomosis.  Therefore, any error associated with circumferential expansion would be accounted for
in the normalization of hemodynamic parameters since the values at each region are normalized by the
average value in the experiment.
For the reconstruction process, we chose to assume that the cross-sections were symmetric ellipses.  We
believe that this assumption is reasonable since we used healthy arterial segments that did not have luminal
pathologies (e.g., asymmetric plaque) and the experimental apparatus held the anastomoses in a plane of
symmetry.  This assumption could be a limitation since the full three dimensional surface was not
incorporated into the models.  However, other studies have shown that incorporating this level of detail into
the model may actually cause more errors than avoid them.  For instance, Moore et al. developed six models
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of a single human femoral-popliteal ETS bypass graft with varying degrees of detail in order to determine
the complexity needed to faithfully reconstruct patient-specific geometries [99].  The most detailed model
(Model 1) was based on smoothed contours obtained from computerized tomography (CT) images.  The first
simplification they made (Model 2) was to fit ellipses to the contours obtained from the CT images.  The next
level of simplification was to develop Model 3 which used circular cross-sections of constant diameter. In
Model 4, the out-of-plane curvature was removed and in Model 5 the graft and host artery diameters were
set equal.  Model 6 consisted of a completely idealized intersection of two intersecting uniform cylinders.
The largest differences in hemodynamic parameters occurred for models 4-6 as compared to model 1.  Little
variation in WSS was observed for model 3 (circular cross-sections) and even less occurred for Model 2
(ellipse cross-sections) as compared to model 1.  They concluded that the most important feature required
for accurate representation for ETS anastomoses is the ratio between the graft and host artery diameters,
while the local arterial caliber and out-of-plane geometry were of secondary importance and the small-scale
surface topology was least critical.  We performed a similar sensitivity analysis by creating three models each
for three separate experiments: one using asymmetric ellipses, one using symmetric ellipses and the third
using circular cross-sections (see Section 4.2.2).  Because the overall goal of this research was to determine
if a correlation exists between the biologic and hemodynamic data, we determined if the different
computational models resulted in a correlation that would lead to a different conclusion about the relative
importance of a biologic or hemodynamic parameter.  The results of these sensitivity analyses (see Section
4.3.4) showed that the use of the asymmetric or symmetric ellipse did not significantly affect the correlation
between the biologic and hemodynamic data although there was a difference between these models and the
circular cross-section reconstructions.  Therefore, we chose the symmetric ellipse cross-section because it
allowed us to take advantage computationally of the geometric symmetry without over-generalizing the shape
of the cross-section.
To determine the mesh density needed for our simulations, we performed a mesh independence study
by creating four grids for one model each for the ETS zero flow case, ETS retrograde flow case and the ETE
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case (see Sections 3.2.3 and 3.3.1).  Ideally, it would be best to perform this same type of study for each of
the 20 reconstructions.  However, this was not feasible due to the computational time required to solve the
highest density mesh (approximately 1 week).  Because similar mesh densities were found to be ideal for the
three models (ETS zero flow, ETS retrograde flow and ETE) that we studied, we believe that this mesh
density is adequate for all models.
3.5 Conclusion
We have developed three-dimensional reconstructions and CFD models of the ETS and ETE
anastomoses perfused ex vivo in the accompanying experimental study (Chapter 2).  From these models, we
have determined that a regional variation of hemodynamic parameters, most notably axial WSS and the
magnitudes of WSS and WSSG, exist in these anastomoses.  Although a number of other studies have
alluded to this regional variation of hemodynamic parameters, particularly in ETS anastomoses, to our
knowledge this is the first study to quantify these parameters in varying regions along the anastomoses and
illustrate that these differences are statistically significant.
The regions with the most hemodynamic parameters that were significantly different from other regions
of interest were the ETS proximal, distal, toe and heel segments.  These regions, particularly the toe and heel,
have previously been shown to be prone to IH formation.  In addition, the hemodynamic parameters which
varied significantly in these regions, particularly the WSS magnitude, have been implicated in IH formation.
Therefore, a correlation between the biologic response of these regions due to the hemodynamic parameters
present in these regions may exist and will be explored in the next chapter.
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4 .0 CORRELATION BETWEEN BIOLOGICAL DATA AND
HEMODYNAMIC PARAMETERS
4.1 Introduction
 Although a number of previous studies have attempted to determine the role of hemodynamics in
intimal hyperplasia formation, a quantitative correlation between a specific hemodynamic parameter and a
particular cellular response leading to intimal thickening has not been established.  There are a number of
reasons why a single hemodynamic predictor of IH has not yet been determined.  Most importantly, many
of the previous studies have not obtained directly-coupled biologic and hemodynamic data.  Most studies
focused on either a detailed analysis of the formation of IH or the hemodynamic environment, and then made
a qualitative comparison to the other.  For example, studies have determined that IH in animal and human
ETS anastomoses occurs preferentially in the heel, toe and floor regions, but there were no quantitative
measurements of hemodynamic parameters in these studies [18, 68, 69, 77, 170, 171].  Idealized and
geometrically realistic physical flow [78, 82, 83] and computational models [86, 87, 89-91, 154] have shown
that the flow field in an ETS anastomosis is complex and causes variations of WSS and WSSG along the
anastomosis.  In particular, the regions of low WSS, oscillating WSS and high spatial and temporal gradients
of WSS occurred in the same general regions (i.e. heel, toe, floor) that IH forms, however these models did
not have any direct, quantitative, biological data.
Although some studies do obtain directly-coupled biologic and hemodynamic data, the correlation
between the data may not be valid.  For example, developments in ultrasound technology allow for the
simultaneous, noninvasive measurement of intimal thickness and WSS.  Studies that have used this
technology to determine the relationship between IH and WSS in human carotid arteries have found that
intimal thickness is increased in regions of lower WSS [172, 173].  However, the hemodynamic data is not
strictly appropriate because the hemodynamic measurements were made after the formation of disease and
therefore do not necessarily indicate the hemodynamic conditions that caused the disease.  Instead, they are
the resulting hemodynamics due to IH formation and do not have predictive value.  Similarly, the
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hemodynamic measurements in casts of human tissue obtained at autopsy are not necessarily predictive of
disease formation [65, 66, 84] .
Another limitation of previous studies with coupled biologic and hemodynamic data is that the
hemodynamic parameters are not rigorously regulated throughout the experiment. For example, in vivo
animal models allow for the measurement of hemodynamic parameters and IH formation in ETE and ETS
anastomoses [79, 164, 174-176].  However, the formation of IH takes days, weeks or months during which
time it is impossible to regulate the hemodynamics. In these studies, the hemodynamics are only measured
at a single time point, usually at the time of graft insertion while the animal is under anesthesia.  Therefore,
the hemodynamic parameters are measured at a snapshot in time and there is no information about how these
change during the course of the study as the animal recovers from surgery and becomes active.  Additionally,
even if these studies were able to continuously measure the hemodynamics, they would still be changing over
time and correlations would require the use of averaged hemodynamic data.
Ex vivo models allow for the collection of directly-coupled biologic and hemodynamic data while also
providing a well-controlled hemodynamic environment that remains constant over the duration of the study.
Additionally, they allow for the perfusion of intact vascular segments, an improvement over cell culture
studies that do not incorporate the effect of the multi-cellular and matrix environment present in the
vasculature.  Although previous ex vivo perfusion studies of vascular graft tissue have been completed, they
did not isolate the effect of hemodynamics in ETS anastomoses.  For example, most ex vivo perfusion studies
related to bypass grafts have documented the pathologic changes in saphenous vein segments exposed to
arterial levels of pressure and flow [72, 148-150].  Therefore the cause of the observed biologic alterations
can not be isolated to just hemodynamics.  Some studies have separated the effects of pressure and flow on
vein grafts but have not incorporated the complex geometry and resulting hemodynamics in ETS bypass
grafts [142, 145, 177].  The only ex vivo study of bypass graft anastomoses found in the literature did not
perfuse the anastomoses [178].  The ETS anastomoses were simply incubated under standard cell culture
conditions and, therefore, this study did not elicit any hemodynamic data.
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Due to the limitations of previous studies, it was necessary to develop a novel study that allows for the
collection of directly-coupled, quantitative biologic and hemodynamic data where the hemodynamics are
well-controlled over time.  We have developed a coupled approach involving the ex vivo perfusion of ETE
and ETS vascular constructs (to obtain quantitative biologic data) and the reconstruction of the flow field
in these anastomoses using computational fluid dynamics (to obtain quantitative hemodynamic data).
Because the experiments were performed with an ex vivo perfusion system, the hemodynamic parameters
were well-controlled throughout the experiment and could be directly correlated with the resulting biologic
response measured at the end of the experiment.  Because the anastomoses consisted of artery-artery
junctions, there was no compliance mismatch and the pressure conditions used were in the physiologic range
for porcine femoral arteries.  Therefore the hemodynamics within the anastomoses was the only variable.
This allowed us to determine if a specific biologic response related to IH (i.e., either c-fos, c-jun, egr-1
protein expression or apoptosis) correlated with a. particular hemodynamic parameter (i.e., either axial,
circumferential components or magnitude of WSS or WSSG).
4.2 Methods
4.2.1 Regression and Statistics
To determine if a correlation existed between any biologic endpoint (c-fos, c-jun, egr-1 protein
expression and apoptosis) and any hemodynamic parameter (axial and circumferential components and
magnitude of WSS and WSSG), linear regression was performed and the Pearson correlation coefficient, r,
was calculated as:
[4.1]
where Lxx and Lyy are the corrected sum of squares for x and y, Lxy is the corrected sum of cross products,
xi are the hemodynamic parameter values, yi are the corresponding biologic parameter values and  and 
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are the mean values of the hemodynamic and biologic parameters, respectively [157].  The Pearson
correlation coefficient is a quantitative measure of whether or not there is a relationship between two
variables.  Specifically, -1 < r < 1 such that a negative value of r indicates a negative correlation and a
positive value of r indicates a positive correlation [157].  To determine if the correlation between two
variables was significant, a one-sample t-test was performed where t is calculated as:
[4.2]
where n is the number of data points and (n-2) are the degrees of freedom.  A correlation is considered
significant if the t value is greater than or equal to the t distribution value for the given degrees of freedom
and for the desired p level.  For example, the t distribution value for 7 degrees of freedom (n=9) and p < 0.05
is 2.365 [157].  
Linear regression was performed on the raw biologic data and hemodynamic data for all regions of
interest for each set of experiments (zero or retrograde flow).  For these analyses, the correlation was based
on a total of 45 data points (5 experiments, 9 regions of interest because the nonperfused segment was not
included) and the correlation was significant (p < 0.05) if t $2.021.  Similarly, linear regression was
performed on the pooled data from both sets of flow conditions.  For these analyses, the correlation was
based on a total of 90 data points (10 experiments, 9 regions of interest) and the correlation was significant
(p < 0.05) if t $2.000.
Linear regression was also performed on the normalized biologic and hemodynamic data (and absolute
values of the normalized data) for all regions of interest for each set of experiments (zero or retrograde flow).
This correlation is more relevant than using the raw data since the data from a number of experiments are
used for linear regression and normalization accounts for the experiment to experiment variation in biologic
and hemodynamic parameters.  For these analyses, the t-distribution values were the same as above for the
raw data correlations.
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Nonlinear regression analysis was also performed on the normalized biologic and hemodynamic data
for the pooled data from all experiments.  The following nonlinear models were used to investigate functional
relationships:
[4.3]
where x and y are the values of the biologic (y) and hemodynamic (x) parameter sets for each region of
interest and a and b are parameters determined from the regression analysis.  These functions were
transformed into their linear counterparts so that linear regression analysis could be applied [179].  The
transformed data (x’ and y’ values) were calculated from the original data (x and y values) as follows:  
[4.4]
which resulted in corresponding linear regression models:  
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[4.5]
Therefore, the transformed, normalized data for c-fos, c-jun, egr-1 and EC and SMC apoptosis at each region
of interest were correlated with the transformed, normalized data for the axial, circumferential and
magnitudes of WSS and WSSG for the same region of interest using each of the above regression models.
For the reciprocal and exponential regression models, both the normalized data and absolute values of the
normalized data were transformed.  This could not be done for the power and logarithmic models since they
necessarily require positive values for the linear transformation. The Pearson correlation coefficient, r, and
t-test parameter were calculated in the same manner as shown in Equations 4.1 and 4.2 except that
transformed data (x’ and y’) were used instead of the original data (x and y).  Note that the goodness of fit
parameter, R2, for the nonlinear models is equal to the square of the Pearson correlation coefficient, r2, for
the transformed models due to the linear transformation procedure [179].
4.2.2 Sensitivity Analysis
To determine the sensitivity of the correlation results to the three dimensional reconstruction technique,
the following technique was used as depicted in the flowchart in Figure 4.1.  First, the geometry of an ETS
anastomosis was reconstructed using three different cross-sectional shapes.  The symmetric ellipse model
used for the above correlations was compared to a more complex, asymmetric ellipse model and a more
simple model constructed from circular cross-sections.  The asymmetric ellipse reconstructions used the same
elliptical cross-sections as the symmetric cross-section technique, however the orientation of the cross-
sections were taken directly from the digitized data and not rotated to the 0 or 90° axis which was done for
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Figure 4.1 Flowchart depicting the sensitivity analysis procedure.
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the symmetric ellipse models (see Section 3.2.1.2).  The circular cross-section reconstructions used a best
fit circle instead of a ellipse to represent each cross-section.  The subsequent surface creation, meshing,
solving and post-processing procedures were identical to those described for the symmetric ellipse models
(see Sections 3.2.1 - 3.2.6). The only difference was that the asymmetric ellipse models could not take the
advantage of symmetry so the entire volume had to be reconstructed and meshed.  Twice as many cells were
used to mesh the asymmetric model in order to maintain the same cell density as the symmetric ellipse and
circular models.  The multiple reconstruction techniques were repeated for three separate (zero flow)
experiments and the normalized hemodynamic parameters were calculated for each anastomosis model.
Linear and nonlinear regression were performed using the normalized biologic parameters.  This yielded
three sets of correlation coefficients, one for each reconstruction technique.  The linear and nonlinear
regressions for each reconstruction type were based on a total of 21 data points (3 experiments, 7 regions of
interest because the ETE regions of interest were not included) and the correlation was significant (p < 0.05)
if t $2.093.  The parameter combinations (e.g., c-fos and axial WSS) found to be significant for each
reconstruction technique were compared to confirm that the symmetric ellipse technique would not result
in a false positive correlation.  Any parameter combination that resulted in a significant correlation for the
symmetric model but not for the asymmetric and/or circular models was eliminated for the final analysis of
the data from all of the symmetric models.
4.3 Results
4.3.1 Raw Data - Linear Regression
Table 4.1 shows the correlation coefficient value (r) from the linear regression analysis on the raw
biologic and hemodynamic data for each set of experiments (zero and retrograde) and for the pooled data
from all experiments.  Significant correlations (p < 0.05) are highlighted in grey.  Graphs of the data that
exhibited a significant correlation (p < 0.05) between the raw biologic and hemodynamic parameters for the
zero flow, retrograde flow and all experiments are shown in Figures 4.2 , 4.3 and 4.4, respectively.
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Axial WSS 0.12 -0.17 -0.20 -0.12 -0.07
Circ WSS 0.13 0.15 -0.08 0.09 0.14
WSS Mag -0.05 -0.20 -0.06 -0.20 -0.18
Axial WSSG -0.01 -0.14 -0.06 -0.28 -0.22
Circ WSSG 0.03 -0.12 -0.14 0.10 0.33
WSSG M ag -0.12 -0.27 -0.05 -0.19 -0.14
RETROGRADE
FLOW




Axial WSS 0.13 -0.25 -0.16 0.03 0.04
Circ WSS 0.09 0.21 0.04 -0.11 -0.10
WSS Mag -0.07 -0.40 -0.09 0.14 0.02
Axial WSSG -0.04 0.14 0.01 -0.19 -0.19
Circ WSSG 0.04 0.04 -0.03 -0.08 0.19
WSSG M ag -0.01 -0.31 -0.08 0.16 0.05
ALL
EXPERIMENTS




Axial WSS -0.05 -0.18 -0.15 -0.19 -0.05
Circ WSS 0.16 0.14 -0.03 0.10 0.10
WSS Mag -0.18 -0.22 -0.05 -0.21 -0.14
Axial WSSG -0.07 -0.07 -0.03 -0.22 -0.21
Circ WSSG 0.04 -0.07 -0.08 0.03 0.28
WSSG M ag -0.21 -0.25 -0.04 -0.20 -0.10
Table 4.1 Correlation coefficient (r) values for the raw data parameter
combinations for the zero flow, retrograde flow and for the data from all
experiments pooled together.  Significant correlations (p < 0.05) are highlighted
in grey.
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Figure 4.2 Plot showing the only significant
correlation (p < 0.05)  for the raw data from the zero
flow experiments.
Figure 4.3 Plots showing the linear regression for biologic and hemodynamic parameter combinations with
significant (p < 0.05) correlation coefficients (r) for the raw data from the retrograde flow experiments. 
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Figure 4.4 Plots showing the linear regression for biologic and hemodynamic parameter combinations with
significant (p < 0.05) correlation coefficients (r) for the raw, pooled data from all experiments.
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For the zero flow experiments, only one combination of parameters had a significant correlation as
shown in Figure 4.2.  The level of SMC apoptosis was positively correlated with circumferential WSSG  (r
= 0.33, p = 0.028).  For the retrograde flow experiments, two combinations of parameters yielded a
significant correlation as shown in Figure 4.3.  The level of EC c-jun protein expression was inversely
correlated with the magnitude of WSS (r = -0.40, p = 0.006) and WSSG (r = -0.31, p = 0.040).  When the
data from all experiments were pooled together, a large number of significant correlations were found as
shown in Figure  4.4.  The level of EC c-fos protein expression correlated inversely with the magnitude of
WSSG (r = -0.21, p = 0.045).  The level of EC c-jun protein expression was inversely correlated with the
magnitude of WSS (r = -0.22, p = 0.040) and WSSG (r = -0.25, p = 0.017).  The level of EC apoptosis was
inversely correlated with axial WSSG (r = -0.22, p = 0.036) and the level of SMC apoptosis was positively
correlated with circumferential WSSG (r = 0.28, p = 0.007).  The level of egr-1 protein was the only biologic
parameter to not have a significant correlation with any hemodynamic parameter for any of the analyses.
4.3.2 Normalized Data - Linear Regression
Table 4.2 shows the correlation coefficient value (r) from the linear regression analysis on the
normalized biologic and hemodynamic data for each set of experiments (zero and retrograde) and for the
pooled data from all experiments.  Significant correlations (p < 0.05) are highlighted in grey.  Graphs of the
data that exhibited a significant correlation (p < 0.05) between the normalized biologic and hemodynamic
parameters for the zero flow, retrograde flow and all experiments are shown in Figures 4.5, 4.6 and 4.7,
respectively.
For the zero flow experiments, four combinations of parameters had significant correlations as shown
in Figure 4.5.  The level of EC c-fos protein expression was inversely correlated with the magnitude of WSS
(r = -0.31, p = 0.036) and WSSG (r = -0.41, p = 0.005).  The level of EC egr-1 protein expression was
positively correlated with circumferential WSS (r = 0.38, p = 0.010) and the degree of SMC apoptosis was
positively correlated with circumferential WSSG (r = 0.31, p = 0.036).  For the retrograde flow experiments,
the only biologic parameter with a significant hemodynamic correlation was egr-1 as shown in Figure 4.6.
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Axial WSS -0.18 -0.11 0.00 -0.08 -0.04
Circ WSS -0.10 0.15 0.38 -0.03 -0.01
WSS Mag -0.31 -0.11 0.17 -0.10 -0.04
Axial WSSG 0.12 -0.01 -0.10 0.19 0.25
Circ WSSG -0.20 -0.24 -0.14 0.21 0.31
WSSG M ag -0.41 -0.25 0.21 0.05 0.16
RETROGRADE
FLOW




Axial WSS 0.12 -0.18 -0.35 0.00 0.17
Circ WSS 0.02 -0.08 -0.27 -0.12 0.20
WSS Mag -0.05 -0.23 -0.42 -0.18 0.09
Axial WSSG 0.18 -0.09 -0.15 0.10 0.18
Circ WSSG 0.13 -0.03 -0.01 -0.12 0.04
WSSG M ag 0.00 -0.19 -0.41 -0.12 0.16
ALL
EXPERIMENTS




Axial WSS -0.02 -0.14 -0.27 -0.03 0.08
Circ WSS -0.06 0.06 0.03 -0.06 0.06
WSS Mag -0.22 -0.16 -0.16 -0.12 0.01
Axial WSSG 0.13 -0.05 -0.14 0.12 0.18
Circ WSSG 0.02 -0.07 -0.03 0.00 0.09
WSSG M ag -0.26 -0.22 -0.14 0.00 0.16
Table 4.2 Correlation coefficient (r) values for the normalized data parameter
combinations for the zero flow, retrograde flow and for the data from all
experiments pooled together.  Significant correlations (p < 0.05) are highlighted
in grey.
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Figure 4.5 Plots showing the linear regression for biologic and hemodynamic parameter combinations with
significant (p < 0.05) correlation coefficients (r) for the normalized data from the zero flow experiments.
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Figure 4.6 Plots showing the linear regression for biologic and hemodynamic parameter combinations with
significant (p < 0.05) correlation coefficients (r) for the normalized data from the retrograde flow
experiments.
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Figure 4.7 Plots showing the linear regression for biologic and hemodynamic parameter combinations with
significant (p < 0.05)  correlation coefficients (r) for the normalized data from the pooled data from all
experiments.
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The level of EC egr-1 protein expression was  inversely correlated with axial WSS (r = -0.35, p = 0.017), the
magnitude of WSS (r = -0.42, p = 0.004) and WSSG (r = -0.41, p = 0.005).  When the data from all
experiments were pooled together, four combinations of parameters had significant correlations as shown
in Figure 4.7.  The level of EC c-fos protein expression was inversely correlated with the magnitude of WSS
(r = -0.22, p = 0.037) and WSSG (r = -0.26, p = 0.012).  The level of EC c-jun protein expression was
inversely correlated with WSSG magnitude (r = -0.22, p = 0.034).  The level of EC egr-1 protein expression
was inversely correlated with axial WSS (r = -0.27, p =  0.011).  The degree of EC and SMC apoptosis did
not have a significant correlation with a hemodynamic parameter.
Table 4.3 shows the correlation coefficient value (r) for the linear regression analysis on the normalized
biologic data and the absolute value of the normalized hemodynamic data for each set of experiments (zero
and retrograde) and for the pooled data from all experiments.  Significant correlations (p < 0.05) are
highlighted in grey.  Graphs of the data that exhibited a significant correlation (p < 0.05) between the
normalized biologic and hemodynamic parameters for the zero flow, retrograde flow and all experiments are
shown in Figures 4.8, 4.9 and 4.10/4.11, respectively.
For the zero flow experiments, the same four combinations of parameters that had significant
correlations for the original, normalized data (see Table 4.2) had significant correlations for the absolute
value of the normalized data as shown in Figure 4.8.  Because the absolute value of the magnitude parameters
did not change, the level of EC c-fos protein expression had the same inverse correlation with the magnitude
of WSS (r = -0.31, p = 0.036) and WSSG (r = -0.41, p = 0.005).  The level of EC egr-1 protein expression
was more strongly positively correlated with circumferential WSS (r = 0.41, p = 0.005) and the degree of
SMC apoptosis was more strongly positively correlated with circumferential WSSG (r = 0.35, p = 0.020).
For the retrograde flow experiments, the only biologic parameter with a significant hemodynamic correlation
was egr-1 as shown in Figure 4.9.  As seen for the original, normalized data, the level of EC egr-1 protein
expression was  inversely correlated with axial WSS (r = -0.43, p = 0.003), the magnitude of WSS (r = -0.42,
p = 0.004) and WSSG (r = -0.41, p = 0.005).  In addition, the level of EC egr-1 protein expression was 
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Axial WSS -0.24 -0.10 0.06 -0.10 -0.05
Circ WSS -0.29 0.20 0.41 -0.09 0.05
WSS Mag -0.31 -0.11 0.17 -0.10 -0.04
Axial WSSG 0.23 -0.04 0.06 -0.09 0.00
Circ WSSG -0.23 -0.24 -0.01 0.23 0.35
WSSG M ag -0.41 -0.25 0.21 0.05 0.16
RETROGRADE
FLOW




Axial WSS 0.00 -0.22 -0.43 -0.20 0.08
Circ WSS -0.23 -0.08 -0.15 -0.17 0.18
WSS Mag -0.05 -0.23 -0.42 -0.18 0.09
Axial WSSG 0.08 -0.10 -0.33 0.13 0.23
Circ WSSG -0.21 -0.03 -0.28 -0.28 -0.22
WSSG M ag 0.00 -0.19 -0.41 -0.12 0.16
ALL
EXPERIMENTS




Axial WSS -0.12 -0.15 -0.27 -0.12 0.02
Circ WSS -0.27 -0.16 0.10 -0.11 0.09
WSS Mag -0.22 -0.16 -0.16 -0.12 0.01
Axial WSSG -0.06 -0.07 -0.23 0.03 0.12
Circ WSSG -0.17 -0.07 -0.21 -0.06 -0.04
WSSG M ag -0.26 -0.22 -0.14 0.00 0.16
Table 4.3 Correlation coefficient (r) values for the absolute values of the
normalized data parameter combinations for the zero flow, retrograde flow and for
the data from all experiments pooled together.  Significant correlations (p < 0.05)
are highlighted in grey.
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Figure 4.8 Plots showing the linear regression for biologic and hemodynamic parameter combinations with
significant (p < 0.05)  correlation coefficients (r) for the absolute value of the normalized data from the zero
flow experiments.
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Figure 4.9 Plots showing the linear regression for biologic and hemodynamic parameter combinations with
significant (p < 0.05)  correlation coefficients (r) for the absolute value of the normalized data from the
retrograde flow experiments.
208
Figure 4.10 Plots showing the linear regression for biologic and hemodynamic parameter combinations with
significant (p < 0.05) correlation coefficients (r) for the absolute value of the normalized data from the
pooled data from all experiments.  Note that only the graphs for c-fos and c-jun are shown in this figure.  The
graphs for egr-1 are shown in the following figure.
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Figure 4.11 Plots showing the linear regression for biologic and hemodynamic parameter combinations with
significant (p < 0.05) correlation coefficients (r) for the absolute value of the normalized data from the
pooled data from all experiments.  Note that only the graphs for egr-1 are shown in this figure.  The graphs
for c-fos and c-jun are shown in the previous figure.
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inversely correlated with axial WSSG (r = -0.33, p = 0.027). When the data from all experiments were pooled
together, seven combinations of parameters had significant correlations (as shown in Figures 4.10 and 4.11)
compared to the four parameter combinations for the original, normalized data.  The same four combinations
had significant correlations including the level of EC c-fos protein expression with the magnitude of WSS
(r = -0.22, p = 0.037) and WSSG (r = -0.26, p = 0.012), the level of EC c-jun protein expression with WSSG
magnitude (r = -0.22, p = 0.034) and the level of EC egr-1 protein with axial WSS  (r = -0.27, p = 0.009).
In addition, the level of EC c-fos protein expression was inversely correlated with circumferential WSS (r
= -0.27, p = 0.010) and the level of EC egr-1 protein was inversely correlated with axial WSSG (r = -0.23,
p = 0.032) and circumferential WSSG  (r = -0.21, p = 0.042).  The degree of EC and SMC apoptosis did not
have a significant correlation with a hemodynamic parameter.
4.3.3 Normalized Data - Nonlinear Regression
Table 4.4 shows the correlation coefficient value (r) for the reciprocal nonlinear regression analysis on
the normalized biologic and hemodynamic data for the pooled data from all experiments.  Tables 4.5, 4.6 and
4.7 show the correlation coefficient values (r) for the exponential, power and logarithmic nonlinear
regression analyses on the same data.  Significant correlations (p < 0.05) are highlighted in grey.  Graphs of
the data that exhibited a significant correlation (p < 0.05) between the normalized biologic and hemodynamic
parameters for the reciprocal, reciprocal absolute value, exponential, exponential absolute value, power and
logarithmic regression analyses are shown in Figures 4.12, 4.13, 4.14/4.15, 4.16/4.17/4.18, 4.19/4.20 and
4.21/4.22, respectively.  The graphs in the left column of the figures show the regressions for the linearly
transformed data and the graphs in the right column show the corresponding nonlinear regression.
For the reciprocal nonlinear regression model, three combinations of parameters had significant
correlations for the original, normalized data and the absolute value of the normalized data as shown in Table
4.4 and Figures 4.12 and 4.13.  Using the linear transformation of the reciprocal model, the level of EC c-fos
protein expression was positively correlated with axial WSS (r = 0.21, p = 0.045) and the  magnitude of WSS
(r = 0.21, p = 0.044) and WSSG (r = 0.23, p = 0.027).  Because the absolute value of the magnitude
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parameters did not change, using the absolute value of the data did not change the correlation coefficients
for the parameter combinations with WSS and WSSG magnitude but the correlation coefficients did change
for all other combinations.  However, similar to the correlation using the original, normalized data, the level
of EC c-fos protein expression was still positively correlated with axial WSS (r = 0.21, p = 0.044) and this
was the only significant combination of parameters other than positive correlation between the level of EC
c-fos protein expression with the magnitude of WSS (r = 0.21, p = 0.044) and WSSG (r = 0.23, p = 0.027).
For the exponential nonlinear regression model, there were a number of combinations of parameters
that had significant correlations for the original, normalized data which were different from the significant
parameter combinations for the absolute value of the normalized data as shown in Table 4.5 and Figures
4.14/4.15 and 4.16/4.17/4.18.  Using the linear transformation of the exponential model, the level of EC c-fos
protein expression was inversely correlated with the magnitude of WSS (r = -0.25, p = 0.020) and WSSG
(r = -0.29, p = 0.006).  The level of EC c-jun protein expression was also inversely correlated with the
magnitude of WSSG (r = -0.25, p = 0.018).  The level of EC egr-1 protein expression was inversely




Axial WSS 0.21 0.06 -0.10 -0.02 0.03
Circ WSS 0.04 0.09 -0.05 -0.08 -0.04
WSS Mag 0.21 0.08 -0.08 -0.01 0.03
Axial WSSG -0.05 -0.15 -0.05 -0.07 -0.06
Circ WSSG -0.17 -0.05 0.06 -0.02 -0.04
WSSG M ag 0.23 0.10 -0.09 -0.04 0.01
RECIPROCAL
ABS VALUE




Axial WSS 0.21 0.06 -0.09 -0.02 0.03
Circ WSS 0.06 0.09 -0.07 -0.09 -0.04
WSS Mag 0.21 0.08 -0.08 -0.01 0.03
Axial WSSG -0.05 -0.15 -0.05 -0.07 -0.06
Circ WSSG 0.18 0.06 -0.06 0.02 0.05
WSSG M ag 0.23 0.10 -0.09 -0.04 0.01
Table 4.4 Correlation coefficient (r) values for the reciprocal nonlinear regression
for the parameter combinations using the original, normalized data and the
absolute value of the normalized data from all experiments.  Significant
correlations (p < 0.05) are highlighted in grey.
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Figure 4.12 Plots showing the reciprocal regression for biologic and hemodynamic parameter combinations
with significant (p < 0.05) correlation coefficients (r) for the normalized data from all experiments.  The
graphs in the left column show the linear regressions using the transformed data and the graphs in the right
column show the corresponding nonlinear regressions.
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Figure 4.13 Plots showing the reciprocal nonlinear regression for biologic and hemodynamic parameter
combinations with significant (p < 0.05) correlation coefficients (r) for the absolute value of the normalized
data from all experiments.  The graphs in the left column show the linear regressions using the transformed
data and the graphs in the right column show the corresponding nonlinear regressions.
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 correlated with axial WSS (r = -0.29, p = 0.005) and the degree of SMC apoptosis was inversely correlated
with WSS magnitude (r = -0.27, p = 0.009). Because the absolute value of the magnitude parameters did not
change, the level of EC c-fos protein expression had the same inverse correlations with the magnitude of
WSS (r = -0.25, p = 0.020) and WSSG (r = -0.29, p = 0.006) when using the absolute value of the data.  The
same is true for the inverse correlations between the level of EC c-jun protein expression was also inversely
correlated with the magnitude of WSSG (r = -0.25, p = 0.018) and the degree of SMC apoptosis was
inversely correlated with WSS magnitude (r = -0.27, p = 0.009).  Similar to the exponential regression using
the original, normalized data, the level of EC egr-1 protein expression was inversely correlated with axial
WSS (r = -0.31, p = 0.005).  However, three additional parameter combinations were significant for the
absolute value of the normalized data including the inverse correlation between the level of EC c-fos protein
expression with circumferential WSS (r = -0.25, p = 0.018) and the inverse correlation between the level of
EC egr-1 protein expression with axial WSSG (r = -0.27, p = 0.010) and circumferential WSSG (r = -0.23,
p = 0.033).




Axial WSS -0.02 -0.15 -0.29 -0.04 -0.11
Circ WSS -0.05 0.08 0.01 -0.05 -0.12
WSS Mag -0.25 -0.17 -0.18 -0.16 -0.27
Axial WSSG 0.13 -0.06 -0.17 0.12 0.18
Circ WSSG 0.03 -0.08 -0.04 0.02 0.04
WSSG M ag -0.29 -0.25 -0.16 -0.05 -0.10
EXPONENTIAL
ABS VALUE




Axial WSS -0.12 -0.16 -0.31 -0.11 -0.13
Circ WSS -0.25 -0.15 0.09 -0.09 -0.09
WSS Mag -0.25 -0.17 -0.18 -0.16 -0.27
Axial WSSG -0.03 -0.07 -0.27 0.04 0.02
Circ WSSG -0.15 -0.06 -0.23 -0.02 0.00
WSSG M ag -0.29 -0.25 -0.16 -0.05 -0.10
Table 4.5 Correlation coefficient (r) values for the exponential nonlinear
regression for the parameter combinations using the original, normalized data and
the absolute value of the normalized data from all experiments.  Significant
correlations (p < 0.05) are highlighted in grey.
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Figure 4.14 Plots showing the exponential nonlinear regression for biologic and hemodynamic parameter
combinations with significant (p < 0.05) correlation coefficients (r) for the normalized data from all
experiments.  The graphs in the left column show the linear regressions using the transformed data and the
graphs in the right column show the corresponding nonlinear regressions.  Note that only the graphs for c-fos
are shown in this figure.  The graphs for c-jun, egr-1 and SMC apoptosis are shown in the following figure.
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Figure 4.15 Plots showing the exponential nonlinear regression for biologic and hemodynamic parameter
combinations with significant (p < 0.05) correlation coefficients (r) for the normalized data from all
experiments. The graphs in the left column show the linear regressions using the transformed data and the
graphs in the right column show the corresponding nonlinear regressions.  Note that only the graphs for c-jun,
egr-1 and SMC apoptosis are shown in this figure.  The graphs for c-fos  are shown in the previous figure.
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Figure 4.16 Plots showing the exponential nonlinear regression for biologic and hemodynamic parameter
combinations with significant (p < 0.05) correlation coefficients (r) for the absolute value of the normalized
data from all experiments.  The graphs in the left column show the linear regressions using the transformed
data and the graphs in the right column show the corresponding nonlinear regressions.  Note that only the
graphs for c-fos are shown in this figure.  The graphs for c-jun, egr-1 and SMC apoptosis are shown in the
two following  figures.
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Figure 4.17 Plots showing the exponential nonlinear regression for biologic and hemodynamic parameter
combinations with significant (p < 0.05) correlation coefficients (r) for the absolute value of the normalized
data from all experiments.  The graphs in the left column show the linear regressions using the transformed
data and the graphs in the right column show the corresponding nonlinear regressions.  Note that only the
graphs for  egr-1 are shown in this figure.  The graphs for c-fos  are shown in the previous figure and the
graphs for c-jun and SMC apoptosis are shown in the following figure.
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Figure 4.18 Plots showing the exponential nonlinear regression for biologic and hemodynamic parameter
combinations with significant (p < 0.05) correlation coefficients (r) for the absolute value of the normalized
data from all experiments.  The graphs in the left column show the linear regressions using the transformed
data and the graphs in the right column show the corresponding nonlinear regressions.  Note that only the
graphs for c-jun and SMC apoptosis are shown in this figure.  The graphs for c-fos and  egr-1 are shown in
the two previous figures.
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For the power nonlinear regression model, the only biologic parameter that had significant correlations
was the level of EC c-fos protein expression as shown in Table 4.6 and Figures 4.19 and 4.20.  Using the
linear transformation of the power model, the level of EC c-fos protein expression was inversely correlated
with circumferential WSS (r = -0.34, p = 0.001) and WSS magnitude (r = -0.27, p = 0.011).  Additionally,
the level of EC c-fos protein expression was inversely correlated with circumferential WSSG (r = -0.26, p
= 0.015) and WSSG magnitude (r = -0.29, p = 0.006).
For the logarithmic nonlinear regression model, the same four parameter combinations had significant
correlations as the power nonlinear regression mode as shown in Table 4.7 and Figures 4.21 and 4.22.  Using
the linear transformation of the logarithmic model, the level of EC c-fos protein expression was inversely
correlated with  circumferential WSS (r = -0.34, p = 0.001) and WSS magnitude (r = -0.29, p = 0.006).
Additionally, the level of EC c-fos protein expression was inversely correlated with circumferential WSSG
(r = -0.31, p = 0.003) and WSSG magnitude (r = -0.30, p = 0.004).
4.3.4 Sensitivity Analysis
The correlation coefficients for the linear regression model are presented in Tables  4.8 and 4.9 for each
parameter combination for each reconstruction technique.  For the symmetric elliptical cross-section
reconstruction technique, four parameter combinations had significant correlations.  The level of EC c-fos
protein expression was inversely correlated with the axial WSS (r = -0.56, p = 0.009) and the magnitudes of
WSS (r = -0.54, p = 0.012) and WSSG (r = -0.50, p = 0.022).  The level of EC egr-1 protein expression was
positively correlated with circumferential WSS (r = 0.61, p = 0.004).  These same parameter combinations
yielded significant correlations in the asymmetric elliptical and circular cross-section reconstructions.
The asymmetric ellipse and circle reconstructions also had significant correlations that did not occur
for the other reconstruction techniques.  The asymmetric ellipse reconstruction showed a significant positive
correlation for EC c-jun protein expression and circumferential WSSG (r = 0.44, p = 0.048).  The degree of
EC apoptosis was inversely correlated with circumferential WSSG (r = -0.54, p = 0.011) as was the degree
of SMC apoptosis and circumferential WSS (r = -0.57, p = 0.007). The circular reconstruction showed a 
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Figure 4.19 Plots showing the power nonlinear regression for biologic and hemodynamic
parameter combinations with significant (p < 0.05) correlation coefficients (r) for the
absolute value of the normalized data from all experiments.  The graphs in the left column
show the linear regressions using the transformed data and the graphs in the right column
show the corresponding nonlinear regressions.  Note that only the graphs for WSS are
shown in this figure.  The graphs for WSSG are shown in the following figure.




Axial WSS -0.18 -0.07 -0.11 -0.04 -0.13
Circ WSS -0.34 -0.19 0.15 -0.05 -0.12
WSS Mag -0.27 -0.12 -0.07 -0.05 -0.16
Axial WSSG -0.17 -0.10 -0.11 -0.05 -0.07
Circ WSSG -0.26 -0.10 -0.03 0.04 -0.05
WSSG M ag -0.29 -0.17 -0.08 -0.08 -0.13
Table 4.6 Correlation coefficient (r) values for the power nonlinear regression for
the parameter combinations using the absolute value of the normalized data from
all experiments.  Significant correlations (p < 0.05) are highlighted in grey.
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Figure 4.20 Plots showing the power nonlinear regression for biologic and hemodynamic parameter
combinations with significant (p < 0.05) correlation coefficients (r) for the absolute value of the normalized
data from all experiments.  The graphs in the left column show the linear regressions using the transformed
data and the graphs in the right column show the corresponding nonlinear regressions.  Note that only the
graphs for WSSG are shown in this figure.  The graphs for WSS are shown in the previous figure.
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Figure 4.21 Plots showing the logarithmic nonlinear regression for biologic and
hemodynamic parameter combinations with significant (p < 0.05) correlation coefficients
(r) for the absolute value of the normalized data from all experiments.  The graphs in the
left column show the linear regressions using the transformed data and the graphs in the
right column show the corresponding nonlinear regressions.  Note that only the graphs for
WSS are shown in this figure.  The graphs for WSSG are shown in the following figure.




Axial WSS -0.21 -0.07 -0.08 -0.05 -0.02
Circ WSS -0.34 -0.19 0.15 -0.04 0.09
WSS Mag -0.29 -0.12 -0.04 -0.06 0.01
Axial WSSG -0.19 -0.11 -0.08 -0.08 0.03
Circ WSSG -0.31 -0.10 -0.01 -0.04 0.00
WSSG M ag -0.30 -0.17 -0.06 -0.06 0.06
Table 4.7 Correlation coefficient (r) values for the logarithmic nonlinear
regression for the parameter combinations using the absolute value of the
normalized data from all experiments.  Significant correlations (p < 0.05) are
highlighted in grey.
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Figure 4.22 Plots showing the logarithmic nonlinear regression for biologic and hemodynamic parameter
combinations with significant (p < 0.05) correlation coefficients (r) for the absolute value of the normalized
data from all experiments.  The graphs in the left column show the linear regressions using the transformed
data and the graphs in the right column show the corresponding nonlinear regressions.  Note that only the
graphs for WSSG are shown in this figure.  The graphs for WSS are shown in the previous figure.
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Axial W SS -0.56 -0.55 -0.46 -0.38 -0.39 -0.42 0.14 0.07 0.07
Circ W SS -0.09 -0.06 -0.05 0.32 0.08 0.26 0.61 0.58 0.64
W SS Mag -0.54 -0.54 -0.47 -0.31 -0.33 -0.40 0.27 0.17 0.09
Axial W SSG -0.33 -0.24 -0.16 -0.18 -0.15 -0.45 0.11 0.14 -0.17
Circ W SSG -0.28 0.25 -0.12 -0.31 0.44 -0.40 -0.37 0.33 -0.09
W SSG Mag -0.50 -0.46 -0.47 -0.38 -0.30 -0.44 0.14 0.19 0.02

















Axial W SS -0.57 -0.53 -0.43 -0.37 -0.37 -0.41 0.15 0.09 0.09
Circ W SS -0.29 -0.26 0.07 -0.19 -0.23 -0.26 0.44 0.14 0.05
W SS Mag -0.54 -0.54 -0.47 -0.31 -0.33 -0.40 0.27 0.17 0.09
Axial W SSG -0.41 -0.27 -0.52 0.15 -0.02 -0.45 0.12 0.16 -0.07
Circ W SSG -0.27 -0.37 -0.30 -0.41 -0.41 -0.02 -0.23 -0.24 -0.11
W SSG Mag -0.50 -0.46 -0.47 -0.38 -0.30 -0.44 0.14 0.19 0.02
Table 4.8 IEG correlation coefficients (r) using the linear regression model for the normalized data and the
absolute value of the normalized data for the three reconstruction techniques.  Significant correlations (p <
0.05) are highlighted in grey.










Axial W SS 0.08 0.26 0.22 -0.17 0.06 0.09
Circ W SS -0.09 -0.10 -0.04 -0.14 -0.57 -0.21
W SS Mag 0.05 0.21 0.17 -0.09 0.10 0.09
Axial W SSG 0.12 0.33 0.38 0.21 0.41 0.37
Circ W SSG 0.31 -0.54 0.19 0.29 -0.42 0.42
W SSG Mag 0.26 0.26 0.22 0.14 0.18 0.16












Axial W SS 0.05 0.25 0.21 -0.13 0.10 0.09
Circ W SS -0.07 -0.08 -0.04 -0.04 0.17 0.09
W SS Mag 0.05 0.21 0.17 -0.09 0.10 0.09
Axial W SSG -0.10 0.24 0.15 -0.18 0.24 0.06
Circ W SSG 0.26 0.26 -0.14 0.37 0.29 -0.08
W SSG Mag 0.26 0.26 0.22 0.14 0.18 0.16
Table 4.9 Apoptosis correlation coefficients (r) using the linear regression model for
the normalized data and the absolute value of the normalized data for the three
reconstruction techniques.  Significant correlations (p < 0.05) are highlighted in grey.
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significant inverse correlation between EC c-jun protein expression and axial WSSG (r = -0.45, p = 0.040)
and WSSG magnitude (r = -0.44, p = 0.049).
For the sensitivity analysis, the most important biologic and hemodynamic parameter combinations are
those that resulted in significant correlations for the data from the symmetric ellipse models for all
experiments shown in section 4.3.2. Specifically, significant correlations existed for c-fos and WSS
magnitude, c-fos and WSSG magnitude, c-jun and WSSG magnitude, and egr-1 and axial WSS (see Table
4.2 - all experiments).  The data presented in this sensitivity analysis section showed the same results (i.e.,
significant or insignificant correlation coefficients) for the symmetric ellipse, asymmetric ellipse and circle
models for all of these parameter combinations except c-jun and WSSG.  For this parameter combination,
the symmetric and asymmetric models had the same results (i.e., insignificant correlation coefficient) while
the circular model resulted in a significant correlation.  Therefore, it is possible that this parameter
combination is sensitive to the reconstruction technique and may not be a valid significant correlation.
The results of the linear regression of the absolute value of the normalized data are also shown in
Tables 4.8 and 4.9.  For the symmetric elliptical cross-section reconstruction technique, the same four
parameter combinations had significant correlations using the absolute value of the normalized data.  The
level of EC c-fos protein expression was inversely correlated with the axial WSS (r = -0.57, p = 0.007) and
the magnitudes of WSS (r = -0.54, p = 0.012) and WSSG (r = -0.50, p = 0.022).  The level of EC egr-1
protein expression was positively correlated with circumferential WSS (r = 0.44, p = 0.049). The inverse
correlations between c-fos and the magnitudes of WSS and WSSG were also significant for the asymmetric
elliptical and circular cross-section reconstructions.  However, the correlation between c-fos and axial WSS
was not significant for the circular cross-section reconstruction and the correlation between egr-1 and
circumferential WSS was not significant for either the asymmetric ellipse or circular cross-section
reconstruction. 
For the sensitivity analysis, the most important biologic and hemodynamic parameter combinations are
those that resulted in significant correlations for the data from the symmetric ellipse models for all
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experiments shown in section 4.3.2. Specifically, significant correlations existed for c-fos and circumferential
WSS, c-fos and WSS magnitude, c-fos and WSSG magnitude, c-jun and WSSG magnitude, egr-1 and axial
WSS, egr-1 and axial WSSG, and  egr-1 and WSSG magnitude (see Table 4.3 - all experiments).  The data
presented in this sensitivity analysis section showed the same results (i.e., significant or insignificant
correlation coefficients) for the symmetric ellipse, asymmetric ellipse and circle models for all of these
parameter combinations except c-jun and WSSG.  For this parameter combination, the symmetric and
asymmetric models had the same results (i.e., insignificant correlation coefficient) while the circular model
resulted in a significant correlation.  Therefore, it is possible that this parameter combination is sensitive to
the reconstruction technique and may not be a valid significant correlation.
The correlation coefficients for the linear transformation of the reciprocal nonlinear regression model
using the original, normalized data and the absolute value of the normalized data are shown in Tables 4.10
and 4.11.  For the symmetric elliptical cross-section reconstruction technique, eight parameter combinations
had significant correlations using the original, normalized data.  Four of these parameter combinations were
significant for all reconstruction techniques.  The level of EC c-fos protein expression was positively
correlated with axial WSS (r = 0.65, p = 0.002, symmetric ellipse), WSS magnitude (r = 0.59, p = 0.005,
symmetric ellipse) and WSSG magnitude (r = 0.60, p = 0.004, symmetric ellipse).  The level of EC egr-1
protein expression was inversely correlated with circumferential WSS (r = -0.56, p = 0.008, symmetric
ellipse).  Four parameter combinations were significant for the symmetric ellipse model but not for the
asymmetric ellipse and/or circle cross-section techniques.  For the symmetric ellipse model, the level of EC
c-fos protein expression was directly correlated with axial WSSG (r = 0.50, p = 0.020) and the degree of
SMC apoptosis was positively correlated with axial WSS (r = 0.47, p = 0.033) and axial WSSG (r = 0.50,
p = 0.021), but these correlations were not significant for the other reconstruction techniques.  Similarly, for
the symmetric ellipse model, the level of EC c-jun protein expression was positively correlated with WSS
magnitude (r = 0.65, p = 0.002, symmetric ellipse) but this correlation was not significant for the asymmetric
ellipse model.  For the symmetric elliptical cross-section reconstruction technique, eight parameter 
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Axial W SS 0.65 0.60 0.53 0.42 0.46 0.47 -0.10 -0.04 -0.02
Circ W SS 0.02 -0.12 -0.02 -0.35 -0.19 -0.27 -0.56 -0.55 -0.63
W SS Mag 0.59 0.60 0.58 0.34 0.40 0.46 -0.22 -0.13 -0.05
Axial W SSG 0.50 0.22 0.17 0.19 0.19 0.61 -0.08 -0.10 0.21
Circ W SSG 0.38 -0.51 0.29 0.42 -0.63 0.40 0.39 -0.37 0.12
W SSG Mag 0.60 0.47 0.57 0.49 0.37 0.54 -0.09 -0.15 0.02

















Axial WSS 0.65 0.60 0.52 0.41 0.46 0.47 -0.12 -0.06 -0.04
Circ WSS 0.15 0.06 -0.04 0.13 0.20 0.18 -0.37 -0.11 0.01
WSS Mag 0.59 0.60 0.58 0.34 0.40 0.46 -0.22 -0.13 -0.05
Axial WSSG 0.46 0.16 0.64 -0.07 0.09 0.60 -0.13 -0.15 0.09
Circ WSSG 0.37 0.48 0.22 0.50 0.58 0.08 0.28 0.24 0.07
Table 4.10 IEG correlation coefficients (r) using the linear transformation of the reciprocal regression model
for the normalized data and the absolute value of the normalized data for the three reconstruction techniques.
Significant correlations (p < 0.05) are highlighted in grey.










Axial W SS 0.09 -0.06 -0.04 0.47 0.25 0.25
Circ W SS 0.05 -0.09 0.02 0.18 0.02 0.07
W SS Mag 0.05 -0.04 -0.03 0.42 0.29 0.31
Axial W SSG 0.22 -0.16 -0.39 0.50 -0.02 -0.41
Circ W SSG -0.11 0.16 0.03 0.03 0.02 0.18
W SSG Mag -0.08 -0.13 -0.11 0.23 0.14 0.17












Axial W SS 0.12 -0.05 -0.05 0.47 0.25 0.25
Circ W SS -0.09 -0.13 -0.18 0.11 -0.15 -0.05
W SS Mag 0.05 -0.04 -0.03 0.42 0.29 0.31
Axial W SSG 0.19 -0.23 -0.05 0.49 -0.09 0.20
Circ W SSG -0.21 -0.11 -0.06 -0.03 -0.08 0.08
W SSG Mag -0.08 -0.13 -0.11 0.23 0.14 0.17
Table 4.11 Apoptosis correlation coefficients (r) using the linear transformation of
the reciprocal regression model for the normalized data and the absolute value of
the normalized data for the three reconstruction techniques.  Significant correlations
(p < 0.05) are highlighted in grey.
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combinations had significant correlations using the absolute value of the normalized data.  Three of these
parameter combinations were significant for all reconstruction techniques.  The level of EC c-fos protein
expression was positively correlated with axial WSS (r = 0.65, p = 0.001, symmetric ellipse), WSS
magnitude (r = 0.59, p = 0.005, symmetric ellipse) and WSSG magnitude (r = 0.60, p = 0.004, symmetric
ellipse).  Five parameter combinations were significant for the symmetric ellipse model but not for the
asymmetric ellipse and/or circle cross-section techniques.  For the symmetric ellipse model, the level of EC
c-fos protein expression was directly correlated axial WSSG (r = 0.46, p = 0.035), the level of EC c-jun
protein expression was directly correlated with circumferential WSSG  (r = 0.50, p = 0.020) and WSSG
magnitude (r = 0.49, p = 0.025) but these correlations were not significant for either the asymmetric ellipse
or the circle cross-section  reconstruction technique.  Similarly, for the symmetric ellipse model, the degree
of SMC apoptosis was positively correlated with axial WSS (r = 0.47, p = 0.031) and axial WSSG (r = 0.49,
p = 0.025) but these correlations were not significant for the other reconstruction techniques.
For the sensitivity analysis, the most important biologic and hemodynamic parameter combinations are
those that resulted in significant correlations for the data from the symmetric ellipse models for all
experiments shown in section 4.3.3.  Specifically, significant correlations existed for c-fos and axial WSS,
c-fos and WSS magnitude, and  c-fos and WSSG magnitude (see Table 4.4)  for both the original, normalized
data and the absolute value of the normalized data.  The data presented in this sensitivity analysis section
showed the same results (i.e., significant or insignificant correlation coefficients) for the symmetric ellipse,
asymmetric ellipse and circle models for all of these parameter combinations.  Therefore, these parameter
combinations are not sensitive to the reconstruction technique and all significant correlations using the
reciprocal nonlinear regression model found in section 4.3.3 are valid.
The correlation coefficients for the linear transformation of the exponential nonlinear regression model
using the original, normalized data and the absolute value of the normalized data are shown in Tables 4.12
and 4.13.  For the symmetric elliptical cross-section reconstruction technique, seven parameter combinations
had significant correlations using the original, normalized data.  Four of these parameter combinations were
230

















Axial WSS -0.63 -0.60 -0.52 -0.40 -0.43 -0.45 0.12 0.05 0.04
Circ W SS -0.06 0.03 -0.02 0.35 0.14 0.28 0.58 0.56 0.64
W SS Mag -0.59 -0.60 -0.55 -0.33 -0.37 -0.44 0.25 0.15 0.07
Axial W SSG -0.45 -0.25 -0.17 -0.19 -0.17 -0.54 0.10 0.12 -0.19
Circ W SSG -0.34 0.41 -0.23 -0.37 0.54 -0.41 -0.38 0.35 -0.11
W SSG Mag -0.58 -0.49 -0.55 -0.43 -0.33 -0.49 0.11 0.17 0.00



















Axial W SS -0.64 -0.60 -0.50 -0.39 -0.42 -0.45 0.13 0.07 0.07
Circ W SS -0.23 -0.16 0.06 -0.16 -0.22 -0.23 0.41 0.12 0.02
W SS Mag -0.59 -0.60 -0.55 -0.33 -0.37 -0.44 0.25 0.15 0.07
Axial W SSG -0.46 -0.22 -0.61 0.12 -0.05 -0.53 0.13 0.15 -0.08
Circ W SSG -0.33 -0.44 -0.27 -0.46 -0.50 -0.05 -0.26 -0.24 -0.09
W SSG Mag -0.58 -0.49 -0.55 -0.43 -0.33 -0.49 0.11 0.17 0.00
Table 4.12 IEG correlation coefficients (r) using the linear transformation of the exponential regression
model for the normalized data and the absolute value of the normalized data for the three reconstruction
techniques.  Significant correlations (p < 0.05) are highlighted in grey.










Axial W SS -0.01 0.17 0.13 -0.47 -0.21 -0.17
Circ W SS -0.06 0.02 -0.02 -0.18 -0.28 -0.14
W SS Mag 0.00 0.13 0.10 -0.38 -0.21 -0.22
Axial W SSG -0.05 0.27 0.39 -0.22 0.23 0.47
Circ W SSG 0.21 -0.36 0.09 0.06 -0.24 0.13
W SSG Mag 0.17 0.21 0.16 -0.15 -0.05 -0.10












Axial W SS -0.04 0.15 0.13 -0.46 -0.19 -0.17
Circ W SS 0.02 0.01 0.10 -0.06 0.10 0.11
W SS Mag 0.00 0.13 0.10 -0.38 -0.21 -0.22
Axial W SSG -0.16 0.26 0.08 -0.49 0.15 -0.18
Circ W SSG 0.24 0.15 -0.05 0.16 0.07 -0.18
W SSG Mag 0.17 0.21 0.16 -0.15 -0.05 -0.10
Table 4.13 Apoptosis correlation coefficients (r) using the linear transformation of
the exponential regression model for the normalized data and the absolute value of
the normalized data for the three reconstruction techniques.  Significant correlations
(p < 0.05) are highlighted in grey.
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significant for all reconstruction techniques.  The level of EC c-fos protein expression was inversely
correlated with axial WSS (r = -0.63, p = 0.002, symmetric ellipse), WSS magnitude (r = -0.59, p = 0.004,
symmetric ellipse) and WSSG magnitude (r = -0.58, p = 0.006, symmetric ellipse).  The level of EC egr-1
protein expression was positively correlated with circumferential WSS (r = 0.58, p = 0.005, symmetric
ellipse).  Three parameter combinations were significant for the symmetric ellipse model but not for the
asymmetric ellipse and/or circle cross-section techniques.  For the symmetric ellipse model, the level of EC
c-fos protein expression was inversely correlated axial WSSG (r = -0.50, p = 0.041) and the degree of SMC
apoptosis was inversely correlated with axial WSS (r = -0.47, p = 0.032) but these correlations were not
significant for either the asymmetric ellipse or the circle cross-section  reconstruction technique.    Similarly,
for the symmetric ellipse model, the level of EC c-jun protein expression was inversely correlated with
WSSG magnitude (r = -0.43, p = 0.049) but this correlation was not significant for the asymmetric ellipse
model.   For the symmetric elliptical cross-section reconstruction technique, eight parameter combinations
had significant correlations using the absolute value of the normalized data.  Three of these parameter
combinations were significant for all reconstruction techniques.  The level of EC c-fos protein expression
was inversely correlated with axial WSS (r = -0.64, p = 0.002, symmetric ellipse), WSS magnitude (r = -0.59,
p = 0.004, symmetric ellipse) and WSSG magnitude (r = -0.58, p = 0.006, symmetric ellipse).  Five parameter
combinations were significant for the symmetric ellipse model but not for the asymmetric ellipse and/or
circle cross-section techniques.  For the symmetric ellipse model, the level of EC c-fos protein expression
was inversely correlated axial WSSG (r = -0.46, p = 0.038) and the level of EC c-jun protein expression was
inversely correlated with circumferential WSSG (r = -0.46, p = 0.036) and WSSG magnitude (r = -0.43, p
= 0.049) but these correlation were not significant for either the asymmetric ellipse or the circular cross-
section reconstruction techniques.  Similarly, for the symmetric ellipse model, the degree of SMC apoptosis
was inversely correlated with axial WSS (r = -0.46, p = 0.037) and axial WSSG (r = -0.49, p = 0.023) but
these correlations were not significant for either the asymmetric ellipse or the circle cross-section
reconstruction technique.
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For the sensitivity analysis, the most important biologic and hemodynamic parameter combinations are
those that resulted in significant correlations for the data from the symmetric ellipse models for all
experiments shown in section 4.3.3.  Specifically, significant correlations existed for c-fos and WSS
magnitude, c-fos and WSSG magnitude, c-jun and WSSG magnitude, egr-1 and axial WSS, SMC apoptosis
and WSS magnitude (see Table 4.5) for both the original, normalized data and the absolute value of the
normalized data.  The data presented in this sensitivity analysis section showed the same results (i.e.,
significant or insignificant correlation coefficients) for the symmetric ellipse, asymmetric ellipse and circle
models for all of these parameter combinations except c-jun and WSSG.  For this parameter combination,
the symmetric and circular models had the same results (i.e., significant correlation coefficient) while the
asymmetric model resulted in an insignificant correlation.  Therefore, it is possible that this parameter
combination is sensitive to the reconstruction technique and may not be a valid significant correlation.
The correlation coefficients for the linear transformation of the power nonlinear regression model using
the absolute value of the normalized data are shown in Tables 4.14 and 4.15.  For the symmetric elliptical
cross-section reconstruction technique, six parameter combinations had significant correlations.  Three of
these parameter combinations were significant for all reconstruction techniques.  The level of EC c-fos
protein expression was inversely correlated with axial WSS (r = -0.56, p = 0.009, symmetric ellipse), WSS
magnitude (r = -0.50, p = 0.021, symmetric ellipse) and WSSG magnitude (r = -0.54, p = 0.012, symmetric
ellipse).  Three parameter combinations were significant for the symmetric ellipse model but not for the
asymmetric ellipse and/or circle cross-section techniques including the inverse correlation of the level of EC
c-fos protein expression with circumferential WSS  (r = -0.51, p = 0.019, symmetric ellipse), axial WSSG
(r = -0.46, p = 0.034, symmetric ellipse) and circumferential WSSG  (r = -0.54, p = 0.012, symmetric ellipse).
For the sensitivity analysis, the most important biologic and hemodynamic parameter combinations are
those that resulted in significant correlations for the data from the symmetric ellipse models for all
experiments shown in section 4.3.3.  Specifically, significant correlations existed for c-fos and
circumferential WSS, c-fos and WSS magnitude, c-fos and circumferential WSSG, and c-fos and WSSG
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Axial W SS -0.56 -0.44 -0.50 -0.34 -0.29 -0.34 0.23 0.11 0.30
Circ W SS -0.46 -0.46 -0.40 -0.27 -0.26 -0.39 0.32 0.32 0.21
W SS Mag -0.50 -0.51 -0.51 -0.30 -0.31 -0.36 0.28 0.23 0.26
Axial W SSG -0.51 -0.31 -0.56 -0.25 -0.21 -0.34 0.24 0.23 0.29
Circ W SSG -0.46 -0.50 -0.42 -0.34 -0.47 -0.23 0.16 0.02 0.11
W SSG Mag -0.54 -0.50 -0.53 -0.34 -0.32 -0.34 0.25 0.22 0.27














Axial W SS -0.62 -0.47 -0.53 -0.34 -0.28 -0.34 0.23 0.11 0.30
Circ W SS -0.52 -0.58 -0.46 -0.27 -0.26 -0.41 0.33 0.32 0.22
W SS Mag -0.55 -0.56 -0.56 -0.31 -0.32 -0.37 0.27 0.23 0.26
Axial W SSG -0.53 -0.33 -0.59 -0.24 -0.20 -0.33 0.23 0.23 0.29
Circ W SSG -0.52 -0.58 -0.47 -0.33 -0.47 -0.24 0.16 0.00 0.10
W SSG Mag -0.59 -0.55 -0.58 -0.34 -0.32 -0.34 0.25 0.22 0.26
Table 4.14 IEG correlation coefficients (r) using the linear transformation of the power and logarithmic
regression models for the absolute value of the normalized data for the three reconstruction techniques.
Significant correlations (p < 0.05) are highlighted in grey.










Axial W SS -0.02 -0.01 0.01 -0.29 -0.24 -0.23
Circ W SS -0.03 -0.03 0.00 -0.19 -0.06 -0.15
W SS Mag -0.01 -0.01 0.01 -0.26 -0.24 -0.23
Axial W SSG 0.01 0.01 0.01 -0.29 -0.13 -0.24
Circ W SSG 0.05 0.08 -0.20 -0.11 -0.05 -0.20
W SSG Mag -0.01 0.02 0.00 -0.23 -0.21 -0.20










Axial W SS -0.04 -0.10 0.02 -0.07 -0.01 -0.01
Circ W SS -0.08 -0.03 -0.09 0.00 0.12 -0.01
W SS Mag -0.05 -0.05 -0.02 -0.06 -0.02 -0.02
Axial W SSG -0.03 -0.05 0.00 -0.02 -0.03 -0.01
Circ W SSG 0.00 0.07 -0.23 0.12 0.18 0.04
W SSG Mag -0.05 -0.04 -0.04 -0.02 0.01 0.03
Table 4.15 Apoptosis correlation coefficients (r) using the linear transformation of
the power and logarithmic regression models for the absolute value of the normalized
data for the three reconstruction techniques.  No significant correlations were found.
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magnitude (see Table 4.6).  The data presented in this sensitivity analysis section showed the same results
(i.e., significant or insignificant correlation coefficients) for the symmetric ellipse, asymmetric ellipse and
circle models for c-fos and WSS as well as c-fos and WSSG.  However, for c-fos and circumferential WSS
as well as c-fos and circumferential WSSG, the symmetric and asymmetric models had the same results (i.e.,
significant correlation coefficient) while the circular model resulted in an insignificant correlation.
Therefore, it is possible that this parameter combination is sensitive to the reconstruction technique and may
not be a valid significant correlation.
The correlation coefficients for the linear transformation of the logarithmic nonlinear regression model
using the absolute value of the normalized data are shown in Tables 4.14 and 4.15.  For the symmetric
elliptical cross-section reconstruction technique, six parameter combinations had significant correlations.
Five of these parameter combinations were significant for all reconstruction techniques.  The level of EC c-
fos protein expression was inversely correlated with axial WSS (r = -0.62, p = 0.003, symmetric ellipse),
circumferential WSS (r = -0.52, p = 0.016, symmetric ellipse), WSS magnitude (r = -0.55, p = 0.009,
symmetric ellipse), circumferential WSSG (r = -0.52, p = 0.015, symmetric ellipse) and WSSG magnitude
(r = -0.59, p = 0.005, symmetric ellipse).  Only one parameter combination was significant for the symmetric
ellipse model but not for the asymmetric ellipse reconstruction technique including the inverse correlation
of the level of EC c-fos protein expression with axial WSSG  (r = -0.53, p = 0.013, symmetric ellipse).
For the sensitivity analysis, the most important biologic and hemodynamic parameter combinations are
those that resulted in significant correlations for the data from the symmetric ellipse models for all
experiments shown in section 4.3.3.  Specifically, significant correlations existed for c-fos and
circumferential WSS, c-fos and WSS magnitude, c-fos and circumferential WSSG, and c-fos and WSSG
magnitude (see Table 4.7).  The data presented in this sensitivity analysis section showed the same results
(i.e., significant or insignificant correlation coefficients) for the symmetric ellipse, asymmetric ellipse and
circle models for all of these parameter combinations.  Therefore, these parameter combinations are not
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sensitive to the reconstruction technique and all significant correlations using the logarithmic nonlinear
regression model found in section 4.3.3 are valid.
4.4 Discussion
4.4.1 Correlation Between Biologic and Hemodynamic Parameters
We have determined significant correlations between immediate early gene protein expression and
hemodynamic parameters using directly-coupled data.  For each region of interest in ETS and ETE
anastomoses,  biologic data were obtained from ex vivo perfusion experiments and hemodynamic data were
obtained from CFD models of each experimental anastomosis.  Linear regression was performed on these
data and three combinations of parameters yielded significant correlations when using either the raw or
normalized data.  For the zero flow experiments, the degree of SMC apoptosis was positively correlated with
circumferential WSSG.  For the pooled data from all experiments, the levels of EC c-fos and c-jun protein
expression were inversely correlated with WSSG magnitude.  A number of other parameter combinations
elicited significant correlations depending on whether raw or normalized data was used and which flow
condition was considered.
The data with the most impact are the normalized data from all experiments.  These correlations are
based on the largest number of data points since all experiments (zero and retrograde flow) are included and
normalization of the data accounts for experiment to experiment variability.  When analyzed with linear
regression, four combinations of parameters yielded significant correlations.  The level of EC c-fos protein
expression was inversely correlated with WSS and WSSG magnitude.  The level of EC c-jun protein
expression was also inversely correlated with WSSG magnitude.  The level of EC egr-1 protein expression
was inversely correlated with axial WSS.  These data suggest that low levels of various WSS and WSSG
parameters cause the upregulation of immediate early gene proteins as shown in Table 4.16.  In addition, the
relationships between low WSS and WSSG magnitude and the increase in EC c-fos protein level were found
when using all three reconstruction techniques.  Therefore, the strongest linear relationship between
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hemodynamic stimuli and IEG expression in these studies is that decreased WSS and WSSG caused an
increase in the level of EC c-fos protein expression. 
The relationship between the hemodynamic parameters and IEG protein expression shown in Table
4.16, specifically the strength of the correlation between WSS/WSSG magnitude with c-fos, was further
validated when nonlinear regression models (reciprocal, exponential, power and logarithmic) were used to
analyze the normalized data from all experiments.  Table 4.17 summarizes the linear and nonlinear regression
results for these parameter combinations.  The linear transformation of the exponential nonlinear regression
model based on the original, normalized data or the absolute value of the normalized data resulted in
significant inverse correlations between the level of EC egr-1 protein expression and axial WSS as well as
the level of EC c-jun protein expression and WSSG.  For the egr-1 and WSS relationship, the same results
were obtained when using any of the three reconstruction techniques indicating that this relationship is
independent of the reconstruction technique.  However, this was not true for the c-jun and WSSG
relationship since the asymmetric ellipse reconstruction technique failed to reach significance.  The linear
transformation of the all of the nonlinear regression models (reciprocal, exponential, power and logarithmic)
based on the original, normalized data or the absolute value of the normalized data resulted in significant
inverse correlations between the level of EC c-fos protein expression and the magnitudes of WSS and WSSG.
Again, the same results were obtained when using any of the three reconstruction techniques.  Because all
of the linear and nonlinear regressions used to analyze these combinations of normalized data resulted in
significant correlations, the strongest relationship between hemodynamic stimuli and IEG expression in these
studies is that decreased WSS and WSSG caused an increase in the level of EC c-fos protein expression.
  \ Axial WSS   [ EGR1
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Table 4.16 Hemodynamic influence on







P Value All reconstructions
have same results?
EGR-1 and Axial WSS y = ax + b -0.27 0.011 yes
EGR-1 and Axial WSS y = a|x| + b -0.27 0.009 yes
EGR-1 and Axial WSS y = aebx 0.29 0.005 yes
EGR-1 and Axial WSS y = aeb|x| 0.31 0.003 yes
CJUN and WSSG Mag y = ax + b -0.22 0.034 no
CJUN and WSSG Mag y = a|x| + b -0.22 0.034 no
CJUN and WSSG Mag y = aebx 0.25 0.018 no
CJUN and WSSG Mag y = aeb|x| 0.25 0.018 no
CFOS and WSS Mag y = ax + b -0.22 0.037 yes
CFOS and WSS Mag y = a|x| + b -0.22 0.037 yes
CFOS and WSS Mag y = a + b/x 0.21 0.044 yes
CFOS and WSS Mag y = a + b/|x| 0.21 0.044 yes
CFOS and WSS Mag y = aebx 0.25 0.020 yes
CFOS and WSS Mag y = aeb|x| 0.25 0.020 yes
CFOS and WSS Mag y = a|x|b 0.27 0.011 yes
CFOS and WSS Mag y = a + b ln|x| 0.29 0.006 yes
CFOS and WSSG Mag y = ax + b -0.26 0.012 yes
CFOS and WSSG Mag y = a|x| + b -0.26 0.012 yes
CFOS and WSSG Mag y = a + b/x 0.23 0.027 yes
CFOS and WSSG Mag y = a + b/|x| 0.23 0.027 yes
CFOS and WSSG Mag y = aebx 0.29 0.006 yes
CFOS and WSSG Mag y = aeb|x| 0.29 0.006 yes
CFOS and WSSG Mag y = a|x|b 0.29 0.006 yes
CFOS and WSSG Mag y = a + b ln|x| 0.30 0.004 yes
Table 4.17 Parameter combinations with the most number of significant correlations using linear and
nonlinear regression models.  The regression equations, correlation coefficients and associated p values are
shown as well as an indication of whether or not the correlation was significant for all reconstruction
techniques. 
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4.4.2 Comparison to Other Research
To our knowledge, these are the first directly-coupled data demonstrating significant correlations
between immediate early gene protein expression and specific hemodynamic parameters at the end-to-side
vascular anastomosis.  Most of the previous research on the biological effect of hemodynamics on IEG
expression has been conducted in endothelial cell culture models.  As discussed in Section 1.6.3.1, studies
conducted by Hsieh et al. [43], Ranjan and Diamond [44] and Nagel et al. [45] exposed human umbilical
vein EC to various levels of WSS for 30 minutes to 4 hours and measured the resulting gene and protein
expression of various IEG.  They found that c-fos, c-jun and egr-1 expression correlates directly with WSS.
In contrast, in vascular bypass grafts perfused ex vivo, we found that egr-1 protein expression was inversely
correlated with axial WSS and c-fos protein expression was inversely correlated with WSS.   Our results also
showed that c-fos and c-jun protein expression was inversely correlated with WSSG magnitude.  However,
Nagel et al. prescribed disturbed flow in their cell culture experiments for 30 minutes and found that the
expression of c-fos, c-jun and egr-1 protein correlated directly with spatial WSSG.  
There are a number reasons that could account for the discrepancy between our results and those of
previous cell culture studies.  The most striking is that cell culture studies can not incorporate the multiple
cellular and extracellular matrix interactions and the effects of the three-dimensional structure and
mechanical environment on the vascular EC that is accounted for in a whole-vessel preparation [177, 180-
182].  For cell culture studies, the cells are grown on a non-physiologic substrate in a monolayer
configuration, which can affect their phenotype and response to external stimuli [180, 183].  Additionally,
the cells used in such cell culture studies are often EC derived from human umbilical veins while the EC
population in our study was from intact porcine femoral arteries.  Vein and artery cells are normally exposed
to very different biomechanical environments and may respond differently to hemodynamic stimuli [7, 184,
185].  Finally,  cells obtained from different species may also exhibit varied responses [185].  Therefore,
although the correlations between IEG protein expression and hemodynamic parameters in our study are
different than the correlations found previously in cell culture models, we believe that our experimental
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design is more physiologically relevant and may come closer to determining the correlations that exist in
vivo. 
Previous research by Gan et al. is most closely related to our study [142].  They perfused intact human
umbilical veins ex vivo for 6 hours at low (< 4 dynes/cm2) or high (<25 dynes/cm2) levels of WSS.  They
found a significant increase in the amount of c-fos and c-jun gene expression, as well as c-jun protein
expression, for the vessels exposed to high WSS c-jun protein compared to the low WSS vessels (see Figure
1.16a). They did not find a significant difference in the level of c-fos protein expression due to the level of
WSS.  We found, however, that low levels of WSS significantly increased EC c-fos protein expression. There
are a number of possible reasons for the discrepancy in our results including the type of vessel used for the
experiment and the techniques for calculating WSS and quantifying c-fos protein expression.  In their study,
Gan et al. used human umbilical veins so the discrepancy could be due to the fact that we used arterial
segments from swine. Also, in the study by Gan et al., only a generalized WSS (J) was calculated for the
entire vessel using a modified form of the Poiseuille equation:
[4.6]
where )P is the pressure drop over the vessel, L is the vessel length, 0 is the kinematic viscosity of the fluid
and Q is the flow rate through the vessel.  This calculation assumes that the vessel has a uniform diameter
along its length which may not be realistic, as seen in the diameter variations along the length of our vessels
even in the regions away from the anastomosis.  Finally, Gan et al. based their quantification of c-fos protein
expression on regions of the entire vessel wall so the quantitative value they report includes the expression
of c-fos by SMC whereas our measurements focus solely on the expression of c-fos by the EC.  Therefore,
there are a number of factors that could account for the fact that we found a significant, inverse correlation
between c-fos protein expression and WSS while the study by Gan et al. did not find a significant change
in c-fos protein expression due to different levels of WSS. 
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As discussed in Section 1.4.3, although a direct correlation between IEG expression and IH has not been
determined previously, there is a large body of evidence leading to the conclusion that IEG expression
precedes and is related to IH.  For example, c-fos expression has been shown to lead to increased SMC
proliferation, a defining characteristic of IH [40, 51, 52].  C-fos expression has also been shown to result in
SMC apoptosis which may upset the balance between proliferation and apoptosis and lead to IH formation
[60].  The most striking evidence that IEG are related to IH is that gene therapy blocking c-fos, c-jun or egr-1
expression inhibits IH formation in vivo [59, 140].
As discussed in Sections 1.5 and 1.7, previous research has not been conclusive on the hemodynamic
implications in IH.  However, many studies have shown that low WSS leads to IH formation [72, 73, 77-83,
86, 87, 94, 102].  If we assume that the level of IEG expression correlates with IH formation, then we can
relate the results of our studies to the previous research on the role of hemodynamics in IH formation.  For
example, our results show that low levels of WSS (specifically axial WSS and WSS magnitude) would result
in increased IH, a similar finding to previous research.  Other studies have previously shown that spatial
WSSG correlates with IH formation [66, 85, 87, 89-91].  However, our study found the opposite result.  We
determined that spatial WSSG magnitude inversely correlates with IH, assuming that IEG expression is
directly related to IH formation.  The discrepancy in our results is most likely due to the fact that the previous
studies focusing on WSSG did not utilize quantitative, directly-coupled hemodynamic and biologic data.
It may initially seem counterintuitive that WSSG would be protective since the hemodynamics in a
physiological, non-diseased state is assumed to be uniform.  However, in reality, the vasculature is constantly
branching and curving and the blood flow is pulsatile which innately causes spatial as well as temporal
WSSG.  Therefore, at least hypothetically, it is conceivable that vessels may be prone to IH formation if the
level of WSSG normally found in the vasculature is decreased.
Previous research by Keynton et al. is most closely related to our study in that they obtained
hemodynamic and biologic data in distal ETS anastomoses as shown in Figure 4.23 [79].  The main
difference between their study and ours is that they used an in vivo dog model and measured wall shear rate
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Figure 4.23 Results from [79] studying correlating WSR and IH formation in ETS vascular bypass grafts.
Mean WSR (solid line) and spatial WSSG (dashed line) distributions for the toe region and the artery floor
are shown for graft-host artery diameter ratios of A1) 1.0 and A2) 1.5.  The corresponding distribution of IH
formation (mean ± standard deviation) along the floor are shown for graft-host artery diameter ratios of B1)
1.0 and B2) 1.5.  The pooled data for both diameter ratios were analyzed and the linear regression with the
best correlation, mean WSR and IH, is shown in C). 
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(WSR) at the time of insertion of a prosthetic graft and the degree of IH formation along the anastomosis 12
weeks after anastomosis construction.  From the WSR measurements, Keynton et al. were able to calculate
a number of hemodynamic parameters including mean, peak, pulse amplitude, absolute mean and absolute
peak WSS and WSSG as well as the oscillatory shear index.  Their linear regression analysis showed that
the best relationship was an inverse correlation between the mean WSR and IH formation (r =  -0.406, p  <
0.05).  This is analogous to our results showing a significant inverse correlation between WSS magnitude
and c-fos protein expression (r = -0.22, p  <  0.05), which, again,  could be extrapolated to IH formation
assuming that IEG expression correlates directly with IH.  Keynton et al. did not, however, find a significant
correlation between spatial WSSG and IH formation while we found a significant inverse correlation between
WSSG magnitude and c-fos (r = -0.26, p  <  0.05) and c-jun (r = -0.22, p  <  0.05) protein expression), which
could be extrapolated to IH formation assuming that IEG expression correlates directly with IH.  One
possible reason that our WSSG results do not match those of Keynton et al. is that their dog model
necessarily incorporated pulsatility and while we imposed steady flow in porcine arteries. Another possible
reason for the discrepancy could be due their inability to obtained directly-coupled biologic and
hemodynamic data.  Because of extensive tissue encapsulation, they could not measure the hemodynamic
data at the end of the experiment when the biologic data was measured and there is no way to regulate the
hemodynamics in a conscious dog over the 12 week period.  In contrast, our use of an ex vivo model allowed
for tight regulation of the hemodynamics such that the resulting biologic parameter can be correlated with
the hemodynamic value  imposed throughout the experiment.  Another possible reason that we found a
significant correlation based on WSSG is that we obtained biologic data from regions in the entire
anastomosis, including the graft and hood while the IH measurements of Keynton et al. were only taken
along the host artery since a prosthetic graft was used.  Also, since a prosthetic graft was used, compliance
mismatch occurs at the anastomosis, increasing the number of parameters that may be responsible for IH
formation whereas our artery-artery constructs do not have compliance mismatch and therefore isolate the
hemodynamics as the cause of the resulting biologic response. 
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4.4.3 Limitations
In order to obtain directly-coupled biologic and hemodynamic data, we chose to obtain the biologic data
from ex vivo perfusion of ETS anastomoses and then reconstruct these anastomoses to determine the
hemodynamic data from CFD analyses.  The main drawback of this approach is that it involves a lot of steps
in the process, which potentially introduce error and are time-consuming.  To obtain the biologic data for
each anastomosis, the perfusion must be completed, the tissue processed, frozen and sliced before
cryosectioning can occur.  For each region of interest, the slides are stained, microscopy images are taken
and then quantified.  The error up to this point in the process is approximately 29% based on the repeatability
studies of the staining quantification (see Appendix D.1).  In addition, if any of these steps is performed
incorrectly, it is possible to lose all the data for a given experiment.  To obtain the hemodynamic data, the
tissue cross-sections are digitized to obtain the luminal boundary and the error associated with the luminal
digitization is approximately 20% (see Appendix D.2).  These two-dimensional shapes are lofted to create
a three-dimensional surface that is meshed and the boundary conditions are applied based on the
experimental flow conditions. The flow rate and viscosity values used in the CFD simulations have a
potential error of approximately 5% and 1.5%, respectively, based on the sensitivity of the flow meter and
the range of media viscosity.  The hemodynamic parameters of interest are derived from the resulting velocity
field and then averaged over the region of interest. The mesh independence analysis (see sections 3.2.3 and
3.3.1) illustrated that the CFD results can have an error ranging up to 20% depending on the imposed flow
condition, type of anastomosis and hemodynamic parameter being calculated.  Because there are so many
steps in determining the biologic and hemodynamic parameters, there is the potential to introduce error, as
outlined above, as well as the potential for this error to propagate throughout the process.  Therefore, we have
focused on the normalized biologic and hemodynamic data in order to account for, and minimize, these errors
(explained in detail in sections 2.2.13 and 3.4.4).   Finally, even if all steps required for the measurement of
biologic parameters and calculation of hemodynamic parameters are performed correctly and in a timely
manner, it takes approximately three weeks to determine the single, quantitative values for the biologic and
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hemodynamic parameters for each region of interest for a given experiment.  However, the ability to obtain
the directly-coupled, quantitative data is unique and an important tool for determining the hemodynamic
parameter responsible for IEG protein expression in vascular bypass grafts.
Because we obtained directly-coupled data, we were able to correlate the biologic endpoints with the
hemodynamic environment in vascular bypass grafts.  We chose to perform the correlation analyses using
parametric statistical tests which assume that the underlying distribution of the data follows the normal
distribution.  Figures 4.24, 4.25, 4.26 and 4.27 show the raw and normalized biologic (IEG and apoptosis)
and hemodynamic (WSS and WSSG) data compared to the normal distribution.  Qualitatively, the data
follow the normal distribution.  The main difference between the data and the normal distribution is that most
of the data have higher peaks indicating less variance compared the normal distribution [157].  For almost
all of the parameters, the peak of the curve for the data occurs at the same point as the normal distribution.
The only parameters showing any evidence of skewness are the normalized axial WSS, WSS and WSSG
magnitude data.  Therefore, based on these plots of the data for each biologic and hemodynamic parameter
compared to the normal distribution, we believe that it is valid assume that the data follow the normal
distribution.  However, further statistical analyses could be completed using the nonparametric analogues
to the parametric tests we used: e.g., the Spearman rank-correlation coefficient could be calculated instead
of the Pearson correlation coefficient [157].  As an example, we calculated the Spearman rank-correlation
coefficient for the linear regression analyses of the normalized data pooled from all experiments. The
parameter combinations with statistically significant correlations using this nonparametric analysis were c-
fos and WSS (inverse correlation), c-fos and WSSG (inverse correlation), and SMC apoptosis and axial
WSSG (direct correlation), while the parameter combinations found using the parametric tests were c-fos
and WSS, c-fos and WSSG, c-jun and WSSG, and egr-1 and axial WSS (all inverse correlations, see Table
4.2).  Therefore, although the results were slightly different depending on whether parametric or
nonparametric analyses were performed, it did not affect our final conclusion that the strongest relationship
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Figure 4.24 Plot of the raw (left) and normalized (right) data for c-fos, c-jun and egr-1.  The data were
separated into 9 even intervals (-4 standard deviations from the mean to +4 standard deviations from the
mean) and the percentage of data points present in each interval were plotted as filled circles connected by
a black curve.  The normal distribution was plotted as the grey curve for comparison where the mean occurs
at the peak and the height is inversely proportional to the standard deviation.  Note that increased height of
the curve indicates less variance in the data.
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Figure 4.25 Plot of the raw (left) and normalized (right) data for EC and SMC apoptosis.  The data were
separated into 9 even intervals (-4 standard deviations from the mean to +4 standard deviations from the
mean) and the percentage of data points present in each interval were plotted as filled circles connected by
a black curve.  The normal distribution was plotted as the grey curve for comparison where the mean occurs
at the peak and the height is inversely proportional to the standard deviation.  Note that increased height of
the curve indicates less variance in the data.
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Figure 4.26 Plot of the raw (left) and normalized (right) data for axial WSS, circumferential WSS and WSS
magnitude.  The data were separated into 9 even intervals (-4 standard deviations from the mean to +4
standard deviations from the mean) and the percentage of data points present in each interval were plotted
as filled circles connected by a black curve.  The normal distribution was plotted as the grey curve for
comparison where the mean occurs at the peak and the height is inversely proportional to the standard
deviation.  Note that increased height of the curve indicates less variance in the data.
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Figure 4.27 Plot of the raw (left) and normalized (right) data for axial WSSG, circumferential WSSG and
WSSG magnitude.  The data were separated into 9 even intervals (-4 standard deviations from the mean to
+4 standard deviations from the mean) and the percentage of data points present in each interval were plotted
as filled circles connected by a black curve.  The normal distribution was plotted as the grey curve for
comparison where the mean occurs at the peak and the height is inversely proportional to the standard
deviation.  Note that increased height of the curve indicates less variance in the data.
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between hemodynamic stimuli and IEG expression in these studies is that decreased WSS and WSSG caused
an increase in the level of EC c-fos protein expression.
We utilized all data obtained from the experiments and CFD models for the regression analyses and did
not examine the data for any possible outliers.  Potential outliers can be detected by determining if any of
the data points is more than four standard deviations from the mean [157].  The plots in Figures  4.24, 4.25,
4.26 and 4.27 illustrate that there were no outliers based on this criteria for the raw and normalized biologic
and hemodynamic data.  However, transformation of the data for the nonlinear regression analyses could
have resulted in outliers.  For example, when transforming the hemodynamic data for the reciprocal
regression analyses, the data were inverted so that WSS magnitude values close to zero became very large.
Therefore, these large reciprocal values (i.e., more than four standard deviations from the mean) may be
outliers for the reciprocal nonlinear regression analysis even though the original data did not have any
outliers.   However, potential outliers should not be removed without careful consideration including a
physical reason for their removal (e.g., experimental mishap). Because the original data did not contain
outliers and there was no experimental or physical reason for removing outliers just for the nonlinear
regression analyses, we did not believe that removing potential outliers was valid.  An alternative approach
for accounting for potential outliers is to analyze the data using nonparametric methods (as discussed in the
previous paragraph) which minimize the effects of outliers on the overall result [157].  As an example, we
calculated the Spearman rank-correlation coefficient for the reciprocal nonlinear regression analyses of the
normalized data pooled from all experiments. The two parameter combinations with statistically significant
direct correlations using this nonparametric analysis were c-fos and WSS, and  c-fos and WSSG, while the
parameter combinations found using the parametric tests were c-fos and axial WSS, c-fos and WSS, c-fos
and WSSG (see Table 4.4).  Therefore, although the results were slightly different depending on whether
parametric or nonparametric analyses were performed, this comparison illustrates that potential outliers do
not affect our final conclusion that the strongest relationship between hemodynamic stimuli and IEG
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expression in these studies is that decreased WSS and WSSG caused an increase in the level of EC c-fos
protein expression.
We chose to complete these studies using steady flow which does not capture the pulsatility found
physiologically.  Due to the technical difficulties in creating the anastomoses ex vivo, we decided to simplify
the protocol and only include steady flow.  To incorporate pulsatility into the CFD models, each
reconstructed anastomosis would have taken approximately sixty times longer to complete since a full steady
flow simulation would essentially have to be solved for each time step of an input waveform sampled at 1
Hertz.  This would have required approximately 120 days to complete each pulsatile simulation with our
current computational resources and was therefore not feasible.  To maintain the ability to obtain directly-
coupled data, we chose to perform the experiments under steady flow conditions.  Therefore, the correlations
were found are only relevant for steady flow.  As part of his cell culture study, Hsieh et al. found that
although EC respond differently to steady and pulsatile flow, the response is simply more pronounced under
pulsatile flow conditions and not radically altered [43].  Therefore, our results may still be valid when
applying them to the pulsatile flow situation but this will have to be validated by future studies that
incorporate pulsatility.  These studies could be completed in our lab with our current experimental equipment
and increased computational resources which are readily available.
4.5 Conclusion
We have determined a significant correlation between the hemodynamic stimuli and biologic response
of the EC layer in ETS and ETE anastomoses.  Vascular bypass graft constructs were exposed to well-
controlled hemodynamics using an ex vivo perfusion system and the expression of IEG proteins in EC as well
as EC and SMC apoptosis were quantified at 9 regions of interest along the anastomoses.  CFD models of
each anastomosis were developed based on the geometry and imposed pressure and flow conditions in each
experiment.  From these models, we determined the axial and circumferential components and magnitude
of WSS and WSSG in the same regions of interest.  Through linear and nonlinear regression analysis on this
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directly-coupled data, we found that low levels of various WSS and WSSG parameters cause the upregulation
of certain IEG proteins.  Although a number of other studies have attempted to determine the influence of
hemodynamics on biologic precursors of IH formation, to our knowledge this is the first study to determine
a quantitative correlation between directly-coupled hemodynamic and biologic data.
Further studies need to be completed in order to determine if the same correlations exist in a pulsatile
environment, but if these correlations remain valid, there are a number of options  that could be investigated
to decrease the amount of IH formation in vascular bypass grafts.  The hemodynamics of graft construction,
particularly the geometry, could be optimized to exclude low levels of axial WSS and magnitudes of WSS
and WSSG.  Alternatively, since surgeons are frequently unable to influence the graft geometry due to local
constraints, regions known to have low levels of WSS or WSSG could be treated locally with gene therapy
or pharmacological agents that would reduce the expression of c-fos, c-jun and/or egr-1. These treatments
could potentially lead to decreased IH formation and increase the success of vascular bypass grafts.
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5 .0 DISCUSSION
5.1 Summary of Results
We have developed a technique for collecting regional, quantitative biologic and hemodynamic data
in ETS and ETE vascular bypass graft anastomoses.  These data were correlated to determine a quantitative
relationship between acute precursors of IH (IEG protein expression, EC and SMC apoptosis) and the
hemodynamic parameters (axial and circumferential components and magnitude of WSS and WSSG) that
cause this biologic response.  To our knowledge, this is the first time that such a directly-coupled approach
has been utilized.  It has allowed for the determination of the association of certain hemodynamic parameters
with the expression of IEG, and possibly with IH formation and eventual bypass graft failure.  
5.1.1 Spatial Variation of IEG and Apoptosis
To accomplish Specific Aim #1, we created ETS and ETE anastomoses of porcine femoral arteries using
vascular clips and perfused them ex vivo under steady flow conditions for six hours.  We found a significant
regional variation of IEG proteins (c-fos, c-jun and egr-1) within the ETS anastomosis (Figures 2.21 and
2.22).  The levels of c-fos and c-jun protein were highest in the ETS proximal and distal artery segments
while the lowest levels of c-fos and c-jun protein occurred in the regions in and near the anastomosis
including the ETS heel, toe, floor and hood.  There was no significant difference between the ETE proximal
and anastomosis regions indicating that the surgical manipulation and use of vascular clips to create an
anastomosis do not contribute to differences in c-fos and c-jun protein expression.  In contrast, the only
region showing consistently different egr-1 protein expression was the ETE anastomosis segment, which was
lower than almost all other regions. Although we found a significant spatial variation in IEG protein
expression, there was no significant regional variation of EC or SMC apoptosis.  To our knowledge, these
are the first data showing a regional variation of IEG protein expression along ETS and ETE anastomoses
of vascular bypass grafts.
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5.1.2 Spatial Variation of Hemodynamic Parameters
To accomplish Specific Aim #2, we reconstructed the three-dimensional inner surface of each
experimental ETS and ETE anastomosis and developed computational fluid dynamics models.  For each CFD
model, the hemodynamic parameters of interest (axial and circumferential components and magnitude of
WSS and WSSG) were calculated everywhere within the three-dimensional domain and the average
hemodynamic parameters were determined for the same regions of interest used for the biologic endpoints.
We determined that a regional variation of hemodynamic parameters, most notably axial WSS and the
magnitudes of WSS and WSSG, exist in these anastomoses (Figures 3.64 - 3.66).  The regions with the most
variation in hemodynamic parameters were the ETS proximal artery, heel, toe and distal artery segments.
The ETS proximal artery and heel regions exhibited significantly lower axial WSS and WSSG magnitude
compared to other regions of interest.  The ETS toe and distal artery segments had significantly higher axial
and circumferential components as well as magnitude of WSS compared to other regions.  Although a
number of other studies have alluded to a regional variation of hemodynamic parameters, particularly in ETS
anastomoses, to our knowledge this is the first study to quantify these difference and illustrate that they are
statistically significant.
5.1.3 Correlation of Biologic and Hemodynamic Data
For Specific Aim #3, we determined if any significant correlations existed between the biologic and
hemodynamic data acquired in Specific Aims #1 and #2.  Through linear and nonlinear regression analyses
on this directly-coupled data, we found four significant correlations:
1) EC egr-1 protein expression was inversely correlated with axial WSS.  
2) EC c-fos protein expression was inversely correlated with WSS magnitude.  
3) EC c-fos protein expression was inversely correlated with WSSG magnitude. 
4) EC c-jun protein expression was inversely correlated with WSSG magnitude.
Therefore, our data suggest that low levels of WSS and WSSG cause the upregulation of IEG proteins.
Based on previous research showing that increased levels of IEG expression correlate with IH formation [40,
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51, 52, 59, 60, 140], our results suggest that low levels of WSS and WSSG ultimately lead to increased IH
formation.  Although a number of other studies have attempted to determine the influence of hemodynamics
on IH formation, to our knowledge this is the first study to determine a quantitative correlation between
directly-coupled hemodynamic and biologic data in ETS and ETE anastomoses of vascular bypass grafts.
Although a significant amount of previous research has attempted to isolate the influence of
hemodynamics on IH formation, a quantitative correlation between a specific hemodynamic parameter and
a particular cellular response leading to IH had not been elucidated.  With the intent of clarifying this
mechanism, we exposed ETS and ETE anastomoses created from intact vascular segments to a well-
controlled hemodynamic environment. We then quantified the resulting biologic and hemodynamic
parameters in a directly coupled manner and determined the parameters with a significant correlation.  By
determining that low levels of axial WSS and magnitudes of WSS and WSSG correlate with upregulation
of IEG protein, we believe that we have taken a significant step toward determining a mechanistic
understanding of how hemodynamic parameters cause the upregulation of biologic precursors of IH
formation.
5.2 Clinical Significance
There are a number of treatments that may improve the clinical success rate of  vascular bypass grafts
based on the correlations we found between low levels of WSS and WSSG and the subsequent increase in
IEG protein expression.  For example, in order to exclude the pathologically low levels of axial WSS and
magnitudes of WSS and WSSG, the hemodynamics of graft construction could be optimized.  Geometric
features of the anastomosis such as the angle of insertion, diameter ratio between the graft and host artery
and flow split between the proximal and distal outflow segments have previously been shown to alter the
hemodynamics [79, 88, 91, 154, 155, 166, 175, 186-189] and could potentially be manipulated to produce
the optimal pattern of WSS and WSSG.  For example, Lei et al. used CFD models to calculate the WSSG
magnitude in ETS distal anastomoses with different geometries  [91, 155].  They concluded that the increased
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patency of the Taylor patch anastomosis compared to a conventional anastomosis was at least partially due
to the altered geometry, which resulted in lower WSSG along the anastomosis.  Moreover, they determined
an optimal graft geometry that minimized the WSSG along the anastomosis.  However, surgeons are
frequently limited in determining the graft geometry due to local constraints.  In this case, regions known to
have low levels of WSS or WSSG based on the configuration they are forced to use, could be treated locally
with gene therapy or pharmacological agents that would reduce the expression of c-fos, c-jun and/or egr-1.
Such treatments have previously shown potential in decreasing the extent of IH [53, 57, 58, 140, 190] and
having the added knowledge of where to focus these treatments locally could further decrease IH formation
and increase the success of vascular bypass grafts.
5.3 Advantages of Methodology
In previous studies there was either no direct coupling between quantitative biologic and hemodynamic
measurements, the values of these parameters were not continuously known or regulated, or the biologic
model was not complete. Our coupled experimental and computational approach has allowed us to collect
and correlate directly-coupled biologic and hemodynamic data.  The advantages of our methodology are
summarized below.
5.3.1 Ex Vivo Perfusions 
Much of the previous research on the effect of WSS and WSSG has been conducted in cell culture or
in vivo models.  Cell culture models are advantageous because they allow for the tight regulation and
alteration of a single hemodynamic parameter.  However, the results may not be relevant to in vivo
conditions.  Cell culture studies can not incorporate the multiple cellular and extracellular matrix interactions
and the effects of the three-dimensional structure and mechanical environment on the vascular EC that occurs
in vivo [177, 180-182].  On the other hand, in vivo models are not ideal because the hemodynamic parameters
can not be regulated over the time course of the experiment which can last for weeks or months, in the case
of intimal hyperplasia formation.  Additionally, it is not possible to alter a single hemodynamic parameter
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at a time since, for example, changing the blood flow will affect the blood pressure and other physiological
functions.  Therefore, we chose to utilize an ex vivo perfusion system which allows us to study intact vascular
segments while also regulating the imposed hemodynamics independent of other parameters, such as
pressure.
5.3.2 Artery-Artery Anastomoses
Most of the previous vascular graft research has used prosthetic conduits or veins as vascular grafts
since these are used most often clinically.  However, when these types of grafts are used, the biologic
response of the vascular cells can not be solely attributed to an alteration in hemodynamics due to the
creation of the anastomosis. For example, the biologic response of the vascular cells in a vein graft are
complicated by the fact that the venous cells are suddenly placed in the high pressure, high flow, pulsatile
environment of the arterial system.  This alone could lead to a biologic response by the venous cells [7, 184,
185], which could not be separated from the response due to the altered hemodynamics at the anastomosis.
In addition, the use of prosthetic or vein grafts causes a compliance mismatch to occur at the anastomosis,
which has been shown to affect vascular cells.  Because our studies were conducted under steady flow
conditions, compliance mismatch was not an issue.  However, artery-artery anastomoses would be critical
for future studies incorporating pulsatility in order to isolate the hemodynamic effects from the compliance
mismatch effects.  Therefore, we have chosen to create artery-artery anastomoses to isolate the effect of
altered hemodynamic parameters on the vascular cells.
5.3.3 Continuous Mapping of Hemodynamic Parameters
Physical models and in vivo studies of the hemodynamics in ETS and ETE anastomoses are not able
to obtain a three-dimensional flow field and therefore are not able to continuously map the hemodynamic
parameters along the entire inner surface of the anastomosis.  In physical flow models, laser Doppler
anemometry (LDA)  measures the velocity at a single point and particle image velocimetry (PIV) measures
the velocity within a single, two-dimensional slice.  Ultrasonic and electromagnetic transducers can directly
measure the flow rate or wall shear rate in vivo, but only at discrete points along the anastomosis.  Therefore,
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we chose to obtain our hemodynamic data from CFD models that allow for the determination of the three-
dimensional flow field based on the geometry of the anastomosis and the imposed flow conditions.
5.3.4 Directly-Coupled Approach
One of the most important advantages of our methodology is that the biologic and hemodynamic data
are measured in the same regions of the same anastomoses.  Most previous work that has measured both
biologic and hemodynamic data has assumed a generalized measurement for one of the data sets.  For
example, in many reports, biologic measurements were made in multiple bypass grafts but the hemodynamic
measurements were made in a single graft reconstruction with global geometric traits similar to the average
of the grafts used to obtain the biologic data [78, 164, 176].  The primary reason this is done is because the
geometry of the anastomosis is lost due to the required tissue processing for the determination of biologic
data.  To avoid this problem, we developed a protocol for processing the tissue so that the IEG protein
expression and EC and SMC apoptosis could be measured while also allowing for the reconstruction of each
ETS and ETE anastomosis to develop CFD models for the calculation of hemodynamic parameters.  This
allowed us to obtain biologic and hemodynamic data from the same regions of the same anastomoses and
resulted in a directly-coupled data set.  Therefore, the results of this study illustrate a cause and effect
relationship between the hemodynamic stimuli (i.e., low WSS and WSSG) and biologic response (IEG
protein expression) in intact vascular bypass grafts that had not been established previously.
5.4 Disadvantages of Methodology
Although our methodology resulted in directly-coupled data from intact vascular bypass graft constructs
exposed to ex vivo perfusion where the effect of hemodynamics could be isolated, there are some issues that
should be kept in mind when interpreting our data, and should be addressed before the results of this study
can be applied clinically.  These potential limitations are outlined below.
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5.4.1 Ex Vivo Perfusion
We chose an ex vivo perfusion model so that we could control the pressure and flow conditions in ETS
and ETE anastomoses in a precise manner.   This system allowed us to alter the hemodynamics independent
of other parameters and we were able to isolate the hemodynamic influence on IEG protein expression and
EC and SMC apoptosis while providing a simulated physiologic environment (i.e. pH, oxygen, temperature,
nutrients, etc.) for the vessels.  However, this simulated environment does not incorporate all the conditions
that occur in vivo.  For example, we perfused the vessels with cell culture media so the effect of blood cells
and coagulation factors, which have been shown to affect EC and SMC response, were not present in our
system [191-201].  In addition, we isolated the effect of hemodynamics on vascular cell response but in
reality, a number of factors change simultaneously when inserting a vascular graft, and isolating one
parameter may not give a good indication of the complex interaction that actually occurs in vivo.  Therefore,
caution must be used when applying the results of an ex vivo model to the in vivo situation.
5.4.2 Level of Shear Stress
The data used for the correlation of the WSS parameters with biologic end points included axial and
circumferential components of WSS ranging from -18 to 18 dynes/cm2 and the magnitude of WSS ranged
from 0 to 30 dynes/cm2 (see section 3.3.5).  Because the normal physiologic value of WSS is 15 dynes/cm2,
the data used for the correlation include both low (<10 dynes/cm2) and high (>20 dynes/cm2) shear stress
values.  However, because the flow rate into the graft was prescribed such that it was exposed to a
physiologic shear rate (~ 440 sec-1, see section 2.2.6.1), the average applied shear stress (viscosity * shear
rate) in the anastomosis was low due to the decreased viscosity of the perfusate.  Cell culture media has the
same dynamic viscosity as water, which is approximately 3.5 times lower than blood, so the resulting WSS
was expected to be 4.3 dynes/cm2.  As expected, the average level of WSS measured in the regions of interest
was ~ 3 dynes/cm2, a low level of WSS (see Figure 3.57).  
To provide a physiologic level of shear stress, either the viscosity of the perfusate needs to be enhanced
or the shear rate needs to be increased.  We chose not to use either of these methods because of the
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complicating factors involved with each.  To match the viscosity, the perfusate could either be blood  or
viscosity enhanced tissue culture media.  We did not perfuse the vessels with blood because of the immediate
thrombosis which would occur when placing it in the perfusion system and because it would cause difficulty
in maintaining and cleaning the perfusion system components.  Anticoagulating the blood would have
introduced unknown factors and would affect the vascular cells’ biologic response.  Some previous studies
have supplemented non-blood perfusate with glycerol or dextran to match the viscosity of blood [138, 202-
204].  However, this also introduces the possibility of an unknown biologic effect of the viscosity supplement
on the cells.  Therefore, because we chose to perfuse the vessels with low viscosity media, the only other
method for achieving physiologic levels of WSS is to apply a high (nonphysiologic) wall shear rate.
However, previous studies have shown that vascular cells respond differently to the same level of WSS
caused by increasing the viscosity or the flow rate of the perfusate [202, 203, 205].  In addition, limitations
in the inherent resistance of our system and the maximum capacity of the flow pump did not allow us to
increase the flow enough to achieve physiologic levels of WSS.  Therefore, we chose to match the
physiologic level of wall shear rate in these experiments.
5.4.3 Steady Flow
We chose to complete these experiments under steady flow conditions because of the technical
difficulties in perfusing anastomoses ex vivo and the large increase in computational time required to
simulate each anastomosis using pulsatile flow.  Previous studies have shown that vascular cells respond
differently when exposed to steady or pulsatile flow [43, 206-211].  Of particular relevance is the study by
Hsieh et al. who placed cultured human umbilical vein endothelial cells in a parallel plate apparatus and
applied a steady or pulsatile WSS for 4 hours [43].  Steady WSS resulted in an increase of c-fos and c-jun
gene expression compared to static controls.  Pulsatile WSS caused a higher increase in c-fos expression than
the steady WSS but the c-jun gene expression for the pulsatile experiments were comparable to the steady
flow results.  Therefore, steady and pulsatile WSS caused the same gene expression results, just different
magnitude of gene expression for c-fos.  Similar studies of the differential gene response to steady and
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pulsatile shear stress were summarized in the review by Malek and Izumo [138].  In all of these studies,
although the magnitude of the response may have varied between the steady and pulsatile experiments, the
same basic correlation existed; i.e., if steady WSS increased gene expression so did pulsatile WSS.  In
addition, previous CFD studies have studied both steady and pulsatile flows in bypass models and have
shown that the WSS results are qualitatively similar for both conditions [85, 102, 166, 212].  Therefore, we
believe that the correlation results we found for steady flow are valid.  Future studies could be completed
in our laboratory to verify this by repeating the experiments using the pulsatile element of our perfusion
system and developing the corresponding pulsatile CFD models using more advanced computational
resources.
5.4.4 Three Dimensional Reconstruction
We used a novel reconstruction technique to develop the CFD models of each anastomosis.  Accurate
reconstruction of the anastomoses is dependent on both the processing of the tissue after the experimental
procedure and the techniques used to represent the geometry.  Although care was taken to maintain the
dimensions of the tissue when removing the anastomoses from the perfusion system and during the
subsequent freezing and slicing procedures, the resulting configuration of each cross-section may have been
altered.  When removing the fixed vessels from the perfusion system, it is possible that they shortened
slightly causing the lumen to expand due to the incompressibility of the tissue.  In the reconstruction process,
this would result in artificially large cross-sectional diameters and consequently, artificially decreased WSS
values.  However, these decreased WSS values would be uniform along the anastomosis and would result
in a decrease in the average hemodynamic values for the entire anastomosis.  Therefore, any error associated
with circumferential expansion would be accounted for in the normalization of hemodynamic parameters
since the values at each region are normalized by the average value in the experiment.
For the reconstruction process, we chose to assume that the cross-sections were symmetric ellipses.  We
believe that this assumption is reasonable since we are using healthy arterial segments that do not have
disease formation (i.e. asymmetric plaque) and the experimental apparatus held the anastomoses in a plane
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of symmetry.  This assumption could be a limitation since the full, three-dimensional topology was not
incorporated into the models.  However, Moore et al. studied the effect of incorporating different levels of
detail in three dimensional models of ETS anastomoses and found that incorporating specific three
dimensional details may actually cause more errors than avoid them [99].  They concluded that the most
important feature required for accurate representation of ETS anastomoses is the ratio between the graft and
host artery diameters, while the local arterial caliber and out-of-plane geometry were of secondary
importance and the small-scale surface topology was least critical.  Similar to that study, we completed a
sensitivity analysis by creating ETS models using asymmetric ellipses, symmetric ellipses and circular cross-
sections for three separate experiments.  We determined if there were any instances when the  asymmetric
ellipse and/or circular cross-section models resulted in significant correlations that were different from the
ones we found using the symmetric ellipse reconstructions of all the anastomoses.  The results of these
sensitivity analyses (see Sections 4.2.2 and 4.3.4) showed that the choice of cross-section shape (asymmetric
ellipse, symmetric ellipse or circular) did not significantly affect the correlation between the level of EC c-fos
protein expression and the magnitudes of WSS and WSSG magnitude.  Similarly, the correlation between
the level of EC egr-1 protein expression and axial WSS was unaffected by the reconstruction technique.  The
correlation between the level of EC c-jun protein expression and WSSG magnitude was affected by the
reconstruction technique, however.  The linear correlation was only significant for the circular reconstruction
indicating that this model had the potential for resulting in a false positive correlation.  Therefore, we chose
the symmetric ellipse cross-section technique because it allowed us to take advantage computationally of the
geometric symmetry without over-generalizing the shape of the cross-section.
5.4.5 Multiple Steps
In order to obtain directly-coupled biologic and hemodynamic data, we chose to obtain the biologic data
from ex vivo perfusion of ETS anastomoses and then reconstruct these anastomoses to determine the
hemodynamic data.  The main drawback of this approach is that it involves a lot of steps in the process and
is time-consuming.  To obtain the biologic data for each anastomosis, the perfusion must be completed, the
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tissue processed, frozen and sliced before cryosectioning can occur.  For each region of interest, the slides
are stained, microscopy images are taken and then quantified.  Improper handling of the tissue during any
of these steps could result in the loss of all biologic data from the perfusion, rendering the experiment
unusable.  To obtain the hemodynamic data, the tissue cross-sections are digitized to obtain the luminal
boundary and these two-dimensional shapes are lofted to create a three-dimensional surface.  This surface
is then meshed and the CFD model is solved.  The hemodynamic parameters of interest are derived from the
resulting velocity field and then averaged over the region of interest.  The reconstruction requires a lot of
technical skill and experience using the CFD pre-processor, solver and post-processor and there is little
automation in the current methodology.  Because there are so many steps in handling the tissue and
reconstructing the anastomosis, there is the potential to introduce error during any of the steps at these errors
may be magnified as the process continues.  Additionally, even if all steps are performed correctly and in a
timely manner, it takes approximately three weeks to determine the single, quantitative values for the
biologic and hemodynamic parameters for each region of interest for a given experiment.  Therefore this
process is very time-consuming.  Although this methodology results in coupled data, the number of steps
required to complete the process have the potential for losing data, introducing error and require a large
amount of time to obtain both the biologic and hemodynamic data.
 
5.5 Future Work
Future work related to this research could address some of the current limitations or extend the model
to address the issue of how IEG expression leads to IH formation.  Two limitations previously mentioned
are the nonphysiologic viscosity of the perfusate and lack of pulsatility.  These issues could easily be
addressed in future studies.  The viscosity of the cell culture media could be enhanced with supplements such
as glycerol or dextran.  Preliminary studies would need to be completed before conducting an anastomosis
experiment to determine if these supplements have any toxic effects on the vascular cells,  interfere with any
of the tissue processing steps or affect the perfusion system equipment.  Once this is confirmed, the same
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perfusion experiments as those in the current study could be repeated using this more viscous perfusate. The
only necessary change in the computational protocol would be the appropriate increase in the viscosity value
of the fluid.  Using the enhanced viscosity perfusate would allow for the application of physiologic levels
of WSS and wall shear rate and the results could be compared to the present study that was only able to
match wall shear rate values.
Another study could incorporate pulsatility into the experimental and computational models.  The
perfusion system is already equipped to provide a pulsatile waveform.  Because of the experience now gained
from using the vascular clips, the introduction of pulsatility should not cause any leaking at the anastomosis,
which was a concern for these studies.  To maintain the process of obtaining directly coupled data, the
boundary conditions for the computational models would need to be altered to allow for pulsatile pressure
and flow.  These models would require an extensive increase in computational resources.  In addition, the
hemodynamic variables of interest would change and could include parameters such as peak, mean and pulse
amplitude WSS, temporal and spatial WSSG and oscillating shear index.  The correlation combinations
involving mean WSS and spatial WSSG could be compared to the steady flow data and this information,
along with the potential correlations with time dependent hemodynamic parameters, would determine the
effect of pulsatility.
Other studies could focus on improving the computational limitations present in this study.  It would
be beneficial to directly validate the reconstruction technique.  In the present study, the reconstruction
technique is indirectly validated using the correlation results from three experiments in which the ETS
anastomosis was reconstructed using three different cross-section shapes.  However, a direct validation could
be done using an ETS anastomosis model of known dimensions created by a process such as stereo
lithography. The key to this study would be creating the physical model out of a material that could
accurately mimic the material properties of tissue.  This physical model could be frozen and sliced according
to the same protocol currently used and the resulting reconstruction could be compared to the known
geometry of the physical model.  Additionally, CFD analysis could be performed for the actual and
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reconstructed models.  The hemodynamic parameters could be calculated for each model in the regions of
interest to determine a quantitative comparison between the actual and reconstructed models.  This would
give a more direct indication of the error associated with the reconstruction technique.
Future computational work could also focus on developing a more automated reconstruction technique.
The current protocol requires a lot of user interface to determine the luminal boundary.  The threshold of the
image must be adjusted for each individual cross-section which is time-consuming since there are up to 40
cross-sections per anastomosis.  This also requires that all cross-sections are digitized at the same time by
the same person in order to provide continuity in judgement of the appropriate threshold level.  Once the
cross-section digitization is complete, the three dimensional surfaces for the graft, proximal artery and distal
artery must be created.  These individual surfaces are intersected to determine the surface of the entire
anastomosis and the model is meshed.  Because the overall geometry and mesh distribution for each
anastomosis is generally the same, it is conceivable that this process could be at least partially automated.
For example, each of these steps could be automatically completed but since the details of the geometry and
mesh do vary from anastomosis to anastomosis, it would be useful to give the user the opportunity to adjust
the reconstruction after each step.  This could potentially save a lot of time on the reconstruction process
while not losing any accuracy.
Future studies could also extend the current study by directly determining the effect of hemodynamic
parameters on IH formation.  This could be accomplished by perfusing the anastomoses ex vivo for days or
weeks.  In this study, we were not able to assess cell proliferation since this can only be measured after 24
hours of stimulation and our experiments were conducted for only six hours.  If the anastomoses were
perfused for 24 to 72 hours, the regional variation in the balance between SMC proliferation and apoptosis
could be determined and could be correlated with hemodynamic parameters.  Additionally, the regional
variation in the proliferation/apoptosis balance found at this later time point could be compared to the
regional variation in IEG expression found at six hours to determine if a correlation exists.  Furthermore, if
the experiments were extended to 2 to 3 weeks, it would be possible to directly measure the degree of IH
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formation.  The regional variation of IH formation could be correlated with hemodynamic parameters.
Additionally, the regional variation in IH could be compared to the regional variation in IEG expression
found at six hours to determine if a correlation exists.  By exposing anastomoses to well-controlled pressure
and flow for a period of weeks,  the hemodynamic parameter(s) that cause IH formation could be determined
directly for the first time.  In addition, if a correlation existed between the acute IEG expression and the
chronic IH formation, then further studies could be completed to determine the effectiveness of local genetic




Determining a quantitative relationship between the effect of hemodynamics on IH formation will
significantly advance the field of cardiovascular surgery, particularly the success of bypass grafts.  As many
as 20-50% of bypass grafts fail due to the formation of intimal hyperplasia (IH) [18, 70, 71].  Studies as early
as 1933 [213] noted that blood vessels could respond to changes in blood flow rate and by the 1970's,
researchers hypothesized that the endothelium was modulating the vessel’s response [162, 214].  By the
1980's, it was theorized that decreased blood flow caused intimal hyperplasia formation in vascular grafts
[68, 215, 216] and further studies determined that low WSS was related to IH formation [8, 217, 218].
However, these and many other subsequent studies have failed to determine a quantitative correlation
between a specific hemodynamic parameter and a particular cellular response that leads to IH formation.
  Using a combined experimental and computational approach, we have determined a quantitative
correlation between specific hemodynamic parameters (axial WSS, WSS and WSSG magnitude) and the
expression of IEG protein in vascular bypass graft anastomoses.  Compared to previous studies of the
hemodynamic implication of IH formation, this research represents a significant advancement in this field.
We used a whole-vessel, ex vivo perfusion model to obtain quantitative values for biologic end points in
specific regions along ETS and ETE anastomoses along with a CFD reconstruction technique to obtain
quantitative, hemodynamic data in the same regions of interest.  This allowed for a direct correlation between
quantitative biologic and hemodynamic data that has not been achieved previously.  However, the
methodology used for this study does have some limitations.  The tissue processing protocol for obtaining
the biologic data and the reconstruction protocol for calculating the hemodynamic parameters are
complicated, time-consuming and have the possibility of incorporating error into the correlation.  In addition,
this study has not accounted for physiologic characteristics such as pulsatility and the viscous and
biochemical influences of blood flow.  However, future research could address these issues and build upon
the results of this study.  
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If the correlation results from future research support the results of this study, there are a number of
treatments that may improve the clinical success rate of vascular bypass grafts based on the correlations we
found between low levels of WSS and WSSG and the subsequent increase in IEG protein expression.  For
example, the hemodynamics of graft construction could be optimized or targeted gene therapy or
pharmacological agents could be employed to reduce the expression of c-fos, c-jun and/or egr-1. Such
treatments have the potential of decreasing the level of IEG protein expression and thereby may decrease IH




3D Reconstruction Protocol using CFD-GEOM
1) Put ellipse data from NIH Image analysis of digital photo into the correct input.dat format:
Prox Anast Distal Graft
4 3 7 2
NOTE: Major, Minor refer to DIAMETERS in METERS and ANGLE is in DEGREES measured from image
x-axis (output from NIH)





2) Use ellipse_symm.f and ellipses.f (attached at the end of the protocol) to output curves to be read by
CFD-GEOM (ellipses.TAB)
3) Choose double ellipse to be used for the block intersection (close to proximal end).
4) Loft proximal artery surface using full ellipses.
Loft graft surgery using full ellipses.
5) Intersect ellipse segments from final graft and proximal artery ellipses and trim.
Intersect double ellipses and trim.  
Cut single ellipses in half.
6) Loft upper distal artery surface using upper halves of intersected double ellipses and upper halves of single
ellipses.
Repeat for lower distal artery surface.
7) Create z=0 surface (x = -0.2, 0.42 and y = -0.025, 0.12) 
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Create y=0 surface (x = -0.2, 0.42 and z = -0.01, 0.01) 
Create y=30/ angle surface by duplicate/rotating y=0 surface
8) To get outline of the model, intersect all anastomosis surfaces with z=0 surface
9) Intersect the graft and proximal artery outlines and TRIM
10) Intersect the graft and proximal artery surfaces.
11)  To get top lines for graft and proximal proximal artery and distal distal artery, intersect surfaces with
y=0 and y=30/ angle plane
12)  Intersect all lines with ellipses and TRIM to get interim block sections.
13)  To make inner blocks, start at the block intersection at the anastomosis.  Draw a line between the
intersections of the 2 ellipses.  A 0.3 cut is used for the height dimension (z-direction). The interim block
ellipses use a height equal to the 0.3 double-ellipse cut and the lengths are 0.3 cuts. The end circles are all
0.3 cut.
14)  Create edges, faces and blocks. Be sure inner box blocks stay along the center of the geometry (can
redraw if needed). 
15) Project all outer faces to appropriate surface. 
16)  Check the cell volumes under grid tools to be sure there aren't any degenerate cells.
17)  Once the proximal artery, graft and distal artery blocks are completed, make vessel extensions (upstream
of graft and proximal artery and downstream of distal artery) by using a circle with radius=(major+minor)/4
of closest ellipse (dimensions from input.dat text file)
For proximal artery: x = -0.0515
For graft: x = -0.2
For distal artery x = 0.4
18) Loft each surface using the ¼ ellipses from previous surfaces and full circles just created
19) Create edges, faces, blocks for the extensions.
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20) In total, there should be 6 main areas (proximal proximal artery, proximal artery, proximal graft, graft,
distal artery, distal distal artery) with inner and outer blocks each for a total of 12 blocks.
21)  Save as .DTF and CAREFULLY check grid and surface projection in CFD-VIEW before proceeding
to CFD-ACE.
---------------------------------------------------------------------------------------------------------------------------------
      PROGRAM ELLIPSE_SYMM
      implicit double precision(a-h,o-z)
      character*30 outfile,infile
      parameter(outfile='input_symm.dat')
      parameter(infile='input.dat')
      parameter(mxcrvs=200)
      dimension d1(mxcrvs),d2(mxcrvs),angle(mxcrvs)
C     This code takes the input from the original ellipse file and
C     and outputs the corresponding SYMMETRICAL ellipse file to be used in
C     ellipses.f to create a CFD-GEOM input file of curves (*.TAB)
C Ncrvs = # of ellipses to be output
C This rotates all ellipses with an angle of orientation between 0 and 45 to 0,
C      between 45 and 90 to 45, between 90 and 135 to 90 and between 135 and 180 to 135
      open(90,file=infile)
      read(90,*)
      read(90,*) nprox,nanast,ndist,ngraft
      ncrvs=nprox + ndist + 2*nanast + ngraft
      read(90,*)
      read(90,*)
      read(90,*)
      do i=1,ncrvs
         read(90,*) d1(i),d2(i),a
         if((a.ge.0.0d0).and.(a.le.45.0d0)) then
            angle(i)=0.0d0
            write(*,*)i,a,angle(i)
         elseif((a.gt.45.0d0).and.(a.le.135.0d0)) then
            angle(i)=90.0d0
            write(*,*)i,a,angle(i)
         elseif((a.gt.135.0d0).and.(a.le.225.0d0)) then
            angle(i)=180.0d0
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            write(*,*)i,a,angle(i)
         elseif((a.gt.225.0d0).and.(a.le.315.0d0)) then
            angle(i)=270.0d0
            write(*,*)i,a,angle(i)
         elseif((a.gt.315.0d0).and.(a.le.360.0d0)) then
            angle(i)=0.0d0
            write(*,*)i,a,angle(i)
         else
            write(*,*) "Angle problem - STOPPING",a
            STOP
         endif
      enddo
      close(90)   
C Output newly rotated, symmetric ellipses to file
      open(99,file=outfile)
      write(99,*) 'Prox Anast   Distal  Graft'
      write(99,*) nprox,nanast,ndist,ngraft
      write(99,*) 'NOTE: Major, Minor refer to DIAMETERS in METERS and
     *     ANGLE is in DEGREES measured from image x-axis (output from
     *     NIH)'
      write(99,*) 'NOTE: Order of the info goes Prox, Anast Floor, Dist,
     *     Graft, Anast Hood'
      write(99,*) 'Major        Minor   Angle'
      do i=1,ncrvs
         write(99,*) d1(i),d2(i),angle(i)
      enddo
      close(99)
      stop
      end
---------------------------------------------------------------------------------------------------------------------------------
      PROGRAM ELLIPSES
      implicit double precision(a-h,o-z)
      character*30 outfile,infile
      parameter(outfile='ellipses.TAB')
      parameter(infile='input.dat')
      parameter(mxpts=100,mxcrvs=200)
      dimension x(mxcrvs,mxpts),y(mxcrvs,mxpts),
     *     z(mxcrvs,mxpts),npts(mxcrvs),r(mxcrvs)
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      dimension rmax(mxcrvs),rmin(mxcrvs),angle(mxcrvs)
      dimension xc(mxcrvs),yc(mxcrvs)
C     This code assumes full elliptical cross-sections with
C     4 segments each - floor to outer, outer to hood, hood
C     to inner and inner to floor - 19 points on each cs
C     Anastomosis c-s split into 2 ellipses (floor and hood)
C Outputs discrete points along curve to be read into CFD-GEOM
C Input file has max diameter, min diameter (meters) and angle of orientation (degrees) info
      pi=ACOS(-1.0d0)
      open(90,file=infile)
      read(90,*)
      read(90,*) nprox,nanast,ndist,ngraft
      ncrvs=nprox + ndist + 2*nanast + ngraft
C Read in diameter and angle of orientation info     
C Convert diameter to radius and angle to radians
      read(90,*)
      read(90,*)
      read(90,*)
      do i=1,ncrvs
         read(90,*) d1,d2,a
         rmax(i)=d1/2.0d0
         rmin(i)=d2/2.0d0
         angle(i)=a*pi/180.0d0
      enddo
C output to screen as double check
      write(*,*)  nprox,nanast,ndist,ngraft
      do i=1,ncrvs
         write(*,*) rmax(i),rmin(i),angle(i)
      enddo
C Check dimensions of arrays to be sure not overwriting anything
      if(ncrvs*4.gt.mxcrvs) then 
         write(*,*)"WARNING!!!!! Number of Circles exceeds Maximum",
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     *    "Change mxcrvs dimension","*******EXITING*******"
         stop
      endif
C Set number of points to be calculated per curve
      nptscrv=19
      do i=1,ncrvs
         npts(i)=nptscrv
      enddo
C Check array dimensions WRT # points per curve
      if(nptscrv*4.gt.mxpts) then 
         write(*,*)"WARNING!!!!! Number of Points exceeds Maximum",
     *        "Change mxpts dimension","*******EXITING*******"
         stop
      endif
C     Create points for all artery ellipses (prox, anast floor, dist) - 2mm apart (slice thickness)
      numcirc=0
      do i=1,nprox+ndist+nanast
         numcirc=numcirc+1
         xshift=float(i-nprox-1)*0.002d0
         xc(i)=xshift
         yc(i)=0.0d0
         start=ATAN(-rmax(i)/rmin(i)*TAN(angle(i)))
         ytemp=rmin(i)*sin(start*pi/180.0d0)
         ztemp=rmax(i)*cos(start*pi/180.0d0)
         ztemp=ztemp*cos(angle(i))-ytemp*sin(angle(i))
         if(ztemp.lt.0.0d0) then
            start=start+pi
         endif
         do j=1,4*npts(i)-3
            x(i,j)=xshift
            y(i,j)=rmin(i)*sin(start+float(j-1)*2.0d0*pi/
     *           (4*npts(i)-4))
            z(i,j)=rmax(i)*cos(start+float(j-1)*2.0d0*pi/
     *           (4*npts(i)-4))
            yhold=y(i,j)
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            zhold=z(i,j)
            y(i,j)=zhold*sin(angle(i))+yhold*cos(angle(i))
            z(i,j)=zhold*cos(angle(i))-yhold*sin(angle(i))
            if(j.eq.1) then
               write(*,100) i,x(i,j),y(i,j),z(i,j)
 100           format(' ',i6,f12.5,f12.5,f12.5)
            endif
         enddo
      enddo
C     Create points for all graft ellipses (graft + anast hood) - 2mm apart (slice thickness)
C 30 degree angle (pi/6) vessel
      do i=nprox+ndist+nanast+1,nprox+ndist+nanast+ngraft+nanast
         xshift=float(i-(nprox+ndist+nanast+ngraft+1))*0.002d0
         ycenter=(x(nprox+nanast+1,1)-xshift)*tan(pi/6.0d0)
         zcenter=0.0d0
         xc(i)=xshift
         yc(i)=ycenter
         start=ATAN(-rmax(i)/rmin(i)*TAN(angle(i)))
         ytemp=rmin(i)*sin(start*pi/180.0d0)
         ztemp=rmax(i)*cos(start*pi/180.0d0)
         ztemp=ztemp*cos(angle(i))-ytemp*sin(angle(i))
         if(ztemp.lt.0.0d0) then
            start=start+pi
         endif
         do j=1,4*npts(i)-3
            x(i,j)=xshift
            y(i,j)=ycenter+rmin(i)*sin(start+float(j-1)*2.0d0*pi/
     *           (4*npts(i)-4))
            z(i,j)=zcenter+rmax(i)*cos(start+float(j-1)*2.0d0*pi/
     *           (4*npts(i)-4))
            yhold=y(i,j)-ycenter
            zhold=z(i,j)
            y(i,j)=zhold*sin(angle(i))+yhold*cos(angle(i))+ycenter
            z(i,j)=zhold*cos(angle(i))-yhold*sin(angle(i))
            if(j.eq.1) then
               write(*,100) i,x(i,j),y(i,j),z(i,j)
            endif
         enddo
      enddo
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C Write output file to be read by CFD-GEOM (file.TAB)
      open(99,file=outfile)
      write(99,*)nprox+ndist+2*nanast+ngraft+5
      do i=1, nprox+ndist+2*nanast+ngraft
         write(99,*) npts(i)*4-3
      enddo
      write(99,*) npts(ncrvs)*4-3
      write(99,*) nprox+nanast+ndist
      write(99,*) nprox+nanast+ndist
      write(99,*) nanast+ngraft+1
      write(99,*) nanast+ngraft+1
      do i=1,nprox+ndist+2*nanast+ngraft
         do j=1,npts(i)*4-3
            write(99,50) x(i,j),y(i,j),z(i,j)
 50         format(' ',f12.6,f12.6,f12.6)
         enddo
      enddo
      do j=1,npts(ncrvs)*4-3                !extra anast c-s
         write(99,50) xc(nprox+nanast+1),y(ncrvs,j)-yc(ncrvs),z(ncrvs,j)
      enddo
      do i=1,nprox+nanast+ndist
         write(99,50) xc(i),yc(i),0.0d0
      enddo
      do i=1,nprox+nanast+ndist
        write(99,50) x(i,1),y(i,1),z(i,1)
      enddo
      do i=nprox+nanast+ndist+1,ncrvs
         write(99,50) xc(i),yc(i),0.0d0
      enddo
C  ***EXTRA ANAST CS:
      write(99,50) xc(nprox+nanast+1),yc(nprox+nanast+1),0.0d0
      do i=nprox+nanast+ndist+1,ncrvs
         write(99,50) x(i,1),y(i,1),z(i,1)         
      enddo
C  ***EXTRA ANAST CS:
      write(99,50) x(nprox+nanast+1,1),y(ncrvs,1)-yc(ncrvs),z(ncrvs,1)
      close(99)
      stop
      end
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APPENDIX B
Example output file from CFD-ACEU
 
      ***************************************************************
 **                                                           **
 **   CCCCC  FFFFF DDDD           AAA     CCCCC   EEEEE   U   U   **
 **   C             F       D       D        A        A   C              E       U   U  **
 **   C             FFFF   D       D    ==  AAAAA   C              EEEE     U   U  **
 **   C             F       D       D      A         A  C              E            U   U  **
 **   CCCCC  F       DDDD       A         A  CCCCC   EEEEE   UUU **
 **                                                           **
 **       Version          :  6. 6. 8                         **
 **       Build Date       : Wed Jul 25 11:15:07 CDT 2001     **
 **       Build OS         : SunOS                            **
 **       Build OS Release : 5.6                              **
 **       Build OS Version : Generic                          **
 **       Build Machine    : pepper                           **
 **                                                           **
 **      Copyright (c) 2000, CFD Research Corporation,        **
 **                   All Rights Reserved                     **
       ***************************************************************
  
 ===============================================================
    CFD-ACEU Run Platform Information : 
 ===============================================================
    Run Date           : 02/22/2002 16:01:55           
    Run OS             : SunOS               
    Run OS Release     : 5.8                 
    Run OS Version     : Generic_108528-07             




  ===================================== 
  Summary of Input Information 
  ===================================== 
  Title              :                                                                                                                                         
  Modules            : FLOW                                                                                                                               
DTF File Name      : symm_4_25_01_half.DTF         
  Model Name         : symm_4_25_01_half             
  Simulation Number  :   1
  Diagnostic         : Basic
  Iterations         :   1000
  Output Frequency   :     25
  Time Dependence    : Steady 
===================================== 
  Summary of 3D Grid Data           
===================================== 
  
  Total No. of nodes :   150787
  No. of quad faces  :   428109
  Total No. of faces :   428109
  No. of hexa. cells :   138852
  Total No. of cells :   138852
  
  ===================================== 
  Summary of Properties 
  ===================================== 
  Total No. of Property VCs :      12
  ===================================== 
    ----------------------------- 
    Key No.          :      2531
    Zone No.         :       1
    VC Name.         : NoName              
    No. of Cells     :    3038
    Material  Type   : Fluid   
    Density   method : Constant      = 1.00E+03
    Viscosity method : Constant_Dyn  = 1.00E-03
    Sp. Heat  method : Constant      = 1.00E+03
    ----------------------------- 
    ----------------------------- 
    Key No.          :      2538
    Zone No.         :       2
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    VC Name.         : NoName              
    No. of Cells     :    9548
    Material  Type   : Fluid   
    Density   method : Constant      = 1.00E+03
    Viscosity method : Constant_Dyn  = 1.00E-03
    Sp. Heat  method : Constant      = 1.00E+03
    ----------------------------- 
    ----------------------------- 
    Key No.          :      2643
    Zone No.         :       3
    VC Name.         : NoName              
    No. of Cells     :    3038
    Material  Type   : Fluid   
    Density   method : Constant      = 1.00E+03
    Viscosity method : Constant_Dyn  = 1.00E-03
    Sp. Heat  method : Constant      = 1.00E+03
    ----------------------------- 
    ----------------------------- 
    Key No.          :      2650
    Zone No.         :       4
    VC Name.         : NoName              
    No. of Cells     :    9548
    Material  Type   : Fluid   
    Density   method : Constant      = 1.00E+03
    Viscosity method : Constant_Dyn  = 1.00E-03
    Sp. Heat  method : Constant      = 1.00E+03
    ----------------------------- 
    ----------------------------- 
    Key No.          :      2733
    Zone No.         :       5
    VC Name.         : NoName              
    No. of Cells     :    7742
    Material  Type   : Fluid   
    Density   method : Constant      = 1.00E+03
    Viscosity method : Constant_Dyn  = 1.00E-03
    Sp. Heat  method : Constant      = 1.00E+03
    ----------------------------- 
    ----------------------------- 
    Key No.          :      2740
    Zone No.         :       6
    VC Name.         : NoName              
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    No. of Cells     :   24332
    Material  Type   : Fluid   
    Density   method : Constant      = 1.00E+03
    Viscosity method : Constant_Dyn  = 1.00E-03
    Sp. Heat  method : Constant      = 1.00E+03
    ----------------------------- 
    ----------------------------- 
    Key No.          :      2848
    Zone No.         :       7
    VC Name.         : NoName              
    No. of Cells     :    2254
    Material  Type   : Fluid   
    Density   method : Constant      = 1.00E+03
    Viscosity method : Constant_Dyn  = 1.00E-03
    Sp. Heat  method : Constant      = 1.00E+03
    ----------------------------- 
    ----------------------------- 
    Key No.          :      2862
    Zone No.         :       8
    VC Name.         : NoName              
    No. of Cells     :    7084
    Material  Type   : Fluid   
    Density   method : Constant      = 1.00E+03
    Viscosity method : Constant_Dyn  = 1.00E-03
    Sp. Heat  method : Constant      = 1.00E+03
    ----------------------------- 
    ----------------------------- 
    Key No.          :      2923
    Zone No.         :       9
    VC Name.         : NoName              
    No. of Cells     :    5782
    Material  Type   : Fluid   
    Density   method : Constant      = 1.00E+03
    Viscosity method : Constant_Dyn  = 1.00E-03
    Sp. Heat  method : Constant      = 1.00E+03
    ----------------------------- 
    ----------------------------- 
    Key No.          :      2930
    Zone No.         :      10
    VC Name.         : NoName              
    No. of Cells     :   18172
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    Material  Type   : Fluid   
    Density   method : Constant      = 1.00E+03
    Viscosity method : Constant_Dyn  = 1.00E-03
    Sp. Heat  method : Constant      = 1.00E+03
    ----------------------------- 
    ----------------------------- 
    Key No.          :      2991
    Zone No.         :      11
    VC Name.         : NoName              
    No. of Cells     :   11662
    Material  Type   : Fluid   
    Density   method : Constant      = 1.00E+03
    Viscosity method : Constant_Dyn  = 1.00E-03
    Sp. Heat  method : Constant      = 1.00E+03
    ----------------------------- 
    ----------------------------- 
    Key No.          :      2998
    Zone No.         :      12
    VC Name.         : NoName              
    No. of Cells     :   36652
    Material  Type   : Fluid   
    Density   method : Constant      = 1.00E+03
    Viscosity method : Constant_Dyn  = 1.00E-03
    Sp. Heat  method : Constant      = 1.00E+03
    ----------------------------- 
  ===================================== 
     Exited input_A  Elapsed Time=  3.999869E+01 Delta-time=  3.999869E+01
     Exited input_A  DBM Memory  =  2.943405E+01 MAX_DBM Memory=  2.943405E+01
     Exited input_B  Elapsed Time=  4.000828E+01 Delta-time=  9.471893E-03
     Exited input_B  DBM Memory  =  2.943405E+01 MAX_DBM Memory=  2.943405E+01
====================================================================
 Summary of Initial Conditions 
 Total No. of Initial Condition VCs :      12
====================================================================
  
 Zone No.         :       1
 Key No.          :      2531
 VC Name.         : NoName              
 No. of Cells     :    3038
 Material  Type   : Fluid   
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====================================================================
 Variable                             Evaluation Method   Value     
====================================================================
 X-Direction Velocity (U)             Constant           1.045E-01
 Y-Direction Velocity (V)             Constant           0.000E+00
 Z-Direction Velocity (W)             Constant           0.000E+00
 Pressure                             Constant           0.000E+00
 Temperature                          Constant           3.000E+02
====================================================================
  
 Zone No.         :       2
 Key No.          :      2538
 VC Name.         : NoName              
 No. of Cells     :    9548
 Material  Type   : Fluid   
====================================================================
 Variable                             Evaluation Method   Value     
====================================================================
 X-Direction Velocity (U)             Constant           1.045E-01
 Y-Direction Velocity (V)             Constant           0.000E+00
 Z-Direction Velocity (W)             Constant           0.000E+00
 Pressure                             Constant           0.000E+00
 Temperature                          Constant           3.000E+02
====================================================================
  
 Zone No.         :       3
 Key No.          :      2643
 VC Name.         : NoName              
 No. of Cells     :    3038
 Material  Type   : Fluid   
====================================================================
 Variable                             Evaluation Method   Value     
====================================================================
 X-Direction Velocity (U)             Constant           1.045E-01
 Y-Direction Velocity (V)             Constant           0.000E+00
 Z-Direction Velocity (W)             Constant           0.000E+00
 Pressure                             Constant           0.000E+00




 Zone No.         :       4
 Key No.          :      2650
 VC Name.         : NoName              
 No. of Cells     :    9548
 Material  Type   : Fluid   
====================================================================
 Variable                             Evaluation Method   Value     
====================================================================
 X-Direction Velocity (U)             Constant           1.045E-01
 Y-Direction Velocity (V)             Constant           0.000E+00
 Z-Direction Velocity (W)             Constant           0.000E+00
 Pressure                             Constant           0.000E+00
 Temperature                          Constant           3.000E+02
====================================================================
  
 Zone No.         :       5
 Key No.          :      2733
 VC Name.         : NoName              
 No. of Cells     :    7742
 Material  Type   : Fluid   
====================================================================
 Variable                             Evaluation Method   Value     
====================================================================
 X-Direction Velocity (U)             Constant           1.045E-01
 Y-Direction Velocity (V)             Constant           0.000E+00
 Z-Direction Velocity (W)             Constant           0.000E+00
 Pressure                             Constant           0.000E+00
 Temperature                          Constant           3.000E+02
====================================================================
  
 Zone No.         :       6
 Key No.          :      2740
 VC Name.         : NoName              
 No. of Cells     :   24332
 Material  Type   : Fluid   
====================================================================
 Variable                             Evaluation Method   Value     
====================================================================
 X-Direction Velocity (U)             Constant           1.045E-01
 Y-Direction Velocity (V)             Constant           0.000E+00
 Z-Direction Velocity (W)             Constant           0.000E+00
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 Pressure                             Constant           0.000E+00




 Zone No.         :       7
 Key No.          :      2848
 VC Name.         : NoName              
 No. of Cells     :    2254
 Material  Type   : Fluid   
====================================================================
 Variable                             Evaluation Method   Value     
====================================================================
 X-Direction Velocity (U)             Constant           1.045E-01
 Y-Direction Velocity (V)             Constant           0.000E+00
 Z-Direction Velocity (W)             Constant           0.000E+00
 Pressure                             Constant           0.000E+00
 Temperature                          Constant           3.000E+02
====================================================================
  
 Zone No.         :       8
 Key No.          :      2862
 VC Name.         : NoName              
 No. of Cells     :    7084
 Material  Type   : Fluid   
====================================================================
 Variable                             Evaluation Method   Value     
====================================================================
 X-Direction Velocity (U)             Constant           1.045E-01
 Y-Direction Velocity (V)             Constant           0.000E+00
 Z-Direction Velocity (W)             Constant           0.000E+00
 Pressure                             Constant           0.000E+00
 Temperature                          Constant           3.000E+02
====================================================================
  
 Zone No.         :       9
 Key No.          :      2923
 VC Name.         : NoName              
 No. of Cells     :    5782
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 Material  Type   : Fluid   
====================================================================
 Variable                             Evaluation Method   Value     
====================================================================
 X-Direction Velocity (U)             Constant           1.045E-01
 Y-Direction Velocity (V)             Constant           0.000E+00
 Z-Direction Velocity (W)             Constant           0.000E+00
 Pressure                             Constant           0.000E+00
 Temperature                          Constant           3.000E+02
====================================================================
  
 Zone No.         :      10
 Key No.          :      2930
 VC Name.         : NoName              
 No. of Cells     :   18172
 Material  Type   : Fluid   
====================================================================
 Variable                             Evaluation Method   Value     
====================================================================
 X-Direction Velocity (U)             Constant           1.045E-01
 Y-Direction Velocity (V)             Constant           0.000E+00
 Z-Direction Velocity (W)             Constant           0.000E+00
 Pressure                             Constant           0.000E+00
 Temperature                          Constant           3.000E+02
====================================================================
  
 Zone No.         :      11
 Key No.          :      2991
 VC Name.         : NoName              
 No. of Cells     :   11662
 Material  Type   : Fluid   
====================================================================
 Variable                             Evaluation Method   Value     
====================================================================
 X-Direction Velocity (U)             Constant           1.045E-01
 Y-Direction Velocity (V)             Constant           0.000E+00
 Z-Direction Velocity (W)             Constant           0.000E+00
 Pressure                             Constant           0.000E+00




 Zone No.         :      12
 Key No.          :      2998
 VC Name.         : NoName              
 No. of Cells     :   36652
 Material  Type   : Fluid   
====================================================================
 Variable                             Evaluation Method   Value     
====================================================================
 X-Direction Velocity (U)             Constant           1.045E-01
 Y-Direction Velocity (V)             Constant           0.000E+00
 Z-Direction Velocity (W)             Constant           0.000E+00
 Pressure                             Constant           0.000E+00
 Temperature                          Constant           3.000E+02
====================================================================
Exited patch_intf_st Elapsed Time=  4.313507E+01 Delta-time=  3.126678E+00
Exited patch_intf_st DBM Memory  =  5.017220E+01 MAX_DBM Memory=  5.017220E+01
Exited cyclic_bc  Elapsed Time=  4.314558E+01 Delta-time=  1.034546E-02
Exited cyclic_bc  DBM Memory  =  5.017220E+01 MAX_DBM Memory=  5.017220E+01
 
  =====================================
  Summary of Solver Control Parameters 
  =====================================
 Spatial Differencing for Velocity = 2ndOrder        
 Blending  factor for Velocity =   1.00E-01
 Spatial Differencing for Density = 2ndOrder        
 Blending factor for Density =   1.00E-01
 Relaxation for Velocity =   2.00E-02
 Relaxation for Pressure Correction =   2.00E-01
 Relaxation for Pressure =   1.00E+00
 Relaxation for Density =   1.00E+00
 Relaxation for Viscosity =   1.00E+00
 Solver for Velocity = CGS+Pre
 Solver for Pressure Correction = CGS+Pre
 Number of sweeps for Velocity = 100
 Number of sweeps for Pressure Correction = 3000
 Solver Criterion for Velocity =   1.00E-04
 Solver Criterion for Pressure Correction =   1.00E-04
 Minimum Limit for U =  -1.00E+20
 Maximum Limit for U =   1.00E+20
 Minimum Limit for V =  -1.00E+20
 Maximum Limit for V =   1.00E+20
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 Minimum Limit for W =  -1.00E+20
 Maximum Limit for W =   1.00E+20
 Minimum Limit for P =  -1.00E+20
 Maximum Limit for P =   1.00E+20
 Minimum Limit for Density =   1.00E-06
 Maximum Limit for Density =   1.00E+20
 Minimum Limit for Viscosity =   1.00E-10
 Maximum Limit for Viscosity =   1.00E+02
  
  ===================================== 
  Summary of Face Angles 
  ===================================== 
  % of faces with 
                   10.000 < angle <   20.000 =    0.012
                   20.000 < angle <   30.000 =    0.763
                   30.000 < angle <   40.000 =    0.959
                   40.000 < angle <   50.000 =    2.489
                   50.000 < angle <   60.000 =    7.083
                   60.000 < angle <   70.000 =   16.931
                   70.000 < angle <   80.000 =   19.662
                   80.000 < angle <   90.000 =   52.101
  ===================================== 
  ===================================== 
  Summary of Geometry Data 
  ===================================== 
  
  Smallest Volume   :   1.008505E-12
  
  Largest  Volume   :   3.764472E-10
  
  Smallest Angle    :   1.070057E+01 at face =    152583
  
  Location of face number    152583 is x =   1.9308E-03 y =  -1.2574E-03 z =   6.1611E-04
  
    Exited geometry  Elapsed Time=  5.522527E+01 Delta-time=  1.207959E+01
    Exited geometry  DBM Memory  =  1.012668E+02 MAX_DBM Memory=  1.012668E+02
    Exited sort_bc  Elapsed Time=  5.526081E+01 Delta-time=  3.543091E-02
    Exited sort_bc  DBM Memory  =  1.012668E+02 MAX_DBM Memory=  1.012668E+02
    Exited cal_bc_profil Elapsed Time=  5.526100E+01 Delta-time=  6.866455E-05 
    Exited cal_bc_profil DBM Memory  =  1.012668E+02 MAX_DBM Memory=  1.012668E+02
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    Exited init0  Elapsed Time=  5.856235E+01 Delta-time=  3.301277E+00
    Exited init0  DBM Memory  =  1.012668E+02 MAX_DBM Memory=  1.149663E+02
  ============================= 
  Start of Iterative Cycle..... 
  ============================= 
 CGS: W     , SWEEP=    5, SUM0=8.44E-07, SUM=3.10E-09
 CGS: U     , SWEEP=   19, SUM0=1.77E+01, SUM=2.25E-02
 CGS: V     , SWEEP=    3, SUM0=5.73E-01, SUM=2.88E-03
 CGS: P     , SWEEP= 3000, SUM0=1.83E+01, SUM=1.84E+11
 Max. Sweeps reached for var = P     
 Data not Updated 
ITER =    1, ICMAX  RES(MAX)  RES(SUM)    VALUE
--------------------------------------------------
 VAR =W      78191   1.55E-12  2.99E-10  0.0000E+00
 Cell= 78191 X,Y,Z= -1.09E-01  6.37E-02  8.66E-05
 VAR =U      72367   9.67E-06  1.83E-02  1.0450E-01
 Cell= 72367 X,Y,Z= -1.73E-01  9.76E-02  2.15E-04
 VAR =V      72478   6.65E-07  2.33E-04  0.0000E+00
 Cell= 72478 X,Y,Z= -1.69E-01  1.04E-01  1.84E-04
 VAR =P      73291   2.11E-04  1.62E-01  1.0000E-05
 Cell= 73291 X,Y,Z= -1.62E-01  9.12E-02  2.15E-04
 CGS: W     , SWEEP=    4, SUM0=1.27E-06, SUM=1.40E-09
 CGS: U     , SWEEP=    6, SUM0=2.14E+01, SUM=1.59E-01
 CGS: V     , SWEEP=    4, SUM0=3.06E-01, SUM=2.90E-03
 CGS: P     , SWEEP= 3000, SUM0=5.80E+00, SUM=1.21E+06
 Max. Sweeps reached for var = P     
 Data not Updated 
ITER =    2, ICMAX  RES(MAX)  RES(SUM)    VALUE
--------------------------------------------------
 VAR =W      78191   3.88E-12  8.36E-10  7.2190E-08
 Cell= 78191 X,Y,Z= -1.09E-01  6.37E-02  8.66E-05
 VAR =U      73291   1.42E-05  2.27E-02 -2.5033E-01
 Cell= 73291 X,Y,Z= -1.62E-01  9.12E-02  2.15E-04
 VAR =V      72394   1.38E-06  9.22E-05 -4.8671E-02
 Cell= 72394 X,Y,Z= -1.69E-01  1.04E-01  2.15E-04
 VAR =P      73599   5.01E-05  3.82E-02  1.0000E-05
 Cell= 73599 X,Y,Z= -1.58E-01  8.91E-02  2.15E-04
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 CGS: W     , SWEEP=    3, SUM0=2.49E-07, SUM=1.25E-09
 CGS: U     , SWEEP=   12, SUM0=3.43E+00, SUM=7.95E-03
 CGS: V     , SWEEP=    5, SUM0=3.19E-01, SUM=3.17E-04
 CGS: P     , SWEEP= 3000, SUM0=1.13E+00, SUM=3.34E+08
 Max. Sweeps reached for var = P     
 Data not Updated 
ITER =    3, ICMAX  RES(MAX)  RES(SUM)    VALUE
--------------------------------------------------
 VAR =W      77911   8.36E-13  1.46E-10 -4.3444E-08
 Cell= 77911 X,Y,Z= -1.10E-01  6.12E-02  2.15E-04
 VAR =U      73907   2.09E-06  2.41E-03 -5.9474E-02
 Cell= 73907 X,Y,Z= -1.54E-01  8.70E-02  2.15E-04
 VAR =V      72371   5.91E-07  7.92E-05 -3.2692E-02
 Cell= 72371 X,Y,Z= -1.72E-01  9.80E-02  1.85E-03
 VAR =P      73599   1.64E-05  1.52E-02  1.0000E-05
 Cell= 73599 X,Y,Z= -1.58E-01  8.91E-02  2.15E-04
 CGS: W     , SWEEP=    3, SUM0=2.71E-07, SUM=8.91E-10
 CGS: U     , SWEEP=   12, SUM0=9.97E-01, SUM=2.55E-03
 CGS: V     , SWEEP=    5, SUM0=2.90E-01, SUM=1.18E-03
 CGS: P     , SWEEP= 3000, SUM0=5.94E-01, SUM=1.11E+07
 Max. Sweeps reached for var = P     








ITER =   17, ICMAX  RES(MAX)  RES(SUM)    VALUE
--------------------------------------------------
 VAR =W      78807   8.77E-15  2.49E-13 -4.2071E-10
 Cell= 78807 X,Y,Z= -1.03E-01  6.00E-02  8.62E-05
 VAR =U      78471   1.05E-07  6.11E-05  4.5522E-02
 Cell= 78471 X,Y,Z= -1.06E-01  6.15E-02  1.01E-04
 VAR =V      78485   6.09E-08  2.79E-05 -2.8689E-02
 Cell= 78485 X,Y,Z= -1.05E-01  6.32E-02  1.52E-03
 VAR =P      72380   5.43E-06  2.74E-03  1.0000E-05
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 Cell= 72380 X,Y,Z= -1.71E-01  1.01E-01  3.81E-03
 CGS: W     , SWEEP=    6, SUM0=1.41E-09, SUM=2.68E-13
 CGS: U     , SWEEP=    4, SUM0=3.42E-01, SUM=3.06E-03
 CGS: V     , SWEEP=    4, SUM0=1.97E-01, SUM=9.19E-04
 CGS: P     , SWEEP= 1751, SUM0=4.86E-01, SUM=4.38E-03
ITER =   18, ICMAX  RES(MAX)  RES(SUM)    VALUE
--------------------------------------------------
 VAR =W      79115   1.01E-14  2.20E-13 -3.3147E-10
 Cell= 79115 X,Y,Z= -9.94E-02  5.82E-02  8.60E-05
 VAR =U      78779   1.02E-07  5.71E-05  4.7603E-02
 Cell= 78779 X,Y,Z= -1.03E-01  5.97E-02  1.01E-04
 VAR =V      78780   5.90E-08  2.68E-05 -2.6858E-02
 Cell= 78780 X,Y,Z= -1.03E-01  5.97E-02  3.03E-04
 VAR =P      72380   5.43E-06  2.70E-03  1.0000E-05
 Cell= 72380 X,Y,Z= -1.71E-01  1.01E-01  3.81E-03
 CGS: W     , SWEEP=   10, SUM0=1.49E+00, SUM=3.20E-03
 CGS: U     , SWEEP=   10, SUM0=8.48E+00, SUM=5.69E-02
 CGS: V     , SWEEP=   12, SUM0=2.81E+00, SUM=7.39E-03
 CGS: P     , SWEEP=   90, SUM0=8.88E+00, SUM=7.12E-02
ITER =   19, ICMAX  RES(MAX)  RES(SUM)    VALUE
--------------------------------------------------
 VAR =W      44141   5.90E-07  8.95E-04  2.8050E-02
 Cell= 44141 X,Y,Z=  3.98E-03  3.02E-03  5.72E-04
 VAR =U     126235   2.09E-06  1.68E-02  3.7827E-03
 Cell=126235 X,Y,Z=  2.32E-01 -3.46E-03  1.69E-04
 VAR =V      42322   6.43E-07  2.00E-03  4.2295E-02
 Cell= 42322 X,Y,Z=  1.71E-03  3.07E-03  2.16E-04
 VAR =P      85303   2.16E-05  5.76E-02  1.7032E+02
 Cell= 85303 X,Y,Z= -4.26E-02  2.26E-02  2.15E-04
 CGS: W     , SWEEP=    8, SUM0=1.56E+00, SUM=1.04E-02
 CGS: U     , SWEEP=   14, SUM0=3.71E+00, SUM=8.28E-03
 CGS: V     , SWEEP=   14, SUM0=2.20E+00, SUM=9.97E-03
 CGS: P     , SWEEP= 1095, SUM0=5.53E+00, SUM=4.59E-02
ITER =   20, ICMAX  RES(MAX)  RES(SUM)    VALUE
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--------------------------------------------------
 VAR =W      32968   4.79E-07  1.01E-03  2.0543E-02
 Cell= 32968 X,Y,Z= -7.81E-03  1.08E-02  1.82E-03
 VAR =U      32970   1.69E-06  3.66E-03  1.1554E-01
 Cell= 32970 X,Y,Z= -7.81E-03  1.14E-02  3.89E-04
 VAR =V      33026   1.58E-06  1.75E-03 -5.7205E-02
 Cell= 33026 X,Y,Z= -7.81E-03  1.04E-02  3.29E-04
 VAR =P      34482   2.04E-05  3.91E-02  1.6762E+02
 Cell= 34482 X,Y,Z= -5.80E-03  1.13E-02  4.15E-04
 CGS: W     , SWEEP=    9, SUM0=1.34E+00, SUM=3.64E-03
 CGS: U     , SWEEP=   16, SUM0=3.53E+00, SUM=3.03E-02
 CGS: V     , SWEEP=   12, SUM0=2.54E+00, SUM=1.05E-02
 CGS: P     , SWEEP=   41, SUM0=6.86E+00, SUM=3.55E-02




ITER =  760, ICMAX  RES(MAX)  RES(SUM)    VALUE
--------------------------------------------------
 VAR =W      43301   1.17E-11  1.03E-08 -2.5065E-03
 Cell= 43301 X,Y,Z=  3.00E-03  2.18E-03  4.18E-04
 VAR =U      43274   2.57E-11  1.42E-08  2.1402E-01
 Cell= 43274 X,Y,Z=  2.91E-03  2.48E-03  1.75E-04
 VAR =V      43274   3.06E-11  1.77E-08 -8.8192E-02
 Cell= 43274 X,Y,Z=  2.91E-03  2.48E-03  1.75E-04
 VAR =P      43246   3.95E-10  4.16E-07  9.1112E+01
 Cell= 43246 X,Y,Z=  2.84E-03  2.74E-03  2.03E-04
 CGS: W     , SWEEP=    3, SUM0=1.44E-05, SUM=6.21E-08
 CGS: U     , SWEEP=    4, SUM0=1.53E-05, SUM=6.33E-08
 CGS: V     , SWEEP=    6, SUM0=2.44E-05, SUM=2.37E-08
 CGS: P     , SWEEP=    7, SUM0=1.13E-04, SUM=7.90E-07
ITER =  761, ICMAX  RES(MAX)  RES(SUM)    VALUE
--------------------------------------------------
 VAR =W      43301   1.15E-11  1.02E-08 -2.5066E-03
 Cell= 43301 X,Y,Z=  3.00E-03  2.18E-03  4.18E-04
 VAR =U      43610   2.54E-11  1.41E-08  2.1900E-01
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 Cell= 43610 X,Y,Z=  3.38E-03  2.25E-03  1.41E-04
 VAR =V      43274   3.01E-11  1.75E-08 -8.8192E-02
 Cell= 43274 X,Y,Z=  2.91E-03  2.48E-03  1.75E-04
 VAR =P      43246   3.90E-10  4.12E-07  9.1112E+01
 Cell= 43246 X,Y,Z=  2.84E-03  2.74E-03  2.03E-04
 CGS: W     , SWEEP=    3, SUM0=1.42E-05, SUM=6.10E-08
 CGS: U     , SWEEP=    4, SUM0=1.51E-05, SUM=6.17E-08
 CGS: V     , SWEEP=    6, SUM0=2.41E-05, SUM=2.45E-08
 CGS: P     , SWEEP=    7, SUM0=1.12E-04, SUM=7.83E-07
ITER =  762, ICMAX  RES(MAX)  RES(SUM)    VALUE
--------------------------------------------------
 VAR =W      43301   1.14E-11  1.01E-08 -2.5066E-03
 Cell= 43301 X,Y,Z=  3.00E-03  2.18E-03  4.18E-04
 VAR =U      43610   2.52E-11  1.39E-08  2.1900E-01
 Cell= 43610 X,Y,Z=  3.38E-03  2.25E-03  1.41E-04
 VAR =V      43274   2.96E-11  1.73E-08 -8.8192E-02
 Cell= 43274 X,Y,Z=  2.91E-03  2.48E-03  1.75E-04
 VAR =P      43246   3.85E-10  4.08E-07  9.1112E+01
 Cell= 43246 X,Y,Z=  2.84E-03  2.74E-03  2.03E-04
 CGS: W     , SWEEP=    3, SUM0=1.40E-05, SUM=6.00E-08
 CGS: U     , SWEEP=    4, SUM0=1.49E-05, SUM=6.00E-08
 CGS: V     , SWEEP=    6, SUM0=2.38E-05, SUM=2.55E-08
 CGS: P     , SWEEP=    7, SUM0=1.11E-04, SUM=7.76E-07
ITER =  763, ICMAX  RES(MAX)  RES(SUM)    VALUE
--------------------------------------------------
 VAR =W      43301   1.13E-11  1.00E-08 -2.5066E-03
 Cell= 43301 X,Y,Z=  3.00E-03  2.18E-03  4.18E-04
 VAR =U      43610   2.50E-11  1.38E-08  2.1900E-01
 Cell= 43610 X,Y,Z=  3.38E-03  2.25E-03  1.41E-04
 VAR =V      43274   2.91E-11  1.71E-08 -8.8192E-02
 Cell= 43274 X,Y,Z=  2.91E-03  2.48E-03  1.75E-04
 VAR =P      43246   3.80E-10  4.04E-07  9.1112E+01
 Cell= 43246 X,Y,Z=  2.84E-03  2.74E-03  2.03E-04
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Problem converged with specified criterion =   1.00E-05
  
  ============================= 
  End   of Iterative Cycle..... 
  ============================= 
 
 Exited  patch_intf_e Elapsed Time=  1.005823E+05 Delta-time=  1.005238E+05 
 Exited  patch_intf_e DBM Memory  =  1.012668E+02 MAX_DBM Memory=  1.318134E+02 
 Final Time   Elapsed Time=  1.005823E+05 Delta-time=  0.000000E+00
 Final Time   DBM Memory  =  1.012668E+02 MAX_DBM Memory=  1.318134E+02
 lap time (CPU|Wallclock) = 100523.77868652344,  101338.42432099998
 cummulative time (CPU|Wallclock) = 100523.77868652344,  101338.42432099998
 Normal Termination      
294
APPENDIX C
Post-Processing Protocol for Calculating WSS and WSSG
1) Take file .DTF output from CFD-ACEU and use either the CFD Toolkit on graft.surgery.pitt.edu or dtf2tec
executable on fusiform to obtain file.TEC (input for Tecplot)
2) FTP File.TEC to PC and open in Tecplot
3) Tools - CFD Analyzer
- Fluid Properties: 
- incompressible, density=1000, specific heat=default, viscosity=0.001
- Close
- Calculate Variables: set vector variables as U,V,W
- set vector variables as U,V,W
- Vector Variables are velocity
- choose Pressure and Not Used and select P for pressure
- under Function choose Grid I Unit Normal (vector)
- Calculate
- repeat for Grid J Unit Normal (vector) 
- repeat for Grid K Unit Normal (vector)
- Close
4) Data - Alter - Specify Equations











5) Data - Data Set Info
- determine which direction is the outer shell (J or K) for each anastomosis zone
- for these files, max = 12
6) Data - Create Zone - Subzone
- for each anastomosis zone, pick only the outer shells (1 to 6 or Mx-5 to Mx)
- double check by turning off all other meshes and just looking at outer shells (rotate about y axis)
7) Data - Create Zone - Subzone
- for each subzone, choose I=1,1 so just have 2D cross-section for each zone to check normals
8) 2D - Axis - Assign XYZ
- X = Z and Y = Y
9) Field - Vector - Vector Variable
- X = Z Grid K Unit Normal (or J)
- Y = Y Grid K Unit Normal (or J)
- Make note of what normals are pointing outward (want them all to be INWARD) and the
corresponding shell subzone number
10) Data - Delete Zone
- delete all 2D zones that had normal facing outward
11) Data - Alter - Specify Equations
- Load Equations - reverse_normals.eqn:
{X Grid J Unit Normal}=-1.0*{X Grid J Unit Normal}   : <Z=[25-26,28-30]>
{Y Grid J Unit Normal}=-1.0*{Y Grid J Unit Normal}   : <Z=[25-26,28-30]>
{Z Grid J Unit Normal}=-1.0*{Z Grid J Unit Normal}   : <Z=[25-26,28-30]>
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- Set zones accordingly (Z = #)
12) Data - Create Zone - Subzone
- recreate the 2D subzones deleted before the normal reversal process
13) Double Check that all normal are facing INWARD.
14) Data - Delete Zone
- delete all 2D zones
15) File - Write Data File
- Choose ONLY the outer shell subzones (6 for asym ellipse, 3 for circle and symm ellipse)
- Choose X,Y,Z, U,V,W, P, STRAIN, XYZ Grid I Unit Normals, XYZ Grid J Unit Normals, XYZ Grid
K Unit Normals, dudx, dudy…………dwdz 




16) FTP File.dat to graft.surgery.pitt.edu






#This gives the info for the zones for the model input to wss_calc.f
#Number of Zones
3
#Imax, Jmax, Kmax for each Zone
32      6       29
32      6       29




WSS_CALC.F: attached at the end of the protocol
18) FTP File_wss.dat to PC and open in Tecplot
19) Data - Alter - Specify Equations










20) File - Write Data File
- Choose the 5 outer shell subzones (6 for ellipse, 3 for circle)
- Choose X,Y,Z, U,V,W, P, STRAIN, XYZ Normal, XYZ Tangent 1, XYZ Tangent 2, WSS_ax,
WSS_circ, WSS_mag, WSS_ax_x, WSS_ax_y …………WSS_mag_z 










WSSG_CALC.F: attached at the end of the protocol
22) FTP File_wssg.dat to PC and open in Tecplot
23) Data - Create Zone - Subzone
- for each anastomosis zone, pick only THE outer shell (1-1 or Mx-Mx)
- double check by turning off all other meshes and just looking at outer shells (rotate about y axis)
24) Determine the IJK values and subzone numbers for the 7 regions of interest 
- proximal artery, heel, toe, distal artery, graft, floor, hood
25) Data - Create Zone - Subzone
- create subzones for each region of interest (2 for each if ellipse, 1 for each if circle)
26) Tools - CFD Analyzer - Perform Integration
- Type in only the region subzones that have J outer shells (ie 13-15,17,21-22)
- Calculate Average of Variable - WSS_ax
- Integrate Over - J Planes
- Integrate
- Save - in default directory 
- avg_wss_ax_perfdate_j.txt
- Repeat for WSS_circ, WSS_mag, WSSG_ax, WSSG_circ, WSSG_mag
- Type in only the region subzones that have K outer shells (ie 16,18-20,23-26)
- Calculate Average of Variable - WSS_ax
- Integrate Over - K Planes
- Integrate
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- Save - in default directory 
- avg_wss_ax_perfdate_k.txt
- Repeat for WSS_circ, WSS_mag, WSSG_ax, WSSG_circ, WSSG_mag
27) Parcel out wss and wssg data from .txt files into Excel file (perfdate_wss_wssg_ stain.xls) and
complete with stain data from data_summary_zeroneg_flow.xls
---------------------------------------------------------------------------------------------------------------------------------
      PROGRAM WSS_CALC
      implicit double precision(a-h,o-z)
      character*50 infile, outfile, zonefile
      parameter(nvars=26, numzones=6, numpts=100000)
      parameter(infile='input.dat')
      parameter(zonefile='zone_info.dat')
      parameter(outfile='wss_calc.dat')
      dimension q(numpts,nvars), vnormal(numpts,3)
      dimension tangent1(numpts,3), tangent2(numpts,3)
      dimension wss_ax(numpts),wss_circ(numpts),wss_mag(numpts)
      dimension imax(numzones),jmax(numzones),kmax(numzones)
C     This program calculate the wall shear stress (WSS) from the unit normal
C     vectors output from Tecplot. These are the inward-facing normals so
C     they are inverted to get the outward-facing normals. Tecplot file
C     includes information for only the outer shell of the anastomosis and
C     the direction normal used (JorK) depends on the grid.
C     *****************WSS units are dynes/cm2**********************
C     The order of the 26 variables from the Tecplot input file are:
C     X,Y,Z,U,V,W,P,STRAIN,X-Inorm,Y-Inorm,Z-Inorm,
C     X-Jnorm,Y-Jnorm,Z-Jnorm,X-Knorm,Y-Knorm,Z-Knorm,
C     dudx,dudy,dudz,dvdx,dvdy,dvdz,dwdx,dwdy,dwdz
C     The first tangential vector follows the I grid direction and is 
C     projected onto the cell surface and normalized.
C     The second tangential vector is the vector perpendicular to the
C     normal and 1st tangential vector. 
C     These tangential vectors are used to calculate WSS from the 
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C     stress tensor.
      open(99,file=zonefile)
      read(99,*)
      read(99,*)
      read(99,*) nzones
      if(nzones.gt.numzones) then
         write(*,*) "Number of Zones is greater than 6.
     *        Change numzones dimension in wss_calc.f and recompile"
         STOP
      endif
      read(99,*)
      npts=0
      do i=1,nzones
         read(99,*) imax(i),jmax(i),kmax(i)
         write(*,*) i,imax(i),jmax(i),kmax(i)
         npts=npts+imax(i)*jmax(i)*kmax(i)
      enddo
      write(*,*) npts
      read(99,*)
      read(99,*) visc
      write(*,*) visc
      if(npts.gt.numpts) then
         write(*,*) "Number of Points ",npts," is greater than 100,000.
     *        Change numpts dimension in wss_calc.f and recompile"
         STOP
      endif
      close(99)
      
      open(99,file=infile)
      do i=1,nvars+1
       read(99,*)
      enddo
      ntot1=0
      ntot2=0
      do i=1,nzones
       nblk=imax(i)*jmax(i)*kmax(i)
       read(99,*)
       read(99,*)
       read(99,*)
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       ntot1=ntot2+1
       ntot2=ntot2+nblk
       do j=ntot1,ntot2
        read(99,*) (q(j,n),n=1,nvars)
       enddo
      enddo
      close(99)
C     Reorder normals based on grid (J dir used for prox art and graft, 
C     K dir used for distal art) and muli by (-1,-1,-1) to get outward
C     normals.
C     Calculate the direction for the 1st tangent (normal(i)-normal(i+1))
C     1st tangent info sorted WRT # I-grid points (prox art and graft=40,
C     dist art = 100)
      ntot1=0
      ntot2=0
      do i=1,nzones
         nblk=imax(i)*jmax(i)*kmax(i)
         ntot1=ntot2+1
         ntot2=ntot2+nblk
         do j=ntot1,ntot2
            if(jmax(i).eq.6) then
               vnormal(j,1)=-1.0d0*q(j,12)
               vnormal(j,2)=-1.0d0*q(j,13)
               vnormal(j,3)=-1.0d0*q(j,14)
C               write(*,*),"Using J normals",i,j
            elseif(kmax(i).eq.6) then
               vnormal(j,1)=-1.0d0*q(j,15)
               vnormal(j,2)=-1.0d0*q(j,16)
               vnormal(j,3)=-1.0d0*q(j,17)
C               write(*,*),"Using K normals",i,j
            else
               write(*,*) "Not know which direction to use (J,K) for normal.
     *              Rewrite data input file so that only have the outer
     *              shell (J or K=1)"
               STOP
            endif
         enddo
         
         do j=ntot1,ntot2
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            if(mod(j-ntot1+1,imax(i)).ne.0) then
               tangent1(j,1)=q(j+1,1)-q(j,1)
               tangent1(j,2)=q(j+1,2)-q(j,2)
               tangent1(j,3)=q(j+1,3)-q(j,3)
            else
               tangent1(j,1)=tangent1(j-1,1)
               tangent1(j,2)=tangent1(j-1,2)
               tangent1(j,3)=tangent1(j-1,3)
C               write(*,*) "End of I grid",i,j
            endif
         enddo
      enddo
      
C     Project current tangent1 (along grid direction) onto the cell surface
C     (t1=tgrid-(tgrid*dot*normal)normal)
C     and then normalize it to get final tangent1
      do j=1,npts
         tdotn=tangent1(j,1)*vnormal(j,1)+tangent1(j,2)*
     *        vnormal(j,2)+tangent1(j,3)*vnormal(j,3)
         do k=1,3
            tangent1(j,k)=tangent1(j,k)-tdotn*vnormal(j,k)
         enddo
         tanmag=sqrt(tangent1(j,1)**2.0d0+tangent1(j,2)**2.0d0+
     *        tangent1(j,3)**2.0d0)
         tangent1(j,1)=tangent1(j,1)/tanmag
         tangent1(j,2)=tangent1(j,2)/tanmag
         tangent1(j,3)=tangent1(j,3)/tanmag
      enddo
C     Check to be sure tangent1 is perpendicular to normal
      do j=1,npts
         tdotn=tangent1(j,1)*vnormal(j,1)+tangent1(j,2)*
     *        vnormal(j,2)+tangent1(j,3)*vnormal(j,3)
         if(tdotn.gt.0.0000000001d0) then
            write(*,*) "OOPS - Tangent1 is not perpendicular to", 
     *           "the normal at point",j
         write(*,*) j,tangent1(j,1),vnormal(j,1),tangent1(j,2),
     *        vnormal(j,2),tangent1(j,3),vnormal(j,3),tdotn
         endif
      enddo
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C     Calculate 2nd tangent by crossing the normal with tangent1
      do j=1,npts
         tangent2(j,1)=vnormal(j,2)*tangent1(j,3)-
     *        vnormal(j,3)*tangent1(j,2)
         tangent2(j,2)=-1.0d0*vnormal(j,1)*tangent1(j,3)+
     *        vnormal(j,3)*tangent1(j,1)
         tangent2(j,3)=vnormal(j,1)*tangent1(j,2)-
     *        vnormal(j,2)*tangent1(j,1)
         tanmag=sqrt(tangent2(j,1)**2.0d0+tangent2(j,2)**2.0d0+
     *        tangent2(j,3)**2.0d0)
         tangent2(j,1)=tangent2(j,1)/tanmag
         tangent2(j,2)=tangent2(j,2)/tanmag
         tangent2(j,3)=tangent2(j,3)/tanmag
      enddo         
C     Check to be sure tangent2 is perpendicular to normal
      do j=1,npts
         tdotn=tangent2(j,1)*vnormal(j,1)+tangent2(j,2)*
     *        vnormal(j,2)+tangent2(j,3)*vnormal(j,3)
         if(tdotn.gt.0.0000000001d0) then
            write(*,*) "OOPS - Tangent2 is not perpendicular to",
     *           "the normal at point",j
         write(*,*) j,tangent2(j,1),vnormal(j,1),tangent2(j,2),
     *        vnormal(j,2),tangent2(j,3),vnormal(j,3),tdotn
         endif
      enddo
C     Check to be sure tangent1 is perpendicular to tangent2
      do j=1,npts
         tdotn=tangent1(j,1)*tangent2(j,1)+tangent1(j,2)*
     *        tangent2(j,2)+tangent1(j,3)*tangent2(j,3)
         if(tdotn.gt.0.0000000001d0) then
            write(*,*) "OOPS - Tangent1 is not perpendicular to",
     *           "the tangent2 at point",j
         write(*,*) j,tangent1(j,1),tangent2(j,1),tangent1(j,2),
     *        tangent2(j,2),tangent1(j,3),tangent2(j,3),tdotn
         endif
      enddo
304
C     Calculate the stress tensor (s11-s33) and then dot with the 
C     normal to get the stress vector. Then dot this with tangent1
C     to get "axial" wss or dot with the tangent2 to get 
C     "circumferential" and calculate magnitude from these squared
      do j=1,npts
         dudx=q(j,18)
         dudy=q(j,19)
         dudz=q(j,20)
         dvdx=q(j,21)
         dvdy=q(j,22)
         dvdz=q(j,23)
         dwdx=q(j,24)
         dwdy=q(j,25)
         dwdz=q(j,26)
         p=q(j,7)
         sxx=-p+2.0d0*visc*dudx
         sxy=visc*(dudy+dvdx)
         sxz=visc*(dudz+dwdx)
         syx=sxy
         syy=-p+2.0d0*visc*dvdy
         syz=visc*(dvdz+dwdy)
         szx=sxz
         szy=syz
         szz=-p+2.0d0*visc*dwdz
         stressx=sxx*vnormal(j,1)+sxy*vnormal(j,2)+sxz*vnormal(j,3)
         stressy=syx*vnormal(j,1)+syy*vnormal(j,2)+syz*vnormal(j,3)
         stressz=szx*vnormal(j,1)+szy*vnormal(j,2)+szz*vnormal(j,3)
C         write(*,*) j, stressx,stressy,stressz
         wss_ax(j)=-10.0d0*(tangent1(j,1)*stressx+tangent1(j,2)*
     *        stressy+tangent1(j,3)*stressz)
         wss_circ(j)=10.0d0*(tangent2(j,1)*stressx+tangent2(j,2)*
     *        stressy+tangent2(j,3)*stressz)
         wss_mag(j)=sqrt(wss_ax(j)**2.0d0+wss_circ(j)**2.0d0)
C         write(*,*),j,wss_ax(j),wss_circ(j), wss_mag(j)
      enddo
      open(99,file=outfile)
      write(99,*)'TITLE = ""'
      write(99,*)'VARIABLES = "X"'
      write(99,*)'"Y"'
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      write(99,*)'"Z"'
      write(99,*)'"U"'
      write(99,*)'"V"'
      write(99,*)'"W"'
      write(99,*)'"P"'
      write(99,*)'"STRAIN"'
      write(99,*)'"X Normal"'
      write(99,*)'"Y Normal"'
      write(99,*)'"Z Normal"'
      write(99,*)'"X Tangent 1"'
      write(99,*)'"Y Tangent 1"'
      write(99,*)'"Z Tangent 1"'
      write(99,*)'"X Tangent 2"'
      write(99,*)'"Y Tangent 2"'
      write(99,*)'"Z Tangent 2"'
      write(99,*)'"WSS_ax"'
      write(99,*)'"WSS_circ"'
      write(99,*)'"WSS_mag"'
C     *******************
C     OUTPUT TECPLOT FILE
C     *******************
      itot1=0
      itot2=0
      do i=1,nzones
         write(99,*)'ZONE T="ZONE', i, '"' 
         write(99,*)'I=', imax(i), ',J=',jmax(i), ',K=',kmax(i),
     *        ',F=POINT'
         itot1=itot2+1
         itot2=itot2+imax(i)*jmax(i)*kmax(i)
         do j=itot1,itot2
            write(99,*)(q(j,n),n=1,8),vnormal(j,1),vnormal(j,2),
     *           vnormal(j,3),tangent1(j,1),tangent1(j,2),tangent1(j,3)
     *           ,tangent2(j,1),tangent2(j,2),tangent2(j,3)
     *           ,wss_ax(j),wss_circ(j),wss_mag(j)
         enddo
      enddo
      close(99)
      end
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--------------------------------------------------------------------------------------------------------------------------------
      PROGRAM WSSG_CALC
      implicit double precision(a-h,o-z)
      character*50 infile, outfile, zonefile
      parameter(nvars=26, numzones=6, numpts=100000)
      parameter(infile='input.dat')
      parameter(zonefile='zone_info.dat')
      parameter(outfile='wss_calc.dat')
      dimension q(numpts,nvars), vnormal(numpts,3)
      dimension tangent1(numpts,3), tangent2(numpts,3)
      dimension wss_ax(numpts),wss_circ(numpts),wss_mag(numpts)
      dimension imax(numzones),jmax(numzones),kmax(numzones)
C     This program calculate the wall shear stress (WSS) from the unit normal
C     vectors output from Tecplot. These are the inward-facing normals so
C     they are inverted to get the outward-facing normals. Tecplot file
C     includes information for only the outer shell of the anastomosis and
C     the direction normal used (JorK) depends on the grid.
C     *****************WSS units are dynes/cm2**********************
C     The order of the 26 variables from the Tecplot input file are:
C     X,Y,Z,U,V,W,P,STRAIN,X-Inorm,Y-Inorm,Z-Inorm,
C     X-Jnorm,Y-Jnorm,Z-Jnorm,X-Knorm,Y-Knorm,Z-Knorm,
C     dudx,dudy,dudz,dvdx,dvdy,dvdz,dwdx,dwdy,dwdz
C     The first tangential vector follows the I grid direction and is 
C     projected onto the cell surface and normalized.
C     The second tangential vector is the vector perpendicular to the
C     normal and 1st tangential vector. 
C     These tangential vectors are used to calculate WSS from the 
C     stress tensor.
      open(99,file=zonefile)
      read(99,*)
      read(99,*)
      read(99,*) nzones
      if(nzones.gt.numzones) then
         write(*,*) "Number of Zones is greater than 6.
     *        Change numzones dimension in wss_calc.f and recompile"
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         STOP
      endif
      read(99,*)
      npts=0
      do i=1,nzones
         read(99,*) imax(i),jmax(i),kmax(i)
         write(*,*) i,imax(i),jmax(i),kmax(i)
         npts=npts+imax(i)*jmax(i)*kmax(i)
      enddo
      write(*,*) npts
      read(99,*)
      read(99,*) visc
      write(*,*) visc
      if(npts.gt.numpts) then
         write(*,*) "Number of Points ",npts," is greater than 100,000.
     *        Change numpts dimension in wss_calc.f and recompile"
         STOP
      endif
      close(99)
      
      open(99,file=infile)
      do i=1,nvars+1
       read(99,*)
      enddo
      ntot1=0
      ntot2=0
      do i=1,nzones
       nblk=imax(i)*jmax(i)*kmax(i)
       read(99,*)
       read(99,*)
       read(99,*)
       ntot1=ntot2+1
       ntot2=ntot2+nblk
       do j=ntot1,ntot2
        read(99,*) (q(j,n),n=1,nvars)
       enddo
      enddo
      close(99)
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C     Reorder normals based on grid (J dir used for prox art and graft, 
C     K dir used for distal art) and muli by (-1,-1,-1) to get outward
C     normals.
C     Calculate the direction for the 1st tangent (normal(i)-normal(i+1))
C     1st tangent info sorted WRT # I-grid points (prox art and graft=40,
C     dist art = 100)
      ntot1=0
      ntot2=0
      do i=1,nzones
         nblk=imax(i)*jmax(i)*kmax(i)
         ntot1=ntot2+1
         ntot2=ntot2+nblk
         do j=ntot1,ntot2
            if(jmax(i).eq.6) then
               vnormal(j,1)=-1.0d0*q(j,12)
               vnormal(j,2)=-1.0d0*q(j,13)
               vnormal(j,3)=-1.0d0*q(j,14)
C               write(*,*),"Using J normals",i,j
            elseif(kmax(i).eq.6) then
               vnormal(j,1)=-1.0d0*q(j,15)
               vnormal(j,2)=-1.0d0*q(j,16)
               vnormal(j,3)=-1.0d0*q(j,17)
C               write(*,*),"Using K normals",i,j
            else
               write(*,*) "Not know which direction to use (J,K) for normal.
     *              Rewrite data input file so that only have the outer
     *              shell (J or K=1)"
               STOP
            endif
         enddo
         
         do j=ntot1,ntot2
            if(mod(j-ntot1+1,imax(i)).ne.0) then
               tangent1(j,1)=q(j+1,1)-q(j,1)
               tangent1(j,2)=q(j+1,2)-q(j,2)
               tangent1(j,3)=q(j+1,3)-q(j,3)
            else
               tangent1(j,1)=tangent1(j-1,1)
               tangent1(j,2)=tangent1(j-1,2)
               tangent1(j,3)=tangent1(j-1,3)
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C               write(*,*) "End of I grid",i,j
            endif
         enddo
      enddo
      
C     Project current tangent1 (along grid direction) onto the cell surface
C     (t1=tgrid-(tgrid*dot*normal)normal)
C     and then normalize it to get final tangent1
      do j=1,npts
         tdotn=tangent1(j,1)*vnormal(j,1)+tangent1(j,2)*
     *        vnormal(j,2)+tangent1(j,3)*vnormal(j,3)
         do k=1,3
            tangent1(j,k)=tangent1(j,k)-tdotn*vnormal(j,k)
         enddo
         tanmag=sqrt(tangent1(j,1)**2.0d0+tangent1(j,2)**2.0d0+
     *        tangent1(j,3)**2.0d0)
         tangent1(j,1)=tangent1(j,1)/tanmag
         tangent1(j,2)=tangent1(j,2)/tanmag
         tangent1(j,3)=tangent1(j,3)/tanmag
      enddo
C     Check to be sure tangent1 is perpendicular to normal
      do j=1,npts
         tdotn=tangent1(j,1)*vnormal(j,1)+tangent1(j,2)*
     *        vnormal(j,2)+tangent1(j,3)*vnormal(j,3)
         if(tdotn.gt.0.0000000001d0) then
            write(*,*) "OOPS - Tangent1 is not perpendicular to", 
     *           "the normal at point",j
         write(*,*) j,tangent1(j,1),vnormal(j,1),tangent1(j,2),
     *        vnormal(j,2),tangent1(j,3),vnormal(j,3),tdotn
         endif
      enddo
C     Calculate 2nd tangent by crossing the normal with tangent1
      do j=1,npts
         tangent2(j,1)=vnormal(j,2)*tangent1(j,3)-
     *        vnormal(j,3)*tangent1(j,2)
         tangent2(j,2)=-1.0d0*vnormal(j,1)*tangent1(j,3)+
310
     *        vnormal(j,3)*tangent1(j,1)
         tangent2(j,3)=vnormal(j,1)*tangent1(j,2)-
     *        vnormal(j,2)*tangent1(j,1)
         tanmag=sqrt(tangent2(j,1)**2.0d0+tangent2(j,2)**2.0d0+
     *        tangent2(j,3)**2.0d0)
         tangent2(j,1)=tangent2(j,1)/tanmag
         tangent2(j,2)=tangent2(j,2)/tanmag
         tangent2(j,3)=tangent2(j,3)/tanmag
      enddo         
C     Check to be sure tangent2 is perpendicular to normal
      do j=1,npts
         tdotn=tangent2(j,1)*vnormal(j,1)+tangent2(j,2)*
     *        vnormal(j,2)+tangent2(j,3)*vnormal(j,3)
         if(tdotn.gt.0.0000000001d0) then
            write(*,*) "OOPS - Tangent2 is not perpendicular to",
     *           "the normal at point",j
         write(*,*) j,tangent2(j,1),vnormal(j,1),tangent2(j,2),
     *        vnormal(j,2),tangent2(j,3),vnormal(j,3),tdotn
         endif
      enddo
C     Check to be sure tangent1 is perpendicular to tangent2
      do j=1,npts
         tdotn=tangent1(j,1)*tangent2(j,1)+tangent1(j,2)*
     *        tangent2(j,2)+tangent1(j,3)*tangent2(j,3)
         if(tdotn.gt.0.0000000001d0) then
            write(*,*) "OOPS - Tangent1 is not perpendicular to",
     *           "the tangent2 at point",j
         write(*,*) j,tangent1(j,1),tangent2(j,1),tangent1(j,2),
     *        tangent2(j,2),tangent1(j,3),tangent2(j,3),tdotn
         endif
      enddo
C     Calculate the stress tensor (s11-s33) and then dot with the 
C     normal to get the stress vector. Then dot this with tangent1
C     to get "axial" wss or dot with the tangent2 to get 
C     "circumferential" and calculate magnitude from these squared
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      do j=1,npts
         dudx=q(j,18)
         dudy=q(j,19)
         dudz=q(j,20)
         dvdx=q(j,21)
         dvdy=q(j,22)
         dvdz=q(j,23)
         dwdx=q(j,24)
         dwdy=q(j,25)
         dwdz=q(j,26)
         p=q(j,7)
         sxx=-p+2.0d0*visc*dudx
         sxy=visc*(dudy+dvdx)
         sxz=visc*(dudz+dwdx)
         syx=sxy
         syy=-p+2.0d0*visc*dvdy
         syz=visc*(dvdz+dwdy)
         szx=sxz
         szy=syz
         szz=-p+2.0d0*visc*dwdz
         stressx=sxx*vnormal(j,1)+sxy*vnormal(j,2)+sxz*vnormal(j,3)
         stressy=syx*vnormal(j,1)+syy*vnormal(j,2)+syz*vnormal(j,3)
         stressz=szx*vnormal(j,1)+szy*vnormal(j,2)+szz*vnormal(j,3)
C         write(*,*) j, stressx,stressy,stressz
         wss_ax(j)=-10.0d0*(tangent1(j,1)*stressx+tangent1(j,2)*
     *        stressy+tangent1(j,3)*stressz)
         wss_circ(j)=10.0d0*(tangent2(j,1)*stressx+tangent2(j,2)*
     *        stressy+tangent2(j,3)*stressz)
         wss_mag(j)=sqrt(wss_ax(j)**2.0d0+wss_circ(j)**2.0d0)
C         write(*,*),j,wss_ax(j),wss_circ(j), wss_mag(j)
      enddo
      open(99,file=outfile)
      write(99,*)'TITLE = ""'
      write(99,*)'VARIABLES = "X"'
      write(99,*)'"Y"'
      write(99,*)'"Z"'
      write(99,*)'"U"'
      write(99,*)'"V"'
      write(99,*)'"W"'
      write(99,*)'"P"'
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      write(99,*)'"STRAIN"'
      write(99,*)'"X Normal"'
      write(99,*)'"Y Normal"'
      write(99,*)'"Z Normal"'
      write(99,*)'"X Tangent 1"'
      write(99,*)'"Y Tangent 1"'
      write(99,*)'"Z Tangent 1"'
      write(99,*)'"X Tangent 2"'
      write(99,*)'"Y Tangent 2"'
      write(99,*)'"Z Tangent 2"'
      write(99,*)'"WSS_ax"'
      write(99,*)'"WSS_circ"'
      write(99,*)'"WSS_mag"'
C     *******************
C     OUTPUT TECPLOT FILE
C     *******************
      itot1=0
      itot2=0
      do i=1,nzones
         write(99,*)'ZONE T="ZONE', i, '"' 
         write(99,*)'I=', imax(i), ',J=',jmax(i), ',K=',kmax(i),
     *        ',F=POINT'
         itot1=itot2+1
         itot2=itot2+imax(i)*jmax(i)*kmax(i)
         do j=itot1,itot2
            write(99,*)(q(j,n),n=1,8),vnormal(j,1),vnormal(j,2),
     *           vnormal(j,3),tangent1(j,1),tangent1(j,2),tangent1(j,3)
     *           ,tangent2(j,1),tangent2(j,2),tangent2(j,3)
     *           ,wss_ax(j),wss_circ(j),wss_mag(j)
         enddo
      enddo
      close(99)
      end
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Appendix D.1 The Mean Normalized Staining Indices ROI quantified by two separate users for one
experiment and compared to determine the error associated with the staining quantification.
APPENDIX D
To determine the amount of error associated with the quantification of the staining, the Mean
Normalized Staining Indices ROI for one experiment quantified by one user were compared to the same data
quantified by a second user.  The results are shown in the following table, Appendix D.1.  The percent
difference averaged over all regions of interest ranged from approximately 11 - 52 %, depending on the
biologic parameter being quantified.  The average value was 29%.
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Appendix D.2 The values for the major and minor axes for all ellipses for one ETS model measured by
two separate users to determine the error associated with the lumen digitization.
To determine the amount of error associated with the ellipse digitization, the major and minor axes for
all ellipses used to develop the CFD model for one ETS anastomosis measured by one user were compared
to the same data measured by a second user.  The results are shown in the following table, Appendix D.2.
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